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Black Cohosh (Actaea racemosa) is one of the highest selling medicinal plants, ranking as the sixth 
best seller in the US in 2015 (Smith et al., 2016).  However, this popularity has been tarnished by 
claims of hepatotoxicity. The investigation of these reports has determined that implicated products 
did not contain Black Cohosh plant material.  Other reports were shown to be incomplete or had 
other factors contributing. This has led to the suspicion that cases of adverse reactions may in fact be 
linked to cases of substitution or adulterations with Asian species of Actaea, rather than to A. 
racemosa. (Jordan et al., 2010). This shows the need for authentication of Black Cohosh products.  
In this study various DNA based authentication methods were developed. The first, PlantID is capable 
of discriminating between Actaea racemosa and four potential adulterant species; Actaea cimicifuga, 
Actaea cordifolia, Actaea podocarpa and Caulophyllum thalictroides, in a single PCR reaction. The 
resulting fragments are scrutinized using gel electrophoresis. Other platforms of analysis were 
trialled with little success. The second was a qPCR based method. These assays are competent in 
detecting A. racemosa, A. cimicifuga and A. dahurica species and are compared to a generic primer 
capable of amplification of ten Actaea species. This enables the user to detect specific species in 
comparison to how much Actaea species are present as a whole. This assay was extensively tested on 
many materials and products available in the UK and the USA. Out of 34 products assessed it was 
possible to extract DNA from 32. From the UK market it was found that five products contained 
undeclared species. From the US market it was found that six products contained undeclared species. 
All of the THR registered products were found to contain only the authentic species Actaea 
racemosa. This was a reassuring result from the analysis and adds further value to the scheme of 
THR.  
Sequence data from GenBank was used to assist in assigning species to sequenced DNA samples. The 
data contained on GenBank was scrutinised using various bioinformatics tools. Sequences were 





visually which sequence entries were reliable to use based upon grouping. This analysis showed that 
the nuclear internal transcribed spacer (nrITS) was an ideal barcoding region and that maturase K 
(MatK) was a poor choice for Actaea species.  
To address the issue of hepatotoxicity claims, cultured human hepatocyte derived cells were treated 
with 60% ethanol extracts of Actaea racemosa and Asian Actaea. A qPCR array was utilised to assess 
84 genes associated with hepatotoxicity across various concentrations of extract. The collective array 
output gave a plethora of data which was analysed using bespoke online software from the 
manufacturer. Stringent quality controls were included on the arrays which gave confidence of 
results. There were small changes noted for Actaea racemosa and some activity for the Asian Actaea 
treated cells was also seen.  An LDH and MTT assay were used to assess cell viability and toxicity in 
two human hepatocyte derived cell lines. Actaea racemosa showed no significant effects whereas 
the Asian Actaea extract showed a notable decrease in cell viability and significant release of LDH 
indicating toxicity. The Asian Actaea material used to manufacture extracts was of questionable 
species origin but determined to be either A. dahurica or A. cimicifuga. The results from these 
experiments were unfortunately not as conclusive as hoped, but did show some evidence of a more 
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1.1 Medicinal Plants 
The use of medicinal plants can be traced back thousands of years. Evidence has been found in 
Ancient Egyptian papyri, e.g. Ebers papyrus (c.1550 BC) and in texts detailing the use of medicinal 
plants dating back as far as 400BC in the Corpus Hipocraticum authored by Hippocrates (460-370 
BC). The next earliest text is from 300BC with Theophrastus of Eresos authoring Enquiry into Plants 
(371-287 BC).  Better known ancient texts include Dioscorides’ De Materia Medica (40-90 BC) and 
Galens’ (129-210 AD) De Simplicium Medicamentorum Facultatibus Libr XI (1561) (Leonti and 
Verpoorte, 2017). Medicinal plant usage has been found to date back centuries all over the globe 
including China, India and Tibet (Schwabl and Vennos, 2015). Today this inherited knowledge is 
known as Traditional herbal medicine (THM), and includes systems such as Ayurvedic and Traditional 
Chinese Medicine. Over time, the use of some systems of THM has declined due in part to the 
introduction of preventative medicine such as vaccines, by the use of antibiotics to treat infectious 
disease and the development of organic chemistry which has allowed synthesis of new effective 
medicines. Natural medicines are however still heavily relied upon in developing countries with up 
to 80% of the world still using them for their primary health care needs. The cost or access to 
modern medicine and distrust are the main factors (Mishra et al., 2016). With advances in 
technology and understanding there is the potential to provide evidence of the efficacy of these 
medicinal plants and due to this their use is on the rise again (Leonti and Verpoorte, 2017). However, 
with the increased use of THM comes the increased need for these products to be regulated, to 
ensure that safe products are on the market. In the UK and Europe, as per the Traditional Herbal 
Medicinal Product Directive (Directive 2004/24/EC), herbal medicines are regulated by Traditional 
Herbal Registration (THR).  Registration does not prove that a herbal medicine has efficacy but gives 





appropriate information. So although efficacy is not proven with clinical data, it is implied with a 
history of use. This was lacking prior to the registration scheme in the UK. This registration arose to 
promote harmonisation of product quality in the UK with other countries of the European Union and 
to address safety concerns. In the US, herbal medicines are regulated as Dietary supplements, by the 
FDA as part of the Dietary Supplement Health and Education Act of 1994 (DSHEA). 
Pharmacovigilance is the assessment, understanding, detection and prevention of adverse effects or 
associated problems of any given drug. Pharmocovigilance of herbal medicines is and remains a 
challenging area due to several factors. When demand of herbal drugs exceeds supply, the risk of 
adulteration or substitution significantly increases. The danger in these cases is that the authentic 
species is replaced with one that has a different effect or no efficacy for the intended use. The 
replacement or adulterant species could also be harmful to the recipient such as the case with 
Stephania based medicines adulterated with Aristolochia which has found to be nephrotoxic and 
even carcinogenic (Tankeu et al., 2016). In TCM the plants have very similar names with Staphania 
being called Han Fang Ji and Aristolochia being called Guang Fang Ji. Registered products must be 
produced with authentic species and be free from heavy metals and other undeclared 
pharmaceutical agents. They must also not contain any species from the ‘Banned and Restricted 
Herbal Ingredients’ list provided by the Medicines Healthcare Regulatory Agency (MHRA). 
Standardisation between products is also an issue which registration will help to overcome (Barber, 
2014). 
In Europe, the use of plants for human medicinal purposes is regulated by the European Union (EU) 
with the Traditional Herbal Medicinal Product Directive (THMPD) (Directive 2004/24/EC). This 
requires evidence of a plant’s traditional use for 30 years within the EU. For a plant medicine from 
outside of the EU, it has to be shown to have been used within the EU for 15 years and 15 years 





The THMPD also has a strict definition for a medicinal herbal product, which avoids confusion with 
‘food supplements’. Food supplements can be derived from herbal products and have a beneficial 
effect on health but do not actually treat human disease as outlined in the definition below. 
A food supplement is defined as; 
“Any food the purpose of which is to supplement the normal diet and which –  
 
a) Is a concentrated source of a vitamin or mineral or other substance with a nutritional or 
physiological effect, alone or in combination; and  
 
b) Is sold in dose form” 
A medicinal herbal product is defined as;  
 “A product presented for treating or preventing disease, or which may be administered with a view 
to restoring, correcting or modifying physiological function in humans, falls within the definition of a 
medicinal product and is subject to the requirements of the Medicines Directive”. 
The directive came into force in 2004. New products have to comply immediately and existing 
products had until May 2011 to be registered. The process of registration, which shows compliance 
with the directive, is both expensive and time consuming. It is hoped that the THMD will improve the 
quality of products on the market (Vlietinck et al., 2009). 
1.2 The British Pharmacopoeia (BP) and the European Pharmacopoeia (Ph. 
Eur.)  
The creation of a Pharmacopoeia in the UK dates back to 1618 with the London pharmacopoeia. This 
text was published by the Royal College of Physicians in Latin, the then common language in science, 
as it was aimed for use by physicians and apothecaries and not the common (uneducated) man. The 
text was proclaimed by King James I to be solely used by apothecaries during the preparation of 
medicinal products. The Edinburgh Pharmacopoeia was first published in 1699 by the Royal College 





first Dublin Pharmacopoeia was produced. The Medical Act 1858 put in place the production of the 
British Pharmacopoeia which would supersede the London, Dublin and Edinburgh Pharmacopoeia. 
This was a vastly difficult task and took considerable time; the British Pharmacopoeia was first 
published in 1864. The text was not popular and was criticised heavily due to its many imperfections. 
(Cartwright, 2014).  
Over the years further editions were published with the publication still causing mass dissatisfaction 
amongst the professions. In 1929 a new commission was formed chaired by of Arthur Beddard, a 
consulting physician. The committee was taken in a new direction with regular meetings and the 
assistance of six sub-committees. The committee appointed Charles Hampshire as secretary, an 
extremely educated individual who at the time was the chief pharmacist at the University College 
Hospital with a degree in chemistry and qualified in medicine. The development of the next edition 
of the pharmacopoeia was supported by The Pharmaceutical Society who set up a laboratory 
dedicated to work on the pharmacopoeia. The next edition was published in 1932 and heralded as 
‘the Chemists’ Bible’. New editions were published regularly. In 1968, following the disaster of the 
drug thalidomide, the copyright of the British Pharmacopoeia was transferred to the crown and the 
commission staff became civil servants of the Department of Health. Thalidomide was a drug that 
first went on sale in Germany as a sedative. It went on to be sold in 46 countries which resulted in 
the deformity of 10,000 babies. This disaster was central to shaping the drug regulation system 
(Rago, 2008). From then on, new editions were published every five years with Addenda regularly 
released in response to the fast advances of drug development and analytical chemistry. This 
continued until 1990 when Robin Hutton was appointed secretary and introduced yearly editions of 
the publication. He also introduced a CD ROM of the text, a first for any pharmacopoeia. Today the 
committee also provides expertise to the European Pharmacopoeia ensuring harmonisation 





The creation of the European Pharmacopoeia began in 1964 when Belgium, Germany, France, 
Luxembourg, Italy, The Netherlands and the UK signed a convention drawn up by the Council of 
Europe. One of the aims of the Council of Europe was to promote the standard of living for the 
people of the countries involved, and another was to promote unity between members. With this in 
mind it was decided that an elaboration of a European Pharmacopoeia was to be made, and for the 
monographs included to become official standards for pharmaceuticals and raw medicinal products 
within the member countries (Council of Europe, 1964). The UK continued to use and develop the 
British Pharmacopoeia incorporating the European Pharmacopoeia where applicable.  
In 1989 a Protocol to the Convention was signed which agreed approval by the members and hence 
the people of these countries (Council of Europe, 1989). This agreement entered into force in 1992. 
Today it is developed by the European Directorate for the Quality of Medicines and Healthcare 
(EDQM), and its mission statement is still true to that of the original Convention; 
“The mission of the European Pharmacopoeia is to: 
 promote public health by the provision of recognized common standards for use by 
healthcare professionals and others concerned with the quality of medicines, 
 facilitate the free movement of medicinal products in Europe, 
 ensure the quality of medicinal products and their components imported into or exported 
from Europe, 
 design European Pharmacopoeia monographs and other texts to be appropriate to the needs 
of regulatory authorities, those engaged in the quality control of medicinal products and 






There are 37 Members of the Ph. Eur. These include the European Union, the EU member states and 
European Free Trade Association countries. There are 30 observers including the World Health 
Organization and The Taiwan Food and Drug Administration (TFDA) of the Ministry of Health and 
Welfare. The observers are made up of European countries and non-European countries. The 
Members benefit from being able to participate in decision making regarding technical content 
whereas Observers can only view the material and participate in the scientific work involved in its 
development. A full list of Members and Observers can be found below in Table 1. 
Table 1: A full list of members and observers of the European Pharmacopoeia (Correct as of August 2017) 
Members 
The European Union  
EU Member States Austria, Belgium, Denmark, Finland, France, 
Germany, Greece, Ireland, Italy, Luxembourg, 
The Netherlands, Portugal, Spain, Sweden and 
The United Kingdom, Croatia, Turkey, Ukraine, 
former Yugoslav Republic of Macedonia, Cyprus, 
The Czech Republic, Estonia, Hungary, Latvia, 
Lithuania, Malta, Poland, The Slovak Republic, 
Slovenia, Bulgaria, Bosnia and Herzegovina, 
Serbia and Montenegro Romania. 
European Free Trade Association Countries  Iceland, Norway and Switzerland. 
Observers 
The World Health Organization  
The Taiwan Food and Drug Administration 
(TFDA) of the Ministry of Health and Welfare 
 
European Countries Azerbaijan , Albania, Armenia, Republic of 
Belarus, Georgia, Kazakhstan, Moldova, and The 
Russian Federation 
Non-European Countries Algeria, Guinea, Argentina, Australia, Brazil, 
Canada, China, Israel, India, Republic of Korea, 
Kazakhstan, Madagascar, Malaysia, Morocco, 
Senegal, Singapore, South Africa, Syria, Tunisia 
and The United States 
 
Within the EDQM, two working bodies develop the Ph. Eur. The European Pharmacopoeia 
Commission is comprised of scientists who prepare the monographs. The Public Health Committee 
of the Council of Europe deals with other administrative aspects of the monographs but does not 






The BP and the Ph. Eur consist of a vast number of monographs. The monographs focused on in this 
work are the herbal drug, and herbal drug preparation monographs. A monograph is a collection of 
information about a pharmaceutical which includes standardised methodology for identification, 
quantification and tests for quality purposes. The monograph begins with the common name of the 
pharmaceutical, and in the case of herbal drug and herbal drug preparations there may or may not 
be an English or Latin name included. There is usually a first and second identification. The second 
identification is usually a simplified version of the first identification but it may contain tests that are 
also listed in the first identification. This is in the case where a pharmacist may be obliged to test a 
product but may not have the necessary equipment to carry it out. Macroscopic characteristics are 
listed for a clear identification, and microscopic characteristics (in the case of a powdered product) 
are included also. Sometimes diagrams are also incorporated where necessary. Identification 
techniques may also be used as quality tests or quantification tests. The main method used for 
identification is Thin Layer Chromatography (TLC), but may be another technique such as gas 
chromatography (GC) or liquid chromatography (LC) (EDQM, 2017b). The monograph also lists a 
number of tests for quality purposes. This is outlined in Table 2; 
Table 2: A list of typical quality tests included in the Herbal monographs of the European Pharmacopoeia 
Test Application When it is used 
Total Ash Carried out on powdered drug Always, unless justified 
Ash insoluble in hydrochloric acid 
Detects unacceptable levels of 
certain minerals 
Depends upon the nature of the 
drug 
TLC Detects unwanted plant species 
If unwanted plant presence is 
suspected 
GC/LC 
Detects unwanted plant species 
Aids control of 
evaporation/degradation of 
substances that must be present 




Parts of the plant/adulterant 
species/minerals not in the 
definition – this is a limit of 2% 
unless otherwise stated 






A general method listed in 
another section 
Used where contamination is 
suspected or when it is known that 
a herbal drug accumulates a 
particular metal 
Loss on drying 
To certify if the drug has been 
dried out 
Herbal drugs that are not dried 
enough may harbour yeasts or 
moulds 
Usually 2 hrs = 10% water loss 
Where herbal drugs may be dried. 
Water 
Determination of water content 
by distillation 
Used when levels of essential oils 
present exceeds 1% 
Swelling index 
Used for certain hydrocolloid-
containing herbal drugs 
 
Bitterness value 
For herbal drugs containing 
bitter principles 
 
Extractable matter  
Where no other suitable assay is 
available 
Microbial quality  
Limits differ for treated and non-
treated material, i.e. Heat. 
Pesticide residues  Where specified 
adapted from (EDQM, 2017c) 
For quantification purposes, assays are listed. This is included at all times where ever feasible. If 
possible, the method of choice is gas or liquid chromatography, but if there are good quality 
chemical markers present, spectrophotometry can be used, although this is not encouraged. The 
EDQM provides information about the sourcing of Herbal Reference standards (HRS). All 
identification and quantification tests will have reference standards for comparison (EDQM, 2017c).  
These monographs are the standards adhered to by members and observers of the Ph. Eur for 
identification, quantification and overall quality testing of herbal products and other 
pharmaceuticals (Council of Europe, 1964). 
In 2014, the BP committee set up a DNA working group with the aim to develop DNA based 
identification methods. Where the DNA method for a herbal medicine is not an identification 
method, the information is provided in a supplementary chapter entitled, SC VII D. DNA Barcoding as 
a tool for Botanical Identification of Herbal Drugs. The methods are detailed in Appendix XI V. 
Deoxyribonucleic Acid (DNA) Based Identification Techniques for Herbal Drugs. This advance is 





explained in the next section: 1.3 DNA Barcoding. The barcode region trnH-psbA has been used for 
identification of Ocimum tenuflorum and a trnH-psbA standard for use in the outlined method has 
been made available for purchase. For barcode development it is noted that nrITS, rbcL, trnL-F and 
matK are also being considered for other plant species (BPC, 2017b).  
1.3 DNA Barcoding 
The Barcoding effort began in 2003 when Dr Paul Hebert, University of Guelph, Canada, proposed 
the use of DNA barcodes to identify organisms at species level. The idea was to use short gene 
sequences as a means of identification (CBOL, 2017). Current methods require very skilled and 
experienced taxonomists to examine the morphology of a specimen in order to identify it, and 
damaged or immature specimens could be impossible to identify even to these experts. Chemical 
methods require the identification of chemical markers. These markers can be present in other 
species and can also be added to a sample falsely to pass as the desired product (Palhares et al., 
2015). It is however possible to extract DNA from these specimens including those that may be aged 
and degraded, so DNA barcoding was considered a possible solution to these problems (Cowan et 
al., 2006).  
The Sloan Foundation awarded The Smithsonian Institution sufficient funds to create a Consortium 
for the Barcode of Life (CBOL). The main aim of the CBOL is to promote the advance of barcoding. 
Since the creation of the CBOL, further large sums of money have been awarded to the Smithsonian 
Institution and major conferences have taken place in the UK, Taiwan and Mexico.  The International 
Barcode of Life Project was initiated in 2010. Scientists from many disciplines all over the world are 
working together in order to construct a library of references for DNA barcodes of multi-cellular 
organisms. The first phase of this effort began in 2010 and includes barcoding 500,000 species. 
There are currently two databases, one of which is the Barcode of Life Database (BOLD) and the 





The ideal barcode for animals was agreed at an early stage to be the cytochrome oxidase 1 gene 
(COX1). This has been demonstrated to have the ability to distinguish 90% of animals (de Boer et al., 
2015). However, the much slower rate of evolution of the COX1 gene in plants has deemed it 
unsuitable for use as a barcode (Kress et al., 2005).  
For plants, several candidate barcodes have been considered, but each proposed region has been 
shown not to be sufficient when used individually. This led to the conclusion that for plants, 
combinations of barcode regions would be required to meet the specification of a good barcode 
According to Hollingsworth (2009) a good barcode should meet the following criteria; 
1. It should be possible to routinely PCR with a single primer pair 
2. It must produce good quality data with bidirectional sequencing 
3. It should require little manual editing of sequence traces 
4. It should have maximum discrimination amongst species. (Hollingsworth et al., 2009) 
Two proposals for a plant barcode were submitted to the CBOL. The first was from Kew Royal 
Botanical Gardens, who came up with two options for combinations of regions to serve as barcodes. 
Option one included the plastid genes rpoC1, rpoB and matK. Option two included rpoC1, matK, and 
trnH-psbA. The reason for submitting two options was the uncertainty of whether or not trnH-psbA 
would fit into the protocols of the CBOL, due to its highly variable length (Kew, Royal Botanical 
Gardens 2009). The second proposal, from the CBOL plant working group was for the plastid genes 
matK and rbcL. One of their original proposals was to include trnH-psbA, but a decision was made 
against this to avoid the added cost and time of sequencing three loci, and the potential delay to 
finding a barcode by including trnH-psbA (Hollingsworth et al., 2009). The reason for these choices 
are summarised in Table 3, but basically none of the regions fulfil all of the criteria alone and a 





Table 3: A summary of analysis of candidate barcode regions against criteria 
Name Function Positive attributes Negative attributes 
rpoC1 Coding plastid region 





rpoB Coding plastid region 





matK Coding plastid region Discrimination high. 
Discordance between forward 
and reverse reads of 
sequencing. 
Requires manual editing of 
sequence traces. 
trnH-psbA Intergenic plastid spacer 
Routine PCR. 
Discrimination high. 
Poor quality sequence data due 
to high levels of 
mononucleotide repeats. 
Requires manual editing of 
sequence traces. 
ITS Intergenic nuclear rRNA spacer 
High quality sequence data. 
Routine PCR 
Not universal across all genera. 
YCF5 Coding plastid region  Deleted from Bryophytes 
accD Coding plastid region  Missing from the grass family. 
ndhJ Coding plastid region  
Truncated/non-functional in 
some Orchid groups. 
psbK-psb1 Intergenic plastid spacer Discrimination high. 
Poor quality sequence data due 
to high levels of 
mononucleotide repeats. 
 
atpf-atpH Intergenic plastid spacer  
Fell below accepted median for 
discrimination. 
Fell below accepted median for 
sequence data. 
rbcL Coding plastid region 





(Adapted from Hollingsworth et al., 2009) 
A committee was created of three independent reviewers who evaluated both proposals. The 
recommendation was for the three-locus proposal. The CBOL executive committee then evaluated 
the two proposals along with the recommendations made by the review committee. They decided 
that the three-locus proposal was more desirable, but the added cost and delay to finding a plant 
barcode swayed them to the two-locus proposal. In late 2009, the CBOL approved the two-locus 
proposal of the CBOL plant working group, with an 18 month review period (CBOL, 2012).  
Since this period, much research has been occurring to develop plant barcodes. It has been 
demonstrated for some plants families that one barcode region is enough to allow discrimination 





Juglandaceae, and Song et al 2009 with Polygonaceae to name a few (Pang et al., 2011b, Xiang et al., 
2011, Song et al., 2009). For some families two barcodes used together has been the answer; 
Hollingsworth et al 2009 used rbcL and matK for angiosperms (all flowering plant species) and 
Madesis et al 2012 for Leguminoceae (trnL and ITS2) (Hollingsworth et al., 2009, Madesis et al., 
2012) . The two locus approach posed issues with alignment of highly variable regions such as those 
seen using trnH-psbA in some plant families. In order to overcome these issues, the ‘tiered 
approach’ was suggested (Newmaster et al., 2013). An easy to amplify region such as rbcL is used as 
a scaffold with which data from highly variable regions can be placed, such as ITS2. The favourite 
candidate for the so called second tier is ITS2 due to its high species discrimination abilities and short 
sequences. For herbal medicinal plants, ITS2 is able to overcome the degradation that often occurs 
from heavy processing. This approach can allow up to 80% of plant species to be identified, not an 
easy feat with some 400,000 species in existence (de Boer et al., 2015). A recent review by Parveen 
et al assesses the development of barcoding for herbal products and addresses the limitations. They 
state that barcoding of extract based products is not feasible which will be explored in this thesis. 
They also point out that due to the ubiquitous nature of DNA, that barcoding cannot be used to 
authenticate the presence of specific parts of plants. This has importance when the requirement for 
specific parts of a plant are needed for efficacy (Parveen et al., 2016).  
1.4 Actaea racemosa L, Black Cohosh 
Black Cohosh (Actaea racemosa L., also known previously as Cimicifuga racemosa (L.) Nutt) is a 
perennial woodland plant native to North America and Canada, and is a member of the buttercup 
family (Ranunculaceae). The plant is tall with racemes of white flowers which blossom in the 
summer. The rhizome and the roots of the plant are used in phytomedicinal preparations used to 
treat menopausal-related complaints in Europe and as a dietary supplement for the same purpose in 
America. These remedies are available over the counter and as prescribed by practitioners (Denham 





in Figure 1. Various American species also share the same habitats (Figure 2). The similar appearance 
and habitat makes contamination of harvested Black Cohosh highly possible (Mahady et al., 2008, 









Figure 1: A selection of Actaea plants native to Northern America and Asia – Similarity of appearance 
between species illustrated  
(Images obtained from: (Missouri Botanical Gardens, 2017b, Mt Cuba Center, 2017, Longwood 

















  Species present and native 
  Species present and rare 
 Species native, but adventive in state 
  Species not present 
   Species extirpated (historic) 
Figure 2: The presence of various Actaea species in Northern America showing overlap of habitat 
[Available from: http://bonap.net/NAPA/TaxonMaps/Genus/State/Actaea] (Kartesz, 2015) 
Historically, Black Cohosh has been used to treat a variety of ailments including anything from 





have traditionally used Black Cohosh for a very long time (Betz et al., 2009) but today in the modern 
world it is used primarily for easing vasomotor symptoms e.g. hot flushes cause by the menopause.  
1.4.1 Conservation of Black Cohosh 
Black Cohosh is at risk of becoming an endangered species in some of its native wild habitats. Large 
scale commercial cultivation of Black Cohosh is almost non-existent; hence the plant is collected 
from the wild. Between 1997 and 2010, just under 33 tonnes of Black Cohosh raw material came 
from cultivation efforts, over 1,700 tonnes was sourced from wild harvesting (Gafner, 2016). Over-
collection and threat to habitat are the primary threats to the wild population. The collection of the 
rhizome and roots leads to destruction of the plant, so collection causes a decline in numbers 
(Applequist, 2003).  
The plants grow in Northern America and Canada. According to NatureServe (2010) areas of these 
regions where the plant has become endangered are; Massachusetts, Mississippi, and Illinois. The 






Figure 3: A map of Northern America and Canada showing Black Cohosh conservation status in different areas. 
[Image available from: http://www.natureserve.org/explorer/] 
CITES, the Convention on International Trade of Endangered species of Wild Fauna and Flora, is an 
agreement between governments across the globe. The purpose of CITES is to prevent the 
endangerment of species through international trade. Black Cohosh was considered for listing in 
Appendix II in 2001 and then Appendix III in 2002.  The decision was made not to include the plant in 
either appendix as it did not fully meet the requirements of listing but its status was to be 
monitored. Although the species is endangered in some single American States, it is not classified as 
an endangered species due to its abundance in other States of America. Actaea podocarpa and 
Actaea rubifolia also share the same habitat and can be collected accidently. These species were also 
considered alongside Actaea racemosa for listing (USFWS, 2002). In 2005 the Medicinal Plant 
Working Group continued to collaborate with the U.S Forest Group and Garden Club of America to 





Further collaboration with the IUCN-Medicinal Plant Specialist Group and the North American 
Pollinator Protection Campaign was established to produce fact sheets for native plants of the USA 
and included Actaea racemosa. The aim of these documents was to promote sustainable use. In the 
United States a permit is required to collect Black Cohosh from National Forest. Between 1995 and 
1997 the number of permits purchased increased from 4 to 50 (Robbins, 1999). This is evidence of 
the increased demand for the plant.  
The plant is listed as endangered on the Natural Resources Conservation Service website of the 
United States Department of Agriculture in Illinois and Massachusetts (USDA, 2017). This gives the 
plant a federal endangered status. It is not listed for Mississippi.  
Conservation projects are up and running for Black Cohosh in parts of the US. In Massachusetts, 
Black Cohosh is covered by the Natural Heritage and Endangered Species Program and listed under 
the Massachusetts Endangered Species Act. This protects the plant against collection, killing, 
possession, sale and activities that could affect the mortality of the plant (NHESP, 2010). Figure 4 
shows the extent of just how endangered Actaea racemosa has become in the State of 
Massachusetts.  
 
Figure 4: A map of Massachusetts showing distribution of Actaea racemosa 
Image available from: http://www.mass.gov/eea/docs/dfg/nhesp/species-and-






Figure 5: A map of Illinois showing distribution of Actaea racemosa 
Image available from: http://www.illinoiswildflowers.info/woodland/plants/black_cohosh.htm 
(Hilty, 2016) 
Actaea racemosa is listed on the Illinois Endangered Species Protection Board’s (IESPB) Checklist of 
Illinois Endangered and Threatened Animals and Plant list. It is worth noting that the plant is listed as 
Cimicifuga racemosa with a common name of false bugbane. Cimicifuga rubifolia (Actaea cordifolia) 
is listed as Black Cohosh on the official list. These names are not correct as Black Cohosh is officially 
the common name for Actaea racemosa and false bugbane refers to non Actaea species that are 
sometimes mistaken for true Actaea. This listing gives both plants protection through the Illinois 
Endangered Species Protection Act (IESPB, 2015).  
United Plant Savers is a non-profit organisation in the US and through research and education they 
aim to conserve native plants. Black Cohosh is currently on their ‘at risk’ list and a recommendation 





1.4.2 Efficacy of Black Cohosh 
During the menopause oestrogen deficiency leads to vasomotor and psychological symptoms 
including; hot flushes, night sweats, mood and cognitive disturbances, sleep loss, vaginal dryness 
and loss of libido (Borrelli and Ernst, 2008). The usual treatment of these symptoms is hormone 
replacement therapy (HRT) but involves undesirable side effects (Pinkerton et al., 2009).  
The first commercially available Black Cohosh product dates back to 1956, with Shaper and Brümmer 
releasing Remifemin, an isopropanolic Actaea racemosa extract based product. In the same period 
of time Kupperman provided a Menopausal Index, KMI which assigned a severity scoring based on 
symptoms.  In 1976 Germany established The German Medicines Act, and this required efficacy of 
medicines to be proven. The German ministry of Health, in 1985, provided guidelines for conducting 
clinical trials. In 1986 the first randomised placebo controlled clinical trial was conducted using a 
Black Cohosh preparation. In 1994 Hauser released a Menopause Rating Scale (MRS) (Henneicke-von 
Zepelin, 2017). The first clinical trial concerned with dosage was conducted in 1995. The trial showed 
that safety was maintained up to 127 mg/day and efficacy was maintained as low as 40 mg/day. 
They also found that women in the perimenopausal stage were finding more relief from symptoms 
with 127 mg/day rather than 40 mg/day (Liske et al., 2002). 2003 saw the first clinical trial of an 
ethanol extract being conducted, Klimadynon from Bionorica. In the time between 2000 and 2015 
there has been 28 clinical trials conducted all over the world. These trials have confirmed the 
efficacy of Black Cohosh extracts as a treatment for Menopause symptoms. In these trials Black 
Cohosh was superior to placebo and in some cases worked better than hormone replacement 
therapy. Other treatments areas have also been explored including osteoporosis fractures, breast 
cancer relapse, sleeping issues and cognitive abilities (Henneicke-von Zepelin, 2017).  
Aside from clinical trials, there has been much scientific research into the efficacy of Black Cohosh. In 
2005, Seidlova´-Wuttke found possible osteoporosis-preventing capabilities of Black Cohosh in aging 





BNO 1055 and a statistically significant reduction in bone demineralization was observed (Seidlova-
Wuttke et al., 2005). Another study in 2013 demonstrated that the German Black Cohosh product 
Remifemin® has the same protection against osteoporosis as hormone therapy in treated rats (Cui et 
al., 2013).  
Hot flushes are the most prominent vasomotor symptom that menopausal women encounter. They 
are often accompanied by perspiration and heart palpitations. There does not seem to be a universal 
set of symptoms experienced by every woman, but factors such as ethnicity show evidence of 
influence, as 24% of Caucasian women experienced hot flushes compared to 37% of African-
American women (Gold et al., 2006). Within the first few seconds of a hot flush episode, peripheral 
dilation, and increased skin temperature and blood flow occur.  
In menopausal women, the reduction of oestrogen causes the pituitary gland to release high levels 
of luteinising hormone (LH) in pulses at regular intervals. These pulses are a result of activation of 
gonadotropin releasing hormone (GnRH) neurons in the hypothalamus, and subsequent release of 
GnRH into portal vessels connecting the pituitary gland to the hypothalamus. In ovariectomised 
(ovaries removed) rats, treatment with oestrogen showed that LH release was inhibited and 
therefore proves the effect of oestrogen on this process (Wuttke et al., 2014). The GnRH pulse 
generator becomes overactive due to erratic neurotransmitter release. Oestrogen regulates release 
of catecholamines, gamma aminobutyric acid (GABA) and serotonin in the hypothalamus which is 
important in episodes of luteinising hormone pulses. When oestrogen levels are lowered these 
compounds are released at much higher levels which come into contact with hypothalamic neurons 
responsible for thermal and cardiac regulation. Kapur (2010) demonstrated that treatment of A. 
racemosa extract BNO 1055 (a Black Cohosh extract manufactured by Bionorica) on ovariectomized 
rats reduced hot flushes. It did not affect uterine weight so is not oestrogenic (Kapur et al., 2010). 
Dopamine and serotonin inhibit pituitary release of LH. Black Cohosh has been shown by Powell 





evidence of dopaminergic compounds being present (Powell et al., 2008, Burdette et al., 2003, Jarry 
et al., 2003, Wuttke et al., 2014).  
Vaginal discomfort is another major issue related to the menopause. Vaginal pH is usually kept low 
by oestrogen, so becomes more alkaline during the menopause, leading to increased risk of 
infections (Pinkerton et al., 2009). In a clinical trial, Wuttke (2003) found that vaginal superficial cells 
significantly increased following treatment using BNO 1055, lowering vaginal pH and increasing 
vaginal lubrication (Wuttke et al., 2003).  
1.4.3 Safety of Black Cohosh 
The safety of use of Black Cohosh is a well-researched and documented area. Over the years there 
have been isolated cases reported of hepatotoxicity in connection with the use of Black Cohosh. 
There were also concerns for the effect of Black Cohosh on breast health due to the belief of the 
herb being oestrogenic. 
 In response to this, in 2004 a small workshop was held with participation from the National Centre 
for Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH), the NIH 
Office of Dietary Supplements (ODS), the Office of Research on Women’s Health, NIH: the National 
Cancer Institute, the National Institute on Aging, the US Food and Drug Administration, the American 
Herbal Products Association and the Centre for Science in the Public Interest. A further workshop 
was held in 2007 and a number of recommendations were made, mostly in regards to clear 
reporting of adverse events, improvements in communication and more thoroughly documented 
clinical trials. Also further research into safety, clinical benefit, mechanism of liver toxicity, 
adulteration, appropriate chemicals markers and mechanism of action studies to be carried out on 
Black Cohosh products (Betz et al., 2009) 
A problematic area was the inconsistencies found with different conducted clinical trials. Several 





replacement therapies and was superior to placebo (Nappi, 2005, Osmers et al., 2005, Wuttke et al., 
2006, Molla et al., 2011). On the other hand another trial found that Black Cohosh had very little 
effect compared to hormone replacement therapies (Newton et al., 2006). In 2013 Beer and Neff 
reviewed available clinical trial information with an aim to determine if there was a difference in 
efficacy from registered products to non-registered (Beer and Neff, 2013). They found that 
registered products demonstrated efficacy in all clinical trials. The clinical trials which failed to prove 
the efficacy of Black Cohosh were found to have used an unregistered product. Interestingly the trial 
mentioned in the previous paragraph (Newton et al., 2006) was found to be an American dietary 
supplement rather than a registered natural medicine. Registered isopropanolic extract products 
have several clinical trials that are able to support efficacy in all cases. The types of trial range from 
randomised controlled, uncontrolled and controlled, and included thousands of women. Trials for 
ethanolic Black Cohosh extracts, although on a smaller scale and lesser in number compared to 
isopropanolic extract trials, are able to prove efficacy also. Combination products of Black Cohosh 
and St John’s Wort were also trialled and evidenced efficacy in both treatment of vasomotor 
symptoms along with psychological complaints.  
Table 4: A table to show the relationship between efficacies of products in trials to type of product 
All clinical trials Registered herbal medicinal product 
Evidenced efficacy? Yes No 
Yes 15 1 
No 0 2 
 
Problems with the identification of Actaea racemosa by the use of questionable chemical marker 
compounds have been found. The marker compound outlined in the Ph. Eur is the triterpenoid 
glycoside, 23-Epi-26-deoxyactein for identification (EDQM, 2017a) with the use of thin layer 
chromatography. This compound was found to be present by Gafner (2006) in other species of 
Actaea, and so is not a good marker for A. racemosa (Gafner et al., 2006). A clear marker needs to be 





that A. racemosa can be distinguished using high performance liquid chromatography (HPLC) 
methodology with the marker cimiracemoside A, another triterpene glycoside, as it was found solely 
in A. racemosa amongst 10 Actaea species (He et al., 2006).  
The current Ph. Eur monograph contains methods to discriminate between A. racemosa and four 
other closely related Actaea species.  
The main issues discussed in the 2004 workshop were those related to safety (Betz et al., 2009). 
There were concerns about the use of Black Cohosh in individuals with breast and other cancers. 
This concern originally rose over speculation that Black Cohosh had oestrogen-like activity. This was 
a study where mice were treated with Black Cohosh extracts and breast cancer cells were also tested 
in vitro with Black Cohosh extracts. Further investigation showed that Black Cohosh did not in fact 
contain any compounds that could serve as ligands for oestrogen receptors (Liu et al., 2001). 
Rockwell (2005) tested 3 different Black Cohosh products on mouse breast cancer cells and found 
that none of the preparations affected the proliferation rate.  They did however find that Black 
Cohosh increased the levels of cytotoxicity of cancer fighting drugs, docetaxel and doxorubicin and 
decreased the cytotoxicity of cisplatin (Rockwell et al., 2005). Other studies carried out since (Bolle 
et al., 2007, Hostanska et al., 2007) found no ill effect of Black Cohosh on breast tissue, so this 
deemed the drug safe for non-cancer patients but questionable for cancer patients receiving 
therapy. Beer and Neff (2013) also reviewed safety from 41 trials aimed at investigation of safety. 
The general safety trials showed that Black Cohosh gives no side effects as when compared to 
placebo, Black Cohosh did not differ significantly in results. Two investigations that were analysed 
showed no significant interaction with cytochrome P450 isoenzymes and P Glycoproteins, and 
therefore no drug interactions involving these pathways would be seen. Studies into effect of Black 
Cohosh on the breast and uterus were also examined. Of the studies examined 22 delved into safety 
of oestrogen sensitive organs. They found that in all cases there were no clinically significant changes 





unaffected; endometrium, breast density, breast cell proliferation or cell morphology of nipple 
aspirate fluid. Trials were also conducted into breast cancer risk. The previous suspicions that Black 
Cohosh increased breast cancer risk were shown to be unfounded, and the isopropanolic extracts 
were actually shown to decrease the risk of breast cancer (Beer and Neff, 2013). In 2007 a clinical 
trial showed that the use of Black Cohosh increased remission to 4.5 years when using an 
isopropanolic extract product (Henneicke-von Zepelin, 2017).  
The next area of safety concerns the liver. For a number of years now, Black Cohosh has been 
suspected of causing hepatic damage. Many types of liver injury have been reported ranging from 
liver failure to autoimmune hepatitis, from patients who were taking a preparation containing Black 
Cohosh.  
In 2002 an Australian report highlighted six cases of hepatitis following the use of herbal drugs. Two 
of these patients were taking Black Cohosh preparations (Whiting et al., 2002). Since the release of 
this report many other reports have been made. The reports have been reviewed extensively by 
various organisations. The European Medicines Agency reviewed 44 of the reports in 2008. They 
found only 18 of the reports to be documented adequately, three of these were considered to 
contain evidence of a possible relationship with Black Cohosh and two were considered to have a 
probable relationship with Black Cohosh. These five reports were then reviewed by a hepatologist 
who found no relationship between Black Cohosh and liver damage in four out of the five. The 
remaining report was deemed to be unlikely to be due to Black Cohosh (Teschke and 
Schwarzenboeck, 2009). Levitsky (2005) found that the patient of one of the cases judged to be of 
probable nature had been receiving 10 times the recommended dose. (Levitsky et al., 2005) Later in 
2008, Levitsky published an erratum declaring that the report in question originally stated: 
“The patient did not drink alcohol or use drugs and was not taking any medications including other 





It was later found that the patient regularly consumed wine and had been taking drugs known to 
influence the health of the liver. (Levitsky et al., 2008)   
The Medicines and Healthcare Products and Regulatory Agency of the UK received around 21 
reports of liver damage associated with the use of Black Cohosh. All cases underwent detailed 
analysis which led to the decision that although adverse reaction was rare the following actions 
would be taken: 
 Warnings to be added to the product information on licensed and unlicensed products 
regarding rare adverse reactions of the liver.  
 Monitoring of further adverse reactions suspected to be linked to Black Cohosh 
 Encouragement for licence holders of Black Cohosh products to carry out research into 
mechanisms of how Black Cohosh may cause liver damage. (MHRA, 2006)  
Warning labels were also issued in Australia after three serious cases of liver damage were reported 
with one leading to death of the patient and all three receiving liver transplantation. There was not 
enough information available to link these cases to Black Cohosh but it was cause enough to issue 
very strong warning labels (Therapeutic Goods Administration, 2006, Therapeutic Goods 
Administration, 2007). 
In 2008 the United States Pharmacopoeia (USP) analysed 30 non-duplicate reports associated with 
Black Cohosh and hepatotoxicity. After assigning possible causality to each of the cases, they found 
none to be certain or even probable. The problem with most of these reports was that other factors 
were present which could also be causing the effects. Some of the patients were reported to be 
consuming alcohol, taking other synthetic drugs known to affect the liver, taking unlicensed 
products and taking poly herbal remedies containing other herbs associated with hepatotoxicity 
such as skull cap, Scutellaria species (Lamiaceae). One patient ‘recalled seeing the words black 





had discarded’, so it could be possible that the patient was not taking Black Cohosh or taking an 
unlicensed product containing other species of plants. One patient was detailed as taking 1000 mg 
daily of black Cohosh extract alongside two glasses of wine and various medications including 
acetaminophen which is known to be toxic to the liver in excess and also tested positive for hepatitis 
B surface antibody and herpes simplex virus immunoglobulin M. Another patient was detailed with 
taking 500 mg of black Cohosh extract daily but regularly consumed wine, used ibuprofen and used 
valacyclovir which is known to influence liver enzyme levels.  
In 2002 Black Cohosh was given a Class 1a rating; 
“Class 1a: Articles for which the Committee is aware of limited human scientific data concerning 
safety of the article but is unaware of significant safety issues that would prohibit monograph 
development when the article is used and formulated appropriately” 
The USP concluded that the link between cases of hepatotoxicity and Black Cohosh was weak due to 
following 
 incomplete case information and unknown products 
 Variables present such as alcohol consumption 
 Other medications being taken 
 Risk factors pre-existing. 
Even with the decision that the link was weak, the Dietary Supplements Information Expert 
Committee (DSI EC) decided to reclassify Black Cohosh into Class 2. The reasons given were that the 
possible adverse reactions were of a serious nature and there were an ever increasing number of 





“Class 2; Articles for which the Committee is unaware of significant safety issues that would prohibit 
monograph development when the article is used and formulated appropriately, provided there is a 
warning statement in the labelling section” 
The DSI EC decided upon the following wording for a labelling statement; 
“Discontinue use and consult a healthcare practitioner if you have a liver disorder or develop 
symptoms of liver trouble, such as abdominal pain, dark urine, or jaundice.” (Mahady et al., 2008) 
Health Canada received four reports of liver damage connected with Black Cohosh use. All four of 
these cases were deemed as serious, three of them were found to have a possible link and one to 
have a probable link. A more recent search through the Health Canada Vigilance Adverse Reaction 
Online Database brings up 9 reports of adverse reactions associated with Black Cohosh use. Again 
provided information is limited, although 6 of the 9 reports give a brand name of product (Painter et 
al., 2010, Betz et al., 2009). In 2011, a number of cases from the aforementioned were studied again 
by Teschke et al. They scrutinised the lack of information that was available from the authors of the 
case reports and also gave differential diagnoses. This is shown in Table 5 which was adapted from 
the publication (Teschke et al., 2011).  
Table 5: A summary of lack of information provided from 40 cases of reported Black Cohosh liver toxicity  
Information presented Availability from 16 
individual case reports 
Availability from 24 
individual spontaneous 
reports 
Brand name 6 17 
Manufacturer 4 9 
Plant part 6 3 
Solvent  2 0 
Daily dose 9 6 
BC Drug 1 5 
BC Polyherbal product 4 12 
Date of BC start 4 11 
Date of BC End 1 8 
Date of symptoms 2 14 
Temporal association 8 8 





Tim to onset 14 9 
ALT Value (Alanine amino transferase 16 5 
ALP Value (Akaline phosphatase) 14 4 
Hepatotoxicity criteria 15 4 
ALT dechallenge 4 1 
Biliary tract imaging 12 2 
HAV (Hepatitis A virus) 16 2 
HBV (Hepatitis B Virus) 15 2 
HCV (Hepatitis C Virus) 16 2 
CMV (Cytomegalovirus) 11 2 
EBV (Epstein-Barr Virus) 11 2 
HSV (Herpes Simplex Virus) 4 0 
VZV (Varicella Zoster Virus) 1 0 
Comedication/Herbal mixture 11 19 
Undetermined BC Product 10 7 
(Adapted from (Teschke et al., 2011) 
According to Teschke et al 2011, there are certain published elevated liver enzyme parameters that 
must be seen in tests to be able to attribute a case to being a liver injury. In Table 5 the spontaneous 
cases are particularly lacking these criteria. A very small proportion of the cases (10%) document a 
re-exposure test and in all cases was negative. Challenge, de-challenge and re-exposure are all 
clinically relevant aspects of assigning causality and were rarely documented (Teschke et al., 2011). A 
number of cases where positive re-exposure was documented were reviewed in 2014. None of the 
cases linked to Black Cohosh were found to have a positive re-exposure (the same negative reaction 
originally seen when the patient was re-exposed to Black Cohosh) (Teschke et al., 2014).  
In recent years there have been further case reports of hepatotoxicity associated with Black Cohosh 
use. In Table 6 these have been briefly summarised from what was available and are still lacking in 
the basic information required from the criteria described by Teshcke et al 2011. Some of these case 
reports even reference and agree with Teshcke et al 2011 yet still miss the required information to 





Table 6: A summary of lack of information and causality in more recent cases reporting hepatotoxicity from 
Black Cohosh use 
Source Liver Injury Product Comments 
Franco et al 2017 Abnormal liver enzymes 150 mg root 
extract/day 
for 1 week 
Very short usage time to be the cause 
and brand not given 
Muqueet-Adnan 
et al 2014 
Liver cirrhosis  Unknown 
brand or 
dose for 1 
month 
The authors declared that they could 
not firmly link this case to Black 
Cohosh as they are unaware of the 
Brand and purity of the product the 
patient was using 
Enbom et al 2014 Abnormal liver enzymes Unknown Products were unknown as was 
duration of usage 
Lim et al 2013 Sub-acute liver failure Unknown 
brand or 
dose for 2 
weeks 
As the brand was unknown it is not 
certain if a registered or authentic 
product was used  
(Franco et al., 2017, Muqeet Adnan et al., 2014, Enbom et al., 2014, Lim et al., 2013) 
Adulteration of Black Cohosh products may explain the cases of hepatotoxicity. Similar binomial and 
common names can cause confusion as outlined in Section 1.4.4: Classification of Black Cohosh. 
Similar ground appearance and habitat sharing of different Actaea species also can cause 
misidentification as outlined in the start of Section 1.4  Actaea racemosa L. Black Cohosh. In the 
previously mentioned Health Canada case reports, the Black Cohosh product from the probable case 
was identified and tested using high performance liquid chromatography-mass spectrometry 
fingerprinting. The product was found to contain no  A. racemosa and was instead another 
undeclared Actaea species, this led to the recall of 7 products and the discovery of 3 more 
substituted products (Jordan et al., 2010).  
Jiang et al 2006 tested 11 commercially available products from the American market. Of the 11 
products 8 were found to contain Actaea racemosa. They stated that 4 of the products that were 
tested were found to be adulterated with Asian Actaea species. They also quantified the amount of 
triterpene glycosides present, as many of these products claim that standardisation of 2.5% 





make any assumptions and commented that different methods of standardisation could be used. 
They also performed stability testing on a chosen product to decide if age of the product would be a 
factor on chemical constituent differences. The product was tested over 30 months and the findings 
showed that no qualitative or quantitative changes occurred (Jiang et al., 2006, Jiang et al., 2011). 
1.4.4 Classification of Black Cohosh 
The scientific name and classification for black Cohosh has changed numerous times over the 
centuries, which no doubt has led to much confusion. In 1705, Plukenet first classified Black Cohosh 
as Christopheriana facie, Herba spicata, ex Provencia floridiana. Between 1705 and 1750 it was most 
commonly known as Actaea with some botanists using Christopheriana. The first Linnaean name was 
Actaea, but was later split to include Cimicifuga for the presence of dry follicles instead of the fleshy 
unicarpellate berries characteristic of Actaea species. Rafinesque renamed the plant as Macrotrys 
based upon the decision that it did not fit with Linnaeus’ classification and Eton later adjusted the 
name to Macrotys. The name was reverted back to the Linnaean Cimicifuga genus until 1998, when 
the morphological characteristics and genetic sequences were thoroughly explored by Compton et al 
1998, who reclassified Black Cohosh along with all other Cimicifuga and Souliea species to Actaea. 
After this work the genus contained 28 species, 8 from North America, 19 from Asia and one from 
Europe (Compton et al., 1998). Two further species have been accepted following this work, both 
are native to America. 
Table 7: A list of all species included in the Actaea genus 
Name Origin 
Actaea arizonica (S.Watson) J.Compton North America 
Actaea asiatica H.Hara Asia 
Actaea austrokoreana (H.W.Lee & C.W.Park) Cubey Asia 
Actaea bifida (Nakai) J.Compton North America 
Actaea biternata (Siebold & Zucc.) Prantl Asia 
Actaea brachycarpa (P.K.Hsiao) J.Compton Asia 
Actaea cimicifuga L. Asia 
Actaea cordifolia DC. North America 





Actaea elata (Nutt.) Prantl North America 
Actaea europaea (Schipcz.) J.Compton Europe 
Actaea frigida (Royle) Prantl Asia 
Actaea heracleifolia (Kom.) J.Compton Asia 
Actaea japonica Thunb. Asia 
Actaea kashmiriana (J.Compton & Hedd.) J.Compton Asia 
Actaea laciniata (S.Watson) J.Compton North America 
Actaea × ludovicii B.Boivin North America 
Actaea mairei (H.Lév.) J.Compton Asia 
Actaea matsumurae (Nakai) J.Compton & Hedd. Asia 
Actaea pachypoda Elliott North America 
Actaea podocarpa DC. North America 
Actaea purpurea (P.K.Hsiao) J.Compton Asia 
Actaea racemosa L. North America 
Actaea rubra (Aiton) Willd. North America 
Actaea simplex (DC.) Wormsk. ex Prantl Asia 
Actaea spicata L. Asia 
Actaea taiwanensis J.Compton, Hedd. & T.Y.Yang Asia 
Actaea vaginata (Maxim.) J.Compton Asia 
Actaea yesoensis (Nakai) J.Compton & Hedd. Asia 
Actaea yunnanensis (P.K.Hsiao) J.Compton Asia 
 
The common names for Actaea species can include the term ‘Cohosh’. For example, Black Cohosh is 
the commonly known name for Actaea racemosa, White Cohosh for Actaea pachypoda and Yellow 
Cohosh for Actaea podocarpa. This also leads to confusion with Blue Cohosh which is in fact a 
completely different plant from another family; Caulophyllum thalictroides (L.) Michx 
(Berberidaceae). There are alkaloids (sparteine and N-methycystisine) and saponins (cauloside A, 
saponin PE, and cauloside C) present in Blue Cohosh that have been reported to lead to birth 
defects, heart failure of neonates, and uterine stimulating effects, so confusion with this species can 
have dangerous consequences (Datta et al., 2014). Confusion is also caused by websites and Chinese 
suppliers referring to the Asian species, Actaea dahurica, as Black Cohosh (Mahady et al., 2008, 
Satchithanandam et al., 2008). Other completely non related genera can also be marketed as Black 
Cohosh such as Serratula (Asteraceae) and Vernonia (Asteraceae) (Gafner, 2015, Gafner, 2016). 
Vernonia is an adulterant of Chinese Actaea products and so can become an adulterant of Black 





Table 8 is taken from the Kew Gardens Plant Naming Service and gives the accepted name for 
Actaea racemosa. Table 9 gives a summary of other names for Actaea racemosa which have been 
found in scientific documents. Cimicifuga racemosa features in the most papers as it was the 
previously accepted name for the herb for many years. 
Table 8: The number of sources using correct naming for Actaea racemosa versus total number of sources as 
detailed in the Kew Gardens Medicinal Plant Naming Service 




Actaea racemosa L. Accepted scientific name from taxonomic source 18 123 
Table 9: A breakdown of naming used for Black Cohosh in all checked sources from the Kew Gardens 
Medicinal Plant Naming Service 
Scientific names as used in medicinal plant references Records referring to name 
Actaea monogyna  1 
Actaea racemosa L.  18 
Cimicifuga racemosa  1 
Cimicifuga racemosa (L.) Nutt.  80 
Cimicifuga racemosa Nutt.  7 
Cimicifuga racemosa Nuttal  1 
Cimicifugia racemosa  1 
Kew Plant Naming Service [accessed from: http://mpns.kew.org/mpns-portal/searchName] 
Table 10: A list of different binominal/common names for Actaea species and other possible adulterants 
Species Name Previous Name (pre 
1998) 
Common Name(s) 
Actaea racemosa (Nutt.) L Cimicifuga racemosa Black Cohosh, Black bugbane, Black snakeroot, Fairy 
Candle, Rattleweed, Squat Root. 
Actaea rubra (Ait.) Wil/d Actaea erythrocarpa Red Baneberry, China berry, Dolls eye. 
Actaea pachypoda (Elliot) N/A Actaea alba, White Cohosh 
Actaea dahurica (Turcz. ex 
Fisch & C.A. Mey) Franch 
Cimicifuga dahurica Xin gan sheng ma 
Actaea podocarpa DC Cimicifuga americana Yellow Cohosh, Dolls eyes, White Baneberry. 
Actaea simplex (DC.) 
Wormsk. ex Prantl 
Cimicifuga simplex Actaea cimicifuga, Var. Simplex. Black bugbane, Ye 
sheng ma 
Actaea heracleifolia (Kom.) 
J. Compton 
Cimicifuga heracleifolia Da san ye sheng ma 
Actaea cimicifuga Cimicifuga foetida Chinese Cohosh, Sheng Ma,  
Actaea cordifolia DC Cimicifuga rubifolia Appalachian Bugbane 
Caulophyllum thalictroides 
(L.) Michx. 
N/A Blue Cohosh 
Vernonia aspera (Buch.-
Ham.) H.Rob. 
N/A Rough leaf iron weed, Hei Sheng Ma 





sawort root, Guang dong sheng ma 
Astilbe biternata (Vent.) 
Britton (Saxifragaceae) 
 
N/A Bitter tea 
 
1.4.5 Published monographs for Actaea species 
The British Pharmacopoeia (BP) as well as the European Pharmacopoeia have legal status in the UK. 
The document is managed by the British Pharmacopoeia Commission and sponsored by the 
Department of Health. The BP also contains herbal monographs. The Black Cohosh monograph is 
identical to the Ph. Eur and in fact is extracted and referenced directly (BPC, 2017a).  
The United States Pharmacopeia Convention governs and aims to standardise many aspects of 
medicine from drugs to food supplements. They produce various regulatory texts including the USP-
NF (United States Pharmacopoeia and National Formulary) and the Dietary Supplements 
Compendium. Black Cohosh products are regulated as a dietary supplement in the USA. The text 
outlines Actaea racemosa as being the one and only species that can be called Black Cohosh (USPC, 
2015).  
The Pharmacopoeia of the People's Republic of China (PPRC) is managed by the Chinese 
Pharmacopoeia Commission (CPC). Although the PPRC does not include a monograph for Black 
Cohosh it does contain a monograph for Sheng Ma. Sheng Ma is a Traditional Chinese Medicine that 
is comprised of Actaea dahurica, Actaea cimicifuga or Actaea heracleifolia. The preparation is also 
called Rhizoma Cimicifugae which is also the name used in the Ph. Eur for Black Cohosh. This can 
lead to confusion (CPC, 2015).  
The Japanese Pharmacopoeia is managed by the Pharmaceutical and Medical Devices Agency 
(PMDA). The publication includes an entry for Cimicifugae Rhizoma and is comprised of Actaea 
simplex, Actaea dahurica, Actaea heracleifolia and Actaea cimicifuga. All four species can be used 





comparison to an isoferulic acid standard. Again this can cause confusion due to the similar Latin 
name to the authentic Black Cohosh product made with Actaea racemosa (PMDA, 2017). 
The World Health Organisation (WHO) has a monograph collection with Black Cohosh included in the 
second volume of the series titled; WHO Monographs on Selected Medicinal Plants. This monograph 
usefully points out the difference in definition of Rhizoma Cimicifugae between the different 
published Monographs of different countries including those mentioned in this section. This 
monograph also includes information about clinical trials and other relevant research findings (WHO, 
2004). 
Another extensive monograph available is published by Frostburg state University of Maryland, USA. 
The series of monographs is titled Appalachian Plant Monographs. This monograph is more of a full 
comprehensive review than a classic monograph (Pengelly, 2011). 
1.5 Authentication of Herbal Medicines 
Ensuring that plant material is the authentic species is of utmost importance in the production of 
herbal medicines. There are many control measures put in place to assure that good quality material 
of the correct species is used. The use of reputable suppliers and security through the chain of 
custody is essential. Some manufacturers have custody from start to end, i.e. they have control over 
the growing of the plants through to packaging the finished goods and in this case the likelihood of 
adulteration or substitution becomes slim. In other cases, and much more commonly, the plant 
materials are purchased from wild collectors or agents who act as ‘middlemen’ and in others the 
plant may be purchased from another supplier readymade in extract form. The latter increases the 
chance of a herbal medicine being produced with contaminated or worse case the wrong material 
(Booker et al., 2012).  
The responsibility of the manufacturer is to scrutinise the material to ensure it is fit for the 





examination to state of the art analytical chemistry. It also includes all the methods set out in the 
earlier section 1.2.1.1 Monographs, which include heavy metal determination, detection of 
unwanted minerals and general foreign body detection. There is also a responsibility at all stages, for 
example storage and processing to maintain quality. The monographs are the minimum 
requirements for analysis of herbal material, most reputable manufacturers will have further in 
house quality control methods (Shinde et al., 2009).   
As mentioned earlier, Black Cohosh has been found to be adulterated with Asian Actaea species, 
other American species that share the same habitat and different families that can appear similar 
such as Astilbe or Caulophyllum. This has been attributed to the fact that Black Cohosh is 
predominantly harvested from the wild, restricted for collection in some areas due to conservation 
and demand for the herb has increased over the years. This has been termed as ‘economical 
motivated adulteration (EMA)’ (Cumberford, 2012). Adulteration of plant material is more difficult to 
recognise than substitution and this is where the importance of research into identification methods 
is a crucial area for the integrity of finished products. Adulteration is defined as the accidental or 
deliberate addition of another substance to an item to increase the quantity. Substitution is defined 
as the replacement of the intended material with other parts of the same plant, different species 
from the same family or from other families. Substitution can be acceptable if the substitute 
material has the same pharmacological effect. In the case of this work substitution is discussed as a 
replacement of the intended material for inferior material. 
Quality assurance covers a wide range of matters that influence the quality of products. Quality 
assurance includes the development stage, quality control testing, production, distribution and 
auditing. Quality control is the inspection of products to determine if defined characteristics are 
being met as an output of a process. This can involve measuring, examining or testing. Assurance of 
quality in the production of a herbal medicine can begin as early as seed procurement for cultivated 





gaining as much information as possible including the name of the collector, date of collection, exact 
site of collection, which part of the plant was collected, organoleptic assessment where applicable, 
how the material has been processed and photographs or sketches of the plant (above ground plant 
and roots if necessary). A sample of the plant should also be collected and retained for reference. 
Ideally the reference sample should be incorporated into a herbarium and should be annotated with 
features of the plant used for identification (Smillie and Khan, 2010).  
 
Since the first use of medicinal plants dates back thousands of years, the original method of 
identification was morphological examination due to available equipment and expertise. This is still a 
valid technique in modern times but has become ‘unfashionable’ with the introduction of chemical 
techniques, and has led to a decline of interest in the area. Although chemical techniques are well 
established, the major flaws of the methods remain a problem. Products can be ‘spiked’ with the 
chemical markers used for identification and the chemical profile of a product can be altered by 
several factors including genetics, age and environmental (Yuk et al., 2016). This is where the 
proposal of using Deoxyribose nucleic acid (DNA) becomes attractive. Techniques are available that 
can identify and quantify a sample simultaneously. These eliminate the problems with chemical 
techniques as DNA is not so affected by factors such as age or environment. With the efforts of the 
Barcoding of Life initiative, the use of DNA techniques in the identification of plants is becoming 
more accepted as a valuable technique that can be used in unison with available chemical methods 
to overcome the flaws of each technique.  
1.5.1 Morphology 
Morphological examination includes macroscopic and microscopic technique. Macroscopic 
identification involves comparison by eye, of visual traits of whole or large parts of a plant. Traits 
including, shape, size, colour, texture, taste and odour of flowers, fruits, stalks and leaves are 





this includes inspection of cellular shape and size, colour under different solutions and presence of 
characteristic plant structures (Smillie and Khan, 2010).  
1.5.1.1 Morphological Identification of Black Cohosh 
Macroscopic identification of Actaea racemosa is possible by a very skilled and experienced 
taxonomist. Microscopic identification is also possible. There are variances present in the roots 
which can help distinguish A. racemosa from other related species. Figure 6 shows an illustration by 
Curtis Gates Lloyd and John Uri Lloyd. This shows clear distinctions in the root anatomy of A. 
racemosa and A. podocarpa. These observations were later backed up by photomicrographs 
produced in 1943 By Youngten. The work of Applequist (2003) further supports that A. racemosa can 
be distinguished from other Actaea species if whole roots are available to examine (Applequist, 
2003). This is unlikely to be the case with most samples as they will have often been powdered or 
shredded. The Monograph supplied by the European Pharmacopoeia states how to identify a 




Figure 6: Sketches by Lloyd & Lloyd (1884). Transverse sections of Actaea roots. 






Figure 7: Photomicrographs of Actaea root sections produced by Applequist (2003). 
A = A. racemosa. (Scale=500µM) C = A. podocarpa. (Scale= 200µM) 
The Ph. Eur states that upon macroscopic observation, the rhizome is dark brown, knotted, hard and 
subcylindrical. The exterior shows branches terminating in the remains of a bud or cup shaped scar. 
The size ranges from 1.5 – 2.5 cm in diameter and can be anywhere between 2-15cm long. 
Transversely it presents a thin outer bark, this surrounds a ring of alternating pale vascular tissue 
and dark medullary rays, with a large central pith. The roots are dark brown, wrinkled, cylindrical/ 
obtusely quadrangular and 1-3mm in diameter. Transversely the outer bark is thick, containing a 
dark brown cylinder which houses a central region of 3-6 light coloured wedges of vascular tissue 
joint at the centre and separated by medullary rays. (EDQM, 2017a) 
1.5.2 Chemical methods 
Chemical identification tests are based upon finding chemical markers or a chemical profile unique 
to a particular species. There are many different methods involved but the most common methods 
involve chromatography and particularly include TLC and HPLC.  
1.5.2.1 Thin Layer Chromatography (TLC) and High Performance Thin Layer 
Chromatography (HPTLC) 
TLC was developed in Russia in 1938 by Izmailov and was later made popular by Egon Stahl. Thin 
layers of absorbent silica gel are coated on to glass, metal or plastic. This makes up the stationary 





mobile phase over the stationary phase. It is simple, cheap, quick and easy to carry out. It does 
however have its disadvantages which include lack of full automation and reproducibility problems 
(Marston and Hostettmann, 2009).  
HPTLC is an advanced development of TLC by utilising cutting edge technologies and instrumentation 
for refinement of all stages in the method. Equipment with the ability for precise plate preparation, 
controlled and reproducible plate development and analysis using state of the art software has 
allowed progression of the technique. HPTLC is also semi-automated only requiring transfer from 
one piece of equipment to another. This allows even junior scientists to perform the method with 
professional results.  In basic terms the occurrence of human error can be eradicated in key stages as 
differences in or poor technique varied the results of TLC. Methodologies are constantly being 
developed which allows the use of standardised validated techniques. The particle size of HPTLC 
plates is much smaller than a TLC plate, which allows a shorter elution distance saving time and plate 
size. Vital factors such as humidity can be controlled allowing results to be reproducible from lab to 
lab. Samples are sprayed onto the plate in very small quantities reducing the volume needed and 
ensuring crisp bands are achieved further improving resolution (CAMAG, 2017).  
1.5.2.1.1 Use of TLC and HPTLC for the identification of Black Cohosh 
TLC is the method of choice for identification of A. racemosa and also the method of choice for 
detection of adulterant species, namely C. foetida (A. cimicifuga), C. americana (A. podocarpa), C. 
heracleifolia (A. heracleifolia) and C. dahurica (A. dahurica). The main problem is that the TLC assay 
for Actaea racemosa is based upon detection of the chemical marker 23-epi-26 deoxyactein. As 
outlined in section 1.5.2.2, this compound is also found in other species of Actaea. The other 






There is another method developed by CAMAG, combining HPTLC methods for triterpenes and plant 
acids. The method produces different banding patterns for several species but is limited to those 
species being significantly dissimilar enough for differentiation (Reich et al., 2008, Ankli et al., 2008).  
This method has been further developed by Verbitsky et al 2008 by coupling TLC with 
bioluminescence. The preliminary work showed that A. racemosa could be distinguished from A. 
podocarpa and A. pachypoda (Verbitski et al., 2008).  
Gaffner 2015 reviewed available (HPTLC) methods and found that they are similar. He also 
commented that the methods are proficient at identifying Black Cohosh in routine testing but, these 
techniques are not yet sufficient to detect adulteration. Figure 8 demonstrates the results of using 
HPTLC and also illustrates the ability of the method to differentiate between Actaea racemosa and 






Figure 8: The A finished silica plate from a HPTLC experiment visualised with white light following 
derivitisation with sulphuric acid. Samples include Actaea racemosa and three other potential adulterant 
species and highlights differences in chemical profiles between the different species. 
1.5.2.2  High Performance Liquid Chromatography (HPLC) 
As long as there is a sample can be dissolved in a liquid, the ability to separate, identify and quantify 
its constituent compounds is possible by HPLC. The method is automated. The stationary phase of 
HPLC is within a coated column and the mobile phase is the solvent which is pumped through the 
column at high pressure (Marston and Hostettmann, 2009).  
1.5.2.2.1 Use of HPLC in identification of Actaea racemosa 
High performance chromatography-evaporative light scattering detection (HPLC-ELSD) method has 






Figure 9: Fingerprint chromatograms obtained by Kan He et al 2006 by the HPLC-ELSD method 
(A) A. racemosa, (B) A. podocarpa, (C) A. cordifolia (D) A. acerina (E) A. biternat, (F) A. dahurica (G) A. 
cimicifuga (H) A. cimicifuga-2 (I) A. heracleifolia (J) A. japonica (K) A. simplex (L) A. simplex-2 (M) 
Remifemim (N) Cimipure (O) Product B. 
Compound 1 is 23-Epi-26-deoxyactein, which is present in A. racemosa and A. cimicifuga. This 
highlights that this is not an ideal marker for A. racemosa as it is present in other species. In other 
methods carried out in the same research paper, A. dahurica is also found to contain 23-Epi-26-





number 8 on Figure 9), which further research may prove to be a suitable chemical marker (He et al., 
2006). 
HPLC-ELSD has been further explored by Avula et al. The method that was previously developed by 
He et al 2006 was re-evaluated and streamlined (Avula et al., 2009).   
More recently Geng et al 2017 developed a method which could differentiate A. racemosa from A. 
dahurica, A. cimicifuga (written as A. foetida in the article – confusion with the synonym C. foetida), 
A. pachypoda and A. podocarpa. This was an LC-MS method combined with principle component 
analysis. Feruloyl dopamine-O-hexosides were used as markers and patterns of markers were used 
to identify the species. This is demonstrated in Figure 10. It is worth noting that it was not possible 
to differentiate A. dahurica and A. cimicifuga (written as A. foetida in the figure) using this technique 
(Geng et al., 2017).  
 
Figure 10: Principal component analysis of Actaea racemosa and 4 related species (Geng et al., 2017) 
1.5.2.3  Other chemistry based methods 





Huang et al 2015 used mass spectrometry to develop a method capable of distinguishing three 
Actaea species including A. racemosa, A. dahurica and A. podocarpa. This was based upon chemical 
fingerprinting. The data was analysed using principal component analysis (PCA) which was able to 
differentiate the species. Although the authors state that the method is simple and quick, there is 
limitation to the number of differentiated species and the capital cost of purchasing such equipment 
is high (Huang et al., 2015).  
1.5.2.3.2 Nuclear Magnetic Resonance  
Harnly et al 2015 conducted a combined study of mass spectrometry, NMR and DNA barcoding for 
Black Cohosh. The mass spectrometry section of the article is the same as what was described by 
Huang et al 2015 with the addition of further Actaea species; A. cimicifuga, A. pachypoda and A. 
rubra. Due to the complexity of the raw data the following species were analysed further; A. 
racemosa, A. podocarpa, A. pachypoda and A. rubra. An NMR based method was developed and 
compared to the mass spectrometry based method. In both cases the results were analysed using 
principal component analysis to cluster species together. In most samples identification matched for 
all three techniques. They did however find that a few of the samples did not fit in the respective 
clusters but were identified through DNA techniques. This shows how chemical methods can 
sometimes be wrong due to chemical constituent patterning in samples. NMR is the most costly out 
of the three methods from a capital perspective (Huang et al., 2015, Harnly et al., 2016).  
1.5.2.3.3 UV Spectroscopy 
Bittner 2016 used UV spectroscopy coupled with principal component analysis to attempt to 
differentiate Actaea racemosa from four other species; Actaea simplex, Actaea heracleifolia, Actaea 
cordifolia and Actaea cimicifuga. From the principal component analysis results it appears that it 
may be difficult to differentiate between Actaea racemosa and other Actaea species, as they cluster 





discrimination analysis). This was able to differentiate the species more clearly as shown in Figure 12 
for five of the included species (Bittner et al., 2016).  
 
A- A. racemosa, B – A. cordifolia, C – A. simplex D – A. cimicifuga, E – A. heracleifolia, F – A. dahurica, G – Unknown Actaea species  






Figure 12: Linear discriminant analysis of Actaea species showing differentiation. 
1.5.3 DNA based methods 
The polymerase chain reaction (PCR) has revolutionised modern molecular science. The method 
allows exponential amplification of a particular DNA target in a cocktail of deoxynucleotide 
triphosphates (dNTPs), DNA polymerase and specific oligonucleotide pairs. The method is utilised in 





There are many different DNA based identification methods in development by researchers across 
the globe. The biggest challenge is making these methods reproducible and easy to perform.  
An example is restriction fragment length polymorphism (RFLP). This method is possible using 
restriction enzymes, which cleave DNA at particular sequences (restriction sites). After treatment 
with restriction enzymes, a DNA sample may be cut into different fragments depending on the 
presence of restriction sites. The digested DNA is analyzed using gel electrophoresis and the pattern 
of fragments obtained is indicative of what DNA is present. This technique is extremely specific but 
can take time and expertise to perform. Masuda 2016 developed an RFLP assay for the detection of 
Actaea racemosa. This was based on Actaea racemosa uniquely having the restriction site BstBI 
within the nrITS region, which resulted in two fragments on digestion with the restriction enzyme. 
This method was useful for detecting Actaea racemosa in products but as undigested fragments 
remained it was not reliable for detecting contamination. The next step was to develop an amplified 
refractory mutation system (ARMS) technique. The region trnL-F was utilised in this case and was 
found to more clearly identify Actaea racemosa from other closely related species. Eight Black 
Cohosh products from the Japanese market were analysed using this method and three of the 
products did not contain Actaea racemosa. To further validate the results TLC and HPLC analysis was 
completed which matched the ARMS results in terms of detecting corresponding marker compounds 
(Masada, 2016).  
Another similar method is amplified fragment length polymorphisms (AFLP). This is based on the 
principles of RFLP. According to Vos (1995) who developed the method, there are three main steps. 
The first is digestion of the DNA using restriction enzymes and ligation of oligonucleotide adapters, 
the second is amplification of selected sets of amplified restriction fragments, and the third is gel 
electrophoresis of amplified fragments (Vos et al., 1995). Once established this method is very quick 





shown to be a tool in identification of A. racemosa and three adulterants, A. pachypoda, A. cordifolia 
and A. podocarpa (Zerega et al., 2002).  
Random amplified polymorphic DNA (RAPD) is a technique that involves the use of sets of random 
primers. These primers anneal at various locations across the DNA sample and may or may not cause 
a region to be amplified depending upon the distance between them. Different banding patterns by 
gel electrophoresis will be the outcome and is reflective of which primer binding sites are present in 
the genome. It is a cheap and easy method to use but variance in results between labs occurs (Yip et 
al., 2007). RAPD analysis has been shown to be useful in identification of A. racemosa and adulterant 
species. Xu et al 2002 was able to discriminate A. racemosa, A. podocarpa and A. cordifolia 
respectively based on the production of different banding patterns (Xu et al., 2002).  
Sequence characterized amplified region (SCAR) is an improvement of RAPD analysis. RAPD analysis 
is carried out and then identified polymorphic bands are excised from the gel and sequenced. 
Seethapathy et al 2014 used this technique to authenticate Ayurvedic medicines Aconitum 
heterophyllum and Cyperus rotundus respectively (Seethapathy et al., 2014). 
STRs (short tandem repeats) or SSRs (simple sequence repeats) are repeated units of short 
nucleotide sequences, typically 2-6 base pairs long. They appear randomly in the genome of humans, 
animals and plants, and are the basis of the forensic method of RFLP. The number of repeats varies 
amongst individuals and the pattern of repeats across several loci can be used as an identification 
tool. Although the technique is established for use as a forensic tool in identification of human 
individuals, there is also much research being conducted to include identification of plants. The 
applications for this include identification and geographical placement of illegal drugs such as 
Cannabis sativa L. (Gilmore et al., 2003), food adulteration studies (Zhang et al., 2011) and several 
more examples. Yuan et al 2015 used this technique to build a cDNA library for the Chinese 






The most thorough and reliable identification technique is direct DNA sequencing (Sanger 
Sequencing). However, this can be expensive and time consuming, and difficult to apply to mixed, 
degraded or contaminated samples, so not always practical.  
In the duration of this thesis there have been many advances in the barcoding effort for Actaea 
racemosa. Baker et al 2012 used the DNA barcode region matK to identify Actaea racemosa from 
other closely related species using Sanger Sequencing. The project involved four barcode regions 
also including nrITS2, trnH-psbA and rbcL, using 61 individual reference samples and 40 commercial 
product test samples. The success rate of the reference samples was good but the success rate of 
the commercial samples was lower. This is not surprising as the rigorous processing steps in 
producing herbal extracts can degrade the DNA somewhat. In these cases a barcoding primer pair 
targeted at an area with a smaller product outcome, mini-matK, was more successful. The purpose 
of mini barcodes is displayed in Figure 13.  
 
Figure 13: A diagram to show how mini barcode primers can overcome DNA degradation, allowing PCR 
amplification and thus enable sequencing (Parveen et al., 2016). 
To validate their DNA method, the group obtained 31 vouchered Actaea samples from the New York 





Table 11: A summary of the success rate of PCR amplification of four barcode regions in Actaea samples 
Barcode region Reference samples success rate Commercial test samples success rate 
matK 79% 0% 
trnH-psbA 97% 10% 
rbcL 100% 10% 
nrITS2 100% 38% 
Mini matK Not used 90% 
 
The sequence data was analysed to find differences in the barcode regions and allow identification 
of the individual species. Of 14 species they were able to find unique sequences in 7 species for 
nrITS2 and tnrH-psbA. Overall it was not possible to use one consistent barcode region for all 14 
species included in the study, but they did show that the matK region can be used for identification 
of Actaea racemosa as it had a unique sequence to the other Actaea species. (Baker et al., 2012). 
 
Masada-Atsumi et al 2014 conducted a study of 19 imported American Black Cohosh products, 6 non 
prescription Black Cohosh drugs from the European market and 5 samples of crude material 
available on the Japanese market used for production of Cimicifuga Rhizoma. The Japanese 
pharmacopoeia states four Actaea species for Cimicifuga Rhizoma; Actaea dahurica, Actaea 
heracleifolia, Actaea cimicifuga and Actaea simplex. DNA was extracted, the nrITS region was 
amplified and then sequenced using Sanger sequencing. Samples containing raw plant material were 
analysed with DNA techniques and the extracts were analysed using LC MS. Out if the 19 American 
products the group were able to sequence the nrITS region of 9. The region trnH-psbA was 
additionally sequenced for one of the products. They found that half of the products contained 
undeclared Actaea dahurica. The remaining products were dry extracts and could not be sequenced 
due to poor quality of DNA. All of the crude drug samples from Japan were found to be Actaea 
dahurica with one sample additionally containing Actaea heracleifolia. This is within the species 
prescribed in the Japanese Pharmacopoeia so legally acceptable to use in Japan for Sheng Ma but 





drugs were all found to contain two commonly used marker compounds of Actaea racemosa, Actein 
and 23-epi-26-deoxyactein, but were not assigned a species due the inability to obtain DNA 
sequences. The other American products were found to contain 23-epi-26-deoxyactein. Some of the 
products contained Actein but some of the others contained slightly different compounds denoted 
as X and Y which were very similar to Actein. Two of the products contained compound Y. This was 
suggested to be acetylacteol 3-O-arabinoside, a compound unique to Actaea cimicifuga. There was a 
discussion of the suitability of Actein and 23-epi-26-deoxyactein as marker compounds for 
authenticating Actaea racemosa as it was detected in all samples. More work is needed for 
conclusive results for all the samples (Masada-Atsumi et al., 2014).  
1.5.3.1 New DNA technologies 
1.5.3.1.1 Next Generation Sequencing (NGS) 
The downsides of Sanger sequencing can be overcome by next generation sequencing. A good 
example of the price difference would be that the human genome project cost £300 million when it 
was achieved. Today using Sanger sequencing this would cost £6 million. Next generation 
sequencing could achieve the same goal for £6000. It would also be much faster as instead of one 
single region up to 1kb being sequenced in each reaction, it can be done in parallel with many 
regions (Illumina, 2017).  
Next generation sequencing (NGS) is a blanket term used to cover several different technologies 
which includes but is not limited to: 
 Illumina sequencing (Illumina, 2017) 
 Ion torrent: Proton/PGM sequencing (ThermoFisher, 2017) 





The general principle of NGS is that large numbers of short reads are sequenced simultaneously and 
together build up a stronger result than classic sequencing with one sequenced strand. It is cheaper, 
more rapid and more reliable than Sanger Sequencing. 
In short Illumina sequencing is based on the following steps; the template is enzymatically cleaved 
up (100-150bp), generic adapters are ligated to the resulting fragments; these are annealed to a 
slide via the adapters and then amplified by PCR using fluorescently labelled nucleotides with 
terminators. For each cycle the slide is imaged, the terminators and fluorescent signal is removed 
and the next labelled base is added. This allows a library to be built up and gives very reliable 
sequence data (Illumina, 2017).  
Roche 454 sequencing is similar but the fragments are much longer up to 1kb. The principle is similar 
to Illumina but the fragments with adapters are annealed to beads rather than a slide. These beads 
are then placed in individual wells of a slide. Each dNTP is added separately and a signal read after 
each is added (Roche, 2017).  
Ion torrent and ion proton sequencing do not use imaging like the other types. It instead uses the 
release of hydrogen ions during nucleotide addition as a measuring tool. As with the other types of 
sequencing the template is cleaved up, this time to 200bp. A single strand is annealed to a single 
bead and placed on an individual well of a slide. Then, like 454 sequencing, each nucleotide is added 
separately and consecutively to the slide. The pH is monitored during the release of hydrogen ions 
and this is how the reaction is measured (ThermoFisher, 2017). 
1.5.3.1.2 Digital PCR 
Another novel method being developed is digital PCR (dPCR). This is becoming better known and 
more researched. The principle of digital PCR is to take a diluted sample and place it into reaction 
chambers that separate down to single molecules of DNA. The chambers are then counted and 





quantification but is relatively expensive to perform at present and so quantitative PCR is more 
favoured (Baker, 2012). Given a few years, dPCR technology will become more affordable and has 
great promise at present. 
Quantitative PCR (qPCR) or real-time PCR is a development of classic end point PCR. It combines the 
PCR amplification and detection steps using a fluorescent marker. As the PCR reaction progresses 
and the number of DNA copies increases, the fluorescent signal also increases which, with today’s 
technology is expressed in graph format. If a reaction is unsuccessful fluorescence will not be 
detected. A dilution series of a target DNA of known quantity can be performed, subjected to PCR 
cycling and analysed using a qPCR machine. The output is a standard curve which can be used to 
quantify unknown samples.  
1.5.3.1.3 High resolution melt curve analysis 
As part of the analysis at the end of a qPCR reaction it is possible to perform a melt curve analysis. 
This involves incrementally increasing the temperature from low to high. This separates the double 
DNA strands within the reaction influencing a change in fluorescence that is released from a DNA 
dye bound to the once double strands of DNA. When the first negative derivative of fluorescence is 
plotted against temperature, a sharp peak will be evident when nearing the melting point of the 
DNA product due to the rapid loss of fluorescence detected. Different length strands of DNA have 
different melting temperatures, and GC content and complementarity of the amplicons is also a 
factor in the melting temperature. Individual peaks will be shown for the different sized strands as 
long as the size difference is great enough. In theory an individual peak will be shown for each sized 
product within a reaction but there are limitations to the technique. There must be a large enough 
difference between the sizes of the DNA products in order to differentiate the two. This method has 
been developed into high resolution melt curve analysis (HRM) and is exactly as the name describes, 
in theory this method is able to differentiate between products of just 1 base pair difference. The 





analysis. SYBR based dyes can inhibit PCR reactions at higher concentrations and tend to re-associate 
with the strands of DNA during melting affecting the end result. The dyes used in HRM are so called 
‘release on demand’ and give a much clearer picture. This method has also been considered for 
barcoding in place of sequencing and has been termed ‘bar-HRM’. The principle is not based on size 
difference but rather single mutations unique to a particular species which could be detected using 
HRM. This has been successfully applied to several plant species so far including; Sideritis species 
using ITS2 (Kalivas et al., 2014) and Panax notoginseng using the region trnH-psbA (Tong et al., 
2014), to name a few examples. As mentioned in an earlier chapter mini barcodes can be used to 
overcome degradation of DNA. This was applied with bar-HRM in the species, Acanthus ebracteatus, 
Andrographis paniculata, and Rhinacanthus nasutus based on the rbcL region (Osathanunkul et al., 
2015) and also to Hypericum perforatum contamination with Hypericum androsaemum using mini 
matK (Costa et al., 2016).  
In general, DNA based methods have an advantage over chemical methods as they give an exact and 
definite identification.  
1.5.3.2 PlantID 
PlantID is an innovative method developed by researchers at De Montfort University in collaboration 
with the East Midlands Forensic Pathology Unit. The PlantID project was supported by the 
Healthcare and Bioscience iNet, which is funded by the East Midlands Development Agency and the 
European Regional Development Fund.  
The original PlantID system was developed using Hypericum perforatum L. , more commonly known 
as St John’s Wort, as the target, and resulted in the ability to discriminate between four closely 
related species of Hypericum (Howard et al., 2011). 
The PlantID system entails two steps in the working assay. The first is multiplex PCR of a sample with 





capillary electrophoresis of the PCR product. The system, once up and running, is easy to carry out 
and rapid (Howard et al., 2011). The main downfall is the expense of using capillary electrophoresis 
but could potentially be overcome by using high resolution gel electrophoresis or mini-capillary 
electrophoresis in place of this. The Lab-on-a-Chip (Agilent) and the QIAxcel (Qiagen) systems are 
examples that could be used.  
The final working PlantID method requires little expertise to perform and analyse, and is 
reproducible. It is also a rapid technique and fairly cheap to run after capital costs.  
1.6 Aims 
 To further develop a high specification DNA assay to distinguish Black Cohosh, Actaea 
racemosa, from extremely closely related likely adulterant species in mixed samples. The 
assay has the ability to detect multiple species in one sample. The number will be increased 
from 3 species to 5 species.  
 To develop a qPCR assay to confirm the identity of commercial Black Cohosh Products. 
 To assess the effect of Actaea racemosa and two closely related species on human liver cells. 
1.7 Objectives 
The above aims would be achieved by carrying out the following; 
 PCR of Actaea species with specific primers. PCR of Actaea species with other species 
specific primers to assess specificity. Optimisation of multiplex PCR and exploration into 
potential platforms for analysis.  
 Apply the above developed test to available commercial products 





 Apply the qPCR assay to assess a wide range of available products from the UK and American 
market. 
 Treat human liver cell lines with extracts of A. racemosa and 2 closely related Actaea 
species. 
 Extract RNA, convert to cDNA and analyse using gene expression with a specifically designed 






2 Genetic analysis of Black Cohosh, Actaea racemosa, 
and potential adulterant species 
2.1 Introduction 
Establishing a library of reference sequences is fundamental in the identification of plants using DNA 
based methods. The identification of specimens by sequencing relies on comparison to reference 
sequences from sequence databases. The identification of the material for these reference 
sequences must be achieved with high confidence. Even samples identified by expert taxonomists 
can be misidentified so thorough analysis of each sequence is paramount (Coutinho Moraes et al., 
2015). According to Chen et al 2014, in order to develop a reliable database of barcode sequences, 
the following must be achieved: three uniquely labeled duplicate collections of samples for each 
species with aliquots of material for DNA extraction and whole flowering plants for herbarium 
voucher samples (Chen et al., 2014b). This is in agreement with Smilie and Khan 2010, with both 
publications also stating the importance of photographs of the herbals in the environment from 
which they were harvested, collector’s details, detailed location, extensive notes of characters not 
evident from herbarium sample and for the material to be free of microbial contamination and 
infestation (Smillie and Khan, 2010). This information would aid a taxonomist in the identification of 
the raw material. It also makes vouchering of the material more conclusive and credible. Vouchered 
samples are not always identified correctly, jeopardizing the validity of any future work based on 
sequencing outcomes (Chen et al., 2014b). The art of taxonomy is becoming a rare career, and the 
talent is slowly diminishing (Coutinho Moraes et al., 2015). More often than not, the 
aforementioned ideal of fully documented vouchering is not achieved or even possible to deliver. 
This is particularly the case with raw material that has been procured processed in some way. These 
are the cases where the chance of misidentification increases. The barcode sequence data that is 





fundamental reason why it is important to ensure that the correct plant species has been used to 
generate this information. The efforts of all the research groups that are generating this information 
are of great value to the Barcode of Life effort.  
The parts of the plant genome focused on in this chapter are the Nuclear Ribosomal Internal 






Figure 15: A diagram to illustrate the chloroplast DNA of a plant and where the matK region is located 
The nrITS region was chosen as it is a proven barcode region of value. It has been demonstrated in 
several species to allow discrimination due to unique points in the region. It has been found to reap 
reproducible results and yield good quality sequence data.  In fact ITS2, a smaller portion of the nrITS 
region, has been identified as a barcode for herbal medicines as well as trnH-psbA (Chen et al., 
2014b). Due to the success of Baker et al 2012 in using mini matK to aid identification of species in 
commercial products, it was decided to use this region where it was not possible to successfully 
amplify the ITS region, however this was used with caution due to the lack of sequence entries for 
some species, for example there are no matK sequences for Actaea heracleifolia.  
 




Figure 14: A diagram to show the nrITS region and placement of primers ITS1 and ITS4 















Figure 16 displays differences in the genetic code of the nrITS region of the chosen species. This 
makes it possible to differentiate between the species and allocate identification. Caulophyllum 
thalictroides is from a completely different family to the Actaea species and therefore was difficult 
to align. 
Some of the sequence data utilized in this work was obtained from GenBank. GenBank is a freely 
accessible database of sequence data generated by researchers all over the world. In fact this is 
where the information was taken from to design species specific primers that were used in the MSc 
by Research degree project (Williams, 2012). At the time of design, barcoding was a relatively new 
idea and at the start of development, so sequence data for barcode regions was not in abundance. 
The Actaea sequence data was gathered from the work of Compton et al 1999, and the original 
purpose of this sequencing effort was to analyse the members of the Actaea genus, which at the 
time were the two separate genera; Cimicifuga and Actaea (Compton et al., 1998).  
The remainder of the sequence data was generated by sequencing vouchered DNA specimens and 
by also extracting DNA and performing sequencing for samples from many other sources. These 
sources ranged from plants grown from seeds to samples of roots provided by other research 
groups. The nrITS region was then amplified using PCR and directly sequenced.  
The main outcomes of this chapter are as follows: 
 To build up a library of reliable reference sequences for several species from the Actaea 
genus, with focus on the Black Cohosh species, Actaea racemosa.  
 Construct contigs of sequence data from multiple reads 
 Analyse the obtained sequence data of reference samples using BLAST (Basic Local 
Alignment Search Tool) and by constructing tree diagrams of the top 100 BLAST sequences 





 Confirm identification for the reference samples. 
2.2 Materials and methods 
2.2.1 Sourcing of plant materials and vouchered DNA samples 
Vouchered DNA specimens were the gold standard to be used in the development of the assays in 
this work, but supply was very limited and vouchers were not available for all the species that were 
to be investigated. Samples were obtained from many sources; the Royal Botanic Gardens, Kew, 
from Dr Eike Reich of CAMAG (Muttenz, Switzerland), samples grown from seeds (Beeches Nursery, 
Saffron Waldon, UK and Secret Seeds, Devon) and samples provided from other researchers such as 
Dr Maged Sharaf from the AHPA and Dr Richard Middleton of the BHMA.  
Table 12: A list of information for reference samples 
Species (Implied or known) Source DNA bank ID/Sample 
No. 
Type 
Actaea racemosa Kew 24092 DNA extract 
Actaea cordifolia Kew 20113 DNA extract 
Actaea pachypoda Kew 550 DNA extract 
Actaea dahurica Kew 24397 DNA extract 
Actaea cimicifuga Kew 10294 DNA extract 
Caulophyllum thalictroides Kew 28066 DNA extract 
Actaea heracleifolia CAMAG 52785BRM Powdered root/rhizome 
Actaea rubra CAMAG 52544 Powdered root/rhizome 
Actaea podocarpa CAMAG 53504BRM Powdered root/rhizome 
Actaea heracleifolia CAMAG 58448 Powdered root/rhizome 
Actaea heracleifolia CAMAG 58449 Powdered root/rhizome 
Actaea dahurica CAMAG 58450 Powdered root/rhizome 
Actaea simplex Beeches Nursery N/A Fresh leaf 
Actaea cimicifuga Secret Seeds N/A Fresh leaf 
Actaea cordifolia Secret Seeds N/A Fresh leaf 
Actaea racemosa Secret Seeds N/A Fresh leaf 
Actaea pachypoda Secret Seeds N/A Fresh leaf 
Actaea racemosa AHPA AHPA – BC037 Cut roots 
Actaea racemosa AHPA AHPA – BC038 Cut roots 
Actaea racemosa AHPA AHPA – BC039 Cut roots 
Actaea racemosa AHPA AHPA – BC040 Cut roots 
Actaea racemosa AHPA AHPA – BC041 Cut roots 
Actaea racemosa AHPA AHPA – BC042 Cut roots 
Actaea racemosa AHPA AHPA – BC043 Powdered roots 
Actaea racemosa AHPA AHPA – BC044 Whole roots 





Actaea racemosa AHPA AHPA – BC046 Whole roots 
Actaea racemosa AHPA AHPA – BC047 Whole roots 
Actaea racemosa AHPA AHPA – BC052 Powdered roots 
Actaea racemosa AHPA AHPA – BC053 Powdered roots 
Actaea racemosa AHPA AHPA – BC056 Powdered roots 
Actaea racemosa AHPA AHPA – BC057 Powdered roots 
Actaea racemosa AHPA AHPA – BC058 Whole roots 
Actaea racemosa AHPA AHPA – BC059 Extract 
Actaea racemosa AHPA AHPA – BC061 Whole roots 
Actaea racemosa AHPA AHPA – BC062 Whole roots 
Actaea racemosa AHPA AHPA – BC063 Whole roots 
Actaea racemosa AHPA AHPA – BC064 Cut roots 
Actaea racemosa AHPA AHPA – BC065 Whole roots 
Actaea racemosa AHPA AHPA – BC066 Whole roots 
Actaea racemosa AHPA AHPA – BC067 Whole roots 
Actaea racemosa AHPA AHPA – BC068 Whole roots 
Actaea racemosa AHPA AHPA – BC069 Whole roots 
Actaea racemosa AHPA AHPA – BC071 Whole roots 
Actaea pachypoda AHPA AHPA – BC078 Whole roots 
Astilbe biternata AHPA AHPA – BC083 Whole roots 
Astilbe biternata AHPA AHPA – BC084 Whole roots 
Serratula chinensis AHPA AHPA – BC091 Cut roots 
Actaea dahurica SynoPhtyo Ch.B.01230952 Sliced root 
Actaea cimicifuga SynoPhtyo Ch.B.13884K116-A Sliced root 
Actaea racemosa Staffort, DHU DR10-014-A Whole dried root and rhizome 
Actaea racemosa Staffort, DHU - Fresh Leaf 
Actaea spicata Staffort, DHU - Fresh Leaf 
Caulophyllum thalictroides Staffort, DHU - Fresh Leaf 
Actaea dahurica BGBM DNA Bank 8499 DNA extract 
Actaea pachypoda BGBM DNA Bank 8495 DNA extract 
Actaea simplex BGBM DNA Bank 8498 DNA extract 
Actaea rubra BGBM DNA Bank 8500 DNA extract 
Actaea heracleifolia BGBM DNA Bank 6700 DNA extract 
2.2.2 Extraction of DNA from plant material using the Qiagen DNeasy Mini Plant Kit 
The Qiagen DNeasy Plant Mini Kit (Qiagen Inc.,CA) and TissueLyser procedure was followed. To a 2 
mL safe-lock centrifuge tube, 100 mg of wet plant material or 20 mg of dry material was added.  A 
3mm tungsten carbide bead was put inside the tube. The tubes were then placed into the 
TissueLyser adapter set, fixed to the clamps and ground for one minute at 30 Hz. The position of the 
tubes was then reversed and the previous step was repeated to ensure equal treatment. Then 400 
µL of buffer AP1 and 4 µl of RNase A stock solution was added to each sample and mixed thoroughly. 
To lyse the cells, the samples were then incubated for 10 minutes at 65°C. The samples were mixed 





The samples were incubated on ice for 5 minutes after the addition of 130 µL of buffer AP2. This was 
carried out to precipitate unwanted substances such as polysaccharides and detergent. The tubes 
were centrifuged for 5 minutes at 20,000 x g to remove the precipitates from the supernatant. The 
supernatant was next pipetted into a QIAshredder Mini spin column placed inside of a 2 mL 
collection tube, and centrifuged at 20,000 x g for 2 minutes. The resultant flow through fraction 
from the previous step was transferred to another tube, the volume was noted and 1.5 times 
volume of buffer AP3/E was added. The samples were then mixed by pipetting.  
To a DNeasy Mini spin column, 650 µL of the mixture from the previous step was added and 
centrifuged for 1 minute at 6000 x g, the flow through was discarded. After this step, the rest of the 
mixture was added to the DNeasy Mini spin column and centrifuged for 1 minute at 6000 x g. This 
flow through was also discarded. The Mini Spin column was placed into a new collection tube and 
500 µL of buffer AW was applied. The column was then centrifuged for 1 minute at 6000 x g and the 
flow through was discarded. Another 500 µL of buffer AW was applied to the column and 
centrifuged this time for 2 minutes at 20,000 x g to dry the membrane, the flow through was again 
discarded. The mini spin column was carefully transferred to another microcentrifuge tube and 100 
µL of buffer AE was pipetted directly onto the membrane of the column. The columns were left to 
incubate for 5 minutes at room temperature and then centrifuged at 6000 x g for 5 minutes. This 
step was carried out to elute the DNA from the membrane and so the flow though was kept. This 
step was repeated and the eluates combined.  
2.2.3 DNA clean up using isopropanol method 
An isopropanol clean-up was used to remove contaminants and also to increase the concentration of 
the DNA if required.  For 50 µL of DNA sample in Tris-EDTA (TE) buffer (pH 8.0), 35 µL of isopropanol 
was added and the solution was mixed. The solution was then centrifuged for 30 minutes at 15,000 × 
g at a temperature of 4°C. The resulting supernatant was removed and the pellet was re-suspended 





supernatant was removed and the remaining ethanol was left to evaporate for approximately 20 
minutes at room temperature. Finally the pellet was re-dissolved in 50 µL of TE buffer. 
2.2.4 Basic DNA clean using the Qiagen DNeasy Mini Kit 
DNA samples from Royal Botanical Gardens, Kew contained residual ethidium bromide and caesium 
salts. Purification was achieved by using a part of the protocol for DNA extraction using the Qiagen 
DNeasy® Plant Mini-kit, with a few alterations. To begin with, 5 µL of the starting material and 15 µL 
of AP3/E buffer (1M Guanidine Hydrochloride (4.78 g in 50 mL 100% EtOH)) were placed in a 1.5 mL 
tube and mixed by vortexing. This solution was then transferred into a DNeasy Mini Spin column 
(white) placed in a 2 mL collection tube and centrifuged for 1 minute at ≥ 6000 x g. The flow through 
was discarded and the collection tube reused for the next step. To the spin column, 400 µL of Buffer 
AW, was added and centrifuged for 1 minute at 6000 x g. The flow through was discarded and the 
collection tube reused for the next step. The previous step was repeated but centrifuged for 2 
minutes at 20,000 x g to dry the membrane of the column. The column was then transferred to a 1.5 
mL tube and 25 µL of buffer AE was applied directly onto the membrane. An Incubation step at room 
temperature was carried out for 5 minutes and then the column was centrifuged for 1 minute at 
6000 x g to elute. This step was repeated to result in a total elution volume of 50 µL.  
2.2.5 Standard (End-point) Polymerase Chain Reaction 
For experiments using the standard polymerase chain reaction, a ready-made mix was used called 
Red Mix (Bioline, London). This mix contains DNA polymerase, dNTPs, MgCl2, and DNA loading buffer 
already in the correct proportions. The addition of nuclease free water, primers and a template 
completed the recipe. Reactions were typically 25 µL final volume except if a reaction was being 
prepared for sequencing and 50 µL would be made. An extra reaction would be included in the 
master mix to compensate for loss during pipetting.  I.e. if 10 reactions were needed the master mix 





Table 13: The recipe required for each PCR reaction when using Red Mix, Bioline.  
Component Amount for 1 reaction (µL) 
2 X Red Mix 12.5 
Forward Primer 0.5 
Reverse Primer 0.5 
Template 1 
Nuclease free water 10.5 
 
2.2.6 Gel Electrophoresis using agarose 
Agarose gel electrophoresis was used to analyse the results of PCR products. A 1 X Tris/Borate/EDTA 
(TBE) buffer (pH 8.0) was used in this case for gel electrophoresis. Various gel tanks were used with 
different capacities. Generally 50mL of TBE and a variable amount of agarose were used to prepare 
the gel. The agarose powder was added to the TBE and melted using the microwave, which was 
typically around 90 seconds. To decide upon the percentage of gel required, Table 14 was consulted; 
Table 14: Required Agarose gel percentage depending upon amplicon size. 
Expected Product Size Agarose Concentration (w/v) 
< 150 bp 3% 
150 - 300 bp 2% 
> 300 bp 1% 
 
To allow detection of DNA amplicons, 1 µL of SYBR® Safe dye (Invitrogen, Carlsbad, CA, USA), was 
added to the melted solution. This was then poured into a gel mould with combs in place to create 
wells and left to solidify. Once set, the combs were removed, the gel was placed into the tank and 
TBE buffer was poured to the fill level. Typically, 5 µl of PCR product was loaded into each well and 
100 V were passed through for 25 minutes. Different voltages and times were required for different 
products. Generally short amplicons were run on a high voltage for a short amount of time. For 
reactions containing multiple products, i.e. multiplex PCR, gels were run at a low voltage and long 





The gels were photographed using a BioRad (BioRad, Hercules, California, United States) illuminator 
with a ChemiDocXRS Camera and Quantity One Software.   
2.2.7 DNA sequencing 
Sanger sequencing was used and was performed externally (Macrogen, Amsterdam). Samples of 
good quality, i.e. amplified with ITS primers and showed a bright crisp band on a gel, was sent to the 
sequencing provider. PCR product was sent to the company who cleaned it up using on column 
technique and sequenced using the Applied Biosystems ABI3730XL genetic analyzer. This machine 
has 96 capillaries and is designed to be suited for high throughput applications. The sequence 
information is then uploaded to an online portal where it is available for the customer.  
2.2.8 Bioinformatics tools 
Basic Local Alignment Search Tool (BLAST) from NCBI was used to search through the GenBank 
database of sequences. BLAST is available from the following web address: 
https://blast.ncbi.nlm.nih.gov/Blast.cgi. The software aligns the query sequence with sequences 
from the database and returns a list of the top 100 closest matches. 
Trees were constructed using MUSCLE to align the sequences, Gblocks to curate the sequences, 
PhyML to construct the tree and TreeDyn to visualise the constructed tree. These tools were 





2.3 Results and discussion 
2.3.1 Creation of a Reference Library of reliable database sequences  
2.3.1.1 Analysis of available sequence data on GenBank 
The reliability of the sequence information used from GenBank was very important in order to be 
able to identify samples in this work. This data therefore had to be analysed before confidence could 
be given to any identification. A search was carried out on GenBank for each of the species of 
interest.  For some of the Actaea species included, there was a plethora of available information, for 
others the data was very limited. Table 15 shows this information. 
Table 15: The number of sequence data accessions for the ITS region for species of interest in this project 
 Region 
Species matK nrITS 
Actaea racemosa 53 29 
Actaea dahurica 5 49 
Actaea cimicifuga 7 25 
Actaea heracleifolia 0 22 
Actaea rubra 17 10 
Actaea cordifolia 2 4 
Actaea simplex 8 150 
Actaea pachypoda 15 8 
Actaea podocarpa 6 7 
Caulophyllum thalictroides 5 2 
(Correct as of 06.03.2017) 
For nrITS, the sequences were aligned and then organised into a tree diagram to assess which of 
them were reliable to use. This is based on the concept of ‘DNA taxonomy’ described by Blaxter 
2004. It is important to note that this is not a phylogenetic tree. The purpose of the tree diagrams in 
this chapter is not to show evolutionary relationships, but rather to show how similar the sequence 
data is. The sequences that are grouped together in a ‘tree branch’ are termed as molecular 
operational taxonomic units or MOTU, and this visually displays similarity and therefore whether the 





sequences in terms of reliability (Blaxter, 2004). If the top sequence hit from BLAST, in other words 
the best matched sequence from GenBank, was grouped into a ‘tree branch’ with other sequences 
of the same labelled species, this would be a reliable identity. Some of the Actaea simplex sequences 
had to be omitted from the diagram as the software has a limit of 200 sequences and there was 































For nrITS most of the entries were clearly grouped into branches with species of the same name. 
These sequences were deemed reliable to use for identification of own sequence data. There were 
some odd entries that did not get grouped in a branch of the same species. If there were any 
matches to these sequences then this identification would not be seen as reliable as they are highly 
likely to have been misidentified.  
For mini-matK the available sequence entries (Shown in Figure 20) were not grouped at all and for 
this reason this region would not be used alone to identify samples. This region would be used if the 
nrITS could not be amplified and would only be used in combination with results from other 
methods. 
2.3.1.2 Identification of reference sample collection using the nrITS and matK region 
Reference samples were collected from many sources. DNA samples from vouchered specimens 
were obtained from Kew Royal Botanical Gardens (RBG), London and also from the Botanical Garden 
and Botanical Museum (BGBM), Berlin. Samples were also obtained from collaborations with other 
researchers from the American Herbal Products Association (AHPA), British Herbal medicines 
Association (BHMA) and CAMAG, Switzerland. Finally there were some samples from material 
suppliers that were of interest to identify for future applications. 
The DNA samples from RBG, Kew had to be cleaned up as there were PCR inhibitors present from 
the DNA extraction method. It was initially found that PCR was unsuccessful without a DNA clean up 
step. The DNA samples from BGBM, Berlin were ready to use. The rest of the samples arrived in a 
form that required DNA extraction. Once this was achieved all the samples were amplified using PCR 
with ITS primers. Where a good product with ITS primers could not be obtained, mini matK primers 
were used instead, but as mentioned this was with caution and only to back up other results. This 
information was never used alone for identification. The PCR products were sent to an external 





The sequences when obtained were first checked for quality. A good quality sequence has good 
strongly signalled single peaks and clearly defined base pair demotions for each peak. 
 
Figure 21: A section of a good quality sequence trace – showing good intensity clear peaks 
Figure 21 displays a section of a good quality sequence. Clear well defined peaks are displayed and 
each peak has been designated a DNA base.  
Usually three reads of a sample are performed; two with the forward primer and one with the 
reverse primer, and this was carried out when a sequence did not match well to a reliable GenBank 
sequence. If a first read was a good match to a sequence from GenBank and the match was assigned 
to a MOTU with the same species, then this read was deemed enough to confirm identification. 
In the cases where multiple reads were performed, contigs were assembled. This involved aligning 
the three reads and then systematically resolving any conflicts of base pair denotation. The 
sequences are also trimmed to remove poor quality sections from the start and/or end of the 
sequence.  
All of the sequence traces supplied by the sequencing providers can be found in the appendix 
section. 
 
Figure 22: A section of the start of a sequence trace to illustrate poor quality areas that would be trimmed 
The sequence trace in Figure 22 shows the beginning of the data and the part in the red box would 





would affect how well a sequence could be matched to one from a database and so must be 
attended to. 
Next the sequences were identified using information from GenBank. This was possible by using 
BLAST to search through the GenBank database. The software aligns the input sequence with the 
available sequences on the Genbank database and returns the top 100 closest matches. It also gives 
a percentage match and coverage percentage. Each sequence accession that a query sample was 
matched to was checked for which MOTU it was assigned to. In general if a sequence match was 
grouped with other of the same species in a MOTU, the result was considered reliable.  
Table 16 shows a summary of each of the reference samples that were analysed. The table shows 
the original species labelling, the identification from BLAST and where the BLAST match sequence is 
organised in the DNA tree. This information will be useful in the later chapters where assays are 
developed and validated with some of these samples. Samples where identification has been 
confirmed can be used. Samples that have had another identification confirmed other than how the 
sample was labelled could be used for validation based on the sequencing information. Some of 
these sequences can be added to the databases to broaden what is available. This will be a very 




















Synophyto Bulk Raw Material for 
making extracts 








BC050 DR10-014-A Staffort, DHU Bulk Raw Material for 
making extracts 
A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
135 53504BRM CAMAG Powdered Roots A .podocarpa A. podocarpa Z98280.1 99% A. podocarpa 
157 52784BRM CAMAG Powdered Roots A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
158 52483BRM CAMAG Powdered Roots A. pachypoda A. pachypoda Z98277.1 99% A. pachypoda 
161 52789BRM CAMAG Powdered Roots A .dahurica A. racemosa GQ409509.1 99% A. racemosa 
BC052 58448 CAMAG Powdered Roots A. heracleifolia A. dahurica GQ351361.1 99% A. dahurica 
BC053 58449 CAMAG Powdered Roots A. heracleifolia A. dahurica JQ033523.1 96% A. dahurica 
132 52544 CAMAG Powdered Roots A. rubra A. rubra Z98278.1 99% A. rubra 
- 550 Kew DNA Extraction A. pachypoda A. pachypoda Z98277.1 99% A. pachypoda 
- 24092 Kew DNA Extraction A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
- 24397 Kew DNA Extraction A. dahurica A. simplex AB987682.1 99% A. simplex 
- 10294 Kew DNA Extraction A. cimicifuga A. cimicifuga GQ351362.1 99% A. cimicifuga 
- 20113 Kew DNA Extraction A. cordifolia A. cordifolia AB987680.1 99% A. cordifolia 
080 - Beeches nursery Fresh Leaves A .simplex A. simplex AB987683.1 99% A. simplex 
067 - Secret Seeds Fresh Leaves A. dahurica A. racemosa GQ409509.1 99% A. racemosa 
068 - Secret Seeds Fresh Leaves A. cimicifuga A. cimicifuga GQ351362.1 98% A. cimicifuga 
069 - Secret Seeds Fresh Leaves A. cordifolia A. cordifolia AB987680.1 99% A. cordifolia 
070 - Secret Seeds Fresh Leaves A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
071  Secret Seeds Fresh Leaves A. rubra A. rubra Z98278.1 99% A. rubra 
072 - Secret Seeds Fresh Leaves A. pachypoda A. pachypoda Z98277.1 99% A. pachypoda 
S12 AHPA – BC064 AHPA Whole roots A. racemosa A. racemosa GQ409511.1 98% A. racemosa 
S13 AHPA – BC065 AHPA Whole roots A. racemosa A. racemosa GQ409509.1 98% A. racemosa 





S15 AHPA – BC078 AHPA Raw Material Roots A. pachypoda A. pachypoda Z98277.1 99% A. pachypoda 
S22 AHPA – BC053 AHPA Powdered Roots A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
S25 AHPA – BC058 AHPA Whole roots A. racemosa A. dahurica AB987685.1 98% A. dahurica 
1119 AHPA – BC044 AHPA Whole roots A. racemosa A. cimicifuga GQ351362.1 99% A. cimicifuga 
1116 AHPA – BC039 AHPA Root and Rhizomes A. racemosa A. racemosa AB987687.1 99% A. racemosa 
S21 AHPA – BC052 AHPA Powdered roots A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
S8 AHPA – BC042 AHPA Root and rhizomes A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
S9 AHPA – BC043 AHPA Powdered 
root/rhizome 
A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
S17 AHPA – BC066 AHPA Whole roots A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
S18 AHPA – BC067 AHPA Whole roots A. racemosa A. racemosa AB987687.1 95% A. racemosa 
1117 AHPA – BC040 AHPA Root and rhizomes A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
BC055 - Staffort, DHU Fresh Leaves A. racemosa A. racemosa GQ409509.1 99% A. racemosa 
BC056 - Staffort, DHU Fresh Leaves A.  spicata A. spicata Z98279.1 99% Species not 
included in tree 
BC057 - Staffort, DHU Fresh Leaves C. thalictroides C. robustrum JX040540.1 98% N/A – non- 
Actaea 
- 8495 BGBM DNA Extraction A. Pachypoda A. pachypoda Z98277.1 98% A. pachypoda 
- 8498 BGBM DNA Extraction A. simplex A. simplex AB987682.1 99% A. Simplex 






The sequence data for the SynoPhyto material was not of the best quality therefore it was not 
possible to obtain a high percentage match. As a guide, anything less than a 95% match does not 
give a reliable identification, as there are several differences in the sequences at this point. 
The identification for the material labelled as Caulophyllum thalictroides is also not firm as there 
were limited sequence entries to obtain a match from. There were just two entries, one for ITS1 and 
one for ITS2 which are separate parts of the nrITS region. The sample BC057 was also a match for 
Caulophyllum thalictroides at 98% but much smaller coverage due to the sequence entry length 
being much smaller than the query sequence. In Figure 23, an alignment of the two matches and the 
query sequence are displayed. It is shown in this figure that there are around the same number of 
differences between the query sequence to each of the matches respectively. This leaves a level of 
uncertainty and this is mainly due to the lack of sequence information on GenBank for this species. 
 
Figure 23: An alignment of BC057 – C. thalictroides with two potential matches from GenBank – red boxes 





There were some other samples that were not in agreement with the labelled species to the 
sequencing identification. One sample from the AHPA was labelled as Actaea racemosa but was 
actually sequenced to be Actaea cimicifuga. A few of the powdered samples from CAMAG were also 
sequenced to be different from the labelled identification and one of the plants grown from seeds 
was identified incorrectly.  
One of the DNA extracts from Kew was identified to be Actaea simplex rather than Actaea dahurica.  
The rest of the samples had their labelled identifies confirmed with sequencing and will make useful 
additions to the sequencing data available along with being reliable samples for assay development 
and validation samples. 
2.4 Conclusions  
Overall it was possible to show that the majority of the GenBank sequences for the nrITS region of 
Actaea were reliable. The tree diagrams were able to show that most of the sequences had the 
correct species assigned to them as these sequences were correctly grouped together. It would be 
useful to the research community to add the sequences obtained in this chapter to what is available 
to broaden the number. Particularly for the species which have limited accessions. Caulophyllum 
thalictroides requires more entries in the database. Although there are two entries, they are two 
separate parts of the nrITS region, one being ITS1 and the other being ITS2. 
The matK region is not reliable to use alone as there is not enough difference to completely separate 
the species in the Actaea genus. This region would only be used if it is not possible to amplify the 
nrITS region when assurances are needed from sequencing to back up other results. They will still be 
used with caution however.  
This is the first time an appraisal of the available sequence data has been completed and the fact that 






2.4.1 Sequencing of raw material from SynoPhyto, China and Staffort, Germany 
The A. cimicifuga material purchased from SynoPhyto was intended to manufacture ethanol extracts 
along with material identified as A. dahurica. The A. dahurica material is not mentioned in the 
summary as it was not possible to obtain a PCR product from the ITS region. This could be for a 
number of reasons including DNA degradation due to processing techniques. It was important to 
attempt to identify these materials as the resulting extracts were intended for treatment of cultured 
human hepatocytes and assessment of hepatotoxicity (Chapter 5. Investigation into potential 
hepatotoxicity of three Actaea species). The A. racemosa material obtained from Staffort, DHU, was 
also intended for extract production and so was of equal importance to identify. The A. cimicifuga 
material was not clearly identified using sequencing. The sequence data was not of high quality and 
so it was not possible to match with GenBank sequences with confidence. The trace obtained from 
the sequencing provider showed a low intensity.  
 
Figure 24: A portion of the sequence trace from the A. cimicifuga material from SynoPhyto 
The blast search showed Actaea dahurica as the top hit at 81% as it had the most coverage of 91% of 
the sequence. Actaea cimicifuga was coming up as a match further down the list of hits, with several 
showing as 87% identification with less coverage of the query sequence (48-51%).  When the top 100 
hits from BLAST are organised into a tree diagram it can be shown that there is very little relationship 
between any of the hits thus reinforcing the bad quality of the sequencing data. This is displayed in 






Figure 25: A tree diagram of the top 100 hits for A. cimicifuga material from SynoPhyto – Query sequence 





For this example it was necessary to look a bit deeper at the alignments. These are shown in Figure 
26. Both hits have many discrepancies and therefore this data is inconclusive. When the two 
different sequences are aligned, Actaea dahurica and Actaea cimicifuga, it can be seen that they are 
themselves very similar. This material will also be assessed with a qPCR assay in a later chapter. The 
PCR product in the qPCR assay was designed to be smaller than the ITS PCR product and so there was 
the potential to obtain a better quality product with this method and overcome any potential 
degradation (Chapter 4 Development of a qPCR assay for the authentication of A. racemosa and 
detection of potential adulterants). A HPTLC assay would also be used to assess chemical constituent 
patterning along with a taxonomist assessment of the raw material.  
 
Figure 26: Alignments of A. cimicifuga material from SynoPhyto with A. dahurica and A. cimicifuga sequences 
available from GenBank. 
The A. racemosa material from Staffort, DHU, was already positively identified using morphological 





2.4.1.1.1 Assessment of vouchered DNA samples from Botanical garden DNA banks 
For the MSc by Research degree project (Outlined in Chapter 3. Further development of the PlantID 
assay) (Williams 2012), the analysis of DNA sample from Kew, Royal Botanical Gardens, i.e. 
identifying the sequences using BLAST, was not carried out to the same extent. The DNA samples 
were sequenced but the data was checked for quality rather than identification. At the time it was 
taken for granted that the samples were identified correctly. These samples were used to develop 
species specific primer pairs with differing sized products from one species to another to enable 
identification within a mixed sample. 
Table 17: A list of relevant information of DNA samples used to develop the plantID assay 
Species Source DNA bank 
ID 
Sequence agreement? Successful in final 
MSc PlantID assay? 
Actaea 
racemosa 
Kew 24092 Yes Yes 
Actaea 
cordifolia 
Kew 20113 Yes No 
Actaea 
pachypoda 
Kew 550 Yes No 
Actaea dahurica Kew - No – A. simplex No 
Actaea 
cimicifuga 
Kew 10294 Yes Yes 
Actaea 
heracleifolia 
CAMAG 52785BRM Sequence data was poor – 
closest match – A. dahurica 
No 
Actaea rubra CAMAG 52544 Yes No 
Actaea 
podocarpa 
CAMAG 53504BRM Yes Yes 
Actaea simplex Beeches 
Nursery 
- Yes No 
Caulophyllum 
thalictroides 




The Actaea dahurica DNA purchased from Kew was extracted from a vouchered sample that would 
have been identified morphologically from a taxonomist. The sequencing data however has a top hit 
for Actaea simplex so this will be explored further.  
The alignments for the top hit, Actaea simplex and the top hit for Actaea dahurica were both studied.  





From looking at the alignments it seems that Actaea simplex is a match in this case. For the purpose 
of developing species specific primers, this DNA sample would not be appropriate.  
It was however at the time used for developing A. dahurica species specific primers for the PlantID 
assay (described in Chapter 3. Further development of the PlantID assay). The designed A. dahurica 
primers were not successful and neither were the A. simplex species specific primers. Each primer set 
produced PCR products with a panel of other Actaea species. The obvious reason for this is that the 
wrong template was used for the A. dahurica species specific primer development which in turn 
prevented both sets of species primers from being specific at the time. This was revisited later on in 
the qPCR assay development as it was very desirable to be able to identify A. dahurica species 
(Chapter 4 Development of a qPCR assay for the authentication of A. racemosa and detection of 
potential adulterants). A new template was procured for the assay development but this could still 
not be included in PlantID due to the high melting temperature required for specificity. The plantID 
assay melting temperature had to be 62.7°C for specificity of certain primer pairs but could not be 
more as other primer pairs would not work at higher temperatures. The A. heracleifolia template 
used at the time gave a poor sequence trace also and the primers were not successfully optimised or 






Figure 27: Comparison of alignments of potential matches of Actaea dahurica DNA from Kew - Actaea 






Figure 28: A tree diagram of the top 100 hits from BLAST when using the Kew DNA sample labelled A. 





In the end only three species were able to be included in the PlantID assay due to issues with some of 
the templates used. The same species specific primers would be used for development of qPCR 
assays and so further work will need to be carried out. 
The species specific primers were first designed in 2009. At the time there were limited sequence 
entries in GenBank and the species specific primers were designed with these available sequences. In 
2013 the qPCR assays began development. By 2015 there was much more sequence data for Actaea 
species deposited into GenBank which allowed the checking of the specificity of the primers on a 
larger pool of information and for sequenced samples to be identified. This helped tremendously 






3 Further Development of the PlantID Assay 
3.1 Introduction 
Adulteration of Black Cohosh with Asian Actaea species is a known occurrence (Jordan et al., 2010, 
Jiang et al., 2006, Jiang et al., 2011). In Chinese and Japanese medicine several Asian Actaea species 
are used in a medicine called Cimicifugae Rhizoma, in Chinese medicine this is called Sheng Ma. This 
is also the Latin name for Black Cohosh and therefore the medicine is sometimes marketed with the 
incorrect name. This can cause confusion and allow the wrong species to be used.  
Due to the wild harvesting of Black Cohosh there is also the potential for contamination with other 
Native American species that grown in a similar habitat. These plants can also look very similar and 
could be mistaken for Black Cohosh and therefore collected by accident. Blue Cohosh, Caulophyllum 
thalictroides can also be labelled as Black Cohosh by mistake due to the similar common names.  
Owing to the fact there are several potential adulterants of Black Cohosh it could be beneficial to 
have a test that is capable of detecting multiple adulterant species simultaneously.  
The idea for PlantID came from Tobe et al 2008 who developed a one tube assay to detect 18 
different mammalian species. The reaction was carried out in multiplex in one tube with a primer mix 
designed to produce different sized products for each species and then analysed using capillary 
electrophoresis (Tobe and Linacre, 2008).  
This was also applied to the medicinal herb St John’s Wort successfully. This was a good development 
of the original assay idea due to the similarity of the Hypericum species compared to the original 
work with very different species that were easy to distinguish. The Hypericum based assay was 
capable of distinguishing the authentic species Hypericum perforatum from three other Hypericum 






















Figure 29: A flow chart to show the development of the PlantID assay for the differentiation of three Actaea 
species – primer design, primer optimisation, multiplex PCR optimisation and visualising separation of PCR 
products with capillary electrophoresis using fluorescently labelled primers. 
Species-specific primers designed 
This was achieved by aligning the nrITS barcode 
sequence of 10 species and finding unique points 
of differentiation. 
 
Designed primer trialled on target and non target species to ensure specificity 
 
Positive PCR bands with the target species ✓No PCR bands with the non-target panel ✓ 
 
  
With target With non target panel 
Ensure primer pairs can work together at the same melting temperature 
 
 











In the MSc by Research degree completed in 2012 (Williams 2012), the PlantID assay was first 
developed for Black Cohosh. It was successful and capable of distinguishing between 3 different 
species of Actaea, namely Actaea racemosa, Actaea cimicifuga and Actaea podocarpa. Figure 29 
displays the steps involved to develop the PlantID assay for Actaea.  
The aim in the current piece of work is to increase the number of species that can be detected. There 
was issues with some of the primer pairs in the original work that could have been resolved if there 
had been more time available. In this piece of work the number of species included has been 
increased to five. This now includes Blue Cohosh, Caulophyllum thalictroides and Actaea cordifolia. 
The method has also been simplified from capillary electrophoresis to agarose gel electrophoresis.  
At current there are no methods for detecting multiple species in Black Cohosh material to the same 
level as this assay. 
The main outcomes of this chapter are to: 
 Increase the number of detectable species to include Caulophyllum thalictroides and Actaea 
cordifolia. This will add to the current assay which is able to detect Actaea racemosa, Actaea 
cimicifuga and Actaea podocarpa. 
 Trial other platforms for analysis including qPCR with high resolution melting (HRM). This 
method has been shown to be useful in identification of species in herbal medicine (Costa et 





3.2 Materials and Method 
3.2.1 Sourcing of plant materials and vouchered DNA samples 
Vouchered DNA specimens were the favoured sample type to be used in the development of this 
assay, but supply was very limited and not available for all the species that were to be investigated. 
Although vouchered DNA specimens are identified by expert taxonomists, they were still further 
identified using sequencing as it was found in the previous chapter that even these experts can 
assign incorrect identity. The following samples were used; from the Royal Botanic Gardens, Kew 
there were six vouchered DNA samples; Actaea racemosa, Actaea pachypoda, Actaea dahurica, 
Actaea cimicifuga, Actaea cordifolia and Caulophyllum thalictroides. Three of the samples were a gift 
from Dr Eike Reich (CAMAG Muttenz, Switzerland): Actaea rubra, Actaea podocarpa and Actaea 
heracleifolia. The remaining sample, Actaea simplex, was from a plant purchased from a commercial 
nursery (Beeches Nursery, Saffron Waldon, UK). 
Table 18: A list of relevant information of DNA samples used to develop the plantID assay. 
Species Source DNA bank ID Collector (Kew) 
Actaea racemosa Kew 24092 
HerbariumKewenseCultivatedPlants 
s.n., TaxonomicNote: 2006 
S.Landrein (K) det. Cimicifuga 
racemosa (L.) Nutt. 
Actaea cordifolia Kew 20113 Chase 
Actaea pachypoda Kew 550 Chase 
Actaea dahurica Kew 24397 TCMK82 
Actaea cimicifuga Kew 10294 Chase 
Actaea heracleifolia CAMAG 52785BRM  
Actaea rubra CAMAG 52544  






Caulophyllum thalictroides Kew 28066 Chase 
 
In the previous chapter, sequencing was attempted for each of the templates in Table 18. It was 





not be identified using sequencing but all of the species that were included in the final assay except 
from Caulophyllum thalictroides were identified successfully with sequencing.  
3.2.2 Extraction of DNA from plant material using the Qiagen DNeasy Mini Plant Kit 
The DNA extractions were carried out using the method outlined in 2.2.2 Extraction of DNA from 
plant material using the Qiagen DNeasy Mini Plant Kit (Qiagen Inc., CA).  
3.2.3 DNA clean up using isopropanol method 
DNA cleans up where required were carried out as outlined in 2.2.3 DNA clean up using isopropanol 
method.   
3.2.4 Basic DNA clean using the Qiagen DNeasy Mini Kit 
DNA purchased from Royal Botanical Gardens, Kew, was cleaned up using the method outlined in 
2.2.4 Basic DNA clean using the Qiagen DNeasy Mini Kit (Qiagen Inc., CA).  
3.2.5 Primer Design 
The primers that were used for the development of the PlantID assay were designed by Professor 
Adrian Slater using the software program AlleleID® (Premier Biosoft., USA). This was achieved by 
aligning the nrITS sequence of all the species of interest and inputting this data into AlleleID®. The 





Table 19: A summary of analysis of the original Genbank sequences used to design species specific primers. 
Species Accession 
number 
Name of sequence Length 
(bp) 
Author(s) MOTU result 
Caulophyllum 
thalictroides 
L77158.1 Caulophyllum thalictroides (L.) 
Michx. internal transcribed 
spacer 1 (ITS1) DNA 








Z98296.1 Cimicifuga racemosa 5.8S 
nuclear rRNA gene and ITS1 







Z98284.1 Cimicifuga dahurica 5.8S 








Z98287.1 Cimicifuga foetida 5.8S nuclear 








Z98280.1 Cimicifuga americana 5.8S 
nuclear rRNA gene and ITS1 
and ITS2 DNA 
605 Culham,A Actaea 
podocarpa 
Actaea rubra Z98278.1 Actaea rubra 5.8S nuclear rRNA 
gene and ITS1 and ITS2 DNA 
607 Culham,A Actaea rubra 
Actaea 
cordifolia 
Z98297.1 Cimicifuga rubifolia 5.8S 
nuclear rRNA gene and ITS1 
and ITS2 DNA 




Z98289.1 Cimicifuga heracleifolia 5.8S 
nuclear rRNA gene and ITS1 
and ITS2 DNA 




Z98298.1 Actaea simplex 5.8S nuclear 
rRNA gene and ITS1 and ITS2 
DNA 




Z98277.1 Actaea pachypoda 5.8S nuclear 
rRNA gene and ITS1 and ITS2 
DNA 
608 Culham,A Actaea 
pachypoda 
 
There was limited sequence data for Caulophyllum thalictroides. Only two accessions are available on 
GenBank which are two separate sections of the region. This means that using BLAST for matching 







Figure 30: The results of using BLAST explorer when using a Caulophyllum thalictroides sequence as the 
query. 
The primer pair for Actaea cordifolia was redesigned as the original design was not compatible in the 
PlantID assay. The primers were not suitable for the necessary melting temperature required for the 
assay. The new primer pairs were designed by studying the sequence alignment of the 9 Actaea 
species. They were based on the existing designed primers with extra base pairs added on to increase 





Figure 31: An alignment of the species included in PlantID – placement of included primers shown







3.2.6 Preparation of non-target panels of DNA 
In order to test primer specificity, non-target panels were made up. This was achieved by creating 
mixtures of all the nrITS high fidelity reactions minus the species that the primers were designed for, 
i.e. Non-A.rac contained DNA for all species except A. racemosa.  The protocol in Table 20 was 
followed to create all the non-target panels. For the non-target panels each ITS Hi-Fi reaction was 
added at 10 times the concentration of what was used for the target template. This is because by 
adding them together they become diluted 10 times. The target DNA templates and non-target 
panels remain a consistent concentration.  
Table 20: A table to show which species were included in respective non-target DNA panels. 



















Non-A.rac           
Non-A.rub           
Non-A.pac           
Non-A.her           
Non-A.pod           
Non-A.cor           
Non-A.dah           
Non-A.sim           
Non-A.cim           
Non-C.thal           
3.2.7 Standard (End-point) Polymerase Chain Reaction 
This is outlined in 2.2.5 Standard (End-point) Polymerase Chain Reaction.   
3.2.8 Multiplex Polymerase Chain Reaction 
The Qiagen Multiplex PCR kit (Qiagen Inc., CA) was used. The kit consisted of 2× Qiagen Multiplex 
PCR Master Mix and RNase free water. To start with, reactions were made up to 50 µL, and included 
25µL of 2× Qiagen Multiplex PCR Master Mix, 5 µL of 10× primer mix (IDT, Iowa USA and Invitrogen, 
Carlsbad, CA, USA), 2 µL of template DNA and 18 µL of RNase free water. The reactions were made 





components of the reaction in the same proportion as before.  The primer mix was prepared to start 
with following suggested protocol, as by Table 21 below.  
Table 21: Preparation of a 10 × primer mix 
Components Primer stock concentration 
 25 µM 100 µM 
Primers (2 µM) 4 µl 1 µl 
Water Variable Variable 
Total volume 50 µl 50 µl 
 
In order to balance efficient and inefficient reactions, the primer concentration was altered and 
optimised in the final mix.  
The following conditions, Table 22, were used for amplification after optimisation; 
Table 22: Conditions required for Multiplex PCR with the candidate primers selected for PlantID. 
Initial Denature 30 cycles Final Extension 
Denature Anneal Extend 
95°C 95°C 62.4°C 72°C 72°C 
15 minutes 30 seconds 90 seconds 60 seconds 10 minutes 
 
3.2.9 Gel Electrophoresis using agarose 
PCR reactions were analysed using gel electrophoresis with the method outlined in 2.2.6 Gel 
Electrophoresis using agarose.  
3.2.10 High resolution melting (HRM) 
The MeltDoctor™ Master Mix (Applied Biosystems, California) was utilised for these experiments. 





Table 23: The recipe required for each high resolution melting reaction using MeltDoctor 
Component Amount (µL) 
MeltDoctor™ MasterMix 2 X 5 
Forward Primer 0.3 
Reverse Primer 0.3 
DNA Template 1 
Nuclease free water 3.4 
 
Each test sample was analysed in triplicate. Samples were evaluated using the StepOnePlus qPCR 
machine (Applied Biosystems, California) under the conditions outlined in Table 24. After cycling was 
complete, the experiment was opened with Applied Biosystems HRM software for analysis.  




40 cycles Melt curve 









95°C 95°C 62.4°C 60°C 95°C 0.3°C/Min 




3.3 Previous development in the MSc by Research project 
IMPORTANT NOTE: All work in this section was carried out during the MSc by Research degree in 
2012 by Sarah Williams and is only included in this thesis for background purposes (Williams 2012). 
The main development covered in the MSc by Research project was to optimise the primers. 
This involved testing pairs of species specific primers with target DNA to ensure that they were 
capable of amplifying the desired species. The next step was to test the species specific primers with 
non-target panels. If any amplification occurred then the temperature of the annealing stage of the 
PCR reaction was increased. If increasing the annealing temperature did not resolve the issue the 





then the primer pair was again discarded. The requirement was for the species specific primer pair to 
amplify only the target at a reasonable temperature. The results of the testing are summarised below 
in Table 25. 
Table 25: Results of optimisation for species specific primers 








Candidate? Number of 
Candidates 
A. racemosa C.ram F.1.5 C.ram R.1.4 65.3 - Failed to amplify target 
2 
A. racemosa C.ram F.1.4 C.ram R.1.4 66.7 - No stringency 
A. racemosa C.ram F.1.3 C.ram R.1.4 65.8 - No stringency 
A. racemosa C.ram F.1.2 C.ram R.1.3 56.4 57 Candidate 
A. racemosa C.ram F.1.1 C.ram R.1.2 52.0 60 Optimised Tm too high 
A. racemosa C.ram F.1.1 C.ram R.1.1 52.4 57 Candidate 
A. rubra A.rub F.1.2 A.rub R.1.6 61 65 Optimised Tm too high 
0 
A. rubra A.rub F.1.1 A.rub R.1.5 64.7 68 Optimised Tm too high 
A. rubra A.rub F.1.2 A.rub R.1.4 62.1 66 Optimised Tm too high 
A. rubra A.rub F.1.2 A.rub R.1.3 61.7 65 Optimised Tm too high 
A. rubra A.rub F.1.1 A.rub R.1.2 64 67 Optimised Tm too high 
A. rubra A.rub F.1.1 A.rub R.1.1 64.4 68 Optimised Tm too high 
A. pachypoda A.pac F.1.6 A.pac R.1.2 67.8 - No stringency 
0 
A. pachypoda A.pac F.1.5 A.pac R.1.2 67.8 - No stringency 
A. pachypoda A.pac F.1.4 A.pac R.1.3 63.8 68 Optimised Tm too high 
A. pachypoda A.pac F.1.3 A.pac R.1.2 67.8 - No stringency  
A. pachypoda A.pac F.1.2 A.pac R.1.2 67.1 - No stringency 
A. pachypoda A.pac F.1.1 A.pac R.1.1 57.0 61 Optimised Tm too high 
A. dahurica A.dah F.1.2 A.dah R.1.5 62.7 65 Optimised Tm too high 
0 
A. dahurica A.dah F.1.3 A.dah R.1.3 55.0 57 Optimised Tm too high 
A. dahurica A.dah F.1.2 A.dah R.1.4 63.3 66 Optimised Tm too high 
A. dahurica A.dah F.1.1 A.dah R.1.3 55.3 57 Optimised Tm too high 
A. dahurica A.dah F.1.2 A.dah R.1.2 63.3 65 Optimised Tm too high 
A. dahurica A.dah F.1.1 A.dah R.1.1 55.0 58 Optimised Tm too high 
A. heracleifolia A.her F.1.3 A.her R.1.1 60.3 - Failed to amplify target 
0 
A. heracleifolia A.her F.1.2 A.her R.1.4 59.0 63 Optimised Tm too high 
A. heracleifolia A.her F.1.3 A.her R.1.2 60.5 66 Optimised Tm too high 
A. heracleifolia A.her F.1.2 A.her R.1.3 59.0 64 Optimised Tm too high 
A. heracleifolia A.her F.1.1 A.her R.1.2 60.2 65 Optimised Tm too high 
A. heracleifolia A.her F.1.1 A.her R.1.1 60.1 - Failed to amplify target 
A. simplex A.sim F.1.4 A.sim R.1.4 57.8 64 Optimised Tm too high 
0 
A. simplex A.sim F.1.4 A.sim R.1.3 58.4 - Failed to amplify target 
A. simplex A.sim F.1.2 A.sim R.1.4 57.4 - Failed to amplify target 
A. simplex A.sim F.1.3 A.sim R.1.3 58.7 64 Optimised Tm too high 
A. simplex A.sim F.1.2 A.sim R.1.2 57.3 63 Optimised Tm too high 
A. simplex A.sim F.1.1 A.sim R.1.1 67.0 - No stringency 
A. podocarpa A.pod F.1.3 A.pod R.1.6 65.8 - Failed to amplify target 
1 
A. podocarpa A.pod F.1.1 A.pod R.1.5 61.2 - Failed to amplify target 
A. podocarpa A.pod F.1.3 A.pod R.1.4 66 - Failed to amplify target 
A. podocarpa A.pod F.1.2 A.pod R.1.3 65.6 - No stringency 
A. podocarpa A.pod F.1.1 A.pod R.1.2 61.9 62.4 Candidate 
A. podocarpa A.pod F.1.1 A.pod R.1.1 63.2 68 Optimised Tm too high 
A. cimicifuga A.cim F.1.5 A.cim R.1.5 63.4 63.4 Candidate 
5 
A. cimicifuga A.cim F.1.4 A.cim R.1.4 61.6 61.6 Candidate 
A. cimicifuga A.cim F.1.3 A.cim R.1.3 64.5 67 Optimised Tm to high 
A. cimicifuga A.cim F.1.1 A.cim R.1.2 59.5 59.5 Candidate 
A. cimicifuga A.cim F.1.2 A.cim R.1.1 59.5 60 Candidate 
A. cimicifuga A.cim F.1.1 A.cim R.1.1 60 63 Candidate 





A. cordifolia A.cor F.1.5 A.cor R.1.1 52.9 - Candidate 
A. cordifolia A.cor F.1.4 A.cor R.1.2 63.8 65 Candidate 
A. cordifolia A.cor F.1.3 A.cor R.1.1 52.9 - Candidate 
A. cordifolia A.cor F.1.2 A.cor R.1.1 52.9 54 Candidate 
A. cordifolia A.cor F.1.1 A.cor R.1.1 52.9 54 Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 57.3 - Failed to amplify target 
8 
C. thalictroides C.thal F.1.1 C.thal R.1.1 65.3 - Failed to amplify target 
C. thalictroides C.thal F.1.1 C.thal R.1.1 66.5 - Failed to amplify target 
C. thalictroides C.thal F.1.1 C.thal R.1.1 62.9 - Failed to amplify target 
C. thalictroides C.thal F.1.1 C.thal R.1.1 64.4 - Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 63 - Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 59.8 - Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 59.8 - Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 57.9 - Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 57.9 - Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 57.3 - Candidate 
C. thalictroides C.thal F.1.1 C.thal R.1.1 57.3 - Candidate 
 
The next step was to choose primers to take on to the next stage of multiplex optimisation. Table 26 
shows which primers were chosen. 



















Came.F.1.1 GGCAAGTGTCGTGGTCTG Came.R.1.2 GTTGAACGGATTATAAGGGGTATG  108 62.4 
Actaea 
cimicifuga 


















The next step was to check if the primers would interact once used in the same reaction. Primer 
dimer software was used to this end and showed no issues. 
A new target panel of all five species was made up. A primer mix was also made up. The multiplex 








1) Multiplex using a primer mix with all 5 primer combinations 
and a DNA mix with all 5 templates. 
 
2) A. racemosa singleplex 
3) A. podocarpa singleplex 
4) A. foetida singleplex 
5) C. thalictroides singleplex 
6) A. cordifolia singleplex 
 





Figure 32: Multiplex and singleplex reactions for PlantID candidate species. 
The annealing temperature required of the multiplex reaction was too high for A. cordifolia specific 
primers to produce a product. They had to be removed from the multiplex at this stage. There were 
also problems with C. thalictroides and this also had to be removed. The fluorescently labelled 
primers ordered for fragment analysis did not produce a product. In the end the PlantID assay was 
capable of detecting and discriminating between 3 species as shown below in Figure 33. 
 
Figure 33: Fragment analysis results of the Black Cohosh PlantID assay. 





Due to time constraints of the MSc by Research project the PlantID assay was only developed to this 
point. 
For the PhD project the aim was to optimise another C. thalictroides primer pair and also to redesign 
an A. cordifolia primer to work at the required multiplex temperature. This would bring the overall 
number of distinguishable species from 3 to 5 species. Other platforms of analysis would also be 
explored. 
3.4 Results and discussion 
As mentioned, the aim was to increase the number of distinguishable species from 3, as seen in the 
MSc work to 5 species. The evaluation of the MSc work showed that it would be possible to detect A. 
cordifolia and C. thalictroides with some further work. The reason that A. cordifolia was not an option 
for the original assay is that the melting temperature of the main assay was too high. The working 
temperature for the assay had to be so in order for A. cimicifuga primers to be specific. Anything 
lower and non-specific amplification would occur. There was another primer pair option for A. 
cordifolia but the melting temperature was 65°C and none of the A. racemosa primers would work at 
this temperature. The solution to this issue was to redesign the A. cordifolia specific primers with the 
outcome of increasing the melting temperature. This could be achieved by increasing the length of 
the primers. Four primers were designed yielding 8 possible combinations. These primers were 
trialled in the same way as the previous primers and an annealing temperature of 62.7°C was used. 
They were first used to amplify the target DNA – A. cordifolia. Of the 8 combinations, 4 were able to 
produce a product. The next stage was to use the successful primers in respective reactions with the 
non-target panel. Again all 4 combinations did not amplify. One of these pairs was put forward for 






Figure 34: An alignment of PlantID species and placement of newly designed A. cordifolia specific primers 
 
Figure 35: Testing of newly designed A. cordifolia primers 
    1          2        3        4          5       6         7        8       9        10        11       12       13      14      15    16   17     18   
18 
 10 
                 With A. cordifolia template        With non-A. cordifolia panel 
1 – F.1.2.1 + R.1.1.1 6 – F.1.5.2 + R.1.1.2 11 – F.1.2.1 + R.1.1.1 16 – F.1.5.2 + R.1.1.2 
2 – F.1.2.2 + R.1.1.2 7 – F.1.5.1 + R.1.1.2 12 – F.1.2.2 + R.1.1.2 17 – F.1.5.1 + R.1.1.2  
3 – F.1.2.1 + R.1.1.2 8 – F.1.5.2 + R.1.1.1 13 – F.1.2.1 + R.1.1.2 18 – F.1.5.2 + R.1.1.1 
4 – F.1.2.2 + R.1.1.1 9 – No template  14 – F.1.2.2 + R.1.1.1 





For the C. thalictroides specific primers it was unknown why the primers ceased to work and due to 
time constraints during the MSc degree this was not explored further. Upon closer analysis it would 
appear that the original primers selected did not yield a good product and the presence of an 
artefact on the gel obscured this fact. Therefore it was a simple case of selecting and trialling another 
potential primer pair.  
 
 
Primer Pair Sense primer Anti-sense primer Tm (°C) 
1 C.tha F.1.5 C.tha R.1.4 57.3 
2 C.tha F.1.4 C.tha R.1.3 65.5 
3 C.tha F.1.3 C.tha R.1.3 66.8 
4 C.tha F.1.2 C.tha R.1.1 63.0 
5 C.tha F.1.2 C.tha R.1.2 64.4 
6 C.tha F.1.1 C.tha R.1.1 63.0 
7 C.tha F.2.6 C.tha R.2.2 59.8 
8 C.tha F.2.5 C.tha R.2.2 59.8 
9 C.tha F.2.4 C.tha R.2.1 57.9 
10 C.tha F.2.3 C.tha R.2.1 57.9 
11 C.tha F.2.2 C.tha R.2.1 57.3 
12 C.tha F.2.1 C.tha R.2.1 57.3 
13 NTC 
Figure 36: The previous results for C. thalictroides primer pair trials (Williams, 2012). Positive PCR 
amplification shown by the presence of a band on the accompanying agarose gel. 
Table 27: The concentration of each primer that was included in the PlantID assay for the first set of 
experiments 
Specific species template Primer Names Concentration 
(nM) 
Size of product 
(bp) 
A. racemosa Arac F.1.2 and Arac R.1.3 400 304 
A. podocarpa Apod F.1.1 and Apod R.1.2 200 108 
A. cimicifuga Acim F.1.4 and Acim R.1.4 300 180 
A. cordifolia Acor F.1.2.2 and Acor R.1.1.2 200 322 
C. thalictroides Cthal F.2.6 and Cthal R.2.2 400 87 
 
These primers were designed in 2009 and at the time there was a limited amount of sequence data 
available from GenBank to use. Since this time there has been much more data added to the 
database. It was sensible to check through the available sequences in Genbank again to see how 
specific the primers are. Each set of primers was checked using BLAST (Basic Local Alignment Search 
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Tool). Only results with coverage of 100% were considered matches due to the search being for the 
primers and the entire primer must match the sequences to be considered. 
Table 28: Results of specific primer BLAST searches. 
Species Primer Match(es) Coverage 
Actaea racemosa Aram.F.1.2   Actaea racemosa 100% 
Actaea racemosa Aram.R.1.1 
Actaea racemosa 100% 
Actaea heracleifolia 100% 
Ranunculus haastii subsp. piliferus   100% 
Actaea podocarpa Apod.F.1.1 Actaea podocarpa 100% 
Actaea podocarpa Apod.R.1.1 Actaea podocarpa 100% 
Actaea cordifolia Acor.F.1.5.1 
Actaea cordifolia 100% 
Actaea elata 100% 
Actaea cordifolia Acor.R.1.1.1 
Actaea cordifolia 100% 
Actaea elata 100% 
Actaea arizonica 100% 
Caulophyllum thalictroides Ctha.F.1.5 
Caulophyllum thalictroides 100% 
Neurada procumbens 100% 
Caulophyllum robustum 100% 
Caulophyllum thalictroides Ctha.R.1.4 
Caulophyllum thalictroides 100% 
Caulophyllum robustum 100% 
Actaea cimicifuga Acim.F.1.4 
Actaea cimicifuga 100% 
Actaea brachycarpa 100% 
Actaea frigida 100% 
Actaea yunnanensis 100% 
Actaea mairei 100% 
Actaea kashmiriana 100% 
Actaea europaea 100% 
Actaea cimicifuga Acim.R.1.4 
Actaea cimicifuga 100% 
Actaea brachycarpa 100% 
Actaea frigida 100% 
Actaea yunnanensis 100% 
Actaea mairei 100% 
Actaea kashmiriana 100% 
Actaea europaea 100% 
   
From the search it found that the Actaea racemosa forward primer was specific only to Actaea 
racemosa. The reverse primers matched to Actaea racemosa but also to Actaea heracleifolia and an 
unrelated species of Rannunculus. This was not an issue as the forward primer was completely 
specific ensuring that in combination the primer pair would be specific to Actaea racemosa. The 
Actaea podocarpa primers were both completely specific to Actaea podocarpa. The Actaea cordifolia 
primers were both a match to Actaea cordifolia but were also both a match to Actaea elata. Actaea 
elata is not a known adulterant for Black Cohosh so in this case is not a concern. The reverse primer 





any issues. The Caulophyllum thalictroides primers were a match to Caulophyllum thalictroides but 
also were both a match to Caulophyllum robustrum. In the previous chapter it was shown that there 
is only one sequence entry to Caulophyllum thalictroides. This again is not a known adulterant of 
Black Cohosh and so was not a concern. The forward primer was a match to Neurada procumbens 
but the reverse was not. The Actaea cimicifuga primers were both a match for various other Asian 
Actaea species not included in the project as they are not known adulterants of Black Cohosh.  
There was also limited data from the Asian Actaea species. The sequences were organised into a tree 
to assess how similar they are and if the sequences of the same names species are grouped together. 
Actaea elata appears to be reasonably differentiated from the other included species but the rest are 
mixed up with the Actaea cimicifuga branch. This raises questions about the identification of these 
species. They could potentially be Actaea cimicifuga. There was limited numbers of sequence data 
for these species with many only having one accession. As these species are not known adulterants 












Figure 38: A 3% agarose gel showing Singleplex reactions for each species (lanes 1-5), a multiplex reaction of 
the five included species (Lane 6) and a mixture of each of the singleplex reactions to use as a reference 
(Lane 7).  
Each of the five templates was amplified in a singleplex reaction with the species specific-primers. 
The templates were also mixed together to be amplified in a multiplex reaction. These samples were 
then run on a 3% gel. There were thought to be issues with separation of the A. cordifolia (Lane 4) 
and C. thalictroides (Lane 1) product as only one band was showing in the multiplex reaction (Lane 6). 
To check this, each of the Singleplex reactions were mixed together (Lane 7) and run alongside the 
multiplex reaction. This revealed that the C. thalictroides product was not forming in the multiplex 
reaction despite forming a product in Singleplex. The concentration of this primer pair was increased. 
The other issue was that it appeared that the product size for A. cordifolia and A. racemosa were too 
similar to be separated using gel electrophoresis. Another primer pair was selected with a greater 
difference in size and used in the next experiment. A new primer mix was made as shown in Table 29. 
Table 29: The concentrations of primers used in the primer mix for PlantID 
Specific species template Primer Names Concentration 
(nM) 
Size of product 
(bp) 
A. racemosa Arac F.1.2 and Arac R.1.3 500 304 
A. podocarpa Apod F.1.1 and Apod R.1.2 200 108 
A. cimicifuga Acim F.1.4 and Acim R.1.4 300 180 
A. cordifolia Acor F.1.5.1 and Acor R.1.1.2 100 223 
C. thalictroides Cthal F.2.6 and Cthal R.2.2 700 87 
    1          2              3               4            5             6            7 
1 – C. thalictroides  
2 – A. cordifolia  
3 – A. racemosa  
4 – A. podocarpa  
5 – A. cimicifuga  
6 – Multiplex reaction with all 
templates  






Figure 39: A 3% agarose gel showing singleplex reactions of each of the included five species and a multiplex 
reaction of the five species combined 
This next experiment worked very well. The gel was allowed to run for a longer time to allow good 
separation of the multiplex products. All of the products were present in the multiplex reaction and 
the new primer pair for A. cordifolia produced a smaller product which could be separated from the 
A. racemosa product. The increased concentration of C. thalictroides primers gave a product in the 
multiplex and so solved that issue.  
The multiplex reaction was also carried out using qPCR and melt curve analysis. The reactions were 
monitored using Meltdoctor as a fluorescent signal. All amplification will be picked up the same and 
there will be no difference seen at the amplification stage. Standard melt curve analysis is not a 
strong enough technique to differentiate between the close sizes of some of the products produced 
by the primers. This is where high resolution melting (HRM) will be trialled to see if this can be 
overcome. During the MSc degree this method was not available. Although high resolution melting 
offers the ability to resolve very small changes in product size, other factors can make a big 
difference to the overall result including overall product size and GC content. Unfortunately one of 
the PCR products exceeds the maximum size of this technique. The maximum size is 250 base pairs 
and one of the products exceeded 300 base pairs. A test run was carried out regardless.  
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1 – C. thalictroides  
2 – A. cordifolia  
3 – A. racemosa  
4 – A. podocarpa  
5 – A. cimicifuga  










Figure 40: High resolution melting of singleplex and multiplex reactions – two variants shown – green variant 
shows A. cordifolia and the blue variant is the remaining species. 
Unfortunately this was not very successful. The technique was only able to detect two variants. 
Actaea cordifolia was found as one variant and all the other species were detected as the same 
C. thalictroides singleplex A. cordifolia singleplex 
A. racemosa singleplex A. podocarpa singleplex 
A. cimicifuga singleplex Multiplex with all five templates 
Overlay of all singleplex reactions 
Overlay of the two variants detected – A. 





variant. New primers would have to be designed for this platform and as the PCR with gel 
electrophoresis works fine no more time will be invested in this technique at present. 
3.5 Conclusions and further work 
The aim of this chapter was to further develop an assay capable of detecting mixtures of different 
plant species within one test. The importance and need for such a test is the ongoing difficulty of 
testing mixtures of polyherbal formulations. It also makes for an efficient test combing five species 
detection assays in one assay.  
The plantID species detection capability was successfully increased from three to five. The more 
species that are added to the assay the more competition there is for the reagents required for 
amplification. This required more optimisation to balance the efficiencies of the primers included.  
There are two levels to this assay; the species specific primers are designed to amplify only the 
species of interest and the primers are designed to amplify products of different sizes so that they 
are able to be combined into one reaction. It was sensible to amplify the templates in individual 
reactions so that it could be visualised in the multiplex reaction if the products were apparent and 
assess if the length of time for running the gel was sufficient.  
The assay was originally visualised using capillary electrophoresis. This method gave a very firm 
conclusion for the results as the peaks were labelled with the species name if detected. The method 
is also more relatively expensive than other methods that exist. The capital cost of purchasing 
equipment is high and the running costs of such equipment are also high. It was possible in this work 
to visualise the multiplex on a simple agarose gel. This reduces the cost significantly in comparison to 
capillary electrophoresis and potentially saves time. Each reaction when using capillary 
electrophoresis takes around 20 minutes to complete. For the gel electrophoresis method the entire 
gel takes 2 hours to complete but there is the potential to run 80 samples simultaneously with the 





electrophoresis apparatus have 96 capillaries capable of running 96 reactions at once. The 
equipment available during the MSc had only one capillary.  
To attempt to reduce the overall time of the assay, qPCR coupled with high resolution melting was 
trialled. This was not successful. If there was an interest to use this method in the future for this 
application, new primers would need to be designed specifically for HRM with products of less than 
250 base pairs as the outcome. The method, like electrophoresis, would require the products to be of 
differing sizes enough to detect each. Other considerations are also the GC nucleotide content of the 
products as this affects the melting temperature. In the HRM assay performed in this work four 
products that were of differing size had the same melting temperature and so were indistinguishable.  
The aim of this chapter was to extend the capability of the PlantID method to differentiate five 
species instead of three. This aim was achieved along with the aim to simplify the analysis of the 
multiplex PCR output using gel electrophoresis in place of capillary electrophoresis. The original 
method using Capillary electrophoresis is lengthy, troublesome and depends on the existence of 
expensive equipment and consumables. It was also found that the capillary electrophoresis method 
was not very reproducible between labs and between varying genetic analyser models. The outcome 
of this chapter was a much improved method with an extended capability of species detection. 
The results of this chapter show the potential to develop assays for complex polyherbal formulations 
where sequencing and indeed most analytical chemistry based method would not be possible. This 
could be particularly useful in Traditional Chinese Medicine and Ayurvedic medicine where the 
products are made up of several different herbs. The plantID system can also be developed to test 





4 Development of a qPCR assay for the 
authentication of A. racemosa and detection of 
potential adulterants 
4.1 Introduction 
Authentication of Black Cohosh has been a well-researched area with several research groups using 
barcoding grouped with UV spectroscopy, mass spectrometry and HPLC. There have also been DNA 
methods developed using restriction enzymes in various applications including RAPD, (Xu et al., 2002) 
RFLP, ARMS (Masada-Atsumi et al., 2014) and AFLP (Zerega et al., 2002). In this chapter novel qPCR 
based methods for detection of Actaea racemosa, Actaea dahurica and Actaea cimicifuga are 
presented as an easier and more rapid method compared to what is already available. The use of 
qPCR cuts out the need to run a separate diagnostic agarose gel as the reaction is plotted in real time 
and results are available immediately after the experiment is concluded. Techniques using qPCR have 
been developed for detection of plants containing aristolochic acid (Wu et al., 2015), for 
authentication of Actaea cimicifuga which is used in traditional Chinese medicine (Xue et al., 2009) 
and for authentication and detection of adulterants in the traditional herbal medicine Drynaria 
fortunei (Xue and Xue, 2008). The assay for Actaea cimicifuga (Xue et al., 2009) is based on melt 
curve analysis and includes detection of adulterant species; Actaea heracleifolia, Actaea acerina and 
Actaea simplex. These kinds of assays are not widely used at present and very little has been 
published. Mishra et al reviewed many available DNA based techniques for identification of herbal 
medicines in 2016 and mentions just two studies for qPCR methods (Mishra et al., 2016).  
Lessons were learned in the last few years after the New York Attourney General Office issued cease 
and desist orders to three large shopping chains for several dietary supplements including some 





declared species in a large proportion of the products.  It is well known within the field that is not 
always possible to amplify or sequence DNA barcode regions in products containing extracts due to 
the extraction process and potential heat and UV treatments of the raw materials. The testing that 
was carried out was from a single laboratory with no other identification techniques being employed. 
The scientist that was consulted also had no expert knowledge in the field of pharmacognosy, botany 
or natural product chemistry. The actions were deemed premature and without full scientific 
evidence. Chemical based methods should have been employed to check the results of the DNA 
study (Blumenthal, 2015). The difficulty in amplifying full-length barcodes from processed materials 
has led to the belief that it is effectively impossible to extract DNA from products made from 
extracts.  However, it was shown by Kazi et al that it is possible to extract short fragments of DNA 
from a wide range of finished products including some made with extracts. This study was based on 
St John’s Wort, Hypericum perforatum. The product range included capsules, tablets and also 
tinctures. In the study, 13 products were included and all 13 products were successful in yielding 
DNA that was verified to be Hypericum perforatum as labelled. It was however necessary to design a 
primer pair capable of amplifying an 80bp product in order to overcome the effects of DNA 
degradation during processing (Kazi et al., 2013). 
The development of the PlantID assay, detailed in Chapter 3. Further development of the PlantID 
assay, yielded some good species-specific primers but not all of them were suitable to be used in a 
multiplex assay due to incompatible annealing temperatures. Due to the development and access to 
better technologies it has since become possible to run qPCR assays in tandem using different 
annealing temperatures. This has led to the development of qPCR assays for the detection of 
adulteration and or substitution of species of Actaea that could not be detected using PlantID. In the 
PlantID work it was not possible to obtain specific Actaea dahurica primers and this was because the 
vouchered DNA was found to be Actaea simplex. Vouchered DNA from another bank was sourced 
and the primers were trialled once again, this time proving to be specific for their intended target. In 





highest interest. This is due to several occasions where Asian Actaea species have been found as 
adulterants or substitutions in Black Cohosh products (Jordan et al., 2010, Jiang et al., 2006).   
Species-specific primer pairs were designed for use in singleplex qPCR assays for the three target 
species. The assays were first optimised using DNA from vouchered sources. Once this was 
completed, the assays were validated using reference samples which were sequenced to reinforce 
the results. Following on from the validation of the assay, commercially available finished products 
were tested. For legal reasons these products have been anonymised using a numerical naming 
system. In some cases, products were found to be adulterated or even substituted.  
Importantly, an Actaea generic primer pair was utilised as a control in this assay. This was designed 
to amplify any Actaea species DNA present in a parallel reaction to the species-specific primers. For 
example, if there was no amplification of a template DNA with the Actaea racemosa primers but 
amplification occurred with the generic primer pair, it could be concluded that there was amplifiable 
DNA, but that it was not from A. racemosa. A negative result with the generic primers would 
indication the absence of any amplifiable DNA, and negative results from all of the species-specific 
primers would be expected. 
Where possible the commercial samples were also sequenced to reinforce any results obtained but 
this was not straight forward when degraded DNA was present. The samples provided by the AHPA 
were also part of a chemical based analysis. The samples were analysed using mass spectroscopy and 
principle component analysis. These results added another layer of identification to the samples but 
were not always in agreement with the DNA based efforts. 
The aims of this chapter are to: 
 Utilise species-specific primers from the PlantID chapter for qPCR based assays (see Chapter 





 Demonstrate specificity of the primers using sequenced templates for Actaea racemosa, 
Actaea dahurica and Actaea cimicifuga. 
 Validate the assay with reference samples (Identification reinforced in Chapter 2 Genetic 
analysis of Black Cohosh, Actaea racemosa, and potential adulterant species) 
 Use the assay to test commercial products for the presence of the included species. 
4.2 Materials and Method 
4.2.1 Extraction of DNA using the Qiagen DNeasy Plant Mini Kit 
For the full method please see: Section 3.2.2: Extraction of DNA from plant material using the Qiagen 
DNeasy Mini Plant Kit. 
4.2.1.1 Extraction of DNA with additional protein digestion step 
 
The Qiagen Dneasy Plant Mini Kit (Qiagen Inc., CA) and TissueLyser procedure was followed. To a 2 
mL safe-lock centrifuge tube, 100 mg of wet plant material or 20 mg of dry material was added.  A 
3mm tungsten carbide bead was put inside the tube. The tubes were then placed into the 
TissueLyser adapter set, fixed to the clamps and ground for one minute at 30 Hz. The position of the 
tubes was then reversed and the previous step was repeated to ensure equal treatment. Then 630 µL 
of buffer AP1 supplemented with 600 µg of Proteinase K was added to each sample, and mixed 
thoroughly. To lyse the cells, the samples were then incubated for 12-18 hours at 42°C. The samples 
were mixed 2 to 3 times during the incubation by inversion.  
The samples were incubated on ice for 5 minutes after the addition of 200 µL of buffer AP2.  
The rest of the protocol is as in Section 3.2.2 Extraction of DNA from plant material using the Qiagen 





4.2.1.2 Extraction of DNA using the Qiagen Dneasy Plant Mini Kit with additional 
centrifugation step in initial material preparation stage 
 
This step was made before extraction began. A few of the commercial samples were soft gel capsules 
and filled with a suspension of extract in oil. Two to three capsules were cut open using a sterile 
blade and the contents were placed inside a 2 mL centrifuge tube. The volume was typically around 
100 µL. The tube was centrifuged for 10 minutes at full speed. The top oil layer was removed and the 
pellet of extract was used for the extraction process. The wet weight outlined in the protocol; 100 mg 
was used. The DNA was then extracted as outlined in section 3.2.2 Extraction of DNA from plant 
material using the Qiagen DNeasy Mini Plant Kit. 
4.2.2 Standard (End Point) Polymerase Chain Reaction 
For the full method please see section 2.2.5 Standard (End-point) Polymerase Chain Reaction.  
4.2.3 Gel electrophoresis 
For the full method please see section 3.2.9 Gel Electrophoresis using agarose.  
4.2.4 Quantitative Polymerase Chain Reaction (qPCR) 
For this method Sensifast™ qPCR Master Mix (Bioline, London) was used. This is a pre-prepared mix 
that just required the addition of primers, a template and nuclease free water. The Applied 
Biosystems StepOnePlus qPCR machine was used for cycling. 
Table 30: The components and amounts required for a qPCR reaction 
Component Amount for 1 reaction (µL) 
Sensifast™ 2x qPCR MasterMix 5 
Forward primer 0.2 
Reverse primer 0.2 
Template 1 
Nuclease free water 3.6 
 





Table 31: The cycling conditions required for amplification using Sensifast™ components for qPCR  
1 cycle 40 cycles Melt curve 









95°C 95°C 60°C/66°C 65°C 95°C 0.5°C/Min 
5 minutes 15 
seconds 
1 minute 
4.3 Results and Discussion 
4.3.1 Initial development of qPCR assays with vouchered DNA reference samples 
Diluted high fidelity ITS PCR products were used as reference samples. Each DNA extraction used was 
also sequenced to ensure that the identification was correct. It was necessary to find a new Actaea 
dahurica template for these assays as it was shown in Chapter 2 that the DNA purchased from the 
Royal Botanic Gardens, Kew DNA Bank was in fact Actaea simplex. The specificity of the A. dahurica 
primers was checked again and is shown later in Figure 41. The specific primers produced a product 
with the new A. dahurica template. The new A. dahurica template was used to produce new sets of 
non-target panels for each of the other species. The specificity of the non A. dahurica species specific 
primers was checked again and no amplification was seen. This is also shown in Figure 41. 
Table 32: Relevant information for target species DNA samples 
Sample name Sample 
number 
Source Labelled Species Sequencing Results 
Arac-5.9 24092 Kew Actaea racemosa Actaea racemosa 
Adah-5.9 DB8499 BGBM Actaea dahurica Actaea dahurica 
Acim-5.9 10294 Kew Actaea cimicifuga Actaea cimicifuga 
 
The aim for each assay was to see a positive result for the target template DNA and no amplification 
for the non-target panel. The non-target panel is outlined in Table 20 of Chapter 3. Further 
development of the PlantID assay. To recap, a non-target panel was made for each species included. 





made up of 10 species templates and so a dilution of 10 times the target DNA was used to ensure the 
resulting concentration of each included species was that of the target DNA.  
Foe each species, a qPCR experiment was performed to test specificity with this application. The 
results are shown in Figure 41. 
  
 
Figure 41: qPCR amplification plots showing positive amplification with the target templates and negative 
amplification with the non-target panel DNA  
In Figure 41 each set of specific primers were used in qPCR reactions to amplify both the target 
template for the specific species and the non-target DNA panel for all species except the target. The 
aim was to see an amplification with the target DNA and amplification with a Ct of less than 35 
(considered a negative result) for the non-target panels respectively for each species specific primer 
pair. For each set of species specific primers this was achieved.  
To see how the assay would perform, some of the DNA extractions (6 initial samples) were tested 
with the A. racemosa specific primers. The results were at first difficult to interpret as is shown in 
Figure 42. It was difficult to see if a sample was negative for the presence of the species attempting 
to be detected or if the amount of DNA was low as there wasn’t anything to compare to. It was only 
Primers: AracF and AracR Primers: AdahF and AdahR 











possible to compare the samples within the experiment. Samples 1 to 3 looked positive but samples 
4 to 6 had lower Ct values. This raised the question of how it was possible to tell which were positive 
and which were negative results.  The difficulty was how to distinguish between positive reactions 
with a low concentration or poor quality templates and false positives resulting from low level primer 
mismatches when comparing against good quality templates. 
 
Figure 42: An amplification plot of A. racemosa specific species primer testing without generic primer 
controls 
It showed that another primer pair was required as a control. This was termed a generic primer and 
was designed to amplify any and all of the Actaea species included in this work. A search of the 
primer sequence was performed using BLAST and it was found that the generic primer matches all 
Actaea species on the database. The results are shown in Table 33. The Ct value of the generic primer 
test also indicates the total number of amplifiable template molecules in the assay. Subtraction of 
this value from the Ct value of the species-specific test gives the ratio of species-specific template 
molecules to total template molecules when adjusted for the differences in efficiencies of the two 












primer pair could be directly compared to the results of the species-specific primers test and 
therefore give an idea of how much DNA was present and how much of that DNA was a particular 
species. This overcame not being able to interpret the results of the species-specific tests alone. If 
the generic primer test was positive but all the species-specific primer tests were negative, it showed 
that another Actaea species was present and sequencing could be used to determine which one, if 
possible. The generic primer was used to amplify all the targets involved in the assays to ensure that 
it was working correctly. The primer pair was successful in being able to do this as shown in Figure 
43.   
The Ct value of the generic primer test also indicates the total number of amplifiable template 
molecules in the assay. Subtraction of this value from the Ct value of the species-specific test gives 
the ratio of species-specific template molecules to total template molecules when adjusted for the 
differences in efficiencies of the two primer pairs using a reference standard template. The results of 
amplification with this generic primer pair could be directly compared to the results of the species-
specific primers test and therefore give an idea of how much DNA was present and how much of that 
DNA was a particular species. This overcame not being able to interpret the results of the species-
specific tests alone. 
Table 33: The matches obtained when using the generic primer sequence as a query in BLAST 
Species match Match to GenBank Sequence 
Actaea racemosa 100% 
Actaea cordifolia 100% 
Actaea rubra 100% 
Actaea pachypoda 100% 
Actaea podocarpa 100% 
Actaea heracleifolia 100% 
Actaea dahurica 100% 
Actaea simplex 100% 
Actaea cimicifuga 100% 
Actaea asiatica 100% 
Actaea brachycarpa 100% 
Actaea japonica 100% 
Actaea frigida 100% 





Actaea yunnanensis 100% 
Actaea purpurea 100% 
Actaea nanchuenensis 100% 
Actaea mairei 100% 
Actaea spicata 100% 
Actaea elata 100% 
Actaea biternata 100% 
Actaea arizonica 100% 
Actaea acerina 100% 
Actaea laciniata 100% 
Actaea kashmiriana 100% 
Actaea europaea 100% 




1 – Actaea racemosa 
2 – Actaea pachypoda 
3 – Actaea dahurica 
4 – Actaea cimicifuga 
5 – Actaea cordifolia 
6 – Actaea rubra 
7 – Actaea heracleifolia 
8 – Caulophyllum thalictroides* 
9 – Actaea podocarpa 
10 – Actaea simplex 
11 – No template control 
*  Intended not to amplify 
Figure 43: A gel to illustrate the ability of the generic primers to amplify any Actaea species but not samples 
from other genera. 
The primer annealing temperatures were already optimised in the PlantID assay to maximise 
specificity so no further development was necessary in that respect.  The primers were however 
tested over a range of concentrations to optimise amplification efficiency. When a new primer pair is 
planned for use in qPCR the efficiency should be analysed. This was carried out by making a serial 
dilution of the high fidelity ITS PCR products and then amplifying each dilution in triplicate. Three 
different concentrations of primers were trialled for each species set; 0.2 µM, 0.1 µM and 0.05 µM. 
Melt curve analysis was also included. The efficiencies of each set of primers is outlined in Figure 44 
and the main aim was not just to choose a concentration that had an efficiency closest to 100% but 
also to choose efficiencies that were matched between the primer pairs, i.e. the generic primers and 





species-specific primers to have the same efficiency so that they behave similar in reactions with the 
same template, and thus are comparable. 
Table 34: The efficiencies obtained from analysing serial dilutions of target templates with species specific 
and generic primers. 
 Primer efficiency (%) 
Primer pair target 0.2 µM 0.1 µM 0.05 µM 
A. racemosa 89.654 97.716 84.797 
A. cimicifuga 112.053 97.948 81.381 
A. dahurica 100.319 96.164 80.290 
Generic 115.339 97.525 54.357 
 
0.2 µM primer 0.1 µM primer 0.05 µM primer 
   
   
Figure 44: An example of optimisation for A. racemosa species specific primers – logarithmic amplification 
plots and standard curves shown 
From the efficiency testing it was decided to use the concentration of 0.1 µM as this gave the most 
consistent efficiency across the primer pairs and was also as close to 100% as possible. The other 
concentrations either gave an over efficiency or were not efficient enough.  
The next stage was to include the generic primers in a test with the reference samples. Tests were 
also set up with the non-target panel to illustrate how a negative test would look. This is shown in 





template with the generic primer and A. racemosa specific primers. Both sets of primers show a 
positive result with a very similar Ct value for each primer pair. On the right hand side of the figure 
the A. racemosa non-target panel was used as a template. The generic primers have amplified the 
panel as Actaea species are present. The A. racemosa specific primers also show amplification of the 
non-target panel, but with a much higher Ct value than the generic test. The difference between the 
two Ct values (specific - generic) is around 16 cycles. Given the exponential nature of PCR 
amplification (the number of amplicons double each cycle at 100% efficiency of amplification), a 16-
cycle difference corresponds to a difference between generic and specific template molecules of 
nearly 10-5, which can be regarded as a negative result. Each sample was amplified in triplicate.  
 
A positive result for a species specific test 
 
A negative result for a species specific test 
Figure 45: Examples of amplification plots for a positive and a negative test result 
4.3.2 Validation of qPCR assays using reference samples coupled with sequencing 
Samples were collected from many sources and sequencing was also performed to validate the 
identity. To start with, each of the DNA extracts from Table 35 was amplified with ITS1 and ITS4 
primers using standard PCR. The resulting reactions were analysed using gel electrophoresis. A 
selection of the results is displayed in Figure 46. A bright crisp band indicated a good PCR product 
and these were selected for sequencing. 
Species specific 









Table 35: A summary of information for validation samples used for the qPCR assays 
Extraction 
number(s) 
Implied species Sample no. Sample Material Concentration (ng/µL) 
S7 Actaea racemosa AHPA-037 Cut Root and Rhizomes 50.4 
1115 Actaea racemosa AHPA-038 Cut Root and Rhizomes 18.9 
1116 Actaea racemosa AHPA-039 Cut Root and Rhizomes 24.8 
1117 Actaea racemosa AHPA-040 Cut Root and Rhizomes 37.4 
1118 Actaea racemosa AHPA-041 Cut Root and Rhizomes 25.3 
S8 Actaea racemosa AHPA-042 Cut Root and Rhizomes 14.2 
S9 Actaea racemosa AHPA-043 Powdered Root and Rhizome 64.6 
1119 Actaea cimicifuga AHPA-044 Whole Raw Material 39.9 
1111 Actaea racemosa AHPA-045 Whole Raw Material 33.0 
S10 Actaea racemosa AHPA-046 Whole Raw Material 12.8 
1120 Actaea racemosa AHPA-047 Whole Raw Material 40.2 
S21 Actaea racemosa AHPA-052 Powdered Raw Material 6.2 
S22 Actaea racemosa AHPA-053 Powdered Raw Material 9.0 
S23 Actaea racemosa AHPA-056 Powdered Raw Material 16.1 
S24 Actaea racemosa AHPA-057 Powdered Raw Material 11.2 
S25 Actaea dahurica AHPA-058 Whole Raw Material 33.2 
S26 Actaea racemosa AHPA-059 Extract 3.0 
S27 Actaea racemosa AHPA-061 Whole Raw Material 9.3 
S11 Actaea racemosa AHPA-062 Whole Raw Material 27.4 
S28 Actaea dahurica AHPA-063 Whole Raw Material 10.4 
S12 Actaea racemosa AHPA-064 Whole Reference sample 37.8 
S13 Actaea racemosa AHPA-065 Whole Reference sample 76.0 
S17 Actaea racemosa AHPA-066 Whole Reference sample 4.7 
S18 Actaea racemosa AHPA-067 Whole Reference sample 4.9 
S14 Actaea racemosa AHPA-068 Whole Reference sample 31.9 
S19 Actaea racemosa AHPA-069 Whole Reference sample 7.1 
S20 Actaea racemosa AHPA-071 Whole Reference sample 17.3 
S15 Actaea pachypoda AHPA-078 Whole Raw Material 124.3 
BC050 Actaea racemosa DR10-014-A Whole Raw Material 62.3 
BC046 Actaea cimicifuga Ch.B.13884K116-A Whole Raw Material 35.8 






Figure 46: An agarose gel to show the presence-absence of a PCR product using ITS primers for a selection of 
samples 
Each sample was amplified with the generic primers, A. racemosa specific primers, A. cimicifuga 
specific primers and A. dahurica specific primers. The qPCR machine could analyse 96 tubes in each 
run and so for each run a set of controls were included for each set of primers used. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Arac Arac Arac 7 7 7 Arac Arac Arac 7 7 7 
B N-Arac N-Arac N-Arac 8 8 8 N-Arac N-Arac N-Arac 8 8 8 
C 1 1 1 9 9 9 1 1 1 9 9 9 
D 2 2 2 10 10 10 2 2 2 10 10 10 
E 3 3 3 11 11 11 3 3 3 11 11 11 
F 4 4 4 12 12 12 4 4 4 12 12 12 
G 5 5 5 13 13 13 5 5 5 13 13 13 
H 6 6 6 B B B 6 6 6 B B B 
Figure 47: A typical layout of the 96 tube plate used for qPCR testing – A. racemosa species-specific test 
(Pink) and generic test shown as an example (Blue). 
                                          1      2      3    4     5     6      7     8    9     10   11  12   13   14 
15   16   17  18   19   20  21   22   23   24   
                                                 25                         26   27   28   29   30   31   
                            POS  NTC 
1-S7, 2-S8, 3-S9, 4-S10, 5-S11, 6-S12, 7-S13, 8-S14,  
9-S15, 10-S16, 11-S17, 12-S18, 13-S19, 14-S20,  
15-S21, 16-S22, 17-S23, 18-S24, 19-S25, 20-S26,  
21-S27, 22-S28, 23-S29, 24-S30, 25-1111, 26-1115,  
27-1116, 28-1117, 29-1118, 30-1119,  31-1120. 






In Figure 47 a typical qPCR test plate is displayed. The positive control is required as a comparison for 
the test samples. In a qPCR test, results are given as Ct (threshold cycle) values. This is the cycle 
number when the detected fluorescence exceeds the threshold set out for the reaction. The Ct value 
of the specific test is subtracted from the Ct value of the generic test for the positive control. The 
same is calculated for each of the test samples. The resulting figure of the positive sample is 
subtracted from the test sample. If this number is 0 (+/-1.0) it is a clear detection for the species that 
is being tested for. This was chosen as it indicates that the variation is less than 2 fold difference 
between the two primers. More than 1.1-6.0 is not as clear and a further test such as sequencing 
may be required to back up the result. It is likely that values that exceed 1 by a marginal amount are 
still indicative of a positive result, but the test replicates may have some variation. Any figure more 
than 6.1 is clearly negative for that species detection. This was chosen as exceeding this number 
suggests a 100 fold difference in effective template concentration between the two assays. In quality 
control terms this is regarded as a negative result as it falls below the threshold of contamination.  
These values are described as Ct and the equation is shown below: 





Table 36: The Ct values of validation samples and controls (Denoted with * with each set of controls 
displayed beneath the samples from the same experiment) 
 
Table 36 shows the positive controls used in each assay with an (*). These are located below each set 
of results from an experiment. Ct values of more than 35 are deemed as a negative result.  
Sample number Extract 
Number 
A. racemosa test 
AVG Ct 
A. dahurica test 
AVG Ct 
A. cimicifuga test AVG 
Ct 
Generic  A. racemosa  Generic  A. dahurica  Generic  A. cimicifuga  
AHPA-BC042 S8 19.84 18.71 17.25 32.25 19.84 26.64 
AHPA-BC064 S12 18.13 16.12 15.71 32.03 18.13 28.77 
AHPA-BC065 S13 15.92 12.85 13.35 30.98 15.92 22.79 
AHPA-BC068 S14 18.64 16.54 16.03 29.90 18.64 27.32 
AHPA-BC078 S15 16.29 19.10 13.85 28.62 16.29 23.38 
AHPA-BC052 S21 21.23 19.13 18.53 35.55 21.23 26.15 
AHPA-BC053 S22 21.45 19.64 19.23 34.69 21.44 31.08 
AHPA-BC058 S25 16.98 22.09 14.36 13.50 16.98 22.79 
A. racemosa* Arac5.9 25.60 24.79 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 23.31 25.37 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 23.60 19.38 
AHPA-BC039 1116 17.39 16.52 17.26 34.30 17.39 28.17 
AHPA-BC044 1119 15.72 25.94 18.02 22.90 15.72 13.89 
A. racemosa* Arac5.9 24.32 24.93 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 24.47 23.66 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 24.66 23.19 
AHPA- BC040 1117 19.78 19.60 15.01 35.83 19.78 27.92 
AHPA- BC041 1118 25.28 24.75 20.22 ND 25.28 29.77 
AHPA-BC043 S9 17.05 15.97 12.61 33.23 17.05 25.04 
A. racemosa* Arac5.9 28.69 28.78 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 23.31 25.37 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 25.61 23.81 
AHPA- BC063 S28 19.42 26.57 16.75 16.51 19.42 26.58 
AHPA-BC066 S17 20.14 18.01 18.26 34.70 20.14 28.86 
AHPA-BC067 S18 18.95 17.05 16.55 38.46 18.98 27.95 
AHPA-BC069 S19 22.49 20.62 19.81 35.86 22.49 30.13 
AHPA- BC071 S20 20.75 17.92 18.47 ND 20.75 29.56 
AHPA-BC057 S24 32.21 28.75 29.39 ND 32.21 30.23 
AHPA-BC038 1115 17.29 14.71 14.93 34.35 17.29 24.61 
A. racemosa* Arac5.9 25.60 24.79 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 23.31 25.37 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 23.60 19.38 
DR10-014-A BC050 13.39 11.74 9.14 27.18 13.39 23.13 
Ch.B.01230952 BC049 18.91 28.01 13.86 13.84 18.91 20.69 
Ch.B.13884K116-A BC046 17.38 32.23 12.61 12.25 17.38 14.99 
A. racemosa* Arac5.9 28.69 28.78 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 23.31 25.37 N/A N/A 





Table 37: The results of specific qPCR assay testing with validation samples – illustrating the capability of the assay. 
Commercial Sample DMU Extract 
number 







AHPA-BC038 1115 A. racemosa -1.8 17.4 11.5 Likely A. racemosa 
AHPA-BC039 1116 A. racemosa -1.5 17.9 12.3 A. racemosa 
AHPA-BC040 1117 A. racemosa -0.3 18.8 10.0 A. racemosa 
AHPA-BC041 1118 - -0.6 17.7 6.3 Likely A. racemosa 
AHPA-BC042 S8 A. racemosa -0.3 15.8 8.6 A. racemosa 
AHPA-BC043 S9 A. racemosa -1.2 18.6 9.8 A. racemosa 
AHPA-BC044 1119 A. cimicifuga 9.6 8.3 -0.4 A. cimicifuga 
AHPA-BC052 S21 A. racemosa -1.3 17.8 6.7 A. racemosa 
AHPA-BC053 S22 A. racemosa -1.0 16.3 11.4 A. racemosa 
AHPA-BC057 S24 - -2.7 8.6 2.2 Possibly A. racemosa and A. cimicifuga 
AHPA-BC058 S25 A. dahurica 6.0 -0.05 7.6 A. dahurica 
AHPA-BC063 S28 A. dahurica 8.0 -2.3 11.4 Likely A. dahurica 
AHPA-BC064 S12 A. racemosa -1.2 17.1 12.4 A. racemosa 
AHPA-BC065 S13 A. racemosa -2.2 18.4 8.6 A. racemosa 
AHPA-BC066 S17 A. racemosa -1.3 14.4 13.0 A. racemosa 
AHPA-BC067 S18 A. racemosa -1.1 19.9 13.2 A. racemosa 
AHPA-BC068 S14 A. racemosa -1.3 14.7 10.4 A. racemosa 
AHPA-BC069 S19 A. racemosa -1.1 14.0 11.9 A. racemosa 
AHPA-BC078 S15 A. pachypoda 3.7 15.6 8.9 A. pachypoda 
DR10-014-A BC050 A. racemosa -1.7 -16.0 -11.6 A. racemosa 
Ch.B.01230952 BC049 - -9.0 2.1 3.6 A. dahurica and possibly A. cimicifuga present 
Ch.B.13884K116-A BC046 A. cimicifuga -14.8 -2.4 -0.6 A. cimicifuga and possibly A. dahurica present 
Ct: [(Ct specific – Ct generic)sample - (Ct specific – Ct generic)reference]. A value of 0.0 +/-1.0 is a clear positive result. A value > 6.0 is a clear negative. 






Table 38: A summary of the BLAST results for validation samples – top hits shown 




Accession number of 
top match 
Match Percentage MOTU 
AHPA-BC038 1115 matK A. racemosa KU662878.1 100% N/A 
AHPA-BC039 1116 ITS A. racemosa AB987687.1 99% A. racemosa 
AHPA-BC040 1117 ITS A. racemosa GQ409509.1 99% A. racemosa 
AHPA-BC042 S8 ITS A. racemosa GQ409509.1 99% A. racemosa 
AHPA-BC043 S9 ITS A. racemosa GQ409509.1 99% A. racemosa 
AHPA-BC044 1119 ITS A. cimicifuga GQ351362.1 99% A. cimicifuga 
AHPA-BC052 S21 ITS A. racemosa GQ409509.1 99% A. racemosa 
AHPA-BC053 S22 ITS A. racemosa GQ409509.1 99% A. racemosa 
AHPA-BC058 S25 ITS A. dahurica AB987685.1 98% A. dahurica 
AHPA-BC063 S28 matK A. dahurica KU662876.1 98% N/A 
AHPA-BC064 S12 ITS A. racemosa GQ409511.1 98% A. racemosa 
AHPA-BC065 S13 ITS A. racemosa GQ409509.1 98% A. racemosa 
AHPA-BC066 S17 ITS A. racemosa GQ409509.1 99% A. racemosa 
AHPA-BC067 S18 ITS A. racemosa AB987687.1 95% A. racemosa 
AHPA-BC068 S14 ITS A. racemosa GQ409509.1 99% A. racemosa 
AHPA-BC069 S19 matK A. racemosa KU662878.1 99% N/A 
AHPA-BC078 S15 ITS A. pachypoda Z98277.1 99% A. pachypoda 
DR10-014-A BC050 ITS A. racemosa GQ409509.1 99% A. racemosa 








Table 38 shows the sequencing results and how they matched to available sequences from the GenBank database. It also gives the MOTU species, which is the 
branch in the DNA tree diagram shown in Chapter 2; Figure 17, Figure 18 and Figure 19. It was not possible to group the MatK sequences into a tree with 
distinguishable branches and in these cases the MOTU box has been filled with N/A. These sequences were used in cases where a successful ITS sequence was 





4.3.3 Testing of commercial Black Cohosh products with the developed qPCR assays 
The first step in this section was to extract DNA from the commercial products. From past experience 
of finding it challenging to extract good quality DNA from these kinds of products, it was decided to 
use a modified method of extraction. Baker et al (2012) discovered that a prolonged protein 
digestion step was useful and so this was used (Baker et al., 2012). Many of the samples also 
required an isopropanol clean up. Table 39 gives a summary of sample type, extraction numbers and 
quantification data.  














103 Capsule, ground raw root 







Capsule, extract and 
ground raw root 
2.5% total triterpene glycosides – 200 






Capsule, extract and 
ground raw root 
2.5% total triterpene glycosides – 200 





106 Capsule, ground raw root 
200 mg root powder, 200 mg extract 
standardised 2.5% total triterpene 





107 Soft gel capsule, extract 
Black Cohosh Extract 160 mg, Root and 
Rhizome, 2.5% total triterpene 





107 Soft gel capsule, extract 
Black Cohosh Extract 160 mg, Root and 
Rhizome, 2.5% total triterpene 





108 Soft gel capsule, extract 
Black Cohosh Extract 160 mg, Root and 
Rhizome, 2.5% total triterpene 





108 Soft gel capsule, extract 
Black Cohosh Extract 160 mg, Root and 
Rhizome, 2.5% total triterpene 





109 Coated caplet, extract 
2.5% total triterpene glycosides – 50 mg. 







Capsule, extract and 
ground raw root 
2.5% total triterpene glycosides – 200 






Capsule, extract and 
ground raw root 
2.5% total triterpene glycosides – 200 















082 Capsule, extract 
Black Cohosh (root) 2.5% total triterpene 





083 Tablet, extract 
Black Cohosh Root Extract 200 mg 











085 Soft Gel Capsule, extract 
Black Cohosh Extract 160 mg, Root and 
Rhizome, 2.5% total triterpene 










Film coated tablet, extract 
– THR registered 







Film coated tablet, extract 
– THR registered 






















































































AHPA-BC017 Capsules, root and extract 
530 mg root, 20 mg extract standardized 
to min. 5% triterpene glycosides 










AHPA-BC019 Capsules, root and extract 
185 mg root, 40 mg extract standardized 





AHPA-BC021 Capsules, root and extract 
380 mg root, 8 mg extract standardized 










AHPA-BC023 Capsules, extract 






AHPA-BC026 Capsules, extract 
40 mg, extract standardized to 2.5% 






AHPA-BC028 Capsules, extract 
135 mg (4:1 extract) + 0.04 (extract 






AHPA-BC031 Capsules, extract 
40 mg, extract standardized to 2.5% 






AHPA-BC032 Capsules, extract 
250 mg, extract standardized to 2.5% 
triterpene glycosides 
50.40 
As can be seen from the DNA quantification results the amounts of DNA that were yielded were 
often low. It was however possible to work with these as can be seen with the ITS PCR results shown 





this showed that some of the other products had a small amount of useable DNA present, which will 





L –   DNA ladder 
1 –   BC023 
2 –   BC024 
3 –   BC025 
4 –   BC026 
5 –   BC027 
6 –   BC028 
7 –   BC029 
8 –   BC030 
9 –   BC031 
10 – BC032 
11 – BC033 
12 – No template control 
Figure 48: ITS PCRs of a selection of the commercial product samples at 30 cycles and 40 cycles respectively  
 
Figure 49: An agarose gel to show the presence-absence of PCR products with ITS primers – commercial 
products 
The Ct values of all the individual tests are outlined in Table 40 for information purposes and the 
CT values are outlined in Table 41. 
  L      1      2     3      4     5     6     7       8     9    10  11    12    L 
  L      1      2     3      4     5     6     7       8     9    10  11    12    L 
1      2      3    4     5     6    7   
                                                                          8     9   10   11  12  13  14   15   16   17 
18  19   20    21   22   23       24  25   26  
                            POS  NTC 
1-S1, 2-S2, 3-S3, 4-S4, 5-S5, 6-S6, 7-S7, 
8-1032, 9-1093, 10-1094, 11-1095, 
12-1096, 13-1097, 14-1098, 15-1099, 
16-1100 17-1101, 18-1105, 19-1106, 
20-1107,  21-1108, 22-1109, 23-1110, 
24-1112, 25-1113, 26-1114. 









Table 40: Ct values of species-specific and generic primer tests with commercial samples (Controls shown 
with *) 
  
Sample number Extract 
Number 
A. racemosa test AVG Ct A. dahurica test AVG Ct A. cimicifuga test AVG Ct 
Generic  A. racemosa  Generic  A. dahurica  Generic  A. cimicifuga  
AHPA-BC001 1032 15.58 24.36 19.11 15.14 16.62 22.40 
AHPA-BC002 1093 26.38 27.39 31.88 28.04 28.43 34.48 
AHPA-BC003 1105 22.56 22.22 26.81 29.42 24.11 ND 
AHPA-BC004 1106 26.76 26.14 32.32 30.26 28.97 ND 
AHPA-BC005 1094 26.70 27.42 31.76 34.97 28.76 ND 
AHPA-BC006 S1 26.36 26.72 35.77 ND 32.50 39.86 
AHPA-BC007 1095 15.94 16.51 20.34 34.31 17.90 33.33 
AHPA-BC008 1096 17.86 19.31 22.29 32.18 19.46 31.91 
AHPA-BC009 1097 26.34 27.59 30.62 32.20 28.18 36.26 
A. racemosa* Arac5.9 13.69 14.40 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 24.77 21.27 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 20.40 20.81 
AHPA-BC010 1098 31.84 ND 32.78 31.05 31.84 36.17 
AHPA-BC011 1099 35.49 34.93 34.09 29.71 35.49 35.22 
AHPA-BC012 1100 34.48 36.99 33.84 31.39 34.48 ND 
AHPA-BC013 1101 17.18 21.14 19.53 30.15 17.18 23.33 
AHPA-BC014 S2 16.51 21.14 30.23 ND 16.51 23.09 
AHPA-BC015 1107 29.34 35.93 25.54 ND 25.54 36.94 
AHPA-BC016 1108 32.96 ND 28.55 ND 28.55 31.91 
A. racemosa* Arac5.9 17.94 21.44 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 20.23 26.96 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 18.67 23.75 
AHPA-BC019 S3 22.50 22.72 20.04 27.91 22.50 30.33 
A. racemosa* Arac5.9 28.69 28.78 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 23.31 25.37 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 25.61 23.81 
103 BC023 28.8 31.0 31.5 29.9 28.8 27.2 
104 BC024 20.30 19.4 22.8 ND 20.3 31.6 
105 BC025 18.6 17.8 20.9 29.4 18.6 30.1 
106 BC026 28.4 28.6 30.7 30.3 28.4 33.2 
107 BC027 29.5 29.5 32.4 32.6 29.5 30.9 
108 BC028 30.3 31.6 33.6 35.5 30.3 32.7 
A. racemosa* Arac5.9 24.5 23.4 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 26.7 23.2 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 22.2 20.2 
109 BC029 31.1 33.0 33.1 ND 31.1 37.1 
120 BC030 21.1 18.1 22.9 32.5 21.1 33.8 
121 BC031 18.2 15.4 20.1 36.5 18.2 30.4 
A. racemosa* Arac5.9 24.3 24.9 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 26.7 23.2 N/A N/A 
A. cimicifuga* Acim5.9 N/A N/A N/A N/A 24.7 23.2 
080 BC038 28.68 32.25 27.49 34.79 28.68 39.10 
081 BC039 12.49 15.46 11.62 28.78 12.49 23.01 
082 BC040 26.56 29.60 25.19 31.36 26.56 30.02 
083 BC041 34.75 34.76 31.39 ND 34.75 ND 
084 BC042 27.54 33.63 26.40 35.07 27.54 35.38 
085 BC043 22.38 25.95 21.01 30.97 22.38 28.82 
086 BC044 33.56 ND 33.83 ND 33.56 ND 
087 BC045 34.84 36.08 34.25 36.72 34.84 33.79 
A. racemosa* Arac5.9 23.86 26.09 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 23.80 28.22 N/A N/A 



















AHPA-BC001 A. cimicifuga 1032 Actaea dahurica 8.1 -0.5 5.4 A. dahurica  
AHPA-BC002 A. racemosa 1093 - 0.3 -0.3 5.6 A. racemosa and A. dahurica 
AHPA-BC003 A. racemosa 1105 Actaea racemosa -1.0 6.1 15.5 A. racemosa 
AHPA-BC004 A. racemosa 1106 - -1.3 1.4 10.6 A. racemosa and possibly A. dahurica 





-0.4 7.7 7.0 
A. racemosa 
AHPA-BC007 A. racemosa 1095 Actaea racemosa -0.1 17.5 15.0 A. racemosa 
AHPA-BC008 A. racemosa 1096 Actaea racemosa 0.7 13.4 12.0 A. racemosa 




4.7 1.8 3.9 
Possibly A. dahurica 
AHPA-BC011 A. racemosa 1099 - 
-4.1 -0.9 -0.7 
NOT A. racemosa. Possible A. dahurica or A. 
cimicifuga 
AHPA-BC012 A. cimicifuga 1100 - -1.0 1.0 5.1 
NOT A. cimicifuga. Possible A. dahurica or A. 
racemosa 
AHPA-BC013 A. racemosa 1101 Actaea racemosa 0.5 14.1 5.7 A. racemosa 
AHPA-BC014 A. racemosa S2 Actaea racemosa 1.1 13.3 6.2 A. racemosa 
AHPA-BC015 A. racemosa 1107 - 4.0 7.7 6.3 NOT A. dahurica or A. cimicifuga 
AHPA-BC016 A. dahurica 1108 - 
3.5 4.7 -1.7 
NOT A. dahurica or A. racemosa. Possible A. 
cimicifuga 
AHPA-BC019  - S3 Actaea racemosa 0.1 5.8 9.6 A. racemosa 
103 - BC023 - 1.6 1.9 3.6 Likely A. racemosa and A. dahurica 
104 - BC024 - 0.2 ND 13.3 A. racemosa 
105 - BC025 Actaea racemosa 0.9 12 13.5 A. racemosa 
106 - BC026 - 1.3 3.1 6.8 A. racemosa 
107 - BC027 Actaea racemosa 1.1 3.7 3.4 Contains A. racemosa.  
108 - BC028 - 2.4 1.6 4.4 Possibly contains  A. dahurica and A. racemosa 
109 - BC029 Not able to sequence 
as polyherbal 





Ct: [(Ct specific – Ct generic)sample - (Ct specific – Ct generic)reference]. A value of 0.0 +/-1.0 is a clear positive result. A value > 6.0 is a clear negative. 
Barcode sequence. ITS, the nuclear ribosomal internal transcribed spacer barcode sequence or maturase K barcode sequence. The nearest hit by BLAST search 
is indicated. Chemistry results obtained by Sharaf et al., 2016.  
 
Table 42: Sequencing information for the commercial product DNA extractions – BLAST matches shown 




Accession number Match Percentage MOTU 
AHPA-BC001 1032 ITS A. dahurica FJ525885.1 97% A. dahurica 
AHPA-BC003 1105 matK A. racemosa KU662878.1 94% N/A 
AHPA-BC007 1095 ITS A. racemosa Z98296.1 94% A. racemosa 
AHPA-BC008 1096 matK A. racemosa KU662878.1 99% N/A 
AHPA-BC013 1101 ITS A. racemosa GQ409509.1 97% A. racemosa 
AHPA-BC014 S2 ITS A. racemosa GQ409511.1 96% A. racemosa 
AHPA-BC019 S3 matK A. racemosa KU662878.1 97% N/A 
105 BC025 ITS A. racemosa GQ409509.1 99% A. racemosa 
107 BC027 ITS A. racemosa GQ409509.1 99% A. racemosa 
081 BC039 ITS A. racemosa GQ409509.1 99% A. racemosa 
082 BC040 ITS A. racemosa KU724194.1 93% A. racemosa 
120 - BC030 - -3.6 13.1 14.2 A. racemosa 
121 - BC031 - -3.4 19.9 13.7 A. racemosa 
080 - BC038 - 1.3 2.9 13.2 Possibly contains A. racemosa and A. dahurica 
081 - BC039 Actaea racemosa 0.7 12.8 13.3 A. racemosa 
082 - BC040 Actaea racemosa 0.8 1.8 6.3 Contains A. racemosa and  Possibly A. dahurica 
083 - BC041 - -2.2 ND ND Possibly A. racemosa 
084 - BC042 - 3.9 4.3 10.6 Possibly contains A. racemosa and A. dahurica 
085 - BC043 - 1.3 5.5 9.2 Possibly A. racemosa 
086 - BC044 - 
ND ND ND 
There was not enough DNA present to conduct the 
tests 
087 - BC045 - 
-1.0 -2.0 1.75 






The chemical analysis that was carried out was by Sharaf et al 2016, and was a system based on using 
UPLC-QTOF-MS (Ultra performance liquid chromatography-quadrupole orthogonal time of flight-
mass spectrometry). Reference samples (A. racemosa, A. podocarpa, A. rubra, A. pachypoda, A. 
dahurica, A. cimicifuga, Astilbe biternata and Serratula chinensis) were collected and their chemical 
profiles characterised using the technique. The chromatograms were converted to ion intensity maps 
and used to perform principle component analysis. The results of the principle component analysis 
(PCA) are shown in Figure 50 and include 16 commercial Black Cohosh products (Sharaf et al., 2016). 
 
Figure 50: Principle Component Analysis (PCA) of Actaea species and adulterant species reference samples 
and 16 commercial Black Cohosh products (Sharaf et al., 2016) 
These results allowed the discrimination of the included species and the results of assigned species 
for the commercial products are shown in Table 41. 
When assigning identification to the tested products using the qPCR assays, several factors came into 
consideration. If the Ct values of the tests were equally over 35 then the confidence level became 
weaker. If the ΔΔCt value exceeded 0.0 +/-1.0 confidence became weaker. If a sample gave a test 
result exceeding 0.0 +/-1.0 but under 6.0 then sequencing was the next desirable step to provide a 
confirmation. This was not always possible with this group of samples for a number of reasons. The 





matK were analysed as described in Chapter 2: Genetic analysis of Black Cohosh, Actaea racemosa, 
and potential adulterant species. These results were purely used to reinforce the qPCR data.  
The first of the products in the table, 1032, was shown to be completely substituted with A. dahurica. 
The qPCR gave a positive detection for A. dahurica and a negative detection for the other species. 
The sequencing of the ITS region also confirmed this. Interestingly, the chemistry results also showed 
substitution by an Asian species, but this was identified as A. cimicifuga. The level of certainty for the 
DNA testing is high as the starting material for the qPCR reference sample was morphologically 
identified from a DNA bank herbarium sample, the sequenced ITS region matches A. dahurica from 
the GenBank database and the A. dahurica accessions are grouped together in the DNA tree. In 
chapter 2 it was clearly shown that all the A. dahurica accessions are clearly distinguished from A. 
cimicifuga and A. heracleifolia as well as all the other Actaea species. 
AHPA-BC002/1093 and AHPA-BC004/1106 were shown to be A. racemosa using the chemical 
methods and the qPCR assay confirms this but the qPCR assay also detected A. dahurica presence.  
AHPA-BC006/S1 was identified in the chemistry work as A. dahurica or Astilbe biternata but in the 
qPCR assays this was identified as A. racemosa. Unfortunately it was not possible to sequence the 
sample. The qPCR assays do not include Astilbe biternata and if this sample was A. racemosa 
contaminated with Astilbe biternata this would not have been detected with these assays.  
AHPA-BC010/1098 was identified as Serratula chinensis using the chemical method. In the qPCR 
assays this was shown to possibly be A. dahurica. Unfortunately the DNA was not successfully 
sequenced so it cannot be known for sure. Again presence of Serratula chinensis cannot be detected 
using the qPCR assay. 
AHPA-BC011/1099 was identified as A. racemosa using the chemical method but the qPCR assay 
gives a less confident result for A. racemosa and a stronger result towards A. dahurica or A. 





AHPA-BC012/1100 was identified as A. cimicifuga using the chemistry method but the qPCR assay is 
showing A. racemosa and A. dahurica.  
For AHPA-BC015/1107 and AHPA-BC016/1108, they were both identified as A. racemosa. The qPCR 
results show a negative result for A. dahurica and A. cimicifuga and a possible result for A. racemosa. 
The ΔΔCt score for the A. racemosa test was in the region of 3.5 – 4.0 which would usually require 
sequencing for confirmation. This was not possible due to the low amount of DNA extracted and 
possible degradation. 
Several of the products were clearly identified and the chemistry results, sequencing results and 
qPCR assay were in agreement; AHPA-BC003/1105, AHPA-BC007/1095, AHPA-BC008/1096, AHPA-
BC013/1101 and AHPA-BC014/S2. This gives further validation to the qPCR assays. All were 
confirmed to be A. racemosa.  
The remainder of the samples were collected independently of the AHPA samples and so were not 
tested chemically.  Four of the products were shown to contain A. racemosa by the qPCR assay and 
sequencing; 105/BC025, 107/BC027, 081/BC03 and 082/BC040. Other products that tested positive 
for A. racemosa without sequencing confirmation were 104/BC024, 120/BC030, 121/BC031, 
083/BC041 and 085/BC043. The remaining products had a mixture of results, with most testing 
positive for A. racemosa and one of the other species. Two of the products did not have enough DNA 
present to conclude; 086/BC044 and 084/BC042.  
One of the products (121/BC031) was advertised as being polyherbal but only containing A. 
racemosa out of the tested species. It was not possible to sequence this sample of DNA but the qPCR 
assay did confirm the presence of A. racemosa. Some of the samples contained multiple traces when 
sequencing was attempted, which could indicate the presence of multiple species, i.e. adulteration or 
sometimes fungal contamination, as the ITS primer pair used can amplify the fungal genome as well 
as plants. Some samples were simply poor quality in regards to DNA presence i.e. degraded DNA or 











4.4 Conclusions and further work 
The importance of this chapter was again to develop reliable tests for authentication of Black Cohosh 
and detection of adulterant species. The utilisation of qPCR as the platform for these assays enables 
the creation of highly sensitive tests.  
The qPCR assays were successfully validated with sequenced reference samples. This gives a high 
level of confidence to results that are obtained even when sequencing of the test samples cannot be 
performed.  
It has even been shown that commercial products can be identified using this technique. This was 
not always possible due to limitations with amount and quality of DNA that can be extracted but of 
34 commercial samples it was possible to obtain results for 32. A good proportion of these results 
could be backed up with sequencing, chemical testing or both.  
The results of these tests for the assay are very provoking. The addition of the generic primer has 
turned these assays into a great tool for identification of Actaea racemosa and detection of 
adulterant species. These qPCR assays could also be developed quite quickly for some of the other 
PlantID species too if it was desirable for those species to be detected. It would also be simple to 
develop tests for species from other families that are well known to be adulterants of Black Cohosh 
products. These species will vary a lot more genetically making them easier to detect.  
This assay would require little skill to carry out and some simple sums using the Ct values to find a 
score. Confidence can be put into samples achieving a Ct under 35, if there is low deviation between 
triplicates and if the scoring is 0.0 +/-1.0. For samples that do not achieve scoring within the 
confidence range, sequencing can be carried out where possible.  
The qPCR assays results agreed with the sequencing results every time where one species was 
detected. There were some incidences where products/samples were found to be adulterated with 





to be adulterated. It must be said that these products were only a minute number compared to what 
is available. There are many batches within each brand and many products available. Within the 
products provided from the American market there were a few adulterations and even complete 
substitutions found. From the results it looks as though six or maybe even seven of the products are 
contaminated with undeclared species. The chemistry tests did not always agree with the DNA based 
tests and there are several possible explanations for this. One explanation is that there was a 
misidentification with the reference material used for building up the chemical identification 
technique (details not known – only final results made available). From the DNA results it looks as 
though the reference material used to develop the chemistry test was the wrong way round, i.e. the 
A. dahurica material was A. cimicifuga and the A. cimicifuga material was A. dahurica. The origins of 
the reference materials used for development of the chemistry tests are not known to the author of 
this thesis. The chemistry test seems to have limitations for detecting contamination of products that 
contain a mixture of species, which could explain why some of the chemistry results didn’t match the 
qPCR assay results. The strong point of the chemical testing is detecting complete substitutions. 
Detection of multiple species was not present with the chemical tests so this could explain why the 
results do not agree; one of the species present could not be detected with the qPCR assay as it was 
not in the scope and the other species could not be discovered by the chemical test as only the more 
abundant species was detected. The qPCR assays did not agree with samples that were identified as 
containing Astilbe biternata or Serratula chinensis because detection of these species is not possible 
with these qPCR assays.  
This adds to the value of the assay showing that there is a requirement for a more robust technique 
which DNA testing can offer. The DNA tests are sensitive and can be designed to detect many 
species, as many as is required for a sample as long as the ability to design and optimise species-






5 Investigation into potential hepatotoxicity of three 
Actaea species 
5.1 Introduction 
As mentioned in the main introduction, the reputation of Black Cohosh has come under jeopardy and 
the safety of the herbal medicine has been heavily scrutinised. The case reports of liver damage, 
although not conclusive, have been enough to require a warning label on commercial products in 
countries across the globe (Mahady et al., 2008).  
This chapter aims to answer the questions; why do some individuals who are taking Black Cohosh 
preparations experience liver injury? Does Actaea racemosa cause toxicity to the liver or not? Do 
Asian Actaea species cause toxicity to the liver or not?  
5.1.1 Existing investigations into the safety of Black Cohosh 
There have been many clinical trials conducted for Black Cohosh, with efficacy and safety in mind, 
over the years. None of these trials have shown Black Cohosh to cause hepatotoxicity and most of 
them have good evidence to suggest efficacy of the herb (Nappi, 2005, Osmers et al., 2005, Wuttke 
et al., 2006, Molla et al., 2011). The numerous isolated cases of liver damage are more of an issue. 
Although many of these case reports have been reviewed and found to show a poor connection to 
Black Cohosh consumption, the sheer number still has a damaging effect on the reputability of Black 
Cohosh use. (Mahady et al., 2009, Teschke et al., 2011, Teschke et al., 2014). There have been 
extensive trials of Black Cohosh use with rats used as a model. Again these trials have shown Black 
Cohosh to be safe (Briese et al., 2007, Mazzanti et al., 2008) (Kapur et al., 2010), non-oestrogenic 
(Liske et al., 2002, Wuttke and Seidlová-Wuttke, 2015) and even protective of bone health (Seidlova-
Wuttke et al., 2005) and showing signs of anti-cancer properties (Nisslein and Freudenstein, 2004, 





There has not been much research in using human cell models in vitro to explore the effect of Black 
Cohosh on the liver. Huang et al used the MTT assay to assess the effect of three Black Cohosh 
extracts; 40% isopropanol, 75% and 80% ethanol on a human hepatocyte derived cell line; HepG2. 
They found that none of the extracts inhibited growth of HepG2 cells significantly therefore 
demonstrating safety in this experiment ((IC50) ranging from 21.9 μg/ml to 65.0 μg/ml). They 
proposed that herb-drug interactions rather than direct hepatotoxicity could be the cause of the case 
reports as the extracts did inhibit CYP isoenzymes (Huang et al., 2010). In response to the proposition 
that herb-drug interactions are the cause of liver injury in Black Cohosh patients, there have been 
rodent based models employing gene expression to study pathways. Pang et al treated mice with 
Black Cohosh extract and could not detect induction of liver specific Cyp3a11. Cyp3a11 was chosen 
for study as it is the major P450 isoenzyme expressed in the liver and functions in drug metabolism. 
Liver enzymes used for markers of liver injury were also unaffected (Pang et al., 2011a). The sporadic 
cases of liver injury in some individuals taking Black Cohosh is still damaging the reputation of the 
medicinal plant and tests specifically designed to answer the question of whether or not Actaea 
racemosa is toxic to the liver are required. 
5.1.2 Possible other causes of hepatotoxicity in adverse case reports of Black Cohosh  
There has been speculation that the cases of liver damage could be caused by substitution or even 
adulteration with closely related Chinese Sheng Ma (translation: ascending hemp) species. These 
include A. heracleifolia, A. cimicifuga and A. dahurica. Some occasions, where products that have 
been implicated in cases of hepatotoxicity, have tested positive for adulteration with Chinese Actaea 
(Jiang et al., 2006, Jordan et al., 2010, Masada-Atsumi et al., 2016). In Chinese medicine Sheng Ma is 
taken as an aqueous decoction i.e. boiled in water. Water versus ethanol as a solvent would render 
different products and therefore different pharmacological effects on the body. 
The point that needs to be addressed is the effect of the Asian Actaea species on the liver. Tian et al 





found that there was less effect on primary mouse hepatocytes and they believed that this could 
mean an anti-tumour property (Tian et al., 2005, Tian et al., 2007). There has been little research into 
the effect of Chinese Actaea species on the liver and no studies specifically designed to assess if they 
are toxic. This is required to try to answer the question of why some individuals who are taking Black 
Cohosh experience liver injury.  
5.1.3 Approach to assessment of hepatotoxicity in this investigation 
In this piece of work the potential hepatotoxicity of two Chinese species, otherwise known as Sheng 
Ma; A. cimicifuga and A. dahurica, along with A. racemosa was investigated by treating cultured 
human hepatocyte cell lines with 60% ethanol extracts. The A. racemosa material has been identified 
using morphology, DNA testing and chemical testing. The two Sheng Ma samples that were included; 
one labelled as Actaea dahurica and the other labelled as Actaea cimicifuga, were also analysed 
using DNA and HPTLC testing. The results suggested that both materials were mixed. 
The main experiment in this chapter is a large hepatotoxicity related gene expression study. This was 
designed to measure changes in expression of key genes in hepatocyte derived cells following the 
exposure to Actaea extracts including Black Cohosh and Sheng Ma species. These changes in gene 
expression can help determine the effect of the extracts on the cells and what disease pathways 
these are related to if any. A hepatotoxicity pathway related qPCR array from Qiagen was chosen to 
screen the effects of the extract treatment. The array was made up of 96 tubes, 84 of which are 
individual gene tests and the remaining 12 being made up of internal controls. Housekeeping genes 
that are involved in the maintenance of basic cell functions were used to normalise the results of the 
test genes. The changes of expression in the included genes can be linked to various liver disease 
pathways including general hepatotoxicity, steatosis, necrosis, nongenotoxic hepatocarcinogenicity, 
cholestasis and phospholipidosis.  
The liver has the important function of uptake, metabolism and excretion of drugs, environmental 





A major function of the liver is to synthesise bile acids. Cholestasis is a condition where the flow of 
bile fluid from the liver to the duodenum is decreased or completely stopped. If left untreated it can 
lead to hepatotoxicity. The condition can be caused by many factors including the use of certain 
drugs (Padda et al., 2011). Steatosis is a condition that if left untreated can progress to the serious 
disease of cirrhosis. It is characterised by the build-up of free fatty acid and triglyceride esters within 
hepatocytes. The mechanism of drug induced steatosis is not understood but is thought to be 
somewhat connected with mitochondria as they play an extensive role in lipid metabolism. Another 
theory is that the process of excreting and converting free fatty acids to very low density cholesterol 
is hindered (Rabinowich and Shibolet, 2015). Injury of the liver leads to hepatic necrosis through 
many different pathways dependant on the cause of the disease so detection of increased necrosis 
related genes can be useful for studying hepatotoxicity (Guicciardi et al., 2013). Nongenotoxic 
hepatocarcinogenicity is the ability of a substance to cause cancer to the liver through a pathway not 
linked to damage of DNA. The pathway in which Nongenotoxic hepatocarcinogenicity occurs is not 
fully understood but it is thought that changes in oxidative stress, peroxisome proliferation, control 
of metabolic enzymes, cellular communication and disruption of apoptosis and cell proliferation, are 
linked from previous studies that have been carried out (Lee et al., 2013). Including genes in the 
array that are involved in these pathways allows study of the nature of toxicity if present. 
Phospholipidosis is a condition caused by faults in lysosomes. Lysosomes have the role of 
metabolising phospholipids and therefore any substance that impairs the pathways associated with 
this task will result in build-up of phospholipids. A substance can be attributed to causing 
phospholipidosis by study of lysosomal pathways (Shayman and Abe, 2013). The remaining genes 
that are to be assessed with the qPCR array are related to other pathways of damage not associated 
with the previous diseases listed. Many of the genes included in the qPCR array were characterised in 
a previous study with drug controls known to cause certain liver injuries (Zidek et al., 2007). The gene 
expression assay approach was chosen as there had not yet been such a wide screening of the effect 





MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and LDH (Lactate 
dehydrogenase) assays were also used to analyse the effect of the extracts on hepatocyte derived 
cells.   
The MTT assay measures cell viability by assessing the ability of the cells to convert MTT reagent to 
formazan. Cells lose the ability to metabolise the MTT reagent when they die so it is presumed that 
the amount of the metabolite formazan that is produced is proportional to the number of viable 
cells. This test will show if the treatment of the Actaea extracts respectively lead to cell death. 
The LDH assay was used to assess how much LDH was released by the cells during treatment with 
Actaea extracts. This assay has the ability to measure cytotoxicity as apotosis and necrosis of the cell 
cause permeation of the cell membrane allowing release of LDH. Therefore the detection of 
increased levels of LDH in the cell culture medium in controlled conditions can indicate that the test 
substances cause cytotoxicity.  
HepaRG™ cells were chosen for the LDH assay and the gene expression study as cells were required 
that were as close to normal functioning liver cells as possible. HepaRG™ cells have been shown to be 
an excellent model for the human liver and retain metabolic activity to a higher level compared to 
other hepatocyte derived cell lines (Mann et al., 2017). The HepaRG™ cells were terminally 
differentiated (unable to proliferate and therefore single use due to limited stock), so another cell 
line was required for the MTT assay. HepG2 cells have also proven to be a good model for toxicity 
assessment (Saad et al., 2006) and so these were also employed for the LDH and MTT assay post 
treatment with extracts. 
The gene expression study started with a pilot experiment of single arrays for one concentration of 
extract along with a positive control. The positive control chosen was paracetamol (APAP, 
Acetaminophen) as it has been proven to be toxic to the liver (Jeong et al., 2006). The main 
experiment concentrated on comparing the Black Cohosh extract and Sheng Ma extracts at three 





array. The paracetamol control was utilised also. The LDH assay was utilised for assessment of 
treatment on both included cell lines and the MTT assay was used to assess the treatment of extracts 
on the HepG2 cells. 
5.1.4 Aims: 
 To produce industry standard extracts from plant material of known identity - the identity to 
be verified by HPTLC, DNA and morphological assessment. 
 To use the manufactured 60% ethanol extracts to treat hepatocyte cell lines in vitro and 
measure effects using qPCR gene expression arrays, an LDH assay and a MTT assay. This will 
provide a much needed direct comparison of Black Cohosh and Sheng Ma with relation to 
hepatotoxicity. 
5.2 Materials and method 
5.2.1 Preparation of 60% ethanol extracts 
As the majority of commercially available products contain 60% ethanol extracts, it was decided to 
follow suit and create the extracts to be used in this chapter with the same method. Sheng Ma, when 
used in Chinese medicine, is administered as an aqueous decoction. However if any Sheng Ma 
species were used to manufacture products labelled as ‘Black Cohosh Extract’, they would most likely 
be subjected to alcoholic extraction. For this reason ethanol extracts of the Sheng Ma material were 
performed to reflect what would happen in the case of substitution or adulteration of Black Cohosh 
products with Sheng Ma species.  
To begin with the plant materials were milled to a fine powder and 100 g was placed in a round 
bottomed flask with 700 ml of 60% ethanol. The mixture was attached to a rotary evaporator (Buchi, 
Essen, Germany) without vacuum at this stage. The round bottomed flask was set to rotate in a water 
bath at 60°C for 60 minutes. After the 60 minute incubation was over the slurry of plant material was 





material was placed back into the round bottomed flask with 700 ml of 60% ethanol and incubated 
again in the 60°C water bath for 60 minutes. After the 60 minute period the slurry was again filtered. 
The two wet extracts were combined and dried using a rotary evaporator under vacuum. The Sheng 
Ma extracts, outlined in Table 43, were very difficult to dry and were finished off using freeze drying. 
This involved freezing the wet extract rapidly in a methanol bath and attaching to a freeze dryer 
under vacuum which removed the water using sublimation. The resulting dry extracts were removed 
from the flasks and passed through a sieve to reduce to a powder. 
All information for the plant materials used in this chapter can be found below in Table 43: 
Table 43: The material used for 60% ethanol extract manufacture and resulting extract information 
Sample label Common 
name 
Sample number Sample type Source 
Actaea racemosa  Black Cohosh DR10-014-A  Root and rhizome Staffort, DHU, 
Germany 
Actaea cimicifuga Sheng Ma Ch.B.13884K116-A Sliced rhizome SynoPhyto, China 
Actaea dahurica Sheng Ma Ch.B.01230952 Sliced rhizome SynoPhyto, China 
 
5.2.2 Analysis of 60% ethanol extracts 
5.2.2.1 High Performance Thin Layer Chromatography (HPTLC) 
The fingerprint of each extract was analysed using HPTLC in order to attempt identification. For this 
technique a semi-automated HPTLC system was used (CAMAG, Switzerland). This included an 
automated plating machine, an automated development tank, a hot plate and equipment capable of 
imaging under several UV wavelengths and white light.  
The process began with weighing out 200 mg of extract, placing in 10 ml of methanol and sonicating 
until visually dissolved. For the reference standards 1 mg was weighed out and dissolved in 10 ml of 
methanol. The included reference standards were actein, 23-epi-26-Deoxyactein, caffeic acid, 
chlorogenic acid and Isoferulic acid. Unfortunately cimicifugin and norcimicifugin were unavailable at 





glass bottles and placed in the rack of the plating equipment. A silica gel 60 F254 plate (Merck, 
Kenilworth, New Jersey, United States) was selected and clipped into position on the plating 
equipment. Using the machine software the plate layout was designed to maximise use. This resulted 
in 8 mm bands using 2 µL of sample.  






5.2.2.1.1 A CAMAG method for identification of Black Cohosh and possible contaminants.  
The mobile phase was made up of toluol, ethyl formate and formic acid at a ratio of 50:30:20. 
Derivitisation was performed using a sulphuric acid reagent (20 mL of sulphuric acid added to 180 mL 
of ice cooled methanol) which was sprayed evenly on the plate and then dried at 100°C for five 
minutes. The plate should be imaged at UV at 366 nm prior to derivitisation and then after 
derivitisation imaging under white light and UV at 366 nm.  
Example plates are shown in Figure 52 which was adapted from the CAMAG protocol.  
 
254nm before derivitisation 
 
366nm before derivitisation 
 




1. 2 μL Isoferulic acid 
2. 2 μL Norcimifugin 
3. 2 μL Actein 
4. 2 μL 23-epi-26-Deoxyactein 
5. 2 μL Cimifugin 
6. 2 μL A. racemosa 
7. 2 μL A. racemosa 
8. 2 μL A. cimicifuga 
9. 2 μL A. heracleifolia 
10. 2 μL A. dahurica 




White light after derivitisation 
 
Figure 52: Example HPTLC plates for analysis of A. racemosa and adulterant species using a combined 
method for detection of plant acids and triterpene glycosides – figure adapted from CAMAG protocol 
(CAMAG) 
The reference bands should be cross checked for presence in the test samples. Unfortunately 
cimicifugin and norcimicifugin were not available when conducting this experiment so the example 





5.2.2.1.2 The CAMAG plant acids detection method.  
The mobile phase was made up of toluol, ethyl formate and formic acid at a ratio of 50:30:20. The 
plate was first heated to 100°C for three minutes. Derivitisation was performed using a 
diphenylborinic acid reagent (1.0 g of diphenylborinic acid dissolved in 200 mL ethyl acetate), which 
was sprayed evenly on the plate and then dried in a stream of cool air. Imaging is recommended 
under UV light at 366 nm.  
Example plates are shown in Figure 53 which was adapted from the CAMAG protocol.  
 
254nm before derivitisation 
 
366nm after derivitisation 
 
1. Serratula sp. (adulterant) 
2. Actaea racemosa 
3. Sheng Ma (adulterant, A. dahurica) 
4. Actaea podocarpa 
5. Isoferulic acid 
6. Caffeic acid 
7. Actaea racemosa 
8. Actaea racemosa 
9. Actaea racemosa 
10. Actaea racemosa 
Figure 53: Example finished HPTLC plates for identification of Black Cohosh using a plant acids based method 
– figure adapted from a CAMAG protocol (CAMAG) 
The presence of the reference bands in the test samples will help to determine which species is 
present.  
5.2.2.1.3 The CAMAG triterpenes method.   
The mobile phase was made up of toluol, ethyl formate and formic acid at a ratio of 50:30:20. 
Derivitisation was performed using a sulphuric acid/anisaldehyde reagent (10 mL sulphuric acid 
added to 170 mL of ice cooled methanol, 20 mL of acetic acid and 1 mL of anisaldehyde), which was 





sprayed evenly on the plate and then dried for 5 minutes at 100°C. Imaging under white light is 
recommended. 
Example plates are shown in Figure 54 which was adapted from the CAMAG protocol. 
 
White light after derivitisation 
1 Serratula sp. (adulterant) 
2 Actaea racemosa 
3 Sheng Ma (A. dahurica) 
4 Actaea podocarpa 
5 Actein 
6 23-epi-26-Deoxyactein 
7 Actaea racemosa  
8 Actaea racemosa 
9 Actaea racemosa 
10 Actaea racemosa 
Figure 54: Example finished HPTLC plate for identification of Black Cohosh using a triterpene glycosides 
based method – figure adapted from a CAMAG protocol (CAMAG) 
The presence of 23-epi-26-Deoxyactein is used to determine if the species is Actaea racemosa. 
Although it is not shown in the example plate, Actein is present in Actaea cimicifuga as well as 
Actaea racemosa.  
5.2.2.2 DNA based analysis of the materials used to manufacture 60% ethanol extracts 
The samples outlined in Table 43 were subjected to DNA extraction following the method outlined in 
section 2.2.2 Extraction of DNA from plant material using the Qiagen DNeasy Mini Plant Kit. The 
resulting DNA extracts were then amplified using PCR as described in 2.2.5 Standard (End-point) 
Polymerase Chain Reaction with ITS1 and ITS4 primers. The ITS PCR products were sent to an 
external supplier and sequenced where possible. The DNA extractions were also analysed using the 
qPCR assays developed in Chapter 4 Development of a qPCR assay for the authentication of A. 
racemosa and detection of potential adulterants, which included a test for A. racemosa, A. dahurica 
and A. cimicifuga. 





5.2.3 Culture of HepaRG™ cells - Initial thawing, counting and plating of cells 
All cell culture work was carried out in an appropriate sterile laminar flow hood using aseptic 
techniques and conditions. The HepaRG™ Thaw, Seed and General purpose medium (Biopredic, 
Saint-Grégoire, France) was pre-warmed in a 37°C water bath. Before use of the medium could occur, 
the outside of the bottle had to be cleaned with 70% ethanol to maintain sterility inside the laminar 
flow hood. Once the bottle was clean, 9mL of medium was placed into a sterile 40 mL polystyrene 
round bottomed container. The cells were placed into liquid nitrogen for cryopreservation upon 
arrival to the lab, so the next step was to thaw the HepaRG™ cells (Biopredic, Saint-Grégoire, France). 
The cryovial of cells was removed from liquid nitrogen storage. Inside the flow hood the lid of the 
cryovial was opened slightly to release any internal pressure and then closed again. The vial was 
placed into the 37°C water bath for two minutes, agitating throughout, without submersion. Again, 
to maintain sterility, the outside of the cryovial was cleaned with 70% ethanol before placing under 
the laminar flow hood. The thawed cells were transferred to the tube containing the 9mL of warmed 
medium resulting in a 1:10 ratio. The inside of the cryovial was rinsed once with 1mL of cell 
suspension and then returned back to the rest of the suspension. The suspension was then 
centrifuged for 3 minutes at 500 x g at room temperature. The medium supernatant was removed 
and the cells resuspended in 5mL of fresh medium.  
Cell counting and viability assessment was achieved using Tryptan Blue staining and a counting 
chamber. The Tryptan Blue stock solution (Sigma-Aldrich, St. Louis, Missouri, United States) was at a 
concentration of 0.4% in PBS buffer. The required concentration was 0.05% and so was appropriately 
diluted. The counting chamber was then prepared by first cleaning it with lens paper and then 
placing a cover slip over the counting grid. To a tube, 400 µL of 0.05% Tryptan Blue was placed with 
100 µL of mixed cell suspension. The solution was then transferred to the counting chamber. The live 
cells do not take up the dye and remain clear and the dead cells are stained blue. Live and dead cells 
were counted and the numbers noted. The cell concentration (million cells/mL) and viable cell 





For the experiments carried out in this work 24 well plates were used. The recommended number of 
viable cells per well for a 24 well plate was 0.48 × 106, so the appropriate amount of cells was added 
to each well with a measure of medium to ensure an overall volume of 500 µL was placed in each 
well.  
For a toxicity study the cells need to culture for 7 days prior to incubation with the test substance. 
The schedule in Table 44 was followed. 
Table 44: A table outlining key activities from culturing to treatment of HepaRG™ Cells 
Day Day of the week Activity Photomicrograph? 
0 Thursday Thaw and seed the cells  
1 Friday Renew the medium Take a 
photomicrograph 
4 Monday Renew the medium Take a 
photomicrograph 
6 Wednesday Renew the medium Take a 
photomicrograph 
7 Thursday Renew the medium and incubate with the 
test substance for 24 hrs 
 
8 Friday Remove medium and begin RNA extraction  
 






Figure 55: The layout of the planned pilot experiment – 24 well plate 
APAP (acetaminophen, paracetamol) was used as a control for toxicity as it has been shown to induce 
various toxicity pathways in cultured liver cells. 
5.2.4 Culture of HepG2 cells 
Aseptic technique was adhered to as with any cell culture experimentation. Minimum Essential 
Eagle’s Medium supplemented with 10 mM L-Glutamine, 1% Non-Essential Amino Acid solution, 5% 
foetal calf serum and 1% Pen-Strep solution (ThermoFisher Scientific, Waltham, Massachusetts, 
United States), was used for culture of HepG2 cells. The HepG2 cells, unlike the HepaRG™ cells are an 
immortalised adherent cell line that continued to grown and divide. For these reason they had to be 
passaged or divided 1:3 every 2-3 days once thawed and seeded to a T75 flask. In order to achieve 
the cells were removed from the flask once confluency reached 90% (usually within 2-3 days) with 
trypsin. The flasks of cells were maintained in an incubator at 37°C with 5% CO2. Once a stable cell 







treatment with extracts for the LDH assay and to a 96 well plate for treatment with extracts for the 
MTT assay.  
5.2.5 RNA extraction using Qiagen RNeasy mini Kit 
RNA extraction was achieved using the Qiagen RNeasy® Mini Kit (Qiagen Inc.,CA). The protocol for 
“Animal Cells Spin” was adhered to as follows; 
The culture medium was completely removed and a phosphate buffered saline (PBS) (ThermoFisher 
Scientific, Waltham, Massachusetts, United States) wash performed once to ensure complete 
removal. The PBS was then removed. The number of cells present in each well was ˂5 × 106 so 350 µL 
of lysis buffer RLT was applied to each well. The lysate was collected using a pipette and placed into a 
microcentrifuge tube and vortexed. The next step was to homogenise the cells and the method of 
choice was to use a QIAshredder spin column. The lysate was pipetted directly to the QIAshredder 
spin column and centrifuged for 2 minutes at full speed. To the homogenised material, 350 µL of 70% 
ethanol was added and mixed by pipetting. The sample (700 µL) was transferred to an RNeasy spin 
column; the lid was gently closed and centrifuged for 15 seconds at ≥8000 × g to wash the spin 
column membrane. The flow through was discarded. DNA elimination was very important for the 
procedures that used the extracted RNA so optional on column DNA elimination was carried out. To 
the RNeasy spin column, 350 µL buffer RW1 was added. The lid was gently closed and centrifuged for 
15 seconds at ≥8000 × g to wash the spin column membrane. The flow through was discarded. For 
each sample a mixture of 10 µL of DNase 1 stock solution and 70 µL of buffer RDD was prepared, the 
solution was mixed gently by inversion of the tube and brief centrifugation to ensure residual liquid 
from the sides of the tube was incorporated. The resulting solution (80 µL) was added directly to the 
RNeasy column membrane and incubated at room temperature for 15 minutes. After incubation, 350 
µL of buffer RW1 was added to the RNeasy spin column. The lid was gently closed and centrifuged for 
15 seconds at ≥8000 × g to wash the spin column membrane. The flow through was discarded. To the 





15 seconds at ≥8000 × g to wash the spin column membrane. The flow through was discarded. A 
further 500 µL of buffer RPE was added to the RNeasy spin column. The lid was gently closed and 
centrifuged for 2 minutes at ≥8000 × g to wash the spin column membrane. The flow through was 
discarded. For an extra measure, the Rneasy spin column was placed into a new collection tube, and 
centrifuged at full speed for 2 minutes to ensure complete removal of buffer RPE. The RNeasy spin 
column was placed into a new collection tube and 50 µL of RNase free water was added.  A final 
centrifugation step was carried out.  
The resulting RNA was quantified using a spectrophotometer.  
5.2.6 Analysis of extracted RNA using BioRad Experion RNA Standard Sensitivity Chip  
The first step was to equilibrate the kit reagents to room temperature; this included the Loading 
Buffer, Stain and Gel (Biorad, Hercules, California, United States). The ladder element of the kit was 
thawed on ice. The kit reagents were briefly centrifuged and the ladder was immediately returned to 
ice. The electrodes of the Experion system (Biorad, Hercules, California, United States) were cleaned 
using the cleaning chip loaded with Experion Electrode Cleaner (Biorad, Hercules, California, United 
States). They were then cleaned twice using the DEPC cleaning chip loaded with DEPC treated water. 
For the gel preparation 600µL of Gel was added to the supplied filter tube and centrifuged at 1500 x 
g for 10 minutes. To prepare the Gel Stain, 65 µL of Gel was added to a separate sterile tube with 1 
µL of Stain, vortexed and centrifuged briefly.  
To the yellow GS well on the chip, 9 μL of Gel Stain was carefully applied. On the Priming Station the 
programme B1 was selected as shown on the chip and the chip was carefully put in place. The 
programme was started and the once finished the chip was removed. The chip was visually inspected 
for any signs of air bubbles as these have a detrimental effect to the results.  
The ladder and test samples were prepared by adding 2 µL respectively into separate labelled tubes 






Figure 56: An example of the layout of a standard sensitivity Experion™ RNA Chip 
To well L, 1 µL of Ladder was carefully applied. To well G, 9 μL of filtered Gel was applied. To the 
remaining GS well, 9 µL of Gel Stain was applied. To wells 1-12 and well L 5 μL of loading buffer was 
applied. Finally 1 µL of denatured sample was added to each of wells 1-12. The chip was placed into 
the Experion system and run using the appropriate programme. Results were given at the end. 
5.2.7 cDNA synthesis using the RT2 First Strand Kit 
The reagents of the RT2 First Strand Kit (Qiagen Inc.,CA) were first thawed out and then briefly 
centrifuged. The genomic DNA elimination mix was prepared according to Table 45. To begin with 4 
µL of RNA was used as this was the recommended amount in the manual for a very similar cell line. In 
later experiments the amount of RNA was quantified and volumes adjusted so that 0.5 μg was 
present as starting template for the cDNA synthesis reaction. 
Table 45: A table to demonstrate the components and amounts needed for genomic DNA elimination 
Component Amount for 1 reaction (µL) 






Buffer GE 2 
RNase-free water 4 
Total 10 
 
The genomic elimination mix was then incubated for 5 minutes at 42°C then placed on ice for 2 
minutes. The next step was to prepare the reverse-transcription mix according to Table 46. 
Table 46: A table to demonstrate components and amounts required for reverse transcription 
Component Amount for 1 reaction (µL) 
5 × Buffer BC3 4 
Control P2 1 
RE3 Reverse Transcriptase Mix 2 
RNase-free water 3 
Total volume 10 
 
If more than one reaction was being conducted then each component was added to the required 
volume. To each completed DNA elimination mix, 10µL of reverse-transcription mix was added and 
mixed gently with pipetting. The reactions were then incubated for 15 minutes at 42°C followed by a 
stop temperature of 95°C for 5 minutes. Each reaction was then diluted with 91µL of RNase-free 
water. The reactions were then immediately stored at -20°C or placed on ice if qPCR was to be 
carried out. 
5.2.8 Preparation and analysis of Quantitative Polymerase Chain Reaction arrays 
The RT2 SYBR Green Mastermix (Qiagen Inc.,CA) was briefly centrifuged to bring all the contents 
together. The components mix was prepared in a 5mL tube as follows in Table 47. 
Table 47: The components and amounts required for application to one Hepatotoxicity RT2 profiler qPCR 
array 
Component Amount for one array (µL) 
2 × RT2 SYBR Green Mastermix 1350 
cDNA synthesis reaction 102 







For analysis of the cDNA the human hepatotoxicity RT2 profiler array PAHS-093Z was used (Qiagen 
Inc.,CA). In each well of the plate, 24 μL of the components mix was applied. The plate was checked 
for the presence of bubbles and then placed into the Icyler (Biorad, Hercules, California, United 
States). The following programme was used outlined in Table 48. 
Table 48: Cycling conditions for running a qPCR reaction and melt curve analysis for each RT
2






40 cycles Melt curve 









95°C 95°C 60°C 65°C 95°C 0.5°C/Min 




Once qPCR was complete the threshold was manually determined using the log view, by selecting an 
area above the background signal and within the lower one third to one half of the log phase on the 
plot, also ensuring that the Ct values of the three positive PCR controls in wells H10-H12 were 






Figure 57: An example of an adjustment of the threshold position on the primary RT2 profiler array – 
background noise and log phase used to determine position of the threshold 
The resulting Ct values were exported to an Excel spread sheet and analysed using the PCR Array Data 
Analysis Web Based Software (Qiagen Inc.,CA). The software automatically calculates all of the gene 
expression figures. This involved firstly normalising the data with housekeeping genes. The arithmetic 
mean of the housekeeping gene panel was used for this purpose. These are outlined on Table 49. In 
order to achieve normalisation the ΔCt of each reaction is calculated as follows: 
ΔCt = Ct (gene of interest) - AVG Ct (chosen housekeeper genes) 
Then the quality control data is assessed. The Ct value of the genomic DNA control should be in 
excess of 35 although this figure can be decided by the researcher, in this case 35 was used. The 
qPCR array reproducibility test is calculated by taking the average of the three positive PCR control 
(PPC) tests and the figure should be 20+/-2. The final quality check is the reverse transcription 
reaction. This is calculated using the positive PCR control tests and the reverse transcription control 











subtracting the average of the three positive PCR controls. This figure should not exceed 5. The 
calculation is as follows:  
ΔCt = (AVG RTC - AVG PPC) 
Table 49: A summary of the controls used for each qPCR array – housekeeping genes, genomic DNA 
detection, reverse transcription control and positive control for PCR. 
Well No. Location Symbol Description  
Gene name 
85 H1 ACTB Actin, beta PS1TP5BP1 
86 H2 B2M Beta-2-microglobulin - 
87 H3 GAPDH Glyceraldehyde-3-phosphate 
dehydrogenase 
G3PD, GAPD, MGC88685 
88 H4 HPRT1 Hypoxanthine 
phosphoribosyltransferase 1 
HGPRT, HPRT 
89 H5 RPLP0 Ribosomal protein, large, P0 L10E, LP0, MGC111226, 
MGC88175, P0, PRLP0, RPP0 
90 H6 HGDC Human Genomic DNA Contamination HIGX1A 
91 – 93 H7 – H9 RTC Reverse Transcription Control RTC 
94 – 96 H10 – H12 PPC Positive PCR Control PPC 
 
After all the steps are complete an overview of the data is given. The next step is to calculate:             
(2^(- Δ Ct)) for each of the genes of interest. The figures in the control set are directly compared to 
calculate a fold change: 
Fold change ((2^(- ΔΔ Ct)) = ((2^(- Δ Ct)) test sample) / ((2^(- Δ Ct)) control sample) 
Fold change values greater than 1 indicate an up regulation or increased expression of a gene and 
values less than 1 indicate a down regulation or decreased expression of a gene. The fold regulation 
is the final calculation in terms of gene expression and displays the fold changes in a biologically 
meaningful way. If a value is greater than 1 it stays the same. If a fold change value is less than 1 the 
fold regulation is the negative inverse of that value. If at least three biological replicates are included 
then a student t-test is performed and the value given as a ‘P value’ which should be at least 0.05. 





Table 50: Positioning and information of the genes analysed 
Well 
No. 
Location Symbol Description Gene name Disease pathway involvement  
1 A1 ABCB1 ATP-binding cassette, sub-family B 
(MDR/TAP), member 1 
ABC20, CD243, CLCS, GP170, MDR1, 
MGC163296, P-GP, PGY1 
Cholestasis, phospholipidosis 
2 A2 ABCB11 ATP-binding cassette, sub-family B 
(MDR/TAP), member 11 
ABC16, BRIC2, BSEP, PFIC-2, PFIC2, 
PGY4, SPGP 
Hepatotoxicity 
3 A3 ABCB4 ATP-binding cassette, sub-family B 
(MDR/TAP), member 4 
ABC21, GBD1, MDR2, MDR2, 3, 
MDR3, PFIC-3, PGY3 
Cholestasis 
4 A4 ABCC2 ATP-binding cassette, sub-family C 
(CFTR/MRP), member 2 
ABC30, CMOAT, DJS, KIAA1010, 
MRP2, cMRP 
Cholestasis 
5 A5 ABCC3 ATP-binding cassette, sub-family C 
(CFTR/MRP), member 3 
ABC31, DKFZp686E22157, EST90757, 
MLP2, MOAT-D, MRP3, cMOAT2 
Cholestasis 




7 A7 APEX1 APEX nuclease (multifunctional DNA 
repair enzyme) 1 




8 A8 ASAH1 N-acylsphingosine amidohydrolase (acid 
ceramidase) 1 
AC, ACDase, ASAH, FLJ21558, 
FLJ22079, PHP, PHP32 
Phospholipidosis 
9 A9 ATP8B1 ATPase, aminophospholipid transporter, 
class I, type 8B, member 1 
ATPIC, BRIC, FIC1, PFIC, PFIC1 Cholestasis 
10 A10 AVPR1A Arginine vasopressin receptor 1A AVPR1 Hepatotoxicity 
11 A11 BHMT Betaine--homocysteine S-
methyltransferase 
BHMT1 Hepatotoxicity 




13 B1 CA3 Carbonic anhydrase III, muscle specific CAIII, Car3, FLJ36434 Hepatotoxicity 
14 B2 CASP3 Caspase 3, apoptosis-related cysteine 
peptidase 
CPP32, CPP32B, SCA-1 Hepatotoxicity 
15 B3 CCNG1 Cyclin G1 CCNG Hepatotoxicity, 
Nongenotoxic Hepatocarcinogenicity 
16 B4 CD36 CD36 molecule (thrombospondin 
receptor) 







17 B5 CD68 CD68 molecule DKFZp686M18236, GP110, SCARD1 Necrosis 
18 B6 CDC14B CDC14 cell division cycle 14 homolog B (S. 
cerevisiae) 
CDC14B3, Cdc14B1, Cdc14B2, 
hCDC14B 
Necrosis 
19 B7 CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, 
Cip1) 
CAP20, CDKN1, CIP1, MDA-6, P21, 
SDI1, WAF1, p21CIP1 
Nongenotoxic Hepatocarcinogenicity, 
Necrosis 
20 B8 COL4A1 Collagen, type IV, alpha 1 arresten Necrosis 
21 B9 CRYL1 Crystallin, lambda 1 GDH, MGC149525, MGC149526, 
lambda-CRY 
Hepatotoxicity 
22 B10 CXCL12 Chemokine (C-X-C motif) ligand 12 IRH, PBSF, SCYB12, SDF1, SDF1A, 
SDF1B, TLSF, TPAR1 
Hepatotoxicity 
23 B11 CYP1A2 Cytochrome P450, family 1, subfamily A, 
polypeptide 2 
CP12, P3-450, P450(PA) Hepatotoxicity 
24 B12 DDIT4L DNA-damage-inducible transcript 4-like REDD2, Rtp801L Hepatotoxicity 
25 C1 DDX39A DEAD (Asp-Glu-Ala-Asp) box polypeptide 
39A 
BAT1, BAT1L, DDX39, DDXL, 
MGC18203, MGC8417, URH49 
Nongenotoxic Hepatocarcinogenicity, 
Necrosis 
26 C2 DNAJB11 DnaJ (Hsp40) homolog, subfamily B, 
member 11 
ABBP-2, ABBP2, DJ9, EDJ, ERdj3, 
ERj3, HEDJ, PRO1080, UNQ537, hDj9 
Hepatotoxicity 
27 C3 DNAJC3 DnaJ (Hsp40) homolog, subfamily C, 
member 3 
FLJ21288, HP58, P58, P58IPK, PRKRI Hepatotoxicity 
28 C4 FABP1 Fatty acid binding protein 1, liver FABPL, L-FABP Phospholipidosis 
29 C5 FADS1 Fatty acid desaturase 1 D5D, FADS6, FADSD5, FLJ38956, 
FLJ90273, LLCDL1, TU12 
Hepatotoxicity 
30 C6 FAM158A Family with sequence similarity 158, 
member A 
C14orf122 Necrosis 
31 C7 FASN Fatty acid synthase FAS, MGC14367, MGC15706, OA-
519, SDR27X1 
Steatosis 
32 C8 FMO1 Flavin containing monooxygenase 1 - Hepatotoxicity 
33 C9 FXC1 Fracture callus 1 homolog (rat) TIM10B, TIMM10B, Tim9b Hepatotoxicity, phospholipidosis 
34 C10 GADD45A Growth arrest and DNA-damage-
inducible, alpha 
DDIT1, GADD45 Hepatotoxicity 
35 C11 GCLC Glutamate-cysteine ligase, catalytic 
subunit 
GCL, GCS, GLCL, GLCLC Hepatotoxicity 
36 C12 GSR Glutathione reductase MGC78522 Hepatotoxicity 
37 D1 HAO2 Hydroxyacid oxidase 2 (long chain) GIG16, HAOX2 Hepatotoxicity 





39 D3 HPN Hepsin TMPRSS1 Phospholipidosis 
40 D4 HYOU1 Hypoxia up-regulated 1 DKFZp686N08236, FLJ94899, 
FLJ97572, Grp170, HSP12A, ORP150 
Hepatotoxicity 
41 D5 ICAM1 Intercellular adhesion molecule 1 BB2, CD54, P3.58 Cholestasis 
42 D6 IGFALS Insulin-like growth factor binding protein, 
acid labile subunit 
ALS Hepatotoxicity 
43 D7 IL6ST Interleukin 6 signal transducer (gp130, 
oncostatin M receptor) 
CD130, CDW130, DKFZp564F053, 
GP130, IL-6RB 
Necrosis 
44 D8 IPO4 Importin 4 FLJ23338, Imp4, MGC131665 Necrosis 
45 D9 KIAA1370 KIAA1370 FLJ10980, MGC126494, MGC126495 Necrosis 
46 D10 KRT18 Keratin 18 CYK18, K18 Hepatotoxicity, 
Nongenotoxic Hepatocarcinogenicity 
47 D11 KRT8 Keratin 8 CARD2, CK8, CYK8, K2C8, K8, KO Hepatotoxicity, 
Nongenotoxic Hepatocarcinogenicity 
48 D12 L2HGDH L-2-hydroxyglutarate dehydrogenase C14orf160, DURANIN, FLJ12618 Necrosis 
49 E1 LGR5 Leucine-rich repeat containing G protein-
coupled receptor 5 
FEX, GPR49, GPR67, GRP49, HG38, 
MGC117008 
Necrosis 
50 E2 LPL Lipoprotein lipase HDLCQ11, LIPD Steatosis 
51 E3 LSS Lanosterol synthase (2,3-oxidosqualene-
lanosterol cyclase) 
FLJ25486, FLJ35015, FLJ39450, 
FLJ46393, OSC 
Phospholipidosis 
52 E4 MAOB Monoamine oxidase B MGC26382 Hepatotoxicity 
53 E5 MAP3K6 Mitogen-activated protein kinase kinase 
kinase 6 
ASK2, MAPKKK6, MEKK6, 
MGC125653, MGC20114 
Necrosis 
54 E6 MBL2 Mannose-binding lectin (protein C) 2, 
soluble 
COLEC1, HSMBPC, MBL, MBP, MBP-
C, MBP1, MGC116832, MGC116833 
Hepatotoxicity 
55 E7 MCM10 Minichromosome maintenance complex 
component 10 
CNA43, DNA43, MGC126776 Necrosis 
56 E8 MLXIPL MLX interacting protein-like CHREBP, MIO, MONDOB, WBSCR14, 
WS-bHLH, bHLHd14 
Necrosis 
57 E9 MRPS18B Mitochondrial ribosomal protein S18B C6orf14, DKFZp564H0223, HSPC183, 




58 E10 NQO1 NAD(P)H dehydrogenase, quinone 1 DHQU, DIA4, DTD, NMOR1, NMORI, 
QR1 
Hepatotoxicity 





synthase 1 homolog (S. cerevisiae) MGC:7199, NgBR 
60 E12 OSMR Oncostatin M receptor MGC150626, MGC150627, 
MGC75127, OSMRB 
Necrosis 
61 F1 SLC51A Organic solute transporter alpha MGC39807, OSTA Cholestasis 
62 F2 PDYN Prodynorphin ADCA, MGC26418, PENKB, SCA23 Cholestasis 
63 F3 PLA2G12A Phospholipase A2, group XIIA GXII, PLA2G12, ROSSY Hepatotoxicity 
64 F4 PPARA Peroxisome proliferator-activated 
receptor alpha 
MGC2237, MGC2452, NR1C1, PPAR, 
PPARalpha, hPPAR 
Steatosis 
65 F5 PSME3 Proteasome (prosome, macropain) 
activator subunit 3 (PA28 gamma; Ki) 
Ki, PA28-gamma, PA28G, REG-
GAMMA 
Necrosis 
66 F6 PYGL Phosphorylase, glycogen, liver GSD6 Hepatotoxicity 
67 F7 RB1 Retinoblastoma 1 OSRC, RB, p105-Rb, pRb, pp110 Hepatotoxicity 
68 F8 RDX Radixin DFNB24 Cholestasis 
69 F9 RHBG Rh family, B glycoprotein 
(gene/pseudogene) 
SLC42A2 Necrosis 
70 F10 S100A8 S100 calcium binding protein A8 60B8AG, CAGA, CFAG, CGLA, CP-10, 
L1Ag, MA387, MIF, MRP8, NIF, P8 
Phospholipidosis 
71 F11 SCD Stearoyl-CoA desaturase (delta-9-
desaturase) 
FADS5, MSTP008, SCD1, SCDOS Steatosis 
72 F12 SERPINA3 Serpin peptidase inhibitor, clade A (alpha-
1 antiproteinase, antitrypsin), member 3 
AACT, ACT, GIG25, MGC88254 Phospholipidosis 
73 G1 SERPINE1 Serpin peptidase inhibitor, clade E (nexin, 
plasminogen activator inhibitor type 1), 
member 1 
PAI, PAI-1, PAI1, PLANH1 Necrosis 
74 G2 SKIL SKI-like oncogene SNO, SnoA, SnoI, SnoN Necrosis 
75 G3 SLC17A3 Solute carrier family 17 (sodium 
phosphate), member 3 
NPT4 Hepatotoxicity 
76 G4 SLC2A3 Solute carrier family 2 (facilitated glucose 
transporter), member 3 
FLJ90380, GLUT3 Phospholipidosis 
77 G5 SLC39A6 Solute carrier family 39 (zinc transporter), 
member 6 
LIV-1 Necrosis 
78 G6 SREBF1 Sterol regulatory element binding 
transcription factor 1 
SREBP-1c, SREBP1, bHLHd1 Steatosis 
79 G7 TAGLN Transgelin DKFZp686B01212, DKFZp686P11128, 






80 G8 THRSP Thyroid hormone responsive LPGP1, Lpgp, MGC21659, S14, 
SPOT14 
Hepatotoxicity 
81 G9 TMEM2 Transmembrane protein 2 - Necrosis 




83 G11 WIPI1 WD repeat domain, phosphoinositide 
interacting 1 
ATG18, ATG18A, FLJ10055, WIPI49 Phospholipidosis 
84 G12 YRDC YrdC domain containing (E. coli) DRIP3, FLJ23476, FLJ26165, IRIP, 
RP11-109P14.4, SUA5 
Hepatotoxicity 
Table adapted from:  http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-093Z.html (Sabiosciences 2017) 
Table 51: A summary of gene activity associated with different liver disease pathways 
Pathology  Upregulated genes Regulated genes Downregulated genes 
Cholestasis  ABCB1, ABCB4, ABCC2, ABCC3, ATP8B1, 
ICAM1, SLC51A, PDYN, RDX 
 
Steatosis CD36, FASN, LPL, SCD  PPARA, SREBF1 
Phospholipidosis ASAH1, FABP1, HPN, LSS, MRPS18B, S100A8, 
SERPINA3, WIPI1 
ABCB1, TIMM10B SLC2A3, TAGLN 
Hepatotoxicity ALDOA, APEX1, BTG2, CASP3, CCNG1, CRYL1, 
DDIT4L, DNAJB11, DNAJC3, GADD45A, GCLC, 
GSR, HMOX1, HYOU1, KRT18, KRT8, NQO1, 
PLA2G12A, SLC17A3, TXNRD1, YRDC 
ABCB11, TIMM10B, MAOB, PYGL AVPR1A, BHMT, CA3, CXCL12, CYP1A2, FADS1, 
FMO1, HAO2, IGFALS, MBL2, RB1, THRSP 
Nongenotoxic Hepatocarcinogenicity ALDOA, APEX1, BTG2, CCNG1, CDKN1A, 
DDX39A, KRT8, KRT18, MRPS18B, TXNRD1 
  
Necrosis CD68, COL4A1, IL6ST, IPO4, MAP3K6, NUS1, 
OSMR, PSME3, SERPINE1, SKIL, SLC39A6, 
TMEM2 
CDKN1A, DDX39A CDC14B, EMC9, FAM214A, L2HGDH, LGR5, 
MCM10, MLXIPL, RHBG 
Table adapted from: http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-093Z.html (Sabioscience 2017)  
Table 51 shows how the included genes are grouped together by disease pathway and what expression change would be expected in the disease pathway that 





5.2.9 Lactic Dehydrogenase (LDH) Assay  
For an initial assessment of toxicity levels, the amount of LDH release was assayed after 24 hours 
incubation with the extracts and paracetamol control. The In Vitro Toxicology Assay Kit, Lactic 
Dehydrogenase based (Sigma-Aldrich, St. Louis, Missouri, United States) was used for this purpose. 
The plate was centrifuged at 250 × g for 4 minutes to pellet the cells. A volume of medium from each 
test well was transferred to a 96 well plate. Equal volumes of LDH Assay substrate solution, LDH 
Assay dye and 1 × LDH Assay Cofactor Preparation were combined to obtain a LDH Assay Mixture. 
The next step was to add double the volume of LDH Assay Mixture to each volume of medium in the 
96 well plate. The plate was covered in foil and incubated at room temperature for 20-30 minutes. 
The reactions were terminated at the end of the incubation period with 1/10 volume of 1 M HCl. The 
samples were then measured spectrophotometrically at 490nm. They were also measured at 690nm 
to measure the background. This background reading was then subtracted from the original reading 
at 490nm.   
5.2.10 MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay 
A 12 mM MTT stock was made up by adding 5 mg of MTT (Invitrogen, Carlsbad, CA, USA) to 1 mL of 
phosphate buffered saline (ThermoFisher Scientific, Waltham, Massachusetts, United States) and 
mixed until dissolved. HepG2 cells at a low passage number (passage 6) were seeded into a 96 well 
plate at a density of 1 x 103 in medium free of phenol red. The cells were incubated at 37°C in a CO2 
incubator for 48 hours with a media change after 24 hours. The cells were then treated with the 
following extracts, in triplicate at three concentrations of 100 μg/ml, 20 μg/ml and 5 μg/ml, Actaea 
racemosa, Actaea cimicifuga and Actaea dahurica. Cells without treatment were used as a 100% 
viability control. After 24 hours of treatment the media with the extracts was removed and replaced 
with fresh media. In each well 10 μL of MTT reagent was applied and incubated for 6 hours at 37°C. 
The next step was to remove the MTT reagent and pipette 10 μL of acidified isopropanol to each well 





treated cells was counted as 100% viability and the viability of the treated cells was calculated from 
this. 
5.3 Results and discussion 
5.3.1 Preparation and analysis of ethanolic extracts 
Firstly plant material (root and rhizome) for each of the included species (Sheng Ma “A. dahurica”, 
Sheng Ma “A. cimicifuga” and A. racemosa) were sourced. It was not possible to source A. 
heracleifolia in large enough quantity which is why it was not included. The plant materials were 
respectively used to prepare ethanolic extracts. These extracts were prepared in the same way as 
commercially available products to best replicate what may be ingested.  
Table 52: Information for the three manufactured 60% ethanol Actaea extracts 
Labelled species Sample number Amount of raw 
material used (g) 
Resulting extract 
amount (g) 
Yield (%) Extract 
number 
A. racemosa DR10-014-A 100.9 40.33 40.69 SW02-001-11 
Sheng Ma  
“A.  dahurica” 
Ch.B.01230952 100 23.77 23.77 SW02-070-A 
Sheng Ma “A. 
cimicifuga” 
Ch.B.13884K116-A 100 21.38 21.38 SW02-070-B 
 
These extracts and the raw plant material were assessed using DNA methods, HPTLC and using 
morphology.  
5.3.1.1 DNA Analysis of the plant material used for the three Actaea 60% ethanol extracts 
In order to be assured of the species identity of the raw materials, genetic sequencing was desirable 










Sample number DNA extraction number Concentration (ng/µL) 
A. racemosa DR10-014-A BC050 62.3 
A. dahurica Ch.B.01230952 BC049 31.9 
A. cimicifuga Ch.B.13884K116-A BC046 35.8 
 
The DNA extracts were amplified using ITS1 and ITS4 primers. The resulting PCR products were sent 
for sequencing. The sequence data was checked using a BLAST search (NCBI, Maryland, USA). BC050 
(A. racemosa) was a 99% match to A. racemosa. BC046 (Sheng Ma “A. cimicifuga”) gave a poor 
quality sequence trace and was only an 89% match to A. cimicifuga. The sequence traces can be 
found in the appendix. BC049 (Sheng Ma “A. dahurica”) yielded a very poor sequence trace and was 
therefore not usable.  
Each of the extracts was checked using the qPCR assay in Chapter 4: Development of a qPCR assay for 
the authentication of A. racemosa and detection of potential adulterants. The results are in Table 54. 
Table 54: Results of qPCR testing with species specific and generic primers – Ct values shown 
 
Ct values less than 35 were deemed to be significant amplification. 



















A. racemosa BC050 13.39 11.74 9.14 27.18 13.39 23.13 
A. dahurica BC049 18.91 28.01 13.86 13.84 18.91 20.69 
A. cimicifuga BC046 17.38 32.23 12.61 12.25 17.38 14.99 
Positive Controls 
A. racemosa* Arac5.9 28.69 28.78 N/A N/A N/A N/A 
A. dahurica* Adah5.9 N/A N/A 23.31 25.37 N/A N/A 


























Not able to 
sequence 
9.0 -2.1 3.6 







14.8 -2.4 -0.6 
A. cimicifuga and possibly A. 
dahurica present 
CT : [(Ct specific – Ct generic)sample - (Ct specific – Ct generic)reference]. A value of 0.0 +/-1.0 is a clear 
positive result. A value > 6.0 is a clear negative. Barcode sequence. ITS - The nuclear ribosomal 
internal transcribed spacer barcode sequence. The nearest hit by BLAST search is indicated. 
 
So it would appear from these results that A. racemosa is the correct identity for the BC050 
extraction as the sequence matches well with what is available on GenBank. The A. cimicifuga 
labelled material had a positive result for A. cimicifuga but A. dahurica was also detected in the qPCR 
assay. The ITS sequence data was checked using BLAST and the top hit was A. dahurica but only at 
89% which is not a convincing match. Further down the match list A. cimicifuga is also shown at 87%. 
The sequence data was not of great quality and so this is inconclusive. It does appear that the 
material could be a mixture of both A. dahurica and A. cimicifuga. The A. dahurica labelled material 
also appears to contain both A. dahurica and A. cimicifuga but this cannot be backed up with 
sequencing as it was not possible to obtain a good product with ITS primers. It is not possible to 
reliably sequence mixed sample which could explain why it was not possible in this case; i.e. the 
material is mixed. The supplier of these materials is based in China and the materials are destined to 
be used in the Traditional Chinese medicine, Sheng Ma. The Chinese pharmacopoeia has a test that 
does not discriminate between A. dahurica or A. cimicifuga as both species are acceptable for use in 





5.3.1.2  High Performance Thin Layer Chromatography of the three Actaea extracts 
The CAMAG developed method for Actaea racemosa identification and adulterant detection was 
used for this purpose. There are three techniques; plant acids, triterpene glycosides and a method 











Figure 58: HPTLC plates using the Black Cohosh combined detection method developed by CAMAG 
Laboratories. A. 366 nm prior to derivitisation, B. 366 nm after derivitisation and C. white light after 
derivitisation. Key bands annotated. 
1            2           3          4         5            6          7           8           
1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 
8 – Caffeic acid 
1            2           3          4         5            6          7            8               





1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 
8 – Caffeic acid 
1            2           3          4         5            6          7           8           
1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 


















Figure 59: HPTLC plates using a plant acid method developed by CAMAG laboratories, A. 254 nm before 





1            2           3          4         5            6          7            8        
Caffeic acid 
1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 
8 – Caffeic acid 




1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 
8 – Caffeic acid 
1            2           3          4         5            6          7            8      
Caffeic acid 
1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 
















Figure 60: HPTLC plates using a triterpene method developed by CAMAG laboratories, A. 366nm before 
derivitisation, B. 366nm after derivitisation and C. white light following derivitisation. Key bands annotated. 
The main difference between Actaea racemosa and the other species is the deoxyactein band is 
present. This is displayed in Figure 60 Plate B.  
According to the sample plate in the method developed by CAMAG (Shown in Figure 52), for Actaea 
cimicifuga, chlorogenic acid, caffeic acid and actein are present. These bands can be seen across the 






1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 
8 – Caffeic acid 
1            2           3            4           5            6            7             8    
Presence of deoxyactein band in 
A. racemosa 
1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 
8 – Caffeic acid 
1            2           3            4           5            6            7             8 
Presence of 
Actein 
1 – A. racemosa extract 
2 – Sheng Ma A. dahurica extract 
3 – Sheng Ma A. cimicifuga extract 
4 – Actein 
5 – Deoxyactein 
6 – Chlorogenic acid 
7 – Isoferulic acid 





different methods in both Sheng Ma extracts (Isoferulic acid and caffeic acid shown in Figure 60 plate 
A, chlorogenic acid shown in Figure 59 plate C) , although actein seems to have a stronger presence 
in the material labelled as Actaea cimicifuga (Shown in Figure 60 plate C). For Actaea dahurica there 
were no reference markers included on the plate that are present in Actaea dahurica and not in 
Actaea cimicifuga although such reference markers do exist as shown by He at al., 2006. There are no 
specific unique markers to A. dahurica, rather the pattern of markers are diagnostic for identification. 
Cimicifugic acid A, cimicifugic acid B, Fukinolic acid, 2-Feruloyl piscidic acid and 2-Isoferuloyl piscidic 
acid are such examples of compounds present in A. dahurica and not A. cimicifuga. These ideally 
would have been utilised but they were unavailable at the time of conducting the technique. The 
recommended markers for the combined CAMAG method include cimicifugin and norcimicifugin. 
These were not available at the time of conducting the experiment but the predicted bands have still 
been annotated on Figure 58 plate B which appear to be present in both Sheng Ma extracts as would 
be expected in either A. dahurica or A. cimicifuga. Both of the materials labelled respectively as 
Actaea dahurica and Actaea cimicifuga give an almost identical profile on the plate. The markers that 
match to the reference markers are not uniquely diagnostic for A. cimicifuga or A. dahurica as a 
whole but they can be used as a guide. The profiles are also different from A. racemosa. It would 
appear that both of the Sheng Ma extracts could be a mix of both A. dahurica and A. cimicifuga, 
which supports the results of the DNA based methods in 5.3.1.1 DNA Analysis of the plant material 
used for the three Actaea 60% ethanol extracts.  
5.3.1.3 Morphological examination of Actaea root material 
All three plant materials were analysed by the Pharmacognosy department at Schwabe Pharma 
GmbH. The botanical identification of the Actaea racemosa material was straightforward flowering 
plants were available as the source for this material. The other two materials, Sheng Ma “Actaea 
dahurica” and Sheng Ma “Actaea cimicifuga” were very difficult for the department to clearly 
identify. There were features present in the Actaea cimicifuga material that were characteristic of 





be given. The Actaea dahurica material could also not be clearly identified due to the processing it 
had been through. For the two species; Actaea dahurica and Actaea cimicifuga fertile flowering 
above ground plants would be required for identification. This further supports the need for more 
robust tests to be developed for these materials, where identification can be given.  
Table 56: A table to summarise all of the methods utilised to attempt identification of the raw plant 
materials used to manufacture 60% ethanol extracts 
Labelled species HPTLC DNA tests Morphology Comments 
Actaea racemosa Actaea racemosa Actaea racemosa Actaea racemosa All test identify as 
Actaea racemosa 
Actaea dahurica Could be Actaea 
dahurica or 
Actaea cimicifuga 
Could be Actaea 
dahurica or 
Actaea cimicifuga 
Not able to 
identify 
Could be Actaea 
dahurica and 
Actaea cimicifuga 
Actaea cimicifuga Likely Actaea 
cimicifuga  could 
also contain 
Actaea dahurica 















5.3.2 Treatment and gene expression analysis of HepaRG™ Cells 
The next stage was to culture and treat HepaRG™ cells and investigate the effect of the extracts after 




Figure 61: Photomicrographs of HepaRG™ cells in culture – Day 1, 4 and 6 displayed showing key features  
The cells performed as was hoped during the 7 days of culturing. On day 1 the cells had started to 
settle into a monolayer, this is not clear in the photomicrograph but the cells had adhered and 
settled into the collagen coating of the 24 well plate. By day 4 bile caniculi were starting to become 














were no signs of infection or contamination. The cells were cultured up to day 7 and then treatment 
could begin. 
5.3.2.1 Pilot experiment of treating the HepaRG™ cells with three different Actaea extracts  
The cells were cultured in a 24 well plate and treated with the extracts. After 24 hours, RNA was 
extracted from each of the wells; duplicate samples were pooled together and converted to cDNA. 
The cDNA was analysed with the human hepatotoxicity RT2 Profiler array. 
After the first array was completed the threshold was manually adjusted as outlined in 5.2.8 
Preparation and analysis of Quantitative Polymerase Chain Reaction arrays. All subsequent arrays 
were adjusted to the same threshold. 
Once all the arrays were completed, the Ct data was imported to an Excel spreadsheet and analysed 
using the Qiagen RT2 profiler web based software. 
The first step on the analysis software was to check through the quality control checks. 
There are three things which are checked; PCR array reproducibility, reverse transcription efficiency 
and genomic DNA contamination. All samples passed in PCR array reproducibility and genomic DNA 
contamination but there was an enquiry for reverse transcription efficiency. This number must be 
less than 5 and is calculated from the average of RTC controls minus the average of the PPC controls.  
This is summarised in Table 57. 
Table 57: A table to show the summary of QC tests that required attention.  
Test Performed Control Group Acetaminophen A. racemosa  
ΔCt (AVG RTC - AVG PPC)  5.03 5.09 5.49 
Result  Inquiry Inquiry Inquiry 
 
The next stage in the process was to perform normalisation using the housekeeping genes. The rule 
for this step was to include genes where differences in the arithmetic mean of the Ct values were not 





Table 58. The housekeeping genes assessed as part of this experiment were; ACTB – Actin Beta, B2M 
– Beta 2 Microglobulin, GADPH - Glyceraldehyde-3-Phosphate Dehydrogenase, HPRT1 - 
Hypoxanthine Phosphoribosyltransferase 1 and RPLP0 – Large Ribosomal Protein. These genes are 
selected as they encode proteins that have critical roles in basic cell maintenance. These genes 
maintain constant expression in all conditions and thus show a minimum variability between 
samples. The Ct values that the housekeeping genes give following qPCR cycling are subtracted from 
the Ct values from each of the 84 test genes. This is termed as normalisation. The genes are used to 
normalise the data only when there is minimal deviation of the values between samples. The average 
of the genes HPRT1 and RPLPO were used for normalisation within this experimental set. 








APAP A. racemosa A. dahurica A. cimicifuga Mean 
H01 ACTB 16.95 18.40 17.02 16.60 16.94 17.182 
H02 B2M 19.37 20.37 19.31 19.65 19.59 19.658 
H03 GAPDH 18.58 20.98 18.43 18.12 18.13 18.848 
H04 HPRT1 25.78 25.97 25.37 24.80 25.31 25.446 
H05 RPLP0 18.69 18.93 18.25 18.08 18.25 18.44 
 
Table 59: A table depicting fold regulation – a comparison of the control group to the test groups – figures 
exceeding 1 show increased expression and negative figures show decreased expression of the genes tested. 
Position Gene Symbol APAP A. racemosa A. dahurica A. cimicifuga 
A01 ABCB1 1.181 -1.3566 -1.5263 -1.3566 
A02 ABCB11 -8.6939 -4.5631 -3.8106 -4.0558 
A03 ABCB4  -6.5432 -3.3404 -2.8679 -3.0314 
A04 ABCC2 -9.9177 -2.4623 -1.5476 -1.7654 
A05 ABCC3 -3.0105 -1.6021 -1.9862 -1.8921 
A06 ALDOA -2.0279 -1.4439 -1.2058 -1.2311 
A07 APEX1 -1.9725 -1.6245 -1.5052 -1.6702 
A08 ASAH1  1.057 -1.9185 -1.7291 -1.9053 
A09 ATP8B1 1.9319 -3.3404 -1.9185 -2.5847 
A10 AVPR1A -1.7654 -1.2483 -1.0792 -1.8661 
A11 BHMT -1.454 -2.0705 -1.6021 -1.1019 
A12 BTG2 -3.0105 -1.057 1.181 -1.0497 
B01 CA3 -1.1975 -3.0951 -2.2501 -2.4116 
B02 CASP3  -1.1019 -1.8404 -1.366 -1.366 





B04 CD36 -2.042 -6.9644 -2.2191 -1.3851 
B05 CD68 -2.7511 -1.0425 1.3472 1.057 
B06 CDC14B -2.114 -2.514 -2.1585 -2.2501 
B07 CDKN1A  1.1567 -1.4142 -1.0943 -1.1251 
B08 COL4A1 2.0705 -2.1287 -1.5052 -1.6133 
B09 CRYL1 -1.1892 -3.0525 -2.4453 -2.6208 
B10 CXCL12 1.181 -1.3566 -1.5263 -1.3566 
B11 CYP1A2 -1.0281 -9.2535 -1.6245 3.7581 
B12 DDIT4L -2.1886 -2.6759 -3.9449 -3.5064 
C01 DDX39A  -2.0705 -1.257 1.2058 -1.1173 
C02 DNAJB11  1.1019 -1.3947 -1.5583 -1.5476 
C03 DNAJC3  -1.1487 -1.3755 -1.8025 -1.6472 
C04 FABP1 -25.2813 -9.9177 -36.0019 -13.4543 
C05 FADS1  -1.0281 -2.0562 -1.6245 -1.5692 
C06 EMC9 1.3472 -1.4743 -1.6133 -1.5801 
C07 FASN  -1.1567 -3.0105 -2.969 -2.5491 
C08 FMO1 -6.0629 -4.0000 -16.3362 -2.8679 
C09 TIMM10B 1.1975 -1.257 -1.4044 -1.1892 
C10 GADD45A  5.5022 -1.3013 -1.1019 -1.181 
C11 GCLC 1.3947 -1.879 -2.2038 -2.1435 
C12 GSR  -1.1647 -1.879 -1.7654 -1.4044 
D01 HAO2 -106.1529 -12.7286 -26.9087 -9.7811 
D02 HMOX1 2.2658 -1.7777 -1.5476 -1.6358 
D03 HPN -10.2674 -1.8277 -3.8371 -2.9079 
D04 HYOU1 2.3295 -1.1567 -1.454 -1.3195 
D05 ICAM1 -2.4284 2.2815 1.5911 1.4641 
D06 IGFALS  -2.5315 -1.5476 -4.0000 -1.2058 
D07 IL6ST -1.0000 -1.3851 -1.4641 -1.5369 
D08 IPO4 1.2397 -1.1647 1.0497 -1.0281 
D09 FAM214A  -2.0139 -1.4743 -1.9053 -1.5911 
D10 KRT18 -2.3457 -1.0644 -1.0425 -1.2058 
D11 KRT8 -2.114 -1.6586 -1.0943 -1.4948 
D12 L2HGDH -1.3566 -2.2191 -1.5476 -1.5583 
E01 LGR5 -5.3147 -4.1125 -9.5798 -8.515 
E02 LPL -1.014 -1.021 -1.2058 -1.1487 
E03 LSS -1.9862 -2.0705 -1.7532 -1.8532 
E04 MAOB -4.5631 -3.2944 -2.8481 -2.5847 
E05 MAP3K6 -2.7702 -1.3195 1.0000 -1.2397 
E06 MBL2 -10.7034 -3.2266 -3.3636 -1.8661 
E07 MCM10 -3.4822 -1.3287 2.6208 1.6245 
E08 MLXIPL -1.2142 -2.8481 -3.5308 -2.4967 
E09 MRPS18B -1.2924 -1.1728 -1.2058 -1.2058 
E10 NQO1  -4.1125 -1.5476 -1.181 -1.6358 
E11 NUS1  -1.3947 -1.257 -1.3195 -1.3287 
E12 OSMR -1.8025 1.2483 -1.0792 -1.0497 
F01 SLC51A -25.1067 -1.0425 -1.0000 1.0353 
F02 PDYN 1.181 -1.3566 4.724 3.8906 
F03 PLA2G12A 1.1408 -1.7171 -1.5052 -1.6702 
F04 PPARA -1.1728 -1.9319 -1.8404 -2.114 
F05 PSME3 -1.0497 -1.5911 -1.2397 -1.4044 
F06 PYGL -4.2575 -1.7053 -1.257 -1.434 
F07 RB1 -1.6818 -1.6133 -1.2924 -1.6021 
F08 RDX -1.3195 -1.815 -1.2834 -1.5157 
F09 RHBG -2.2346 -3.6553 -2.114 -1.6245 
F10 S100A8 -9.3827 1.0867 -3.9177 -1.4743 
F11 SCD -2.0279 -1.9319 -1.6702 -1.6358 
F12 SERPINA3 -5.5022 1.6472 -1.1647 1.0644 
G01 SERPINE1 -1.2142 1.0353 1.5263 1.1019 
G02 SKIL -1.7777 -2.0994 -1.8404 -2.5491 
G03 SLC17A3 -6.2767 -2.969 -2.2501 -1.6133 
G04 SLC2A3 1.181 1.0792 -1.5263 1.0497 
G05 SLC39A6 1.4241 -1.4439 1.0353 -1.2142 
G06 SREBF1 -4.1125 -2.1435 -2.114 -2.0279 





G08 THRSP -3.1602 -16.7955 -28.84 -15.6707 
G09 TMEM2 -1.0943 -1.1173 -1.3013 -1.2142 
G10 TXNRD1 1.7777 -2.4116 -1.7532 -1.7171 
G11 WIPI1 1.6702 -1.0425 -1.7053 -1.6133 






As the first experiment was a pilot to check the feasibility of the set of experiments there were not 
biological replicates; the RNA was pooled from the duplicates. The final experiment will be made up 
of biological triplicates which will each be analysed by a separate array. 
  
  
Figure 62: Scatter plots giving an overall view of the effects of the extracts on regulation of the assessed 
genes – increased expression of genes are shown as yellow dots, decreased expression of genes is shown as 
blue dots and normal expression of genes is shown as black dots within the dotted lines. All expression 
changes are as compared to the control. 
APAP vs. Control A. racemosa vs. Control 






















The scatter plots in Figure 62 give a quick visual on the number and changes in gene expression that 
have occurred in the experiments. As can be seen in the scatter plot there was a lot of change in 
expression of the genes analysed for the APAP treated cells, the majority of the changes were 
decreases in expression. The scatter plot displays the over expressed genes with yellow dots, the 
under expressed genes with blue dots and the genes that are not significantly over or under 
expressed are black dots. The fold regulation values are used for creating these plots. 
Sheng Ma A. cimicifuga and Sheng Ma A. dahurica have a very similar profile. Considering that they 
also had the same chemical profile on the HPTLC plate this is not surprising (Section 5.3.1.2 High 
Performance Thin Layer Chromatography of the three Actaea extracts).  
Following on from the successful completion of the pilot study a full scale experiment was designed. 
Having proven that the method was capable of measuring the hepatotoxicity of the included extracts 
further investigation of the Black Cohosh and Sheng Ma extracts was embarked upon.  
5.3.2.2 Biological triplicates of two Actaea species at three concentrations 






Figure 63: The layout of the 24 well plate used for culturing and treating the HepaRG™ for the final 
experiment 
Following 24 hours of treatment RNA was extracted from each well respectively. The quality and 













3 – 5. DMSO 
 
6 – 8. A. dahurica 100 μg/ml 
 
9 – 11. A. dahurica 20 μg/ml 
 
12-14. A. dahurica 5 μg/ml 
 
15-17. A. racemosa  100 
μg/ml 
 
18 – 20. A. racemosa 20 
μg/ml 
 
21-23. A. racemosa 5 μg/ml 
 
Figure 64: Results of extracted RNA analysis on a BioRad RNA Chip – the 28S and 18S subunits shown 
indicating good quality RNA extractions 
The results show that the RNA is of good quality as the 18S and 28S regions are present. The 18S and 
28S bands are intense indicating that there is a good quantity of RNA present and another point 
worth noting is the ratio of 28S to 18S appears to be 2:1 a well-known indication of good quality. 







There are no bands above the 28S band indicating that there is no genomic DNA contamination as 
genomic DNA runs slower on the gel. 
The next step was to quantify the RNA as this is useful for the cDNA synthesis step. 
Table 60: Quantification data for the RNA extractions – obtained using spectrophotometry 
Sample Description Concentration 
(ng/μL) 
A260 A280 A260/A280 
1 Normal control 155.39 3.884732 1.840235 2.110997 
2 Acetaminophen 10mM 93.69 2.342211 1.12603 2.080061 
3 DMSO 165.34 4.133544 1.96246 2.106308 
4 DMSO 183.65 4.59135 2.213783 2.073984 
5 DMSO 156.18 3.904527 1.88203 2.074636 
6 Actaea dahurica 100μg/ml 171.62 4.290485 2.057635 2.085153 
7 Actaea dahurica 100μg/ml 137.79 3.444759 1.652092 2.08509 
8 Actaea dahurica 100μg/ml 185.90 4.647447 2.229838 2.084209 
9 Actaea dahurica 20μg/ml 143.46 3.586533 1.704871 2.103698 
10 Actaea dahurica 20μg/ml 199.23 4.980789 2.440569 2.040831 
11 Actaea dahurica 20μg/ml 168.96 4.223925 2.012511 2.098834 
12 Actaea dahurica 5μg/ml 147.39 3.684646 1.74898 2.106739 
13 Actaea dahurica 5μg/ml 162.34 4.058522 1.952972 2.078126 
14 Actaea dahurica 5μg/ml 135.02 3.375463 1.624415 2.077957 
15 Actaea racemosa 100μg/ml 41.89 1.047333 0.523771 1.999602 
16 Actaea racemosa 100μg/ml 164.72 4.117878 1.981429 2.078237 
17 Actaea racemosa 100μg/ml 150.40 3.760097 1.781039 2.111182 
18 Actaea racemosa 20μg/ml 160.56 4.013945 2.220012 1.808074 
19 Actaea racemosa 20μg/ml 134.04 3.350977 1.620174 2.068282 
20 Actaea racemosa 20μg/ml 188.34 4.708404 2.328769 2.021843 
21 Actaea racemosa 5μg/ml 154.41 3.860323 1.874301 2.059607 
22 Actaea racemosa 5μg/ml 136.18 3.404568 1.625911 2.093945 
23 Actaea racemosa 5μg/ml 122.10 3.052606 1.478947 2.06404 
 
The A260/A280 ratio is an indication of RNA purity. A figure of around 2 is accepted as ‘pure’ and the 
majority of the samples are close to this figure. Anything considerably lower could indicate 
contamination with proteins or phenols for example. The results look encouraging at this point. 
The next step now is to convert the RNA to cDNA using the First Strand Kit. The kit uses an enzyme, 
reverse transcriptase, to convert the RNA into cDNA. There is a built in genomic DNA digestion step 





conversion to cDNA. Although the RNA chip results indicate no genomic DNA contamination is 
present it is still worthwhile to take every precaution possible as any contamination would be 
detrimental to the gene expression results. There is a genomic DNA control on the array also for 
absolute confidence. 
Depending on the concentration of the RNA samples various volumes were used as a template in the 
cDNA synthesis reactions. The arrays could be completed now that the cDNA was ready. 
Once the first array was complete, the threshold was manually altered as previously described in the 
pilot experiment. 
 
Melt Curve Chart (F vs. T) 
 
Melt Curve Peak Chart (-dF/dt vs. T) 
Figure 65: Melt curve plots for the triplicate reverse transcription controls. On the left is the dissociation 
curve of measured fluorescence plotted against temperature, on the right is the negative first derivative plot 
which displays the rate of change of fluorescence vs. temperature – the point of maximum rate of change 
shows the melting point of the amplicon 
The melt curves of the reverse transcription controls were studies as shown in Figure 65 to ascertain 
that one peak is seen indicating one product is present and the control has been successfully 






Melt Curve Chart (F vs. T) 
 
Melt Curve Peak Chart (-dF/dt vs. T) 
Figure 66: Melt curve plots for the positive PCR Control. On the left is the dissociation curve of measured 
fluorescence plotted against temperature, on the right is the negative first derivative plot which displays the 
rate of change of fluorescence vs. temperature – the point of maximum rate of change shows the melting 
point of the amplicon 
Each triplicate has the same melting point displaying that the same product is being formed in each 
reaction. Each triplicate also displays one peak showing that a single product is being formed in the 
reaction.  
 
Melt Curve Chart (F vs. T) 
 
Melt Curve Peak Chart (-dF/dt vs. T) 
Figure 67: Melt curve analysis for the Housekeeping genes. On the left is the dissociation curve of measured 
fluorescence plotted against temperature, on the right is the negative first derivative plot which displays the 
rate of change of fluorescence vs. temperature – the point of maximum rate of change shows the melting 






Melt Curve Chart (F vs. T) 
 
Melt Curve Peak Chart (-dF/dt vs. T) 
Figure 68: Melt curve analysis of 12 of the genes of interest. On the left is the dissociation curve of measured 
fluorescence plotted against temperature, on the right is the negative first derivative plot which displays the 
rate of change of fluorescence vs. temperature – the point of maximum rate of change shows the melting 
point of the amplicon 
The melt curves are just a selection of what was carried out but are representative of the success of 
all the plates carried out. The desired outcome was to produce reactions with a single peak on the 
melt curve. This indicated that one product was produced. 
Once all the arrays were completed, the next step was to import all the raw data from the qPCR 
cycler into the online analysis tool (Available from: http://www.qiagen.com/gb/shop/genes-and-
pathways/data-analysis-center-overview-page/). Once all the data was imported it was necessary to 
choose housekeeping genes for normalisation and review all the QC data. The QC data comes from 
the controls built into the plate. There is a genomic DNA control which if successful will not produce 
a product. Fortunately, the Ct value for every plate was more than 35. There were three wells used 
for reproducibility testing and a further three wells used for a reverse transcription control. All of the 
































































H01 ACTB No 17.62 17.62 17.52 19.19 18.03 17.78 17.79 18.62 17.74 17.49 17.49 17.96 17.08 17.60 17.33 17.75 16.83 17.70 17.68 17.45 17.58 
H02 B2M Yes 18.87 18.69 19.21 21.30 19.34 19.20 19.03 20.07 19.17 19.01 19.14 19.35 18.80 19.40 18.67 19.17 18.43 19.11 19.12 18.94 19.17 
H03 GAPDH Yes 19.79 19.82 19.11 21.66 19.63 19.65 19.83 20.40 19.17 19.13 19.06 19.58 18.96 19.42 19.31 19.81 18.92 19.93 19.76 19.62 19.45 
H04 HPRT1  Yes 25.45 25.28 25.26 26.78 25.80 25.92 25.88 26.67 25.75 25.61 25.68 25.91 25.36 25.80 25.40 25.72 25.17 25.60 25.68 25.74 25.75 
H05 RPLP0 No 18.24 18.07 18.22 20.04 18.53 18.25 18.35 19.02 18.85 18.15 18.23 18.69 18.03 18.48 17.78 18.30 17.61 18.27 18.30 18.19 18.44 
Arithmetic Mean  21.37 21.26 21.19 23.25 21.59 21.59 21.58 22.38 21.36 21.25 21.29 21.61 21.04 21.54 21.13 21.57 20.84 21.55 21.52 21.43 21.46 
Avg. of Arithmetic Mean  21.27 22.14 21.77 21.38 21.24 21.32 21.47 
*Greyed out sample was not included in the analysis as the Ct values of the housekeeping genes deviated from the other samples too greatly. 





















12 CD 5 13 CD 5 14 CD 5 
PCR Array Reproducibility 
Average Ct 
(PPC)  
19.52 19.57 19.77 19.57 20.27 19.62 19.89 19.91 19.85 19.50 19.82 19.8 19.91 19.93 20.12 20.54 19.70 19.85 19.93 21.38 20.02 
Result  Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass 
Reverse Transcription Control (RTC) 
Delta CT 
(AVG RTC - 
AVG PPC)  
3.5 3.4 3.5 3.9 3.2 3.4 3.4 3.2 3.2 3.4 3.4 3.5 3.4 3.2 3.4 3.3 3.5 3.4 3.9 1.7 2.6 
Result  Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass Pass 
Genomic DNA Contamination (GDC) 
CT(GDC)  0 37.94 37.61 35 35 35 35 35 35 35 35.91 35 35.81 35 35 36.08 35 35 35 35.98 35 







Table 63: A summary of the fold regulation values obtained for the A. racemosa extract and Sheng Ma extract – values exceeding 2 show significant increased expression of 
a gene and negative values exceeding 2 show significant decreased expression of a gene compared to the control group 
Position Symbol APAP AR 100 AR 20 AR 5 Sheng Ma 100 Sheng Ma 20 Sheng Ma 5 
Fold Regulation Fold Regulation Fold Regulation Fold Regulation Fold Regulation Fold Regulation Fold Regulation 
A01 ABCB1 1.026 1.1893 1.4189 1.0464 -1.0725 -1.0041 1.1264 
A02 ABCB11 -6.8829 -1.4656 -1.3934 -1.0055 1.0063 -1.1376 -1.4389 
A03 ABCB4 -2.4335 -1.028 -1.0013 -1.0604 1.0109 1.0773 1.0461 
A04 ABCC2 -5.6687 -1.2583 -1.0682 -1.0801 1.0227 1.1256 -1.0485 
A05 ABCC3 -1.9359 -1.1863 -1.0511 1.1882 -1.0336 -1.0371 -1.0754 
A06 ALDOA -2.3506 -1.1539 -1.1214 1.0225 -1.0217 -1.1297 -1.1185 
A07 APEX1 -1.1119 -1.0841 -1.2018 -1.0927 -1.131 1.031 1.0012 
A08 ASAH1 2.1096 -1.3255 -1.213 -1.2994 -1.1284 -1.0371 -1.1211 
A09 ATP8B1 4.6816 -1.4555 -1.2074 -1.0242 -1.2725 -1.1914 -1.0245 
A10 AVPR1A -1.1511 -1.4355 -1.5895 -1.771 -1.455 1.0334 1.0632 
A11 BHMT 2.1992 -1.2085 -1.0535 -1.2152 -2.0529 1.123 -1.1796 
A12 BTG2 -2.4335 -1.3332 -1.0036 1.0537 -1.0408 -1.0371 -1.0412 
B01 CA3 -1.0231 1.0282 -1.1008 -1.0776 -1.6986 1.0999 1.2879 
B02 CASP3 1.4211 -1.1987 -1.3934 -1.7628 -1.1001 -1.1014 -1.0705 
B03 CCNG1 -1.3407 -1.3533 -1.2413 -1.3831 -1.232 -1.1297 -1.1823 
B04 CD36 -1.4671 -2.8909 -1.8216 -3.5175 -2.034 -1.2769 -1.5386 
B05 CD68 -2.2238 1.237 -1.013 1.1319 1.2218 1.2606 1.2157 
B06 CDC14B 1.1543 -1.1946 -1.1582 -1.3206 -1.1873 -1.0252 -1.1447 
B07 CDKN1A 1.3632 -1.1754 -1.1136 -1.147 -1.1389 -1.0371 -1.0151 
B08 COL4A1 2.8619 -1.2612 1.1055 1.5606 -1.1155 -1.7005 -1.0631 
B09 CRYL1 2.7453 -1.4222 -1.0857 1.0513 -1.3829 -1.0444 -1.0293 
B10 CXCL12 1.026 1.1893 1.4189 1.0464 -1.0725 -1.0041 1.1264 
B11 CYP1A2 1.0331 1.0498 1.0056 1.1398 10.2603 1.6943 1.1007 
B12 DDIT4L -2.0463 -2.1089 1.4288 -1.3391 -1.3389 1.3263 -1.142 
C01 DDX39A -2.1038 -1.015 -1.1034 -1.0902 -1.1655 1.0051 -1.0606 
C02 DNAJB11 1.092 -1.1341 -1.1663 -1.1875 -1.2066 -1.1402 -1.185 
C03 DNAJC3 -1.0519 -1.2715 -1.1136 -1.1338 -1.2066 -1.0158 -1.1368 





C05 FADS1 -2.6445 -1.0448 -1.0832 -1.0604 -1.0504 -1.0371 -1.0245 
C06 EMC9 -1.0966 1.039 -1.0295 -1.0055 -1.08 1.0263 1.0583 
C07 FASN -1.4773 -1.4792 -1.0807 1.6156 -1.2784 -1.2739 -1.2819 
C08 FMO1 -2.7189 -1.1069 -1.2822 -1.4319 1.0086 1.7951 1.3272 
C09 TIMM10B 1.195 -1.0569 -1.0319 -1.0433 -1.0336 -1.0064 1.0461 
C10 GADD45A 3.2198 -1.0606 -1.0438 1.0908 -1.003 1.0748 1.2556 
C11 GCLC 2.5973 -1.3978 1.2641 -1.7345 1.1453 1.448 1.1395 
C12 GSR 1.4409 -1.5983 -1.0658 -1.364 1.091 -1.1219 1.0317 
D01 HAO2 -20.4356 -2.0347 -1.3213 -1.182 -2.5158 -1.3067 -1.3118 
D02 HMOX1 1.5988 1.188 1.0753 1.0709 1.1011 1.0334 1.0981 
D03 HPN -11.1813 1.3 1.1794 1.2618 -1.0077 -1.0134 1.1342 
D04 HYOU1 2.6335 -1.2482 -1.1239 1.0984 -1.2263 -1.2024 -1.1988 
D05 ICAM1 -2.178 1.027 -1.0584 -1.029 1.236 1.0382 1.0152 
D06 IGFALS 1.7496 1.1278 1.3994 2.6984 1.219 1.123 1.4258 
D07 IL6ST 1.4409 -1.3409 -1.2733 -1.364 -1.1232 -1.0565 -1.1159 
D08 IPO4 1.6099 -1.0618 1.1904 1.5787 1.1856 -1.03 1.0755 
D09 FAM214A -1.5294 -1.1341 -1.1423 -1.2727 -1.1468 1.0798 1.0012 
D10 KRT18 -2.0181 1.0919 1.0556 1.0537 1.1506 1.0624 1.0755 
D11 KRT8 -1.8063 -1.1686 -1.2158 1.1398 -1.003 -1.0419 1.0058 
D12 L2HGDH 2.7076 -1.4371 -1.0153 -1.2322 -1.2377 -1.0252 -1.2016 
E01 LGR5 -1.8961 -2.2681 1.0244 -1.4187 -1.5995 -1.4532 -1.3707 
E02 LPL -1.1591 -1.1018 -1.1798 -1.1711 -1.0651 -1.0444 -1.098 
E03 LSS -1.9766 -1.3409 -1.0487 1.3903 -1.3389 -1.4135 -1.2212 
E04 MAOB -2.0322 -1.4707 -1.1188 1.0131 -1.3327 -1.1615 -1.1741 
E05 MAP3K6 -1.7814 -1.2424 -1.0366 1.3093 -1.1001 -1.0712 -1.068 
E06 MBL2 -1.7814 -1.3754 -1.1344 -1.2815 -1.6107 -1.2164 -1.1315 
E07 MCM10 -1.6737 -1.138 -1.3001 -1.1105 1.3186 1.1178 1.0175 
E08 MLXIPL 2.4742 1.0894 1.3737 2.0592 -1.0577 1.0145 1.1527 
E09 MRPS18B 1.077 1.0013 1.022 -1.1417 1.0986 1.1816 1.1608 
E10 NQO1 -3.3012 -1.3818 -1.3031 -1.6035 1.0086 1.0649 -1.2016 
E11 NUS1 1.0189 -1.0791 -1.1449 -1.3863 -1.0312 1.0674 -1.046 
E12 OSMR -2.6263 -1.0643 -1.0807 -1.4858 1.0539 1.0005 -1.196 
F01 SLC51A -38.9354 -1.0557 -1.0511 -1.2465 2.625 1.0773 -1.1714 
F02 PDYN 1.026 1.1893 1.4189 1.3461 1.8734 1.0239 1.1264 





F04 PPARA 1.6099 -1.2907 -1.1529 -1.0314 -1.2377 -1.0492 -1.1031 
F05 PSME3 1.3077 -1.1673 -1.0983 1.0392 -1.1655 -1.0324 -1.0436 
F06 PYGL -2.4846 -1.2759 -1.2674 -1.1902 -1.0577 -1.0762 -1.098 
F07 RB1 -1.2596 -1.4438 -1.4128 -1.4024 -1.2666 -1.1859 -1.2071 
F08 RDX 1.195 -1.2877 -1.2558 -1.4824 -1.0775 -1.0614 -1.1031 
F09 RHBG 2.2926 -1.7409 -1.2733 2.0076 -1.9022 -1.3434 -1.719 
F10 S100A8 -4.8333 1.6116 1.2409 1.0108 1.7806 1.4547 1.3457 
F11 SCD -2.8739 -1.2367 -1.2046 -1.3176 -1.1495 -1.1323 -1.0754 
F12 SERPINA3 -5.3258 1.2185 1.1659 -1.0433 1.1347 1.0334 1.1661 
G01 SERPINE1 -1.857 -1.1288 -1.2102 -1.0653 1.4035 -1.0787 -1.1159 
G02 SKIL 1.2544 -1.7031 -1.4194 -1.4319 -1.2992 -1.2419 -1.4158 
G03 SLC17A3 -4.0084 -1.098 -1.0106 -1.1182 1.0039 1.1127 -1.0412 
G04 SLC2A3 1.026 1.1123 1.3269 -1.0219 -1.1468 -1.0737 1.0534 
G05 SLC39A6 2.0951 -1.2656 -1.2911 -1.4552 -1.0775 -1.1193 -1.1159 
G06 SREBF1 -4.0926 -1.4388 1.0508 1.7437 -1.1103 -1.1695 -1.15 
G07 TAGLN -1.6621 -1.1301 1.0803 1.5285 -3.9659 1.1981 -1.0779 
G08 THRSP -1.4671 -3.2188 -1.2529 1.1664 -4.1631 -1.2622 -1.1185 
G09 TMEM2 1.3538 -1.0741 -1.1609 -1.3609 1.049 1.0028 -1.0436 
G10 TXNRD1 3.8825 -1.5456 -1.3152 -1.2322 -1.0553 -1.208 -1.1905 
G11 WIPI1 1.7987 -1.2892 -1.2529 -1.204 -1.2962 -1.1297 -1.2127 
G12 YRDC 2.6518 -1.046 1.0483 1.1086 1.0514 1.0215 1.0981 
H01 ACTB -2.163 -1.0484 1.0291 1.0038 1.1088 1.1127 1.1395 
H02 B2M -1.0966 -1.0692 1.0033 -1.1312 -1.0976 1.0098 1.0128 
H03 GAPDH -4.541 1.1356 1.2126 1.3032 1.1829 1.0098 1.0981 
H04 HPRT1 1.1305 -1.2141 -1.2018 -1.2639 -1.2235 -1.1271 -1.166 
H05 RPLP0 1.4015 1.0259 -1.0414 -1.0826 -1.0147 1.0798 1.027 
H06 HGDC 1.026 1.1893 1.4189 1.0464 -1.0725 -1.0041 1.1264 
H07 RTC 1.0118 1.0024 1.4454 1.6008 1.1011 1.2261 1.2213 
H08 RTC 1.0845 1.0806 1.3929 1.6045 1.1088 1.2782 1.2326 
H09 RTC 1.077 1.1757 1.4929 1.7117 1.1037 1.308 1.2969 
H10 PPC 1.1463 1.0223 1.1605 -1.0851 1.0063 1.0999 1.1342 
H11 PPC -1.1119 -1.052 1.0654 -1.1054 -1.075 1.0823 1.0558 





As mentioned in section 5.3.2. Treatment and gene expression analysis of HepaRG™ cells, the Ct 
values are converted to fold change and fold regulation values through several calculation stages. 
 
Figure 69: A Scatter plot of gene activity in HepRG™ cells treated with acetaminophen  – increased 
expression of genes shown as yellow dots, decreased expression of genes shown as blue dots and unaffected 
genes are displayed as black dots within the dotted line zone.  











A. racemosa 100μg/ml 
Under expressed genes 
CD36  -2.8909 
DDIT4L  -2.1089 
HA02  -2.0347 
LGR5  -2.2681 
THRSP  -3.2188 
 
A. racemosa 20μg/ml 
No significant gene expression changes 
 
A. racemosa 5μg/ml 
 
Over expressed genes 
IGFALS  2.6984 
MLXIPL  2.0592 
RHBG  2.0076 
 
Under expressed 
CD36  -3.5175 
  
Figure 70: Scatter plots of gene activity in HepRG™ cells treated with an extract of A. racemosa at three 
different concentrations. A. A. racemosa 100µg/ml, B. A. racemosa 20µg/ml, and C. A. racemosa 5µg/ml, – 
increased expression of genes shown as yellow dots, decreased expression of genes shown as blue dots and 
unaffected genes shown as black dots within the dotted line zone.  
A. racemosa 100μg/ml compared to control 




















Sheng Ma “A. dahurica” 100μg/ml 
 
Under expressed genes 
BHMT  -2.0529 
CD36  -2.034 
FABP1  -2.9711 
HA02  -2.5158 
TAGLN  -3.9659 
THRSP  -4.1631 
 
Over expressed genes 
 
CYP1A2 10.2603 
SLC51A  2.625 
 
Sheng Ma “A. dahurica” 20μg/ml 
No Significant Gene Expression changes 
 
Sheng Ma “A. dahurica” 5μg/ml 
No Significant Gene Expression changes 
 
  
Figure 71: Scatter plots of gene activity in HepRG™ cells treated with an extract of A. racemosa at three 
different concentrations. A. Sheng Ma 100µg/ml, B. Sheng Ma 20µg/ml, and C. Sheng Ma 5µg/ml, – 
increased expression of genes shown as yellow dots, decreased expression of genes shown as blue dots and 
unaffected genes shown as black dots within the dotted line zone. 
The Log10 of the fold regulation is displayed in the scatter plots as under expressed genes are made 
negative from the calculation and allows for a meaningful visual plot.  
Sheng Ma 100μg/ml compared to control 

















The results for Actaea racemosa treated cells show decreases in expression of genes at 100μg/ml. 
The gene expression changes of all three concentrations are displayed in Figure 72. There were no 
over expressed genes shown. CD36 (thrombospondin receptor), DDIT4L (DNA-damage-inducible 
transcript 4-like), HA02 (Hydroxyacid oxidase 2 (long chain)), LGR5 (Leucine-rich repeat containing G 
protein-coupled receptor 5) and THRSP (Thyroid hormone responsive) are all under expressed (i.e. 
more than a 2 fold change in expression) compared to the control. Increased expression of CD36 is 
seen in steatosis but the opposite was seen in the experiment. Increased expression of DDIT4L is 
seen in hepatotoxicity but a decreased expression was seen. HA02 and THRSP are seen as down 
regulated in hepatotoxicity which is what was seen in this experiment but HA02 was marginal. LGR5 
is decreased in expression in necrosis as was seen in the experiment. At the lower concentration of 
5μg/ml there are a few marginal over expressions seen in IGFALS (Insulin-like growth factor binding 
protein, acid labile subunit), and marginal over expression seen in MLXIPL (MLX interacting protein-
like) and RHBG (Rh family, B glycoprotein (gene/pseudogene)). IGFALS, MLXIPL and RHBG are under 
expressed in hepatotoxicity but they were over expressed in these tests. A marginal under expression 
was shown in CD36 which is over expressed in steatosis. The only significant changes are perhaps 
THRSP or HAO2 which are down regulated as seen in hepatotoxicity and LGR5 which is shown in 







Figure 72: Bar charts to show gene expression changes in cells treated with Black Cohosh and Sheng Ma extracts. A. Under expressed genes after treatment with Black Cohosh extract. B. Over 
expressed genes after treatment with Black Cohosh extract. C. Under expressed genes after treatment with Sheng Ma extract. D. Over expressed genes after treatment with Sheng Ma extract.  
Under expressed genes 
Under expressed genes 
Over expressed genes 







As for the Sheng Ma extract, several changes are seen in gene expression. Figure 72c and d display 
the changes of expression in chart form. At 100μg/ml CYP1A2 (Cytochrome P450, family 1, subfamily 
A, polypeptide 2) and SLC51A (Organic solute transporter alpha) were seen to be over expressed. 
CYP1A2 is usually seen to be down regulated in hepatotoxicity but this change is still interesting as it 
is a significant increase. SLC51A has an involvement in cholestasis. THRSP is under expressed as seen 
in hepatotoxicity, TAGLN (Transgelin) is under expressed as seen in phospholipidosis, FABP1 (Fatty 
acid binding protein 1, liver) is under expressed but usually over expressed in phospholipidosis, and 
HAO2 is under expressed in hepatotoxicity. There was also decreased expression of CD36 which is 
usually increased in steatosis and BHMT (Betaine--homocysteine S-methyltransferase) was 
marginally under expressed as seen in hepatotoxicity. There were no changes seen in the other two 
concentrations. These changes are very interesting and show that at certain doses of the Sheng Ma 
extract induces changes in genes associated with phospholipidosis, cholestasis and hepatotoxicity.  It 
could be said more firmly if the Sheng Ma extract induced these disease pathways if more genes 
included in the same pathway were found to be altered in line with what would be expected. The 
grouping of the genes expected to change for each pathway is outlined in Table 51.  
5.3.3 Lactic dehydrogenase (LDH) assay 
For this assay the treated HepaRG™ cells and treated HepG2 cells were analysed. The media was 
assayed for this test as the released LDH was the indication of toxicity. Various concentrations and all 
three extracts were utilised. Each differing sample was analysed in triplicate and the average result is 








Table 64: The spectrophotometry values obtained when measuring released LDH in treated HepG2 and 
HepaRG™ cultured cells. 
Sample Average reading at 490nm 
HepaRG™ HepG2 
Control (DMSO) 0.368 0.366 
A. racemosa 100μg/ml 0.385 0.416 
A. racemosa 20μg/ml 0.369 0.396 
A. racemosa 5μg/ml 0.372 0.387 
Sheng Ma A. dahurica 100μg/ml 0.372 0.523 
Sheng Ma A. dahurica 20μg/ml 0.356 0.447 
Sheng Ma A. dahurica 5μg/ml 0.368 0.363 
Sheng Ma A. cimicifuga 100μg/ml 0.376 0.946 
Sheng Ma A. cimicifuga 20μg/ml 0.362 0.364 
Sheng Ma A. cimicifuga 5μg/ml 0.326 0.358 
  
 
Figure 73: A bar chart to show the spectrophotometry readings of each cell type after treatment with the A. 
racemosa and Sheng Ma extracts. The HepaRG™ and HepG2 cells are shown side by side for comparison. 
The HepaRG™ cells when treated with Actaea extracts did not appear to release much LDH or have 





appeared to be much more sensitive to the treatment of the extracts. The amount of LDH release 
dropped as the concentration was decreased.  
5.3.4 MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay 
HepG2 cells were seeded into a 24 well plate and treated with various concentrations of Actaea 
extracts. This analysis was not available for the HepaRG™ cells at the time of experimentation and 
the cells are required for this test rather than the media as in the LDH assay. Each test was 
completed in triplicate and the average readings are shown. Results are summarised in Table 65 and 
shown in Figure 74. The number of viable cells is directly related to how intense the colour reaction is 
as healthy cells are able to reduce the MTT reagent to formazan.  
Table 65: Results of the MTT assay - HepG2 cells treated with Actaea extracts at three concentrations – 
calculated viability shown. 
Sample Average reading at 490nm % viability 
Cells only 1.23 100.00 
Sheng Ma A. dahurica 100μg/ml 1.14 92.68 
Sheng Ma A. dahurica 20μg/ml 1.07 86.99 
Sheng Ma A. dahurica 5μg/ml 1.09 88.60 
Sheng Ma A. cimicifuga 100μg/ml 0.73 59.35 
Sheng Ma A. cimicifuga 20μg/ml 0.81 65.85 
Sheng Ma A. cimicifuga 5μg/ml 0.91 73.98 
A. racemosa 100μg/ml 0.97 78.86 
A. racemosa 20μg/ml 1.01 82.11 
A. racemosa 5μg/ml 1.05 85.37 








Figure 74: A chart to show the calculated cell viability of the cells after treatment with the A. racemosa and 
Sheng Ma extracts. 
It was shown in the MTT assay that the extracts had an effect on viability of the cells. The viability 
increased as the concentration of extracts decreased.  
5.4 Conclusions and further work 
The Actaea dahurica and Actaea cimicifuga samples that were obtained appear to be a mixture of 
both species in both materials. Morphological examination was unable to help with identification due 
to the nature of the materials, i.e. only dried roots were present for study and they had been 
processed by cutting making microscopy difficult. The Actaea racemosa material was grown under 
the control of Schwabe GmbH so had the advantage of flowering plants being available for 
identification. The other two materials could not be identified conclusively using macro or 
microscopic visual methods. The rhizomes had been processed into slices and this hindered the 
identification using these methodologies. The HPTLC results showed also a mixture of the two 
species being present in both samples. Markers for both Actaea cimicifuga were seen in both 
samples. The results from the DNA analysis support this. The materials were sourced from China. The 





Isoferulic acid using TLC) does not discriminate between any of the following; Actaea cimicifuga, 
Actaea dahurica or Actaea heracleifolia. The reason for this is that all of these species are acceptable 
to be used in the Chinese medicine Sheng Ma interchangeably. This Chinese Pharmacopoeia 
identification method is presumably used by the company that the materials were sourced from, as 
they supply Chinese medicinal herbs, so one could assume that identification was made during 
harvesting and just affirmed to be one of the four desired species later on using Chinese 
Pharmacopoeia monograph methods. The Actaea racemosa material was shown to be the true 
identity using all three methods.  
The materials labelled as Actaea racemosa, Actaea cimicifuga and Actaea dahurica were all used in 
the pilot qPCR gene expression study. Due to the lengthy process of cell treatment through to gene 
expression, the pilot study was kept minimal. Once it was shown that all the steps could be 
successfully completed the main experiment was carried out. Due to the Actaea dahurica and Actaea 
cimicifuga samples both appearing to be a mixture of the two species, only one of these was 
included in the rest of the study and was termed as Sheng Ma. This maximised the variation of 
concentrations that could be used and allowed biological triplicates to be utilised: the qPCR array 
data showed that Actaea racemosa was not harmful. There were some gene expression differences 
present but none that were significant. The Sheng Ma Actaea dahurica extract did seem to induce 
gene expression changes linked with hepatotoxicity, cholestasis and phospholipidosis. An interesting 
finding is that the Sheng Ma species extract was found to increase expression of CYP1A2. There have 
been many substances proven to be inducers of CYP1A2 such as coffee, cigarette smoke, cruciferous 
vegetables and various prescription drugs including Omeprazole and Nelfinavir (Zanger and Schwab, 
2013), but there has not been previous evidence of Sheng Ma as an inducer. There were various 
genes changes that were seen related to hepatotoxicity and phospholipidosis. THRSP, BHMT and 
HAO2 were seen to be under expressed which can be seen in hepatotoxicity. TAGLN (Transgelin) is 
under expressed in phospholipidosis which was seen in the experiment. SLC51A (Organic solute 





of this gene has been found in patients with primary biliary cirrhosis (Ballatori et al., 2013). BHMT has 
been shown to have a role in protecting the liver and has been found to be decreased in expression 
in diseased liver (Feng et al., 2011). HAO2 has a role in fatty acid metabolism and is impaired in 
hepatotoxicity (Mattu et al., 2016).TAGLN is down regulated in phospholipidosis as demonstrated by 
Nioi et al. It was found to become under expressed when treating HepG2 cells with known 
phospholipidosis inducing drugs. The function of this gene is not understood (Nioi et al., 2007).  
The changes seen in the cells treated with the Actaea racemosa extract where just as numerous but 
the majority of the changes were the opposite of what would be expected in liver disease and liver 
injury. There were some slight changes seen in two genes associated with hepatotoxicity compared 
to the control; THRSP and HAO2, as was also seen in Sheng Ma, but both genes were not increased as 
much as Sheng Ma. LGR5 (Leucine-rich repeat containing G protein-coupled receptor 5) was slightly 
under expressed and this gene is related to necrosis when under expressed according to the 
manufacturer of the qPCR array. A review of some current literature (Huch and Dolle, 2016, Khan et 
al., 2017, Khan et al., 2015) has shown that the expression of LGR5 is in fact increased in liver injury 
as the function of the gene has a role in regeneration following injury to the liver. 
The reliability of the control is very important as any changes in gene expression are a result of 
comparison. The use of proven housekeeping genes is also fundamental to the study as they are used 
for normalisation. In the final gene expression study each test sample was analysed in biological 
triplicates. Controls for detection of genomic DNA contamination, reproducibility of the arrays and 
reverse transcription were built into each array and so a good level of confidence can be given to the 
results obtained. The gene changes that were detected for the treatment with the Sheng Ma extract 
were not large in comparison to acetaminophen for example but they were still significant. It can’t be 
concluded from the study that Sheng Ma i.e. Asian Actaea causes hepatotoxicity but there are signs 
of the extract causing changes within the cells at a molecular level. A study for a longer period of 





The LDH results were interesting as it gave the opportunity to compare the effects of two different 
liver cell lines. The HepG2 cells seemed to be much more sensitive to the effects of the extracts, 
particularly with Sheng Ma Actaea cimicifuga. The MTT assay was also carried out. The MTT assay 
allows the measurement of conversion of the MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) to formazan. MTT is soluble and formazan is insoluble within the 
media. This allows the formazan to be precipitated. The precipitate is then dissolved in another 
solvent (in this case acidified isopropanol) and intensity of the colour measured. The more dissolved 
formazan present the more active the cells are, as they are able to carry out the conversion. This 
shows viability of the cells. The HepG2 cells were used in this experiment. All three of the Actaea 
extracts were used as treatments. All of the extracts had an effect on the cells at the highest 
concentrations. The effect of the extracts reduced as the concentrations reduced. The Actaea 
cimicifuga Sheng Ma extract had the largest effect on the cells, second was Actaea dahurica Sheng 
Ma extract and finally Actaea racemosa had the least effect. These results are all interesting. It shows 
that Sheng Ma species are potentially more harmful than Actaea racemosa. As mentioned in the 
introduction it has been found that Actaea cimicifuga is cytotoxic to cancer cell lines (HepG2 cells IC50 
value was 21 µg/mL) (Tian et al., 2007, Chen et al., 2014a), and as HepG2 cells were used for this 
treatment it is perhaps not very surprising that a reduction in cell viability was seen. The important 
point would be to find out if the same is seen in primary human hepatocytes.  
Overall the Sheng Ma extracts showed more evidence of causing ill effects to the liver cells that they 
were used to treat. The Actaea racemosa extract showed a slight under expression in two genes 
associated with hepatotoxicity but they did not show such an effect with the LDH or MTT assays. On 
the other hand the Sheng Ma species extracts showed gene expression changes in several liver 
disease pathways and triggered an over expression of CYP1A2 which although is not a marker of 
hepatotoxicity, is an interesting change as it has not been seen in any published literature to date. 
The Sheng Ma species extracts also caused the cells to produce more LDH and showed the least 





6 Overall Conclusions 
6.1 The importance of prior quality control of reference databases 
The key theme overall in this thesis is the reliable identification of raw medicinal plant materials. This 
is not just important for the manufacture of herbal medicines, but it is also fundamental in 
developing the use of barcode sequences for identification means. In order for a plant sample to be 
used as a reference, there have been extensive conditions set out in the literature by Smillie and 
Khan 2010. These include full documentation of the site of harvest, photos, sampling and inclusion 
into a formally recognised herbarium. There also needs to be a full morphological characterisation of 
the above ground plants and of the part of the plant that is used in the herbal medicine, e.g. flowers, 
leaves, stem, root etc. This rarely occurs and as a consequence the wrong plant species have been 
used for barcoding (Smillie and Khan, 2010). This means that some herbal medicines will be made 
with the incorrect species and also that identification methods become based on the wrong plant 
species completely mixing up the resulting identification. Using the wrong material in production of 
herbal medicines has had detrimental effects (Tankeu et al., 2016). The available literature supports 
the safety and efficacy of authentic Black Cohosh products containing only the species Actaea 
racemosa (Nappi, 2005, Osmers et al., 2005, Wuttke et al., 2006, Molla et al., 2011). Where possible, 
products associated with adverse reactions have been tested, and have been found to be substituted 
with Asian Actaea species known as Sheng Ma in Chinese medicine(Jordan et al., 2010). Clinical trials 
that have shown poor efficacy have been linked to products that are not registered and therefore not 
as robustly tested (Beer and Neff 2013). There has not been a great deal of accessible research into 
the safety and efficacy of Sheng Ma products. Sheng Ma products are intended for use in Chinese 
medicine for skin disorders.   
When the original PlantID assay for Black Cohosh was designed, there were a small number of ITS 





the databases, there is the potential to overcome this problem by looking at trends rather than 
individual sequences. Several Actaea racemosa sequences that all cluster together give more 
confidence than a single sequence. This is therefore an iterative process – as more sequences 
accumulate, the tests can and should be re-evaluated. The available DNA sequence data for the nrITS 
region of the included species was re-assessed. There had to be a high level of confidence in the 
species identification assigned to the sequence data in order to be able to use it for classification of 
the test materials. An analysis was carried out based on the similarity of the published DNA 
sequences and the output for this was represented as a tree diagram. Sequences that were similar 
were clustered together into branches. The tree was then studied; any sequence accessions that did 
not match the other entries in the branch that they were assigned to, were not used for identifying 
materials. Once the sequence data had been assessed it could be used to assign identification to any 
sequenced samples. This confirmed or sometimes contradicted the species identification that had 
been assigned to the sequence accession.  
6.2 Development of DNA based identification tests – choice and 
development of suitable assays 
The first DNA based identification test was a one tube assay capable of detecting five different 
species. The assay was developed with reference materials from vouchered herbarium samples 
which were also positively identified using genomic sequencing. A species specific primer mix was 
used in a multiplex reaction and showed that when all five target species were present they could all 
be detected. The main limitation to the assay is the time it takes to develop and optimise it. Once the 
assay has been developed though, it is a great tool for identification and is easy to perform and gives 
a solid conclusion. A mixture of singleplex reactions can be run alongside the test reactions to give 
something to compare to, so that it can be easily seen if a species is present in the test sample or not. 
The assay requires only the basic tools that a molecular biology lab is equipped with; a PCR machine 





formulations such as those seen in Chinese and Ayurvedic medicine. The assay design is not limited 
to identification of Black Cohosh as it has also been developed for St John’s Wort. The second of the 
DNA based identification tests to be developed was the qPCR assays. The same species-specific 
primers developed for the PlantID assay were utilised. Multiplex qPCR has two main approaches; 
primers labelled with different fluorescent markers or the use of high resolution melting for 
assessment of the resulting amplicons. The differently labelled primer detection is restricted to the 
number that the qPCR machine is able to differentiate between. This number does not usually 
exceed five and can be financially demanding not to mention difficult technically to develop. High 
resolution melting is also limited by amplicon size and GC content of the primers. This was shown in 
this work not to be feasible using the species-specific primers that have been developed. Only two 
variants were detected from five when attempted using the PlantID assay. It was decided to develop 
individual species assays using qPCR. This would require more individual reactions which were a 
downside compared to the PlantID assay but it would not be restricted by the collective annealing 
temperature required for specificity in the multiplex reaction. Most qPCR machines now have the 
ability to apply a temperature gradient across the block which opened up the possibility of running 
reactions with different annealing temperature requirements together. This means that the qPCR 
assays would not necessarily take longer to complete compared to the plantID assay. The qPCR 
assays also did not require a separate diagnostic agarose gel and results were available immediately 
after the reaction was complete. The qPCR assays were developed for Actaea racemosa, Actaea 
dahurica and Actaea cimicifuga. The reason these three species were chosen is that they are the 
most relevant of all the species included in this work. Actaea racemosa of course as it is the authentic 
species for Black Cohosh preparations and then the other two as they have been found to most 
commonly be detected as adulterants in tested Black Cohosh products. It would have been ideal to 
include Actaea dahurica in the PlantID assay but the required annealing temperature to maintain 





their identification verified with sequencing. In each tested material the results were consistent with 
the sequencing results.  
6.3 Trialling the developed assay qPCR with genuine commercial products 
More than 30 commercial samples were tested using the qPCR assays. The results of this testing 
were often confirmed with sequencing or a separate chemical analysis completed by Sharaf et al., 
2016. This chemical test was mass spectroscopy based and results were visualised using principle 
component analysis (PCA). It appeared that the reference material used to develop the chemical 
analysis for Actaea dahurica and Actaea cimicifuga were identified incorrectly and therefore gave the 
opposite results of the qPCR assay. These are the kinds of issues that prove how important the 
reference material of an identification technique is in terms of ensuring that it is of the correct 
species. Overall the qPCR assays were easy to perform and interpret. Of the 34 commercial products 
tested 32 were successfully analysed. Five of the products from the UK market had undeclared 
species detected and 6 of the products from the US market had undeclared species detected. These 
undeclared species were Asian Actaea and demonstrate that current QC testing regimes are either 
not sensitive enough, or that suppliers are deliberately adulterating or substituting for Asian species. 
There are other DNA based assays that have been developed for authentication of Black Cohosh but 
they have so far been based around restriction enzyme digestions (Xu et al., 2002, Masada-Atsumi et 
al., 2014, Zerega et al., 2002). These tests are not very reproducible. They are also time consuming to 
carry out as they all require a diagnostic gel. This can be overcome by using qPCR as utilised in the 
qPCR assays in this work.  
There has not yet been a validated qPCR assay such as the one in this work published. The qPCR 
assay in this work was validated by using it to test samples with known identities from sequencing 
efforts. The work of Baker et al., 2012 was a validated study carried out on many samples but the 
researchers only went as far as to sequence the barcoding region of the included samples. The study 





further and cuts out the need to sequence the samples. Sequencing can be relatively expensive 
compared to a qPCR reaction and is limited to the presence of good quality DNA that is not 
degradated. The group did use mini-matK barcodes to overcome DNA degradation but as shown in 
Chapter 2 the matK region is not ideal for identifying Actaea species due to the sequence entries in 
GenBank clustering together when organised in a DNA tree. This shows that the mini-matK region is 
too similar between different species within the Actaea genus to reliable as a means of identification 
alone. The matK region was only sequenced in this work to backup existing results. This work also 
shows that there are still products available on the market that contains undeclared species. The 
Traditional Herbal Medicines Directive (Directive 2004/24/EC) was put in place to regulate the 
products available on the market but there are grey areas in the legislation which allow products to 
be sold as supplements. In order to sell a product as a supplement there can be no claim to treat 
disease. The products that are registered as herbal medicines go through a costly process which 
includes being able to show traditional usage and safety of use. This shows the importance of having 
assays that are able to detect adulterant species and that are able to do so at a highly sensitive level. 
None of the THR (Traditional Herbal Registration) products were found to contain undeclared species 
although the included number was few. Products from the US are regulated as ‘dietary supplements’ 
through the Dietary Supplement Health and Education Act (DSHEA) of 1994. The current legislation 
allows the presence of products on the US market without first demonstrating efficacy or safety and 
so are not scrutinised as much as THR products on the UK and European market. Although these 
products are not allowed to be marketed with claims of treating disease, they are permitted to make 
loose claims about benefiting health (Bent, 2008). These are further reasons of the need for robust 
tests being available. The qPCR assays in this work could be the answer to this issue. They could also 
be developed for other Actaea species and other non Actaea species.  
The next aim will be to publish the sequence data generated as part of this work. For some of the 
Actaea species there are limited entries for the ITS region and so this data will be useful for many 





The conclusion of this work is that raw materials must be authenticated prior to being used and sold 
in products. The assays developed in this work could contribute to that cause. The British 
Pharmacopeia are already ahead on this aspect. DNA based authentication is in use and included in 
recommended protocols. DNA barcoding is moving forward at great speed and will one day be a 
rapid analysis available to all.  
6.4 Assessment of potential hepatotoxicity of Actaea racemosa and Asian 
Actaea species 
The next issue to be addressed are the claims that Black Cohosh has caused liver injury in isolated 
case reports. These case reports have been reviewed again and again using different methods. Each 
time it is found that the link to the use of Black Cohosh is weak (Mahady et al., 2008, Teschke et al., 
2011). The patients are often found to be taking other medicines that can affect the liver or they 
consume alcohol. The cases are also found to be poorly documented and key events such as 
dechallenge and rechallenge either do not occur or are not recorded (Teschke et al., 2014). 
Important tests such as measure of liver enzymes are either not taken or not recorded (Teschke et 
al., 2011). A review of the case reports was carried out by (Teschke et al., 2013) who looked for 
alternative causes of hepatotoxicity in each instance. It was found that of 96 reports, 52 were due to 
other causes such as hepatitis infection, cirrhosis or liver injury from comedication to name but a 
few. Even though the case reports have found to have a poor connection to Black Cohosh usage, it is 
still required in countries across the globe to include a warning label on Black Cohosh products. As 
said previously, products indicated in liver injury cases have been tested when available and have 
been found to contain other undeclared Asian Actaea species. This raises the question of whether 
the presence of Asian Actaea species is in fact the cause of liver toxicity in these cases. Clinical trials 
support the safety and efficacy of Black Cohosh when the products contain only Actaea racemosa 
(Nappi, 2005, Osmers et al., 2005, Wuttke et al., 2006, Molla et al., 2011). There are no clinical trials 





Cohosh and this has shown to be safe (Briese et al., 2007, Mazzanti et al., 2008). Some in vitro 
studies have been conducted using human hepatocyte cell lines. Huang et al., 2010 treated hepG2 
cells with different types of Black Cohosh extracts and did not find any significant cell viability 
changes using the MTT assay as an assessment. Tian et al., 2005 and 2007 treated HepG2 cells with 
fractions and isolates from the aerial parts of A. dahurica and A. cimicifuga. They found that 
treatment induced apoptosis in the cells. It cannot be known without further testing if ethanol 
extracts of the roots/rhizomes would induce the same changes however. This is where a gap in the 
conducted research has been identified. There needs to be in vitro testing of Actaea racemosa and 
Sheng Ma species to determine if any cause hepatotoxicity.  
To address the uncertainty of toxic activity of Actaea racemosa or Sheng Ma species extracts, a series 
of cell culture based assays were employed. The first of the assays was a large gene expression study 
assessing 84 genes associated with hepatotoxicity. Rhizome material for Actaea racemosa, Actaea 
dahurica and Actaea cimicifuga were sourced and confirmation of identification was attempted using 
DNA testing, morphological assessment and HPTLC. The identification of the Actaea racemosa 
material was confirmed with all tests. The identification of the other two materials was much more 
difficult to confirm and the outcome was that both materials appeared to be a mixture of Actaea 
dahurica and Actaea cimicifuga. For this reason only one was used for the final gene expression 
study. The materials were used to manufacture 60% ethanol extracts and these were used for the 
treatment of HepaRG™ cultured human liver cells. The results of these tests showed gene expression 
changes in the cells treated with both the A. racemosa extract and the Sheng Ma extract. The Sheng 
Ma ethanolic extract induced changes associated with hepatotoxicity, cholestasis and 
phospholipidosis. Unfortunately there were only a few genes from each disease pathway that 
showed an expression change. It would have been more conclusive if more of the genes associated 
with each of the disease had the expected changes. An interesting finding is that Sheng Ma was 
found to increase expression of CYP1A2. There have been many substances proven to be inducers of 





including Omeprazole and Nelfinavir (Zanger and Schwab, 2013), but there has not previously been 
evidence of Sheng Ma species as an inducer. The Actaea racemosa induced changes which were 
often the opposite of what would be expected in liver injury. There were some gene expression 
changes associated with liver injury and although these changes were a significant fold change, 
(more than 2) in the highest concentration, they were few in number compared to the Sheng Ma 
results. 
The MTT assay was performed following extract treatment on the HepG2 cell line. This has been 
performed on these cells following treatment with Actaea racemosa in a previous published study 
(Huang et al., 2010) but this has not yet been used to assess the effect of Sheng Ma extracts on liver 
cells. This assay did show a reduction in viability of the cells in all three extracts. The Sheng Ma 
“Actaea cimicifuga” extract reduced viability of the cells most of the three extracts across the three 
concentrations used. The Actaea racemosa extract reduced viability at the highest of the 
concentrations used and viability increased with decreased concentration. The Sheng Ma “Actaea 
dahurica” did not reduce viability as much as the other extracts. This was surprising as the chemical 
profile was similar to that of the other Sheng Ma extract.  
The LDH assay was performed on both sets of cultured cells, HepG2 and HepaRG™ following 
treatment with the extracts. There were no significant changes in any of the treated HepaRG™ cells 
seen. The HepG2 cells however gave a very different result. The Sheng Ma extracts both caused the 
release of increased amounts of LDH particularly the Sheng Ma “Actaea cimicifuga” extract. This test 
indicates apoptosis and necrosis when LDH release is increased. 
The three different cell culture assays give different clues about the toxicity of the extracts. The 
Actaea racemosa extract induced changes at the highest concentration with a reduction in viability of 
the cells seen in the MTT assay. There was no significant change in the LDH assay. The Sheng Ma 
extracts induced gene expression changes in line with several liver injury pathways. The LDH and 





the HepG2 cell line. These results could show that another pathway other than those assessed with 
the hepatotoxicity array is involved.  
The individual genes that were shown to be affected by the extracts could be explored further in the 
future. The cell culture assays as a whole showed that the Sheng Ma extracts had more of an adverse 
effect than that of the Actaea racemosa extract.  
There are a number of key messages from this work. In spite of wide spread belief, it is possible to 
use DNA based testing for identification of plant species in commercially available herbal medicines. 
Following on from the loss of confidence in DNA testing due to the New York Attourney cease and 
desist of Black Cohosh products, this work has shown that it is possible to use DNA based testing for 
products even when made with alcohol extracts. This is contrary to the statements made by Parveen 
et al in their review of the use of barcoding for herbal products although they did discuss the 
potential of mini-barcode use (Parveen et al., 2016). This is further backed up with the fact that the 
British Pharmacopoeia is developing and investing in DNA based tests to incorporate into the herbal 
monographs. These developments will make it possible for the industry to utilise standardised, 
validated DNA methods that can be used with confidence and will complement the current 
chemistry/morphological based tests. The validated DNA assays will also help to overcome the 
existing issues that occur when using current methods. The DNA tests have shown that a number of 
commercially available Black Cohosh products are adulterated or substituted with Asian Cohosh 
species, and they identify species more accurately than chemical testing has shown. Finally ethanolic 
extracts of Asian Sheng Ma species show features consistent with them being more likely to be 
hepatotoxic that A. racemosa. There was previously not a study on this scale that aimed to attend to 
many of the questions and doubts surrounding Black Cohosh use. These major findings show that it is 
highly possible that adulterated products are the cause of liver injury rather than authentic products 
containing A. racemosa. The available literature suggests efficacy and safety from a clinical trial point 
of view when using high quality authentic Black Cohosh products. The conclusions of this thesis 





quality and are made only with A. racemosa. This is the surest route to ensure safety and confidence 
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8.1 GenBank sequence information 
Table 66: A list of GenBank sequences for the nrITS region of Actaea species 
Accession No. Labelled species 
GQ409511.1 Actaea racemosa 
GQ409510.1 Actaea racemosa 
GQ409509.1 Actaea racemosa 
KU724194.1 Actaea racemosa 
JQ033561.1 Actaea racemosa 
JQ033560.1 Actaea racemosa 
JQ033559.1 Actaea racemosa 
JQ033558.1 Actaea racemosa 
JQ033557.1 Actaea racemosa 
JQ033556.1 Actaea racemosa 
JQ033555.1 Actaea racemosa 
JQ033554.1 Actaea racemosa 
JQ033553.1 Actaea racemosa 
JQ033552.1 Actaea racemosa 
JQ033551.1 Actaea racemosa 
JQ033550.1 Actaea racemosa 
JQ033549.1 Actaea racemosa 
JQ033548.1 Actaea racemosa 
JQ033547.1 Actaea racemosa 
JQ033546.1 Actaea racemosa 
JQ033545.1 Actaea racemosa 
JQ033544.1 Actaea racemosa 
JQ033543.1 Actaea racemosa 
JQ033542.1 Actaea racemosa 
JQ033541.1 Actaea racemosa 
JQ033540.1 Actaea racemosa 
EU796898.1 Actaea racemosa 
AB987687.1 Actaea racemosa 
Z98296.1 Actaea racemosa 
JQ033570.1 Actaea rubra 
JQ033569.1 Actaea rubra 
JQ033568.1 Actaea rubra 
JQ033567.1 Actaea rubra 
JQ033566.1 Actaea rubra 
JQ033565.1 Actaea rubra 
JQ033564.1 Actaea rubra 
JQ033563.1 Actaea rubra 
JQ033562.1 Actaea rubra 
Z98278.1 Actaea rubra 
KT598539.1 Actaea dahurica 
KF233848.1 Actaea dahurica 





KX674805.1 Actaea dahurica 
KX674804.1 Actaea dahurica 
KJ488053.1 Actaea dahurica 
KJ488052.1 Actaea dahurica 
KJ488051.1 Actaea dahurica 
KJ488050.1 Actaea dahurica 
KJ488049.1 Actaea dahurica 
KJ488048.1 Actaea dahurica 
KJ488047.1 Actaea dahurica 
KJ488046.1 Actaea dahurica 
KJ488045.1 Actaea dahurica 
KJ488044.1 Actaea dahurica 
KJ488043.1 Actaea dahurica 
KJ488042.1 Actaea dahurica 
KJ488041.1 Actaea dahurica 
KJ488040.1 Actaea dahurica 
KJ488039.1 Actaea dahurica 
KJ488038.1 Actaea dahurica 
KJ488037.1 Actaea dahurica 
KJ488036.1 Actaea dahurica 
KJ488035.1 Actaea dahurica 
KJ488034.1 Actaea dahurica 
KJ488033.1 Actaea dahurica 
KJ488032.1 Actaea dahurica 
KJ488031.1 Actaea dahurica 
KJ488030.1 Actaea dahurica 
KJ488029.1 Actaea dahurica 
KJ488028.1 Actaea dahurica 
KJ488027.1 Actaea dahurica 
KJ488026.1 Actaea dahurica 
KJ488025.1 Actaea dahurica 
KJ488024.1 Actaea dahurica 
KJ488023.1 Actaea dahurica 
KJ488022.1 Actaea dahurica 
KJ488021.1 Actaea dahurica 
KJ488020.1 Actaea dahurica 
KJ488019.1 Actaea dahurica 
GQ434611.1 Actaea dahurica 
JQ033523.1 Actaea dahurica 
JQ033522.1 Actaea dahurica 
FJ525885.1 Actaea dahurica 
GQ351361.1 Actaea dahurica 
AB987685.1 Actaea dahurica 
AB194179.1 Actaea dahurica 
AB194178.1 Actaea dahurica 
Z98284.1 Actaea dahurica 
KT598541.1 Actaea heracleifolia 
KX675069.1 Actaea heracleifolia 
KX675068.1 Actaea heracleifolia 
KX675067.1 Actaea heracleifolia 
KJ487985.1 Actaea heracleifolia 
KJ487984.1 Actaea heracleifolia 





KJ487982.1 Actaea heracleifolia 
KJ487981.1 Actaea heracleifolia 
KJ487980.1 Actaea heracleifolia 
KJ487978.1 Actaea heracleifolia 
KJ487977.1 Actaea heracleifolia 
KJ487976.1 Actaea heracleifolia 
KJ487975.1 Actaea heracleifolia 
FJ525884.1 Actaea heracleifolia 
GQ351364.1 Actaea heracleifolia 
FJ597989.1 Actaea heracleifolia 
KJ487979.1 Actaea heracleifolia 
AB987686.1 Actaea heracleifolia 
AB194180.1 Actaea heracleifolia 
Z98290.1 Actaea heracleifolia 
Z98289.1 Actaea heracleifolia 
KX675066.1 Actaea cimicifuga 
KX675065.1 Actaea cimicifuga 
KX675064.1 Actaea cimicifuga 
KJ488013.1 Actaea cimicifuga 
KJ488012.1 Actaea cimicifuga 
KJ488011.1 Actaea cimicifuga 
KJ488010.1 Actaea cimicifuga 
KJ488009.1 Actaea cimicifuga 
KJ488008.1 Actaea cimicifuga 
KJ488007.1 Actaea cimicifuga 
KJ488006.1 Actaea cimicifuga 
KJ488005.1 Actaea cimicifuga 
GQ434610.1 Actaea cimicifuga 
GQ434609.1 Actaea cimicifuga 
JQ033519.1 Actaea cimicifuga 
JQ033518.1 Actaea cimicifuga 
JQ033517.1 Actaea cimicifuga 
JQ033516.1 Actaea cimicifuga 
JQ033515.1 Actaea cimicifuga 
FJ525886.1 Actaea cimicifuga 
GQ351362.1 Actaea cimicifuga 
FJ597988.1 Actaea cimicifuga 
AB194182.1 Actaea cimicifuga 
AB194181.1 Actaea cimicifuga 
Z98287.1 Actaea cimicifuga 
JQ033521.1 Actaea cordifolia 
JQ033520.1 Actaea cordifolia 
AB987680.1 Actaea cordifolia 
Z98297.1 Actaea cordifolia 
JQ033533.1 Actaea pachypoda 
JQ033532.1 Actaea pachypoda 
JQ033531.1 Actaea pachypoda 
JQ033530.1 Actaea pachypoda 
JQ033529.1 Actaea pachypoda 
JQ033528.1 Actaea pachypoda 
JQ033527.1 Actaea pachypoda 
Z98277.1 Actaea pachypoda 





JQ033538.1 Actaea podocarpa 
JQ033537.1 Actaea podocarpa 
JQ033536.1 Actaea podocarpa 
JQ033535.1 Actaea podocarpa 
JQ033534.1 Actaea podocarpa 
Z98280.1 Actaea podocarpa 
KT598534.1 Actaea simplex 
KX171664.1 Actaea simplex 
KX171663.1 Actaea simplex 
KJ487994.1 Actaea simplex 
KJ487993.1 Actaea simplex 
KJ487992.1 Actaea simplex 
KJ487991.1 Actaea simplex 
KJ487990.1 Actaea simplex 
KJ487989.1 Actaea simplex 
KJ487988.1 Actaea simplex 
KJ487987.1 Actaea simplex 
KJ487986.1 Actaea simplex 
JQ033575.1 Actaea simplex 
JQ033574.1 Actaea simplex 
JQ033573.1 Actaea simplex 
JQ033572.1 Actaea simplex 
JQ033571.1 Actaea simplex 
EU591988.1 Actaea simplex 
FJ525887.1 Actaea simplex 
GQ351363.1 Actaea simplex 
FJ597990.1 Actaea simplex 
AB777781.1 Actaea simplex 
AB777780.1 Actaea simplex 
AB777779.1 Actaea simplex 
AB777778.1 Actaea simplex 
AB777777.1 Actaea simplex 
AB777776.1 Actaea simplex 
AB777775.1 Actaea simplex 
AB777774.1 Actaea simplex 
AB777773.1 Actaea simplex 
AB777772.1 Actaea simplex 
AB777771.1 Actaea simplex 
AB777770.1 Actaea simplex 
AB777769.1 Actaea simplex 
AB777768.1 Actaea simplex 
AB777767.1 Actaea simplex 
AB777766.1 Actaea simplex 
AB777765.1 Actaea simplex 
AB777764.1 Actaea simplex 
AB777763.1 Actaea simplex 
AB777762.1 Actaea simplex 
AB777761.1 Actaea simplex 
AB777760.1 Actaea simplex 
AB777759.1 Actaea simplex 
AB777758.1 Actaea simplex 
AB777757.1 Actaea simplex 





AB777755.1 Actaea simplex 
AB777754.1 Actaea simplex 
AB777753.1 Actaea simplex 
AB777752.1 Actaea simplex 
AB777751.1 Actaea simplex 
AB777750.1 Actaea simplex 
AB777749.1 Actaea simplex 
AB777748.1 Actaea simplex 
AB777747.1 Actaea simplex 
AB777746.1 Actaea simplex 
AB777745.1 Actaea simplex 
AB777744.1 Actaea simplex 
AB777743.1 Actaea simplex 
AB777742.1 Actaea simplex 
AB777741.1 Actaea simplex 
AB777740.1 Actaea simplex 
AB777739.1 Actaea simplex 
AB777738.1 Actaea simplex 
AB777737.1 Actaea simplex 
AB777736.1 Actaea simplex 
AB777735.1 Actaea simplex 
AB777734.1 Actaea simplex 
AB777733.1 Actaea simplex 
AB777732.1 Actaea simplex 
AB777731.1 Actaea simplex 
AB777730.1 Actaea simplex 
AB777729.1 Actaea simplex 
AB777728.1 Actaea simplex 
AB777727.1 Actaea simplex 
AB777726.1 Actaea simplex 
AB777725.1 Actaea simplex 
AB777724.1 Actaea simplex 
AB777723.1 Actaea simplex 
AB777722.1 Actaea simplex 
AB777721.1 Actaea simplex 
AB777720.1 Actaea simplex 
AB777719.1 Actaea simplex 
AB777718.1 Actaea simplex 
AB777717.1 Actaea simplex 
AB777716.1 Actaea simplex 
AB777715.1 Actaea simplex 
AB777714.1 Actaea simplex 
AB777713.1 Actaea simplex 
AB777712.1 Actaea simplex 
AB777711.1 Actaea simplex 
AB777710.1 Actaea simplex 
AB777709.1 Actaea simplex 
AB777708.1 Actaea simplex 
AB777707.1 Actaea simplex 
AB777706.1 Actaea simplex 
AB777705.1 Actaea simplex 
AB777704.1 Actaea simplex 





AB777702.1 Actaea simplex 
AB777701.1 Actaea simplex 
AB777700.1 Actaea simplex 
AB987684.1 Actaea simplex 
AB987683.1 Actaea simplex 
AB987682.1 Actaea simplex 
AB194177.1 Actaea simplex 
AB194176.1 Actaea simplex 
AB194175.1 Actaea simplex 
AB194174.1 Actaea simplex 
AB194173.1 Actaea simplex 
AB194172.1 Actaea simplex 
AB194171.1 Actaea simplex 
AB194170.1 Actaea simplex 
AB194169.1 Actaea simplex 
AB194168.1 Actaea simplex 
AB194167.1 Actaea simplex 
AB194166.1 Actaea simplex 
AB194165.1 Actaea simplex 
AB194164.1 Actaea simplex 
AB194163.1 Actaea simplex 
AB194162.1 Actaea simplex 
AB194161.1 Actaea simplex 
AB194160.1 Actaea simplex 
AB194159.1 Actaea simplex 
AB194158.1 Actaea simplex 
AB194157.1 Actaea simplex 
AB194156.1 Actaea simplex 
AB194155.1 Actaea simplex 
AB194154.1 Actaea simplex 
AB194153.1 Actaea simplex 
AB194152.1 Actaea simplex 
AB194151.1 Actaea simplex 
AB194150.1 Actaea simplex 
AB194149.1 Actaea simplex 
AB194148.1 Actaea simplex 
AB194147.1 Actaea simplex 
AB194146.1 Actaea simplex 
AB194145.1 Actaea simplex 
AB194144.1 Actaea simplex 
AB194143.1 Actaea simplex 
AB194142.1 Actaea simplex 
AB194141.1 Actaea simplex 
AB194140.1 Actaea simplex 
AB044409.1 Actaea simplex 
AB044408.1 Actaea simplex 
Z98301.1 Actaea simplex 
Z98300.1 Actaea simplex 
Z98299.1 Actaea simplex 






8.2 Placement of species specific primers 
8.2.1 Actaea rubra                                                                                  
 
Actaea_dahurica                 GCTTTGC-AGAATGACCCGTGAACACGTTAAAAAA-TATTAT--GTGGAT 55 
Actaea_cimicifuga               GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 55 
Actaea_rubra                    ---------GAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 37 
Actaea_pachypoda                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_racemosa                 GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 96 
Actaea_cordifolia               ---------GAACGACC-GTGAACATGTTAAAAAAACATTAT--GTGGAT 38 
Actaea_podocarpa                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_heracleifolia            ---------GAACGACC-GTGAACACGTTAAAAAA-TATTAT--GTGGAT 37 
Actaea_simplex                  GCTTCGC-AGAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 66 
Caulophyllum_thalictroides      GCAAAGCGAGAACGACCCGCGAACACGTGAAAAAG-CATTGTCGGGGGAC 58 
                                         *** **** * ***** ** *****   *** *  * ***  
 
Actaea_dahurica                 TGATGAGGAG-YGTGAGCTCTA-AATCATCCATTGTYGGGGCATGGGA-- 101 
Actaea_cimicifuga               TGAGGAGGAG-CATGAGCTCTT-AATCATCCATTGTCGAGTCATGGGA-- 101 
Actaea_rubra                    TGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 83 
Actaea_pachypoda                TGACGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_racemosa                 CGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 142 
Actaea_cordifolia               TGATTAGGAG-TGTGAGCTCTT-AATCATCTATTGTTGGGTCATGGGA-- 84 
Actaea_podocarpa                CGATGAGGGG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_heracleifolia            TGACGAGGAG-CGTGAGCTTTA-AATCATCCATTGTCGGGGCATGGGA-- 83 
Actaea_simplex                  TGACGAGGAG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 112 
Caulophyllum_thalictroides      GGAGGAGGGGGCGCAAGCCCCGGAATCCTTCCCTGCTGGGCCTCGGGGGC 108 
                                 **  *** *     ***     **** *    **  * * *  ***    
 
Actaea_dahurica                 -TCGA-CTATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_cimicifuga               -TCGA-CCACG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_rubra                    -TTGA-CCATG-GTTGATCTTATGCTCTT--GTACAAACACAAAACTCGG 128 
Actaea_pachypoda                -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 129 
Actaea_racemosa                 -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 187 
Actaea_cordifolia               -TTGA-CCACA-ATTGATCCTATGCTC----ATACAAACACAAAACCCGG 127 
Actaea_podocarpa                -TCGA-CCACG-GTGGATCCTATGCTCTC--GTACAAACACAAAACCCGA 129 
Actaea_heracleifolia            -TCGA-CCATG-GTTGATCGTATGCTCTC--GTACAAACACAAAACCCGG 128 
Actaea_simplex                  -TCGA-CCATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 157 
Caulophyllum_thalictroides      GTCGAGCCTTGCGACGACGGCGTCCCCGTGGGTCCTAACAACAAACCCGG 158 




Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 




Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 





8.2.2 Actaea pachypoda 
                                                                                   
 
Actaea_dahurica                 GCTTTGC-AGAATGACCCGTGAACACGTTAAAAAA-TATTAT--GTGGAT 55 
Actaea_cimicifuga               GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 55 
Actaea_rubra                    ---------GAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 37      
Actaea_pachypoda                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_racemosa                 GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 96 
Actaea_cordifolia               ---------GAACGACC-GTGAACATGTTAAAAAAACATTAT--GTGGAT 38 
Actaea_podocarpa                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_heracleifolia            ---------GAACGACC-GTGAACACGTTAAAAAA-TATTAT--GTGGAT 37 
Actaea_simplex                  GCTTCGC-AGAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 66 
Caulophyllum_thalictroides      GCAAAGCGAGAACGACCCGCGAACACGTGAAAAAG-CATTGTCGGGGGAC 58 




Actaea_dahurica                 TGATGAGGAG-YGTGAGCTCTA-AATCATCCATTGTYGGGGCATGGGA-- 101 
Actaea_cimicifuga               TGAGGAGGAG-CATGAGCTCTT-AATCATCCATTGTCGAGTCATGGGA-- 101 
Actaea_rubra                    TGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 83 
Actaea_pachypoda                TGACGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_racemosa                 CGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 142 
Actaea_cordifolia               TGATTAGGAG-TGTGAGCTCTT-AATCATCTATTGTTGGGTCATGGGA-- 84 
Actaea_podocarpa                CGATGAGGGG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_heracleifolia            TGACGAGGAG-CGTGAGCTTTA-AATCATCCATTGTCGGGGCATGGGA-- 83 
Actaea_simplex                  TGACGAGGAG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 112 
Caulophyllum_thalictroides      GGAGGAGGGGGCGCAAGCCCCGGAATCCTTCCCTGCTGGGCCTCGGGGGC 108 
                                 **  *** *     ***     **** *    **  * * *  ***    
 
Actaea_dahurica                 -TCGA-CTATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_cimicifuga               -TCGA-CCACG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_rubra                    -TTGA-CCATG-GTTGATCTTATGCTCTT--GTACAAACACAAAACTCGG 128 
Actaea_pachypoda                -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 129 
Actaea_racemosa                 -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 187 
Actaea_cordifolia               -TTGA-CCACA-ATTGATCCTATGCTC----ATACAAACACAAAACCCGG 127 
Actaea_podocarpa                -TCGA-CCACG-GTGGATCCTATGCTCTC--GTACAAACACAAAACCCGA 129 
Actaea_heracleifolia            -TCGA-CCATG-GTTGATCGTATGCTCTC--GTACAAACACAAAACCCGG 128 
Actaea_simplex                  -TCGA-CCATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 157 
Caulophyllum_thalictroides      GTCGAGCCTTGCGACGACGGCGTCCCCGTGGGTCCTAACAACAAACCCGG 158 




Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 




Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 






8.2.3 Actaea heracleifolia 
                                                                                 
 
Actaea_dahurica                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_cimicifuga               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_rubra                    TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_pachypoda                TGCGCYCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 374 
Actaea_racemosa                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 432 
Actaea_cordifolia               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 371 
Actaea_podocarpa                TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_heracleifolia            TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 372 
Actaea_simplex                  TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 401 
Caulophyllum_thalictroides      TGCGCCCGAGGCCACTTAGGTCGAGGGCACGCTTGCTTGGGCGTCACACA 402 




Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 
Actaea_podocarpa                CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 
                                 **    * ***  ** * ** **  *           *       *    
 
Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 




Actaea_dahurica                 GTCCTCGACGGCAAGTGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 523 
Actaea_cimicifuga               GTCCTCGGCGGCAAGCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 523 
Actaea_rubra                    GTCCTTGACGGCAATCGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 508 
Actaea_pachypoda                GTCCTTGACGGCAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 509 
Actaea_racemosa                 GTCCTCGACGACAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 567 
Actaea_cordifolia               GTCCTCGATGACAAGTATCGCGGTCTGCGGTGGTTGTAAA--TTCATCCC 504 
Actaea_podocarpa                GTCCTCGRCGGCAAGTGTCGTGGTCTGCGGTGGTTGTAAA--CTCATCCC 506 
Actaea_heracleifolia            GTCCTCGACGGCAAGTGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 505 
Actaea_simplex                  GTCCTCGGCGGCAAGTGTTGCGGTCTACGGTGGTTGTAAA--CTCATCCC 534 
Caulophyllum_thalictroides      ACCCTCGGCGACGAGCGTCACGATCATTGGTGGTTGAGAAGCCCCCTCGT 551 




Actaea_dahurica                 CCTAAGACAAAATAAGACGCRTAGACTTGTCGTCTAAA-GGACCAACATA 572 
Actaea_cimicifuga               CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTATAAY-GGACCAACATA 572 
Actaea_rubra                    CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 557 
Actaea_pachypoda                CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 558 
Actaea_racemosa                 CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAT-AGACCAACATA 616 
Actaea_cordifolia               CCCAAGACGAAATAAGACGTGTAGCCTTGTTGTCTAAT-GGACCAACATA 553 
Actaea_podocarpa                CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 555 
Actaea_heracleifolia            C-TAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 553 
Actaea_simplex                  CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACTAACATA 583 
Caulophyllum_thalictroides      CGTAGACCGGCGT----CGTGGCGCCTCGTCGCCTTACCGGGTCGGAAGA 597 






8.2.4 Actaea dahurica 
                                                                                   
Actaea_dahurica                 -TCGA-CTATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_cimicifuga               -TCGA-CCACG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_rubra                    -TTGA-CCATG-GTTGATCTTATGCTCTT--GTACAAACACAAAACTCGG 128 
Actaea_pachypoda                -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 129 
Actaea_racemosa                 -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 187 
Actaea_cordifolia               -TTGA-CCACA-ATTGATCCTATGCTC----ATACAAACACAAAACCCGG 127 
Actaea_podocarpa                -TCGA-CCACG-GTGGATCCTATGCTCTC--GTACAAACACAAAACCCGA 129 
Actaea_heracleifolia            -TCGA-CCATG-GTTGATCGTATGCTCTC--GTACAAACACAAAACCCGG 128 
Actaea_simplex                  -TCGA-CCATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 157 
Caulophyllum_thalictroides      GTCGAGCCTTGCGACGACGGCGTCCCCGTGGGTCCTAACAACAAACCCGG 158 




Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 




Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 
                                 **  *** *  *   * *   ******  *     ** *********** 
 
Actaea_dahurica                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_cimicifuga               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_rubra                    ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_pachypoda                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 274 
Actaea_racemosa                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 332 
Actaea_cordifolia               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 271 
Actaea_podocarpa                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_heracleifolia            ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 272 
Actaea_simplex                  ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 301 
Caulophyllum_thalictroides      ATGGATATCTCGGCTCTCGCATCGATGAAGAACGTAGCAAAATGCGATAC 302 
                                * *************** ******************** *********** 
 
Actaea_dahurica                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_cimicifuga               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_rubra                    TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_pachypoda                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 324 
Actaea_racemosa                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 382 
Actaea_cordifolia               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 321 
Actaea_podocarpa                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_heracleifolia            TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 322 
Actaea_simplex                  TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 351 
Caulophyllum_thalictroides      TTGGTGTGAATTGTAGAATCCCATGAACCATCGAGTTTTTGAACGCAAGT 352 
                                ************* ******** ************* ************* 
 
Actaea_dahurica                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_cimicifuga               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_rubra                    TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_pachypoda                TGCGCYCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 374 
Actaea_racemosa                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 432 
Actaea_cordifolia               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 371 
Actaea_podocarpa                TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 





Actaea_simplex                  TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 401 
Caulophyllum_thalictroides      TGCGCCCGAGGCCACTTAGGTCGAGGGCACGCTTGCTTGGGCGTCACACA 402 
                                ***** ******** ****** *********  *** ************* 
 
 
Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 
Actaea_podocarpa                CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 
                                 **    * ***  ** * ** **  *           *       *    
 
Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 
                                *** ******** *** * **       *** **** ***  ***  *   
 
Actaea_dahurica                 GTCCTCGACGGCAAGTGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 523 
Actaea_cimicifuga               GTCCTCGGCGGCAAGCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 523 
Actaea_rubra                    GTCCTTGACGGCAATCGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 508 
Actaea_pachypoda                GTCCTTGACGGCAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 509 
Actaea_racemosa                 GTCCTCGACGACAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 567 
Actaea_cordifolia               GTCCTCGATGACAAGTATCGCGGTCTGCGGTGGTTGTAAA--TTCATCCC 504 
Actaea_podocarpa                GTCCTCGRCGGCAAGTGTCGTGGTCTGCGGTGGTTGTAAA--CTCATCCC 506 
Actaea_heracleifolia            GTCCTCGACGGCAAGTGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 505 
Actaea_simplex                  GTCCTCGGCGGCAAGTGTTGCGGTCTACGGTGGTTGTAAA--CTCATCCC 534 
Caulophyllum_thalictroides      ACCCTCGGCGACGAGCGTCACGATCATTGGTGGTTGAGAAGCCCCCTCGT 551 




Actaea_dahurica                 CCTAAGACAAAATAAGACGCRTAGACTTGTCGTCTAAA-GGACCAACATA 572 
Actaea_cimicifuga               CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTATAAY-GGACCAACATA 572 
Actaea_rubra                    CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 557 
Actaea_pachypoda                CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 558 
Actaea_racemosa                 CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAT-AGACCAACATA 616 
Actaea_cordifolia               CCCAAGACGAAATAAGACGTGTAGCCTTGTTGTCTAAT-GGACCAACATA 553 
Actaea_podocarpa                CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 555 
Actaea_heracleifolia            C-TAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 553 
Actaea_simplex                  CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACTAACATA 583 
Caulophyllum_thalictroides      CGTAGACCGGCGT----CGTGGCGCCTCGTCGCCTTACCGGGTCGGAAGA 597 




Actaea_dahurica                 ACCCTTGGAAGCCGTTCAACGGTGTTCACCCT------------------ 604 
Actaea_cimicifuga               ACCCTTRGAAGCCGTTCAACGGTTTTCACCCT------------------ 604 
Actaea_rubra                    ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 607 
Actaea_pachypoda                ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 608 
Actaea_racemosa                 ACCCTTGGAAGCCGTTTAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 666 
Actaea_cordifolia               ACCCTTTGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_podocarpa                CCCCTTATAATCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 605 
Actaea_heracleifolia            ACCCTTGGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_simplex                  ACCCTTGGAAGCCGTTCATCGGTGTTCACCCTGCGACCCCAGGTCAGGCG 633 
Caulophyllum_thalictroides      ACCCTC-----------------GTTTGTCCTGCA--------------- 615 










Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 





Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 
                                 **  *** *  *   * *   ******  *     ** *********** 
 
Actaea_dahurica                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_cimicifuga               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_rubra                    ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_pachypoda                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 274 
Actaea_racemosa                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 332 
Actaea_cordifolia               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 271 
Actaea_podocarpa                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_heracleifolia            ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 272 
Actaea_simplex                  ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 301 
Caulophyllum_thalictroides      ATGGATATCTCGGCTCTCGCATCGATGAAGAACGTAGCAAAATGCGATAC 302 
                                * *************** ******************** *********** 
 
Actaea_dahurica                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_cimicifuga               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_rubra                    TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_pachypoda                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 324 
Actaea_racemosa                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 382 
Actaea_cordifolia               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 321 
Actaea_podocarpa                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_heracleifolia            TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 322 
Actaea_simplex                  TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 351 
Caulophyllum_thalictroides      TTGGTGTGAATTGTAGAATCCCATGAACCATCGAGTTTTTGAACGCAAGT 352 
                                ************* ******** ************* ************* 
 
Actaea_dahurica                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_cimicifuga               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_rubra                    TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_pachypoda                TGCGCYCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 374 
Actaea_racemosa                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 432 
Actaea_cordifolia               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 371 
Actaea_podocarpa                TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_heracleifolia            TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 372 
Actaea_simplex                  TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 401 
Caulophyllum_thalictroides      TGCGCCCGAGGCCACTTAGGTCGAGGGCACGCTTGCTTGGGCGTCACACA 402 
                                ***** ******** ****** *********  *** ************* 
 
Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 





Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 




Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 





Actaea_dahurica                 GTCCTCGACGGCAAGTGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 523 
Actaea_cimicifuga               GTCCTCGGCGGCAAGCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 523 
Actaea_rubra                    GTCCTTGACGGCAATCGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 508 
Actaea_pachypoda                GTCCTTGACGGCAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 509 
Actaea_racemosa                 GTCCTCGACGACAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 567 
Actaea_cordifolia               GTCCTCGATGACAAGTATCGCGGTCTGCGGTGGTTGTAAA--TTCATCCC 504 
Actaea_podocarpa                GTCCTCGRCGGCAAGTGTCGTGGTCTGCGGTGGTTGTAAA--CTCATCCC 506 
Actaea_heracleifolia            GTCCTCGACGGCAAGTGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 505 
Actaea_simplex                  GTCCTCGGCGGCAAGTGTTGCGGTCTACGGTGGTTGTAAA--CTCATCCC 534 
Caulophyllum_thalictroides      ACCCTCGGCGACGAGCGTCACGATCATTGGTGGTTGAGAAGCCCCCTCGT 551 






8.2.6 Actaea simplex 
 
 
Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 
Actaea_podocarpa                CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 




Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 




Actaea_dahurica                 GTCCTCGACGGCAAGTGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 523 
Actaea_cimicifuga               GTCCTCGGCGGCAAGCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 523 
Actaea_rubra                    GTCCTTGACGGCAATCGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 508 
Actaea_pachypoda                GTCCTTGACGGCAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 509 
Actaea_racemosa                 GTCCTCGACGACAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 567 
Actaea_cordifolia               GTCCTCGATGACAAGTATCGCGGTCTGCGGTGGTTGTAAA--TTCATCCC 504 
Actaea_podocarpa                GTCCTCGRCGGCAAGTGTCGTGGTCTGCGGTGGTTGTAAA--CTCATCCC 506 
Actaea_heracleifolia            GTCCTCGACGGCAAGTGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 505 
Actaea_simplex                  GTCCTCGGCGGCAAGTGTTGCGGTCTACGGTGGTTGTAAA--CTCATCCC 534 
Caulophyllum_thalictroides      ACCCTCGGCGACGAGCGTCACGATCATTGGTGGTTGAGAAGCCCCCTCGT 551 
                                  *** *  * * *   *   * **   ********  **    * **   
 
 
Actaea_dahurica                 CCTAAGACAAAATAAGACGCRTAGACTTGTCGTCTAAA-GGACCAACATA 572 
Actaea_cimicifuga               CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTATAAY-GGACCAACATA 572 
Actaea_rubra                    CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 557 
Actaea_pachypoda                CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 558 
Actaea_racemosa                 CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAT-AGACCAACATA 616 
Actaea_cordifolia               CCCAAGACGAAATAAGACGTGTAGCCTTGTTGTCTAAT-GGACCAACATA 553 
Actaea_podocarpa                CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 555 
Actaea_heracleifolia            C-TAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 553 
Actaea_simplex                  CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACTAACATA 583 
Caulophyllum_thalictroides      CGTAGACCGGCGT----CGTGGCGCCTCGTCGCCTTACCGGGTCGGAAGA 597 
                                *  *   *    *    **    * ** ** *  * *   *      * * 
 
 
Actaea_dahurica                 ACCCTTGGAAGCCGTTCAACGGTGTTCACCCT------------------ 604 
Actaea_cimicifuga               ACCCTTRGAAGCCGTTCAACGGTTTTCACCCT------------------ 604 
Actaea_rubra                    ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 607 
Actaea_pachypoda                ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 608 
Actaea_racemosa                 ACCCTTGGAAGCCGTTTAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 666 
Actaea_cordifolia               ACCCTTTGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_podocarpa                CCCCTTATAATCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 605 
Actaea_heracleifolia            ACCCTTGGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_simplex                  ACCCTTGGAAGCCGTTCATCGGTGTTCACCCTGCGACCCCAGGTCAGGCG 633 
Caulophyllum_thalictroides      ACCCTC-----------------GTTTGTCCTGCA--------------- 615 







8.2.7 Actaea podocarpa 
                                                                                   
 
Actaea_dahurica                 GCTTTGC-AGAATGACCCGTGAACACGTTAAAAAA-TATTAT--GTGGAT 55 
Actaea_cimicifuga               GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 55 
Actaea_rubra                    ---------GAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 37 
Actaea_pachypoda                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_racemosa                 GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 96 
Actaea_cordifolia               ---------GAACGACC-GTGAACATGTTAAAAAAACATTAT--GTGGAT 38 
Actaea_podocarpa                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_heracleifolia            ---------GAACGACC-GTGAACACGTTAAAAAA-TATTAT--GTGGAT 37 
Actaea_simplex                  GCTTCGC-AGAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 66 
Caulophyllum_thalictroides      GCAAAGCGAGAACGACCCGCGAACACGTGAAAAAG-CATTGTCGGGGGAC 58 




Actaea_dahurica                 TGATGAGGAG-YGTGAGCTCTA-AATCATCCATTGTYGGGGCATGGGA-- 101 
Actaea_cimicifuga               TGAGGAGGAG-CATGAGCTCTT-AATCATCCATTGTCGAGTCATGGGA-- 101 
Actaea_rubra                    TGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 83 
Actaea_pachypoda                TGACGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_racemosa                 CGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 142 
Actaea_cordifolia               TGATTAGGAG-TGTGAGCTCTT-AATCATCTATTGTTGGGTCATGGGA-- 84 
Actaea_podocarpa                CGATGAGGGG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_heracleifolia            TGACGAGGAG-CGTGAGCTTTA-AATCATCCATTGTCGGGGCATGGGA-- 83 
Actaea_simplex                  TGACGAGGAG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 112 
Caulophyllum_thalictroides      GGAGGAGGGGGCGCAAGCCCCGGAATCCTTCCCTGCTGGGCCTCGGGGGC 108 
                                 **  *** *     ***     **** *    **  * * *  ***    
 
 
Actaea_dahurica                 -TCGA-CTATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_cimicifuga               -TCGA-CCACG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_rubra                    -TTGA-CCATG-GTTGATCTTATGCTCTT--GTACAAACACAAAACTCGG 128 
Actaea_pachypoda                -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 129 
Actaea_racemosa                 -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 187 
Actaea_cordifolia               -TTGA-CCACA-ATTGATCCTATGCTC----ATACAAACACAAAACCCGG 127 
Actaea_podocarpa                -TCGA-CCACG-GTGGATCCTATGCTCTC--GTACAAACACAAAACCCGA 129 
Actaea_heracleifolia            -TCGA-CCATG-GTTGATCGTATGCTCTC--GTACAAACACAAAACCCGG 128 
Actaea_simplex                  -TCGA-CCATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 157 
Caulophyllum_thalictroides      GTCGAGCCTTGCGACGACGGCGTCCCCGTGGGTCCTAACAACAAACCCGG 158 
                                 * ** *        **     * * *     * * ****  **** **  
 
 
Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 
                                **  **  *** *** ***** * *  ****  *  **     **      
 
Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 
                                 **  *** *  *   * *   ******  *     ** *********** 
 
 
Actaea_dahurica                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_cimicifuga               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_rubra                    ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_pachypoda                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 274 
Actaea_racemosa                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 332 
Actaea_cordifolia               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 271 





Actaea_heracleifolia            ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 272 
Actaea_simplex                  ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 301 
Caulophyllum_thalictroides      ATGGATATCTCGGCTCTCGCATCGATGAAGAACGTAGCAAAATGCGATAC 302 
                                * *************** ******************** *********** 
 
Actaea_dahurica                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_cimicifuga               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_rubra                    TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_pachypoda                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 324 
Actaea_racemosa                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 382 
Actaea_cordifolia               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 321 
Actaea_podocarpa                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_heracleifolia            TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 322 
Actaea_simplex                  TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 351 
Caulophyllum_thalictroides      TTGGTGTGAATTGTAGAATCCCATGAACCATCGAGTTTTTGAACGCAAGT 352 
                                ************* ******** ************* ************* 
 
Actaea_dahurica                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_cimicifuga               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_rubra                    TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_pachypoda                TGCGCYCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 374 
Actaea_racemosa                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 432 
Actaea_cordifolia               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 371 
Actaea_podocarpa                TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_heracleifolia            TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 372 
Actaea_simplex                  TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 401 
Caulophyllum_thalictroides      TGCGCCCGAGGCCACTTAGGTCGAGGGCACGCTTGCTTGGGCGTCACACA 402 
                                ***** ******** ****** *********  *** ************* 
 
Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 
Actaea_podocarpa                CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 
                                 **    * ***  ** * ** **  *           *       *    
 
Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 




Actaea_dahurica                 GTCCTCGACGGCAAGTGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 523 
Actaea_cimicifuga               GTCCTCGGCGGCAAGCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 523 
Actaea_rubra                    GTCCTTGACGGCAATCGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 508 
Actaea_pachypoda                GTCCTTGACGGCAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 509 
Actaea_racemosa                 GTCCTCGACGACAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 567 
Actaea_cordifolia               GTCCTCGATGACAAGTATCGCGGTCTGCGGTGGTTGTAAA--TTCATCCC 504 
Actaea_podocarpa                GTCCTCGRCGGCAAGTGTCGTGGTCTGCGGTGGTTGTAAA--CTCATCCC 506 
Actaea_heracleifolia            GTCCTCGACGGCAAGTGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 505 
Actaea_simplex                  GTCCTCGGCGGCAAGTGTTGCGGTCTACGGTGGTTGTAAA--CTCATCCC 534 
Caulophyllum_thalictroides      ACCCTCGGCGACGAGCGTCACGATCATTGGTGGTTGAGAAGCCCCCTCGT 551 





















Actaea_dahurica                 CCTAAGACAAAATAAGACGCRTAGACTTGTCGTCTAAA-GGACCAACATA 572 
Actaea_cimicifuga               CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTATAAY-GGACCAACATA 572 
Actaea_rubra                    CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 557 
Actaea_pachypoda                CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 558 
Actaea_racemosa                 CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAT-AGACCAACATA 616 
Actaea_cordifolia               CCCAAGACGAAATAAGACGTGTAGCCTTGTTGTCTAAT-GGACCAACATA 553 
Actaea_podocarpa                CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 555 
Actaea_heracleifolia            C-TAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 553 
Actaea_simplex                  CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACTAACATA 583 
Caulophyllum_thalictroides      CGTAGACCGGCGT----CGTGGCGCCTCGTCGCCTTACCGGGTCGGAAGA 597 




Actaea_dahurica                 ACCCTTGGAAGCCGTTCAACGGTGTTCACCCT------------------ 604 
Actaea_cimicifuga               ACCCTTRGAAGCCGTTCAACGGTTTTCACCCT------------------ 604 
Actaea_rubra                    ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 607 
Actaea_pachypoda                ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 608 
Actaea_racemosa                 ACCCTTGGAAGCCGTTTAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 666 
Actaea_cordifolia               ACCCTTTGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_podocarpa                CCCCTTATAATCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 605 
Actaea_heracleifolia            ACCCTTGGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_simplex                  ACCCTTGGAAGCCGTTCATCGGTGTTCACCCTGCGACCCCAGGTCAGGCG 633 
Caulophyllum_thalictroides      ACCCTC-----------------GTTTGTCCTGCA--------------- 615 







8.2.8 Actaea cimicifuga 
 
 
                                                                                   
 
Actaea_dahurica                 GCTTTGC-AGAATGACCCGTGAACACGTTAAAAAA-TATTAT--GTGGAT 55 
Actaea_cimicifuga               GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 55 
Actaea_rubra                    ---------GAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 37 
Actaea_pachypoda                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_racemosa                 GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 96 
Actaea_cordifolia               ---------GAACGACC-GTGAACATGTTAAAAAAACATTAT--GTGGAT 38 
Actaea_podocarpa                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_heracleifolia            ---------GAACGACC-GTGAACACGTTAAAAAA-TATTAT--GTGGAT 37 
Actaea_simplex                  GCTTCGC-AGAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 66 
Caulophyllum_thalictroides      GCAAAGCGAGAACGACCCGCGAACACGTGAAAAAG-CATTGTCGGGGGAC 58 




Actaea_dahurica                 TGATGAGGAG-YGTGAGCTCTA-AATCATCCATTGTYGGGGCATGGGA-- 101 
Actaea_cimicifuga               TGAGGAGGAG-CATGAGCTCTT-AATCATCCATTGTCGAGTCATGGGA-- 101 
Actaea_rubra                    TGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 83 
Actaea_pachypoda                TGACGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_racemosa                 CGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 142 
Actaea_cordifolia               TGATTAGGAG-TGTGAGCTCTT-AATCATCTATTGTTGGGTCATGGGA-- 84 
Actaea_podocarpa                CGATGAGGGG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_heracleifolia            TGACGAGGAG-CGTGAGCTTTA-AATCATCCATTGTCGGGGCATGGGA-- 83 
Actaea_simplex                  TGACGAGGAG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 112 
Caulophyllum_thalictroides      GGAGGAGGGGGCGCAAGCCCCGGAATCCTTCCCTGCTGGGCCTCGGGGGC 108 
                                 **  *** *     ***     **** *    **  * * *  ***    
 
Actaea_dahurica                 -TCGA-CTATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_cimicifuga               -TCGA-CCACG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_rubra                    -TTGA-CCATG-GTTGATCTTATGCTCTT--GTACAAACACAAAACTCGG 128 
Actaea_pachypoda                -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 129 
Actaea_racemosa                 -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 187 
Actaea_cordifolia               -TTGA-CCACA-ATTGATCCTATGCTC----ATACAAACACAAAACCCGG 127 
Actaea_podocarpa                -TCGA-CCACG-GTGGATCCTATGCTCTC--GTACAAACACAAAACCCGA 129 
Actaea_heracleifolia            -TCGA-CCATG-GTTGATCGTATGCTCTC--GTACAAACACAAAACCCGG 128 
Actaea_simplex                  -TCGA-CCATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 157 
Caulophyllum_thalictroides      GTCGAGCCTTGCGACGACGGCGTCCCCGTGGGTCCTAACAACAAACCCGG 158 




Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 




Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 




Actaea_dahurica                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 





Actaea_rubra                    ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_pachypoda                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 274 
Actaea_racemosa                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 332 
Actaea_cordifolia               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 271 
Actaea_podocarpa                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_heracleifolia            ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 272 
Actaea_simplex                  ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 301 
Caulophyllum_thalictroides      ATGGATATCTCGGCTCTCGCATCGATGAAGAACGTAGCAAAATGCGATAC 302 
                                * *************** ******************** *********** 
 
 
Actaea_dahurica                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_cimicifuga               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_rubra                    TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_pachypoda                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 324 
Actaea_racemosa                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 382 
Actaea_cordifolia               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 321 
Actaea_podocarpa                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_heracleifolia            TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 322 
Actaea_simplex                  TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 351 
Caulophyllum_thalictroides      TTGGTGTGAATTGTAGAATCCCATGAACCATCGAGTTTTTGAACGCAAGT 352 




Actaea_dahurica                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_cimicifuga               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_rubra                    TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_pachypoda                TGCGCYCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 374 
Actaea_racemosa                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 432 
Actaea_cordifolia               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 371 
Actaea_podocarpa                TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_heracleifolia            TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 372 
Actaea_simplex                  TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 401 
Caulophyllum_thalictroides      TGCGCCCGAGGCCACTTAGGTCGAGGGCACGCTTGCTTGGGCGTCACACA 402 





Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 
Actaea_podocarpa                CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 
                                 **    * ***  ** * ** **  *           *       *    
 
Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 
























Actaea_dahurica                 GTCCTCGACGGCAAGTGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 523 
Actaea_cimicifuga               GTCCTCGGCGGCAAGCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 523 
Actaea_rubra                    GTCCTTGACGGCAATCGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 508 
Actaea_pachypoda                GTCCTTGACGGCAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 509 
Actaea_racemosa                 GTCCTCGACGACAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 567 
Actaea_cordifolia               GTCCTCGATGACAAGTATCGCGGTCTGCGGTGGTTGTAAA--TTCATCCC 504 
Actaea_podocarpa                GTCCTCGRCGGCAAGTGTCGTGGTCTGCGGTGGTTGTAAA--CTCATCCC 506 
Actaea_heracleifolia            GTCCTCGACGGCAAGTGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 505 
Actaea_simplex                  GTCCTCGGCGGCAAGTGTTGCGGTCTACGGTGGTTGTAAA--CTCATCCC 534 
Caulophyllum_thalictroides      ACCCTCGGCGACGAGCGTCACGATCATTGGTGGTTGAGAAGCCCCCTCGT 551 







8.2.9 Actaea cordifolia 
                                                                                   
 
Actaea_dahurica                 GCTTTGC-AGAATGACCCGTGAACACGTTAAAAAA-TATTAT--GTGGAT 55 
Actaea_cimicifuga               GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 55 
Actaea_rubra                    ---------GAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 37 
Actaea_pachypoda                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_racemosa                 GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 96 
Actaea_cordifolia               ---------GAACGACC-GTGAACATGTTAAAAAAACATTAT--GTGGAT 38 
Actaea_podocarpa                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_heracleifolia            ---------GAACGACC-GTGAACACGTTAAAAAA-TATTAT--GTGGAT 37 
Actaea_simplex                  GCTTCGC-AGAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 66 
Caulophyllum_thalictroides      GCAAAGCGAGAACGACCCGCGAACACGTGAAAAAG-CATTGTCGGGGGAC 58 




Actaea_dahurica                 TGATGAGGAG-YGTGAGCTCTA-AATCATCCATTGTYGGGGCATGGGA-- 101 
Actaea_cimicifuga               TGAGGAGGAG-CATGAGCTCTT-AATCATCCATTGTCGAGTCATGGGA-- 101 
Actaea_rubra                    TGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 83 
Actaea_pachypoda                TGACGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_racemosa                 CGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 142 
Actaea_cordifolia               TGATTAGGAG-TGTGAGCTCTT-AATCATCTATTGTTGGGTCATGGGA-- 84 
Actaea_podocarpa                CGATGAGGGG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_heracleifolia            TGACGAGGAG-CGTGAGCTTTA-AATCATCCATTGTCGGGGCATGGGA-- 83 
Actaea_simplex                  TGACGAGGAG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 112 
Caulophyllum_thalictroides      GGAGGAGGGGGCGCAAGCCCCGGAATCCTTCCCTGCTGGGCCTCGGGGGC 108 




Actaea_dahurica                 -TCGA-CTATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_cimicifuga               -TCGA-CCACG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_rubra                    -TTGA-CCATG-GTTGATCTTATGCTCTT--GTACAAACACAAAACTCGG 128 
Actaea_pachypoda                -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 129 
Actaea_racemosa                 -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 187 
Actaea_cordifolia               -TTGA-CCACA-ATTGATCCTATGCTC----ATACAAACACAAAACCCGG 127 
Actaea_podocarpa                -TCGA-CCACG-GTGGATCCTATGCTCTC--GTACAAACACAAAACCCGA 129 
Actaea_heracleifolia            -TCGA-CCATG-GTTGATCGTATGCTCTC--GTACAAACACAAAACCCGG 128 
Actaea_simplex                  -TCGA-CCATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 157 
Caulophyllum_thalictroides      GTCGAGCCTTGCGACGACGGCGTCCCCGTGGGTCCTAACAACAAACCCGG 158 
                                 * ** *        **     * * *     * * ****  **** **  
 
Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 





Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 










Actaea_dahurica                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_cimicifuga               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_rubra                    ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_pachypoda                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 274 
Actaea_racemosa                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 332 
Actaea_cordifolia               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 271 
Actaea_podocarpa                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_heracleifolia            ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 272 
Actaea_simplex                  ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 301 
Caulophyllum_thalictroides      ATGGATATCTCGGCTCTCGCATCGATGAAGAACGTAGCAAAATGCGATAC 302 
                                * *************** ******************** *********** 
 
Actaea_dahurica                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_cimicifuga               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_rubra                    TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_pachypoda                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 324 
Actaea_racemosa                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 382 
Actaea_cordifolia               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 321 
Actaea_podocarpa                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_heracleifolia            TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 322 
Actaea_simplex                  TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 351 
Caulophyllum_thalictroides      TTGGTGTGAATTGTAGAATCCCATGAACCATCGAGTTTTTGAACGCAAGT 352 
                                ************* ******** ************* ************* 
 
Actaea_dahurica                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_cimicifuga               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_rubra                    TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_pachypoda                TGCGCYCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 374 
Actaea_racemosa                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 432 
Actaea_cordifolia               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 371 
Actaea_podocarpa                TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_heracleifolia            TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 372 
Actaea_simplex                  TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 401 
Caulophyllum_thalictroides      TGCGCCCGAGGCCACTTAGGTCGAGGGCACGCTTGCTTGGGCGTCACACA 402 




Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 
Actaea_podocarpa                CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 




Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 











Actaea_dahurica                 GCTTTGC-AGAATGACCCGTGAACACGTTAAAAAA-TATTAT--GTGGAT 55 
Actaea_cimicifuga               GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 55 
Actaea_rubra                    ---------GAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 37 
Actaea_pachypoda                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_racemosa                 GCTTTGC-AGAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 96 
Actaea_cordifolia               ---------GAACGACC-GTGAACATGTTAAAAAAACATTAT--GTGGAT 38 
Actaea_podocarpa                ---------GAACGACCCGTGAACACGTTAAAAAA-CATTAT--GTGGAT 38 
Actaea_heracleifolia            ---------GAACGACC-GTGAACACGTTAAAAAA-TATTAT--GTGGAT 37 
Actaea_simplex                  GCTTCGC-AGAACGACC-GTGAACACGTTAAAAAA-CATTAT--GTGGAT 66 
Caulophyllum_thalictroides      GCAAAGCGAGAACGACCCGCGAACACGTGAAAAAG-CATTGTCGGGGGAC 58 
                                         *** **** * ***** ** *****   *** *  * ***  
 
Actaea_dahurica                 TGATGAGGAG-YGTGAGCTCTA-AATCATCCATTGTYGGGGCATGGGA-- 101 
Actaea_cimicifuga               TGAGGAGGAG-CATGAGCTCTT-AATCATCCATTGTCGAGTCATGGGA-- 101 
Actaea_rubra                    TGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 83 
Actaea_pachypoda                TGACGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_racemosa                 CGATGAGGAG-TGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 142 
Actaea_cordifolia               TGATTAGGAG-TGTGAGCTCTT-AATCATCTATTGTTGGGTCATGGGA-- 84 
Actaea_podocarpa                CGATGAGGGG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 84 
Actaea_heracleifolia            TGACGAGGAG-CGTGAGCTTTA-AATCATCCATTGTCGGGGCATGGGA-- 83 
Actaea_simplex                  TGACGAGGAG-CGTGAGCTCTT-AATCATCCATTGTCGGGTCATGGGA-- 112 
Caulophyllum_thalictroides      GGAGGAGGGGGCGCAAGCCCCGGAATCCTTCCCTGCTGGGCCTCGGGGGC 108 




Actaea_dahurica                 -TCGA-CTATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_cimicifuga               -TCGA-CCACG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 146 
Actaea_rubra                    -TTGA-CCATG-GTTGATCTTATGCTCTT--GTACAAACACAAAACTCGG 128 
Actaea_pachypoda                -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 129 
Actaea_racemosa                 -TTGA-CCACG-GTTGATCTTATGCTCTT--GTACAAACACAAAACCCGG 187 
Actaea_cordifolia               -TTGA-CCACA-ATTGATCCTATGCTC----ATACAAACACAAAACCCGG 127 
Actaea_podocarpa                -TCGA-CCACG-GTGGATCCTATGCTCTC--GTACAAACACAAAACCCGA 129 
Actaea_heracleifolia            -TCGA-CCATG-GTTGATCGTATGCTCTC--GTACAAACACAAAACCCGG 128 
Actaea_simplex                  -TCGA-CCATG-GTTGATCTTATGCTCTC--GTACAAACACAAAACCCGG 157 
Caulophyllum_thalictroides      GTCGAGCCTTGCGACGACGGCGTCCCCGTGGGTCCTAACAACAAACCCGG 158 




Actaea_dahurica                 CGCAATTGGCGTCAAGGAAATCTTAACGGAAATAGAGTGTTGCCCATTTA 196 
Actaea_cimicifuga               CGCAATTGGCGTCAAGGAAATCTTAGTGGAAACAAAGTGTTGCCCATTTA 196 
Actaea_rubra                    CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTATCCATTTA 178 
Actaea_pachypoda                CGCAATTAGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTACCCATTTA 179 
Actaea_racemosa                 CGCAATTAGCGTCAAGGAAATCTTAACGGAAACAGAGTGTCACCCATTTA 237 
Actaea_cordifolia               CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAAAGTGTCGCCCATTTA 177 
Actaea_podocarpa                CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 179 
Actaea_heracleifolia            CGCAATTGGCGTCAAGGAAATCTTAACGGAAACAGAGTGTTGCCCATTTA 178 
Actaea_simplex                  CGCAATTGGCGTCAAGGAAATCTTAGCGGAAACAGAGTGTTGCCCATTTA 207 
Caulophyllum_thalictroides      CG--ATCGGCGCCAACGAAAT-TCAACGGAACCAGCGT-CCCTCCGCGCG 204 
                                **  **  *** *** ***** * *  ****  *  **     **      
 
Actaea_dahurica                 TAGT-GGGTGATGCTACGAA--TCCGATATTT---AAACGACTCTCGGCA 240 
Actaea_cimicifuga               TAGT-GGGCGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 240 
Actaea_rubra                    TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_pachypoda                TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 224 
Actaea_racemosa                 TAGTTGGGCGATGCTTCGAA--TCCGATACTT---AAACGACTCTCGGCA 282 
Actaea_cordifolia               TAGT-GGGCGATGCTACAAA--TCCGATACTT---TAATGACTCTCGGCA 221 
Actaea_podocarpa                TAGT-GGGCGATGCTGCGAA--TCCGATACTT---AAACGACTCTCGGCA 223 
Actaea_heracleifolia            TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 222 
Actaea_simplex                  TAGT-GGGTGATGCTACGAA--TCCGATACTT---AAACGACTCTCGGCA 251 
Caulophyllum_thalictroides      -AGC-GGGCGGCGTCGCGACACTCCGATCTTCTTCGAACGACTCTCGGCA 252 




Actaea_dahurica                 ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_cimicifuga               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 290 
Actaea_rubra                    ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_pachypoda                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 274 





Actaea_cordifolia               ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 271 
Actaea_podocarpa                ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 273 
Actaea_heracleifolia            ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 272 
Actaea_simplex                  ACGGATATCTCGGCTCTTGCATCGATGAAGAACGTAGCGAAATGCGATAC 301 
Caulophyllum_thalictroides      ATGGATATCTCGGCTCTCGCATCGATGAAGAACGTAGCAAAATGCGATAC 302 
                                * *************** ******************** *********** 
 
Actaea_dahurica                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_cimicifuga               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 340 
Actaea_rubra                    TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_pachypoda                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 324 
Actaea_racemosa                 TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 382 
Actaea_cordifolia               TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 321 
Actaea_podocarpa                TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 323 
Actaea_heracleifolia            TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 322 
Actaea_simplex                  TTGGTGTGAATTGCAGAATCCCGTGAACCATCGAGTCTTTGAACGCAAGT 351 
Caulophyllum_thalictroides      TTGGTGTGAATTGTAGAATCCCATGAACCATCGAGTTTTTGAACGCAAGT 352 
                                ************* ******** ************* ************* 
 
Actaea_dahurica                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_cimicifuga               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 390 
Actaea_rubra                    TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_pachypoda                TGCGCYCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 374 
Actaea_racemosa                 TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 432 
Actaea_cordifolia               TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 371 
Actaea_podocarpa                TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 373 
Actaea_heracleifolia            TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 372 
Actaea_simplex                  TGCGCCCGAGGCCATTTAGGTTGAGGGCACGTCTGCCTGGGCGTCACACA 401 
Caulophyllum_thalictroides      TGCGCCCGAGGCCACTTAGGTCGAGGGCACGCTTGCTTGGGCGTCACACA 402 
                                ***** ******** ****** *********  *** ************* 
 
Actaea_dahurica                 CAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 427 
Actaea_cimicifuga               CAG----CGTCGTTCCTAACC-AATTT-------TATTA-GTTSGGGAAC 427 
Actaea_rubra                    CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_pachypoda                TAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 411 
Actaea_racemosa                 CAG----CTTCGATCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 469 
Actaea_cordifolia               CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTGGAGAAT 408 
Actaea_podocarpa                CAG----CGTCGTTCCCAACC-AATTT-------TGTTA-GTTAGGGAAC 410 
Actaea_heracleifolia            TAG----CGTCGTTCCCAACC-AATTT-------TATTA-ATTGGGGAAC 409 
Actaea_simplex                  CAG----CGTCGTTCCCAACC-AATTT-------TATTA-GTTGGGGAAT 438 
Caulophyllum_thalictroides      CAGACAGCGTCGCCCCCACCCCAACGTGCACACGCACCACAGGGAGGGGC 452 
                                 **    * ***  ** * ** **  *           *       *    
 
Actaea_dahurica                 GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_cimicifuga               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 475 
Actaea_rubra                    GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 460 
Actaea_pachypoda                GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTCAAATATTG 461 
Actaea_racemosa                 GGAAATTGGCCCCCCGAGTCCTCTTTTGGGCACGGTTGGCTTAAATATTG 519 
Actaea_cordifolia               GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 456 
Actaea_podocarpa                GGAAATTGGCCCTCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 458 
Actaea_heracleifolia            GGAAATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTG 457 
Actaea_simplex                  GGAGATTGGCCCCCCGAGTCC--TTTTGGGCACGGTTGGCTCAAATATTC 486 
Caulophyllum_thalictroides      GGAGATTGGCCCCCCGTG-CCGTAAGCAGGCGCGGTCGGCCCAAAAGTCG 501 




Actaea_dahurica                 GTCCTCGACGGCAAGTGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 523 
Actaea_cimicifuga               GTCCTCGGCGGCAAGCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 523 
Actaea_rubra                    GTCCTTGACGGCAATCGTCGCGGTCTGTGGTGGTTGTAAA--CTCATCCC 508 
Actaea_pachypoda                GTCCTTGACGGCAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 509 
Actaea_racemosa                 GTCCTCGACGACAATCGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 567 
Actaea_cordifolia               GTCCTCGATGACAAGTATCGCGGTCTGCGGTGGTTGTAAA--TTCATCCC 504 
Actaea_podocarpa                GTCCTCGRCGGCAAGTGTCGTGGTCTGCGGTGGTTGTAAA--CTCATCCC 506 
Actaea_heracleifolia            GTCCTCGACGGCAAGTGTCGCGGTCTGCGGTGGTTGTAAA--CTCATCCC 505 
Actaea_simplex                  GTCCTCGGCGGCAAGTGTTGCGGTCTACGGTGGTTGTAAA--CTCATCCC 534 
Caulophyllum_thalictroides      ACCCTCGGCGACGAGCGTCACGATCATTGGTGGTTGAGAAGCCCCCTCGT 551 




Actaea_dahurica                 CCTAAGACAAAATAAGACGCRTAGACTTGTCGTCTAAA-GGACCAACATA 572 
Actaea_cimicifuga               CCTAAGACGAAATAAGACGCGTAGCCTTGTCGTATAAY-GGACCAACATA 572 
Actaea_rubra                    CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 557 
Actaea_pachypoda                CCTAAGACGAAATAAGACGCGTAGCCTTGTTGTCTAAT-AGACCAACATA 558 
Actaea_racemosa                 CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAT-AGACCAACATA 616 
Actaea_cordifolia               CCCAAGACGAAATAAGACGTGTAGCCTTGTTGTCTAAT-GGACCAACATA 553 





Actaea_heracleifolia            C-TAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACCAACATA 553 
Actaea_simplex                  CCTAAGACAAAATAAGACGCGTAGCCTTGTCGTCTAAC-GGACTAACATA 583 
Caulophyllum_thalictroides      CGTAGACCGGCGT----CGTGGCGCCTCGTCGCCTTACCGGGTCGGAAGA 597 
                                *  *   *    *    **    * ** ** *  * *   *      * * 
 
Actaea_dahurica                 ACCCTTGGAAGCCGTTCAACGGTGTTCACCCT------------------ 604 
Actaea_cimicifuga               ACCCTTRGAAGCCGTTCAACGGTTTTCACCCT------------------ 604 
Actaea_rubra                    ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 607 
Actaea_pachypoda                ACCCTTGGAAGCCGTTTAACGGTGTTCACCTTGCGACCCCAGGTCAGGCG 608 
Actaea_racemosa                 ACCCTTGGAAGCCGTTTAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 666 
Actaea_cordifolia               ACCCTTTGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_podocarpa                CCCCTTATAATCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 605 
Actaea_heracleifolia            ACCCTTGGAAGCCGTTCAACGGTGTTCACCCTGCGACCCCAGGTCAGGCG 603 
Actaea_simplex                  ACCCTTGGAAGCCGTTCATCGGTGTTCACCCTGCGACCCCAGGTCAGGCG 633 
Caulophyllum_thalictroides      ACCCTC-----------------GTTTGTCCTGCA--------------- 615 





8.3 nrITS sequence traces of samples used in the development of PlantID 
 
Figure 75: Sequence trace of Actaea rubra – DNA extracted from material supplied by CAMAG, Switzerland 
 
 






Figure 77: Sequence trace of Actaea racemosa– DNA extract supplied by Royal Botanical Gardens, Kew 
 







Figure 79: Sequence trace of Actaea dahurica from Botanical Gardens and Botanical Museum, Germany 
 







Figure 81: Sequence trace of Actaea simplex – DNA extract from plant material provided by Beeches Nursery 
 







Figure 83: Sequence trace of Actaea cimicifuga – DNA extract from Royal Botanical Gardens, Kew 
 






Figure 85: Sequence trace of Caulophyllum thalictroides – DNA extract supplied by Royal Botanical Gardens, 
Kew 
 
8.4 Sequence trace information for reference and test samples 
 






Figure 87: nrITS - Actaea simplex – BGBM 8498 
 






Figure 89: 067 - nrITS - Actaea racemosa – Secret Seeds 
 






Figure 91: 069 - nrITS -– Actaea cordifolia – Secret Seeds 
 






Figure 93: 072 – nrITS - Actaea pachypoda –Secret Seeds 
 







Figure 95: S3 – matK – Actaea racemosa – AHPA-BC019 
 






Figure 97: S9 – nrITS – Actaea racemosa – AHPA-BC043 
 






Figure 99: S13 – nrITS – Actaea racemosa - AHPA-BC065 
 






Figure 101: S15 - nrITS – Actaea racemosa - AHPA-BC078 
 






Figure 103: S18 – nrITS – Actaea racemosa - AHPA-BC067 
 
 






Figure 105: S20 – nrITS – Bad quality sequence – AHPA-BC071 
 






Figure 107: S24 – nrITS – Bad quality sequence – AHPA-BC057 
 






Figure 109: S28  - nrITS – Bad quality sequence– AHPA-BC063 
 






Figure 111: 1095 – nrITS – Actaea racemosa – AHPA-BC007 
 






Figure 113: 1101 – nrITS -  Actaea racemosa – AHPA-BC013 
 






Figure 115: 1115 – nrITS – Bad quality sequence – AHPA-BC038 
 






Figure 117: 1119 – nrITS – Actaea cimicifuga – AHPA-BC044 
 






Figure 119: BC025 – nrITS – Actaea racemosa – Product 105 
 






Figure 121: BC030 – nrITS – Bad quality sequence – Product 120 
 






Figure 123: BC039 – nrITS – Actaea racemosa – product 081 
 






Figure 125: BC046 – nrITS – SynoPhyto - Ch.B.13884K116-A 
 






Figure 127: BC052 – nrITS – Actaea dahurica – CAMAG 58448 
 






Figure 129: BC056 – nrITS – Actaea spicata – Staffort, DHU 
 






Figure 131: 157 – nrITS – Actaea racemosa – CAMAG - 52784BRM 
 






Figure 133: 161 – nrITS – Actaea racemosa – CAMAG - 52789BRM 
8.5 qPCR data for hepatotoxicity arrays from Actaea treated HepaRG™ cells 
8.5.1 Experiment 1 – Pilot study 
8.5.1.1 Full Ct data for the pilot gene expression study 
Well 1 Normal 2 APAP 3 DMSO 4 CD 5 CF 6 CR 
A01 24.71 23.94 24.71 26.56 25.21 25.89 
A02 29.41 32.77 29.41 31.16 30.73 30.99 
A03 25.65 28.60 25.65 26.95 26.56 26.81 
A04 22.67 26.22 22.67 23.53 22.69 23.05 
A05 22.73 24.56 22.73 22.97 23.11 23.21 
A06 19.93 21.19 19.93 20.02 19.59 19.79 
A07 22.70 23.92 22.7 22.96 22.68 23 
A08 23.70 23.86 23.7 24.2 23.88 24.19 
A09 26.42 25.71 26.42 27.72 26.75 27.35 
A10 28.85 29.91 28.85 28.73 28.35 29.31 
A11 32.62 33.40 32.62 33.23 32.69 32.32 
A12 28.11 29.94 28.11 27.75 27.26 27.74 
B01 31.13 31.63 31.13 32.32 31.69 31.96 





B03 22.56 23.81 22.56 22.71 22.6 22.88 
B04 30.76 32.03 30.76 33.12 31.3 30.79 
B05 25.14 26.84 25.14 24.76 24.1 24.62 
B06 26.08 27.40 26.08 26.97 26.58 26.81 
B07 22.19 22.22 22.19 22.25 21.71 21.92 
B08 29.69 28.88 29.69 30.34 29.67 29.94 
B09 24.64 25.13 24.64 25.81 25.32 25.59 
B10 37.43 35 35 35 35 35 
B11 30.88 31.16 30.88 33.65 30.97 28.53 
B12 33.63 38.19 33.63 34.61 35 35 
C01 25.07 26.36 25.07 24.96 24.19 24.79 
C02 24.63 24.73 24.63 24.67 24.66 24.82 
C03 23.39 23.83 23.39 23.41 23.63 23.67 
C04 20.70 25.60 20.7 23.57 25.26 24.01 
C05 23.26 23.54 23.26 23.86 23.35 23.47 
C06 26.63 26.44 26.63 26.75 26.71 26.85 
C07 21.95 22.40 21.95 23.1 22.91 22.86 
C08 31.58 34.42 31.58 33.14 35 32.66 
C09 25.87 25.85 25.87 25.76 25.75 25.68 
C10 25.70 23.48 25.7 25.64 25.23 25.5 
C11 22.90 22.66 22.9 23.37 23.43 23.56 
C12 26.04 26.50 26.04 26.51 26.25 26.09 
D01 23.82 30.79 23.82 27.05 27.96 26.67 
D02 24.62 23.68 24.62 25.01 24.64 24.89 
D03 23.56 27.16 23.56 23.99 24.89 24.66 
D04 23.56 22.58 23.56 23.33 23.49 23.52 
D05 23.68 25.20 23.68 22.05 22.4 22.69 
D06 33.42 37.60 33.42 33.61 34.81 33.25 
D07 22.36 22.60 22.36 22.39 22.3 22.54 
D08 26.44 26.37 26.44 26.22 25.76 26.04 
D09 25.97 27.22 25.97 26.09 26.29 26.2 
D10 21.69 23.16 21.69 21.34 21.14 21.52 
D11 22.45 23.77 22.45 22.74 21.97 22.59 
D12 26.86 27.54 26.86 27.57 26.88 27.06 
E01 32.35 35 32.35 33.95 35 35 
E02 24.76 25.02 24.76 24.35 24.42 24.52 
E03 23.65 24.88 23.65 24.26 23.85 24.1 
E04 23.73 26.16 23.73 25.01 24.63 24.66 
E05 25.76 27.47 25.76 25.72 25.15 25.63 
E06 29.51 33.17 29.51 30.76 30.65 29.97 
E07 28.59 30.63 28.59 28.56 26.59 27.45 
E08 23.89 24.41 23.89 24.96 25.1 24.77 
E09 25.22 25.83 25.22 25.01 24.88 25.05 





E11 24.89 25.61 24.89 24.78 24.68 24.86 
E12 24.18 25.27 24.18 23.42 23.68 23.81 
F01 26.61 31.50 26.61 26.23 26 26.12 
F02 35 35 35 35 32.15 32.6 
F03 25.57 25.62 25.57 25.91 25.55 25.87 
F04 24.60 25.07 24.6 25.11 24.87 25.24 
F05 23.66 23.97 23.66 23.89 23.36 23.71 
F06 22.26 24.59 22.26 22.59 21.98 22.34 
F07 24.22 25.21 24.22 24.47 23.98 24.46 
F08 23.28 23.92 23.28 23.7 23.03 23.44 
F09 33.57 34.97 33.57 35 34.04 33.83 
F10 25.79 29.26 25.79 25.23 27.15 25.91 
F11 19.50 20.76 19.5 20.01 19.63 19.77 
F12 18.26 20.96 18.26 17.1 17.87 17.73 
G01 18.06 18.58 18.06 17.57 16.84 17.48 
G02 26.85 27.92 26.85 27.48 27.12 27.76 
G03 29.04 31.93 29.04 30.17 29.6 29.29 
G04 35.24 37.80 35 34.45 35 34.49 
G05 25.37 25.10 25.37 25.46 24.71 25.21 
G06 25.49 27.77 25.49 26.15 25.96 26.07 
G07 29.56 30.58 29.56 29.71 29.6 30.04 
G08 27.76 29.66 27.76 31.39 32 31.29 
G09 24.18 24.55 24.18 23.9 23.95 24.02 
G10 20.84 20.25 20.84 21.67 21.04 21.18 
G11 25.32 24.82 25.32 24.94 25.48 25.57 
G12 26.85 26.39 26.85 26.96 26.83 26.95 
H01 16.95 18.40 16.95 17.02 16.6 16.94 
H02 19.37 20.37 19.37 19.31 19.65 19.59 
H03 18.58 20.98 18.58 18.43 18.12 18.13 
H04 25.78 25.97 25.78 25.37 24.8 25.31 
H05 18.69 18.93 18.69 18.25 18.08 18.25 
H06 35 35 35 35 35 35 
H07 23.27 23.59 23.27 23.82 23.11 23.34 
H08 23.39 23.48 23.39 23.78 23.08 23.38 
H09 23.34 23.47 23.34 23.76 23.04 23.19 
H10 18.38 18.47 18.38 18.22 18.45 18.41 
H11 18.49 18.56 18.49 18.57 18.46 18.57 





8.5.2 Experiment 2 – Triplicate arrays  
















































A01 26.96 24 25.07 25.07 25.29 25.42 25.75 25.18 25.55 25.03 25.4 25.63 25.57 25.72 26.99 26.03 26.01 25.65 26.67 25.37 25.12 25.18 25.39 
A02 30.61 33.43 29.12 29.18 29.64 29.14 29.5 28.97 29.58 29.63 29.27 29.87 30.02 30.14 31.87 30.08 30.15 30.14 30.7 30.05 29.23 29.34 29.59 
A03 27.04 28.36 25.88 25.85 26.12 25.78 26.13 25.59 26.21 25.46 25.84 26.15 25.86 26.16 28.38 26.3 26.18 26.19 26.85 26.33 25.89 26.14 26.27 
A04 24.01 26.55 23.68 23.65 23.9 23.49 23.73 23.61 23.75 23.23 23.72 23.89 24 24.06 25.51 24.52 24.13 24.11 25.09 23.83 23.72 23.77 24.27 
A05 23.27 24.26 23.18 23.06 23.07 22.86 23.18 23.11 23.41 22.83 23.21 23.34 23.58 23.22 24.88 23.57 23.63 23.63 24.37 23.04 22.79 22.86 23.11 
A06 19.88 21.15 20.02 19.95 19.74 19.71 20.05 19.74 20.25 19.66 20.31 20.23 20.35 20.13 21.8 20.29 20.43 20.54 21.12 20.06 19.79 19.85 20.17 
A07 23.4 23.59 22.59 22.6 22.8 22.57 23.08 22.57 22.92 22.12 22.8 22.84 22.82 22.84 24.38 23.14 22.92 22.97 24.03 23.3 22.59 22.67 23.31 
A08 24.64 23.6 23.79 23.53 23.82 23.67 24.02 23.67 23.9 23.48 23.9 24.08 24.02 24.05 25.59 24.41 24.33 24.24 24.99 24.26 23.87 24.04 24.56 
A09 28.78 26.59 27.65 27.63 27.71 27.77 28.09 27.87 28.12 27.7 27.91 27.83 27.82 27.96 29.12 28.62 28.29 28.52 28.92 27.88 27.5 27.81 27.98 
A10 29.64 29.88 27.76 27.66 28.95 28.36 28.97 28.36 28.35 27.64 28.22 28.2 28.05 28.37 31.08 29.59 28.2 28.19 29.75 29.95 28.68 28.3 30.06 
A11 31.7 30.6 30.57 30.69 30.95 31.33 32.59 31.1 30.39 30.67 30.63 30.79 31.31 31.34 32.82 31.81 30.71 31.22 31.85 30.88 31.23 30.86 31.16 
A12 27.77 29.09 27.75 27.85 27.23 27.33 27.8 27.57 27.69 27.35 27.93 27.98 27.83 27.71 28.89 28.26 28.29 28.12 28.98 27.26 27.15 27.52 28.13 
B01 30.85 30.92 30.41 30.21 30.61 30.8 31.38 31.04 30.23 30.25 30.32 30.46 29.85 30.34 33.51 30.84 30.4 30.73 31.6 30.83 30.25 30.43 31.07 
B02 26.35 25.88 25.96 25.86 26.01 25.9 26.27 25.77 26.31 25.76 26.16 26.21 26.28 26.15 27.63 26.49 26.42 26.5 27.62 26.66 26.72 26.79 26.97 
B03 22.54 23 22.86 22.74 22.9 22.85 23.41 22.84 23.38 22.49 23.14 23.24 23.1 23.4 24.67 23.74 23.3 23.4 24.22 23.33 23.16 23.2 23.74 
B04 31.97 32.56 30.6 30.19 31.44 31.48 32.02 31.5 31.27 30.92 31.08 31.01 32.4 31.2 32.04 33.28 31.77 31.82 32.64 31.88 32.21 31.21 34.45 
B05 25.35 26.54 25.66 25.79 25.79 25.05 25.73 25.29 25.69 24.76 25.77 25.67 25.59 25.65 28.21 25.96 25.42 25.86 26.76 26.19 25.46 25.18 26.26 
B06 26.75 26.58 25.41 25.11 25.57 25.56 25.78 25.19 25.61 25.1 25.47 25.71 25.63 25.85 27.74 25.84 25.9 25.72 26.4 26.12 25.68 25.89 25.92 
B07 22.15 21.74 21.73 21.62 21.74 21.74 22.11 21.5 22.01 21.35 21.87 21.87 21.85 21.95 23.35 22.14 22.22 22.07 22.83 22.17 21.77 21.89 22.22 
B08 31.6 30.12 31.96 32.58 32.3 32.64 31.81 32.56 32.99 32.67 33.46 32.36 33.19 32.07 32.68 32.5 33.23 32.91 33.55 31.46 31.46 31.53 32.12 
B09 26.23 24.81 24.78 24.53 24.87 24.88 25.49 24.91 25.01 24.49 24.85 25.02 24.88 24.92 26.68 25.51 25.46 25.11 25.94 25 24.62 24.72 24.82 
B10 35 35.94 35 35 35 38.33 35 35 35 35 35 37.73 35 35 35 35 35 36.78 35 35 38.15 35 35 





B12 33.93 35.29 32.61 31.76 32.15 31.76 32.41 33.31 32.21 30.79 32.28 32.81 32.02 32.78 36.19 34.53 32.47 32.25 33.08 31.16 31.97 31.58 34.43 
C01 24.28 25.39 23.83 23.63 24.01 23.88 24.31 23.64 24.14 23.43 23.86 24.13 24.08 24.03 24.71 24.08 24.11 24.23 24.91 24.27 23.81 24.01 24.22 
C02 24.79 24.7 24.28 24.25 24.26 24.2 24.91 24.19 24.7 23.95 24.69 24.73 24.55 24.76 25.87 24.64 24.75 24.79 25.79 24.39 24.44 24.52 24.77 
C03 23.74 23.85 23.42 23.36 23.49 23.47 23.93 23.38 23.64 23.13 23.55 23.72 23.8 23.82 25.32 24.16 23.88 23.89 24.67 23.69 23.57 23.59 23.85 
C04 22.59 28.69 20.14 19.77 20.54 21.56 22.06 21.24 20.79 20.18 20.4 20.64 20.41 20.78 22.82 21.11 21.12 20.64 21.04 20.69 20.07 20.32 20.22 
C05 22.81 24.25 22.67 22.62 22.5 22.57 22.78 22.35 22.91 22.25 22.77 22.81 22.77 22.83 24.63 22.89 22.93 23.07 23.74 22.84 22.63 22.74 22.87 
C06 26.43 26.6 26.62 26.84 26.7 26.63 26.97 26.59 26.98 26.16 26.89 26.9 26.77 26.76 27.88 27.02 26.81 27.22 27.83 26.75 26.69 26.66 27.03 
C07 22.28 22.88 21.19 21.37 21.46 21.53 21.62 21.63 21.71 21.61 21.73 21.66 22.08 21.87 23.07 22.14 22.17 22.31 22.86 20.7 20.58 20.63 20.93 
C08 33.52 35 32.85 33.68 33.41 33.33 32.55 33.72 32.8 32.13 32.46 33.39 32.58 33.26 35 34.22 33.2 35.08 33.49 34.04 33.51 33.18 35.2 
C09 26.1 25.88 25.67 25.78 25.68 25.6 25.83 25.54 25.95 25.35 25.84 25.84 25.88 25.73 27.45 26.01 26.07 26.16 26.84 25.78 25.73 25.72 26.06 
C10 25.68 24.03 25.02 25.24 25.58 25.02 25.55 24.98 25.6 24.57 25.34 25.15 24.99 25.23 26.49 25.83 25.4 25.54 26.26 25.74 25.01 25 25.65 
C11 24.73 23.39 24.63 24.03 26.06 24.36 24.84 24.63 24.82 23.39 24.89 24.83 24.6 25.24 27.43 26.56 24.72 24.94 26.03 24.25 25.61 24.34 27.35 
C12 26.91 26.42 26.62 26.3 26.89 26.23 26.49 26.41 27.14 25.85 27.3 26.69 26.76 26.74 28.04 27.91 27.15 27.57 27.68 26.35 26.75 26.89 27.71 
D01 26.53 30.92 24.45 24.04 24.68 25.41 25.91 25.54 25.01 24.66 24.64 24.97 24.86 25.03 26.85 25.65 25.68 25.28 25.71 24.9 24.63 24.71 24.75 
D02 25.62 24.98 25.47 25.72 25.17 24.91 25.63 25.1 25.55 24.85 25.8 25.49 25.63 25.35 27.7 25.48 25.43 25.67 26.6 25.29 25.15 25.31 25.8 
D03 24.99 28.51 25.55 25.3 25.06 24.92 25.56 25.16 25.67 24.58 25.7 25.58 25.16 25.14 28.77 25.24 25.11 25.25 26.19 25.27 24.89 24.9 25.31 
D04 23.89 22.53 23.04 23.12 23.08 23.17 23.57 23.08 23.49 23.03 23.5 23.44 23.5 23.6 24.71 23.55 23.75 23.76 24.61 22.89 22.85 22.95 23.23 
D05 22.79 23.95 23.71 23.67 23.43 23.09 23.4 23.1 23.75 23.1 23.78 23.73 23.81 23.72 25.74 23.89 23.74 23.93 24.72 23.92 23.57 23.59 23.97 
D06 35 34.23 35 36.17 34.65 33.99 34.5 35.07 35.26 36.24 34.13 34.47 35.67 34.16 36.38 35.41 34.92 35.63 35.61 34.71 34.15 33.26 33.14 
D07 22.36 21.87 22.52 22.53 22.62 22.46 22.89 22.52 22.82 22.24 22.83 22.82 22.92 22.92 24.63 23.42 23.04 22.99 24 23.24 22.85 22.8 23.56 
D08 26.79 26.14 26.57 26.75 26.61 26.13 26.34 26.42 26.83 26.2 27.01 26.65 26.91 26.57 27.19 26.84 27.12 26.96 27.61 26.12 25.82 25.87 26.46 
D09 26.34 26.99 25.72 25.45 26.24 25.71 26.3 25.69 25.93 25.22 25.91 25.86 25.87 26.19 27.93 26.43 26.04 26.05 26.8 26.65 25.99 25.89 26.77 
D10 22.14 23.19 21.95 21.78 21.69 21.33 21.78 21.4 22.03 21.23 21.88 21.88 21.91 21.83 23.29 21.84 22.02 22.07 22.79 21.84 21.65 21.69 22.05 
D11 23.25 24.14 22.77 22.94 23.02 22.72 22.99 22.73 23.31 22.6 22.98 22.91 23.16 23.15 24.28 23.42 23.35 23.72 24.55 22.82 22.67 22.67 23.02 
D12 28.21 26.81 26.68 26.75 27.23 26.91 27.41 26.96 27.16 26.62 26.97 27.15 27.23 27.59 28.65 27.75 27.57 27.36 28.09 26.79 27.15 26.97 27.64 
E01 34.04 35 32.44 32.59 32.06 32.47 33.74 32.61 33.34 32.05 33.3 32.95 33.05 32.97 34.81 34.73 32.86 32.77 33.42 32.31 32.58 33.2 33.02 
E02 24.2 24.45 24.13 23.8 23.92 23.86 24.22 23.74 24.23 23.66 24.13 24.22 24.24 24.31 26.26 24.28 24.4 24.39 25.36 24.33 24.09 24.18 24.46 
E03 23.33 24.35 23.77 23.71 23.61 23.81 24.07 24.17 24.43 23.83 24.31 24.18 24.32 23.97 25.93 24.23 24.51 24.58 25.19 23.04 23.17 23.22 23.47 





E05 25.88 26.75 25.82 25.83 25.8 25.67 26.06 25.83 26.03 25.62 26.08 26.03 26.18 26.04 27.15 26.37 26.39 26.44 27.04 25.64 25.27 25.46 25.75 
E06 32.91 33.78 30.22 29.52 30.29 30.47 31.04 30.28 30.56 30.04 30.26 30.3 30.02 30.76 32.13 30.78 30.66 30.49 31.23 30.37 30.58 30.02 30.7 
E07 29.27 30.05 29.29 29.3 29.68 28.86 29.16 28.75 29.5 28.83 29.44 29.59 29.47 29.65 29.36 29.92 29.8 29.9 31.06 29.96 29.26 29.71 29.95 
E08 25.99 24.72 24.06 24.36 24.01 23.86 24.22 24.29 24.42 23.58 24.35 24.33 24.34 23.66 26.41 24.16 24.38 24.26 24.89 23.42 22.85 23.08 23.57 
E09 25.49 25.42 24.64 24.57 24.85 24.42 24.72 24.21 24.86 23.87 24.59 24.73 24.42 24.78 26.34 25.09 24.78 24.89 25.39 25.2 24.76 24.71 25.36 
E10 28.33 30.09 27.78 27.4 28.17 27.66 27.82 27.53 28.02 27.29 27.75 28 28.15 28.51 28.12 28.83 28.17 28.21 28.74 29.06 28.4 28.37 28.82 
E11 25.36 25.37 25.08 24.93 25.26 24.91 25.44 24.75 25.46 24.41 25.1 25.35 25.24 25.39 26.83 25.67 25.23 25.18 26.06 26.13 25.29 25.25 26.34 
E12 22.48 23.91 23.78 23.75 23.72 23.32 23.83 23.57 24.06 23.14 24.03 24.35 24.03 24.16 26.19 24.21 23.97 24.35 25.03 23.72 24.23 23.95 24.98 
F01 26.49 31.81 29.47 28.95 28.15 27.49 27.03 27.57 29.25 27.98 29 29.87 29.12 28.78 31.94 29.65 28.72 29.29 29.97 29.04 29.17 28.96 29.59 
F02 36.01 36.89 35 35 36.57 33.57 34.54 33.87 34.88 36.42 35.17 37.29 35.41 35.6 36.06 35 35.75 35.16 38.2 35.13 36.92 33.91 37.42 
F03 26.14 24.62 25 24.79 25.33 25.05 25.61 24.85 25.05 24.7 25.17 25.41 25.35 25.47 26.85 25.75 25.4 25.41 26.2 25.54 25.17 25.2 25.73 
F04 25.47 24.82 24.79 24.6 25.09 25 25.23 24.87 25.13 24.66 24.88 25.12 25.07 25.23 26.87 25.42 25.47 25.32 25.95 25.34 24.8 24.84 25.17 
F05 24.24 23.89 23.5 23.36 23.39 23.36 23.77 23.48 23.71 23.04 23.62 23.62 23.64 23.69 24.81 23.78 24 23.85 24.71 23.61 23.28 23.41 23.59 
F06 22.71 24.06 22.91 23.07 22.85 22.69 23.26 22.82 23.31 22.62 23.2 23.22 23.28 23.25 24.74 23.65 23.44 23.61 24.31 23.45 23.14 23.03 23.61 
F07 25.08 25.45 24.87 24.82 25.01 25.14 25.37 24.91 25.41 24.85 25.16 25.32 25.34 25.37 26.35 25.66 25.7 25.73 26.54 25.44 25.29 25.49 25.58 
F08 23.8 23.58 23.59 23.59 23.71 23.61 23.87 23.43 23.88 23.46 23.79 23.87 23.88 24.08 25.05 24.25 24.24 24.2 24.87 24.32 24.12 24.16 24.51 
F09 34.83 33.67 33.31 33 35.54 34.32 36.32 34.47 35.75 33.66 33.91 36.11 34.17 35.28 35 35.65 34.64 34.14 34.73 35.83 32.25 32.4 33.84 
F10 23.99 26.3 22.78 22.77 22.77 21.69 22.34 21.49 22.37 21.54 22.77 22.66 22.31 22.58 26.29 22.58 22.09 22.35 23.43 23.12 22.71 22.37 23.39 
F11 19.7 21.26 20.17 20.28 19.8 20.03 20.33 20.19 20.61 19.78 20.38 20.38 20.36 20.34 23.4 20.71 20.57 20.75 21.18 20.64 20.46 20.34 20.84 
F12 18.2 20.65 18.89 19.06 18.69 18.35 18.88 18.56 19.03 18.18 19.27 18.74 18.91 18.84 21.58 18.97 18.72 19.07 19.78 18.64 18.79 18.69 19.54 
G01 17.57 18.5 21.33 21.02 20.02 19.93 20.34 20.33 21.24 20.22 21.22 21.41 21.08 20.87 21.01 21.29 21.14 21.54 22.32 20.85 20.91 20.78 21.15 
G02 27.88 27.59 27.71 27.91 28.31 28.01 28.74 28.01 28.15 28.18 28.52 28.46 28.84 28.65 29.75 29.33 28.66 28.71 29.76 28.49 28.57 28.44 28.67 
G03 30.5 32.54 29.65 29.34 29.75 29.55 29.79 29.08 29.66 28.98 29.62 29.99 29.79 29.65 31.39 30.04 29.89 29.83 30.5 29.97 29.7 29.61 30.11 
G04 35 35 35 35 34.71 35 35.92 35 35 35 35 37.46 35 38.44 35 35 35 35 35 37.97 35 35 35 
G05 25.76 24.73 25.51 25.29 25.4 25.36 25.69 25.17 25.82 25.09 25.76 25.68 25.76 25.75 26.82 25.98 26 26.03 26.83 25.96 25.88 25.94 26.2 
G06 26.48 28.55 25.64 25.76 25.91 25.68 25.81 25.97 26.19 25.71 26.07 26.21 26.29 25.93 27.91 26.38 26.71 26.56 27.05 25 24.92 24.97 25.21 
G07 29.64 30.41 29.32 29.61 29.04 35 29.65 28.98 29.03 28.9 29.24 29.8 29.69 29.32 30.85 29.61 29.89 29.48 30.58 29.09 28.49 28.68 29.16 
G08 34.41 37.06 30.64 30.51 32.04 32.83 33.51 32.72 31.68 31.41 31.09 31.42 31.15 31.62 33.49 32.91 33.09 31.57 31.99 32.12 30.83 31.02 30.87 





G10 22.58 20.66 21.91 22.02 22 21.96 21.97 21.93 22.44 21.86 22.43 22.38 22.56 22.26 23.06 22.86 22.85 22.86 23.41 22.36 22.23 22.17 22.63 
G11 25.55 24.74 24.86 24.83 24.99 25.01 25.5 24.99 25.38 24.64 25.17 25.4 25.23 25.4 27.26 25.5 25.52 25.56 26.06 25.55 25.07 24.94 25.67 
G12 27.43 26.06 26.89 27.12 27.26 26.75 27.09 26.91 27.22 26.61 27.33 26.84 27.34 27.2 27.97 27.44 27.37 27.41 28.46 26.71 26.87 26.79 27.36 
H01 17.29 18.44 17.62 17.62 17.52 17.08 17.6 17.33 17.75 16.83 17.7 17.68 17.45 17.58 19.19 18.03 17.78 17.79 18.62 17.74 17.49 17.49 17.96 
H02 19.14 19.31 18.87 18.69 19.21 18.8 19.4 18.67 19.17 18.43 19.11 19.12 18.94 19.17 21.3 19.34 19.2 19.03 20.07 19.17 19.01 19.14 19.35 
H03 18.8 21.02 19.79 19.82 19.11 18.96 19.42 19.31 19.81 18.92 19.93 19.76 19.62 19.45 21.66 19.63 19.65 19.83 20.4 19.17 19.13 19.06 19.58 
H04 25.53 25.39 25.45 25.28 25.26 25.36 25.8 25.4 25.72 25.17 25.6 25.68 25.74 25.75 26.78 25.8 25.92 25.88 26.67 25.75 25.61 25.68 25.91 
H05 18.61 18.16 18.24 18.07 18.22 18.03 18.48 17.78 18.3 17.61 18.27 18.3 18.19 18.44 20.04 18.53 18.25 18.35 19.02 18.85 18.15 18.23 18.69 
H06 35 37.94 37.61 35 35 35 35 35 34.25 35 35.91 34.84 35.81 35 35 36.08 35 35 35 35.98 35 34.72 35 
H07 22.93 22.95 23.11 23.43 23.43 22.88 23.22 23.15 23.04 22.84 23.19 23.35 23.21 23.06 23.55 23.8 23.34 23.21 23.79 22.89 22.58 22.45 23.1 
H08 23.07 22.99 23.26 23.44 23.34 22.96 23.2 23.13 23.02 22.85 23.09 23.28 23.27 23.1 23.48 23.81 23.16 23.18 23.87 23.07 22.6 22.57 23.02 
H09 23.15 23.08 23.49 23.6 23.6 23.17 23.58 23.21 23.25 22.98 23.28 23.38 23.38 23.32 23.62 23.96 23.2 23.33 23.82 23.32 22.73 22.55 23.28 
H10 19.71 19.55 19.77 19.66 20.35 19.61 19.89 19.95 19.93 19.51 19.91 19.87 19.95 19.93 20.15 20.61 19.68 19.73 19.96 20.96 20.08 19.57 20.68 
H11 19.39 19.58 19.74 19.56 20.12 19.64 19.91 19.88 19.82 19.43 19.81 19.88 19.89 19.93 20 20.55 19.71 19.86 19.87 20.93 19.86 19.54 20.65 
H12 19.46 19.6 19.79 19.49 20.33 19.62 19.87 19.9 19.8 19.57 19.74 19.65 19.88 19.92 20.21 20.47 19.72 19.95 19.96 22.26 20.12 19.59 20.58 
 
 
 
 
 
 
